{"id": "20201030_10-K_320193_part2_item7_para1", "text": "the following discussion should be read in conjunction with the consolidated financial statements and accompanying notes included in part ii, item 8 of this form 10-k. this section of this form 10-k generally discusses 2020 and 2019 items and year-to-year comparisons between 2020 and 2019. discussions of 2018 items and year-to-year comparisons between 2019 and 2018 that are not included in this form 10-k can be found in \"management's discussion and analysis of financial condition and results of operations\" in part ii, item 7 of the company's annual report on form 10-k for the fiscal year ended september 28, 2019.", "highlight": "consolidated financial statements and accompanying notes included in part ii, item 8 of this form 10-k. ||| management's discussion and analysis of financial condition and results of operations\" in part ii, item 7", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para2", "text": "Fiscal year highlights Covid-19 update covid-19 has spread rapidly throughout the world, prompting governments and businesses to take unprecedented measures in response. such measures have included restrictions on travel and business operations, temporary closures of businesses, and quarantines and shelter-in-place orders. the covid-19 pandemic has significantly curtailed global economic activity and caused significant volatility and disruption in global financial markets. the covid-19 pandemic and the measures taken by many countries in response have adversely affected and could in the future materially adversely impact the company's business, results of operations, financial condition and stock price.", "highlight": "have adversely affected and could in the future materially adversely impact the company's business, results of operations, financial condition and stock price.\r\n ||| covid-19", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para3", "text": "during 2020, aspects of the company's business were adversely affected by the covid-19 pandemic, with many of the company's retail stores, as well as channel partner points of sale, temporarily closed at various times, and the vast majority of the company's employees working remotely. the company has reopened some of its offices and the majority of its retail stores, subject to operating restrictions to protect public health and the health and safety of employees and customers, and it continues to work on safely re-opening the remainder of its offices and retail stores, subject to local rules and regulations.", "highlight": "the company has reopened some of its offices and the majority of its retail stores, subject to operating restrictions to protect public health and the health and safety of employees and customers", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para4", "text": "the full extent of the future impact of the covid-19 pandemic on the company's operational and financial performance is currently uncertain and will depend on many factors outside the company's control, including, without limitation, the timing, extent, trajectory and duration of the pandemic, the development and availability of effective treatments and vaccines, the imposition of protective public safety measures, and the impact of the pandemic on the global economy and demand for consumer products. refer to part i, item 1a of this form 10-k under the heading \"risk factors,\" for more information.", "highlight": "the full extent of the future impact of the covid-19 pandemic on the company's operational and financial performance is currently uncertain and will depend on many factors outside the company's control", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para5", "text": "the company believes its existing balances of cash, cash equivalents and marketable securities, along with commercial paper and other short-term liquidity arrangements, will be sufficient to satisfy its working capital needs, capital asset purchases, dividends, share repurchases, debt repayments and other liquidity requirements associated with its existing operations.", "highlight": "its existing balances of cash, cash equivalents and marketable securities, along with commercial paper and other short-term liquidity arrangements, will be sufficient to satisfy its working capital needs", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para6", "text": "Fiscal 2020 highlights total net sales increased 6% or $14.3 billion during 2020 compared to 2019, primarily driven by higher net sales of services and wearables, home and accessories. the weakness in foreign currencies had an unfavorable impact on net sales during 2020.", "highlight": "driven by higher net sales of services and wearables, home and accessories. the weakness in foreign currencies had an unfavorable impact on net sales", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para7", "text": "in april 2020, the company announced an increase to its current share repurchase program authorization from $175 billion to $225 billion and raised its quarterly dividend from $0.1925 to $0.205 per share beginning in may 2020. during 2020, the company repurchased $72.5 billion of its common stock and paid dividends and dividend equivalents of $14.1 billion.", "highlight": "announced an increase to its current share repurchase program authorization from $175 billion to $225 billion and raised its quarterly dividend from $0.1925 to $0.205 per share ||| repurchased $72.5 billion of its common stock |||  paid dividends and dividend equivalents of $14.1 billion.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para8", "text": "on august 28, 2020, the company effected a four-for-one stock split to shareholders of record as of august 24, 2020. all share, rsu and per share or per rsu information has been retroactively adjusted to reflect the stock split.", "highlight": "effected a four-for-one stock split to shareholders ||| rsu and per share or per rsu information has been retroactively adjusted", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para9", "text": "Products and services performance The following table shows net sales by category for 2020, 2019 and 2018 (dollars in millions): 2020 Change 2019 Change 2018 Net sales by category: Iphone (1) $ 137,781 -3 % $ 142,381 -14 % $ 164,888 Mac (1) 28,622 11 % 25,740 2 % 25,198 Ipad (1) 23,724 11 % 21,280 16 % 18,380 Wearables, home and accessories (1)(2) 30,620 25 % 24,482 41 % 17,381 Services (3) 53,768 16 % 46,291 16 % 39,748 Total net sales $ 274,515 6 % $ 260,174 -2 % $ 265,595 -1) products net sales include amortization of the deferred value of unspecified software upgrade rights, which are bundled in the sales price of the respective product.", "highlight": "2020 Change 2019 Change 2018 Net sales by category: Iphone (1) $ 137,781 -3 % $ 142,381 -14 % $ 164,888 Mac (1) 28,622 11 % 25,740 2 % 25,198 Ipad (1) 23,724 11 % 21,280 16 % 18,380 Wearables, home and accessories (1)(2) 30,620 25 % 24,482 41 % 17,381 Services (3) 53,768 16 % 46,291 16 % 39,748 Total net sales $ 274,515 6 % $ 260,174 -2 % $ 265,595 -1)", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para10", "text": "-2) wearables, home and accessories net sales include sales of airpods, apple tv, apple watch, beats products, homepod, ipod touch and apple-branded and third-party accessories.", "highlight": "include sales of airpods, apple tv, apple watch, beats products, homepod, ipod touch and apple-branded and third-party accessories.", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para11", "text": "-3) services net sales include sales from the company's advertising, applecare, digital content and other services. services net sales also include amortization of the deferred value of maps, siri, and free icloud storage and apple tv+ services, which are bundled in the sales price of certain products.", "highlight": "services net sales include sales from the company's advertising, applecare, digital content and other services ||| which are bundled in the sales price of certain products", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para12", "text": "Iphone iphone net sales decreased during 2020 compared to 2019 due primarily to the absence of new iphone models in the fourth quarter of 2020 and the weakness in foreign currencies relative to the u.s. dollar, partially offset by the introduction of iphone se in the third quarter of 2020.", "highlight": "due primarily to the absence of new iphone models ||| and the weakness in foreign currencies relative to the u.s. dollar, partially offset by the introduction of iphone se in the third quarter of 2020", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para13", "text": "Mac mac net sales increased during 2020 compared to 2019 due primarily to higher net sales of macbook pro.", "highlight": "due primarily to higher net sales of macbook pro", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para14", "text": "Ipad ipad net sales increased during 2020 compared to 2019 due primarily to higher net sales of 10-inch versions of ipad, ipad air and ipad pro.", "highlight": "due primarily to higher net sales of 10-inch versions of ipad, ipad air and ipad pro", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para15", "text": "Wearables, home and accessories wearables, home and accessories net sales increased during 2020 compared to 2019 due primarily to higher net sales of airpods and apple watch.", "highlight": "due primarily to higher net sales of airpods and apple watch.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para16", "text": "Services services net sales increased during 2020 compared to 2019 due primarily to higher net sales from the app store, advertising and cloud services.", "highlight": "due primarily to higher net sales from the app store, advertising and cloud services.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para17", "text": "Segment operating performance The company manages its business primarily on a geographic basis. the company's reportable segments consist of the americas, europe, greater china, japan and rest of asia pacific. americas includes both north and south america. europe includes european countries, as well as india, the middle east and africa. greater china includes china mainland, hong kong and taiwan. rest of asia pacific includes australia and those asian countries not included in the company's other reportable segments. although the reportable segments provide similar hardware and software products and similar services, each one is managed separately to better align with the location of the company's customers and distribution partners and the unique market dynamics of each geographic region. further information regarding the company's reportable segments can be found in part ii, item 8 of this form 10-k in the notes to consolidated financial statements in note 11, \"segment information and geographic data.\" The following table shows net sales by reportable segment for 2020, 2019 and 2018 (dollars in millions): 2020 Change 2019 Change 2018 Net sales by reportable segment: Americas $ 124,556 7 % $ 116,914 4 % $ 112,093 Europe 68,640 14 % 60,288 -3 % 62,420 Greater china 40,308 -8 % 43,678 -16 % 51,942 Japan 21,418 % 21,506 -1 % 21,733 Rest of asia pacific 19,593 10 % 17,788 2 % 17,407 Total net sales $ 274,515 6 % $ 260,174 -2 % $ 265,595 Americas americas net sales increased during 2020 compared to 2019 due primarily to higher net sales of services and wearables, home and accessories. the weakness in foreign currencies relative to the u.s. dollar had an unfavorable impact on americas net sales during 2020.", "highlight": "The company manages its business primarily on a geographic basis ||| for 2020, 2019 and 2018 (dollars in millions): 2020 Change 2019 Change 2018 Net sales by reportable segment: Americas $ 124,556 7 % $ 116,914 4 % $ 112,093 Europe 68,640 14 % 60,288 -3 % 62,420 Greater china 40,308 -8 % 43,678 -16 % 51,942 Japan 21,418 % 21,506 -1 % 21,733 Rest of asia pacific 19,593 10 % 17,788 2 % 17,407 Total net sales $ 274,515 6 % $ 260,174 -2 % $ 265,595", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para18", "text": "Europe europe net sales increased during 2020 compared to 2019 due primarily to higher net sales of iphone, wearables, home and accessories and services. the weakness in foreign currencies relative to the u.s. dollar had an unfavorable impact on europe net sales during 2020.", "highlight": "due primarily to higher net sales of iphone, wearables, home and accessories and services. the weakness in foreign currencies relative to the u.s. dollar had an unfavorable impact", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para19", "text": "Greater china greater china net sales decreased during 2020 compared to 2019 due primarily to lower net sales of iphone, partially offset by higher net sales of services and ipad. the weakness in foreign currencies relative to the u.s. dollar had an unfavorable impact on greater china net sales during 2020.", "highlight": "due primarily to lower net sales of iphone, partially offset by higher net sales of services and ipad", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para20", "text": "Japan japan net sales were flat during 2020 compared to 2019 due primarily to lower net sales of iphone, offset by higher net sales of services and wearables, home and accessories. the strength of the japanese yen relative to the u.s. dollar had a favorable impact on japan net sales during 2020.", "highlight": "due primarily to lower net sales of iphone, offset by higher net sales of services and wearables, home and accessories. the strength of the japanese yen relative to the u.s. dollar had a favorable impact on japan", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para21", "text": "Rest of asia pacific rest of asia pacific net sales increased during 2020 compared to 2019 due primarily to higher net sales of wearables, home and accessories, services and iphone. the weakness in foreign currencies relative to the u.s. dollar had an unfavorable impact on rest of asia pacific net sales during 2020.", "highlight": "due primarily to higher net sales of wearables, home and accessories, services and iphone. the weakness in foreign currencies relative to the u.s. dollar had an unfavorable impact", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para22", "text": "Gross margin Products and services gross margin and gross margin percentage for 2020, 2019 and 2018 were as follows (dollars in millions): 2020 2019 2018 Gross margin: Products $ 69,461 $ 68,887 $ 77,683 Services 35,495 29,505 24,156 Total gross margin $ 104,956 $ 98,392 $ 101,839 Gross margin percentage: Products 31.5 % 32.2 % 34.4 % Services 66.0 % 63.7 % 60.8 % Total gross margin percentage 38.2 % 37.8 % 38.3 % Products gross margin products gross margin increased during 2020 compared to 2019 due primarily to higher products volume and material cost savings, partially offset by the weakness in foreign currencies relative to the u.s. dollar and a different products mix. products gross margin percentage decreased during 2020 compared to 2019 due primarily to the weakness in foreign currencies relative to the u.s. dollar and a different products mix, partially offset by material cost savings and higher leverage.", "highlight": "2020, 2019 and 2018 were as follows (dollars in millions): 2020 2019 2018 Gross margin: Products $ 69,461 $ 68,887 $ 77,683 Services 35,495 29,505 24,156 Total gross margin $ 104,956 $ 98,392 $ 101,839 Gross margin percentage: Products 31.5 % 32.2 % 34.4 % Services 66.0 % 63.7 % 60.8 % Total gross margin percentage 38.2 % 37.8 % 38.3 %  ||| Products gross margin products gross margin increased ||| different products mix. products gross margin percentage decreased", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para23", "text": "Services gross margin services gross margin increased during 2020 compared to 2019 due primarily to higher services net sales and a different services mix. services gross margin percentage increased during 2020 compared to 2019 due primarily to a different services mix and higher leverage, partially offset by higher services costs.", "highlight": "due primarily to higher services net sales and a different services ||| due primarily to a different services mix and higher leverage, partially offset by higher services costs.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para24", "text": "the company's future gross margins can be impacted by a variety of factors, as set forth in part i, item 1a of this form 10-k under the heading \"risk factors.\" as a result, the company believes, in general, gross margins will be subject to volatility and remain under downward pressure.", "highlight": "the company believes, in general, gross margins will be subject to volatility and remain under downward pressure", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para25", "text": "Operating expenses Operating expenses for 2020, 2019 and 2018 were as follows (dollars in millions): 2020 Change 2019 Change 2018 Research and development $ 18,752 16 % $ 16,217 14 % $ 14,236 Percentage of total net sales 7 % 6 % 5 % Selling, general and administrative $ 19,916 9 % $ 18,245 9 % $ 16,705 Percentage of total net sales 7 % 7 % 6 % Total operating expenses $ 38,668 12 % $ 34,462 11 % $ 30,941 Percentage of total net sales 14 % 13 % 12 % Research and development the year-over-year growth in r&d expense in 2020 was driven primarily by increases in headcount-related expenses. the company continues to believe that focused investments in r&d are critical to its future growth and competitive position in the marketplace, and to the development of new and updated products and services that are central to the company's core business strategy.", "highlight": "\\ ||| the company continues to believe that focused investments in r&d are critical to its future growth and competitive position in the marketplace, and to the development of new and updated products and services that are central to the company's core business strategy.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 1, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para26", "text": "Selling, general and administrative the year-over-year growth in selling, general and administrative expense in 2020 was driven primarily by increases in headcount-related expenses, higher spending on marketing and advertising, and higher variable selling expenses.", "highlight": "was driven primarily by increases in headcount-related expenses, higher spending on marketing and advertising, and higher variable selling expenses.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para27", "text": "Other income/(expense), net Other income/(expense), net (\"oi&e\") for 2020, 2019 and 2018 was as follows (dollars in millions): 2020 Change 2019 Change 2018 Interest and dividend income $ 3,763 $ 4,961 $ 5,686 Interest expense -2,873 -3,576 -3,240 Other income/(expense), net -87 422 -441 Total other income/(expense), net $ 803 -56 % $ 1,807 -10 % $ 2,005 the year-over-year decrease in oi&e during 2020 was due primarily to lower interest income and net impairment/gain activity on non-marketable securities, partially offset by lower interest expense. the weighted-average interest rate earned by the company on its cash, cash equivalents and marketable securities was 1.85% and 2.19% in 2020 and 2019, respectively.", "highlight": "due primarily to lower interest income and net impairment/gain activity on non-marketable securities, partially offset by lower interest expense", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para28", "text": "Provision for income taxes Provision for income taxes, effective tax rate and statutory federal income tax rate for 2020, 2019 and 2018 were as follows (dollars in millions): 2020 2019 2018 Provision for income taxes $ 9,680 $ 10,481 $ 13,372 Effective tax rate 14.4 % 15.9 % 18.3 % Statutory federal income tax rate 21 % 21 % 24.5 % the company's effective tax rate for both 2020 and 2019 was lower than the statutory federal income tax rate due primarily to the lower tax rate on foreign earnings, including the impact of tax settlements, and tax benefits from share-based compensation.", "highlight": "due primarily to the lower tax rate on foreign earnings, including the impact of tax settlements, and tax benefits from share-based compensation.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para29", "text": "the company's effective tax rate for 2020 was lower compared to 2019 due primarily to a one-time adjustment of u.s. foreign tax credits in response to regulations issued by the u.s. department of the treasury in december 2019 in connection with the u.s. tax cuts and jobs act of 2017 (the \"act\") and higher tax benefits from share-based compensation.", "highlight": "due primarily to a one-time adjustment of u.s. foreign tax credits in response to regulations issued by the u.s. department of the treasury ||| with the u.s. tax cuts and jobs act of 2017", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para30", "text": "as of september 26, 2020, the company had net deferred tax assets arising from deductible temporary differences and tax credits of $11.0 billion and deferred tax liabilities of $2.8 billion. management believes it is more likely than not that forecasted income, including income that may be generated as a result of certain tax planning strategies, together with future reversals of existing taxable temporary differences, will be sufficient to recover the net deferred tax assets. the company will continue to evaluate the amount of the valuation allowance, if any, by assessing the realizability of deferred tax assets.", "highlight": "the company had net deferred tax assets arising from deductible temporary differences and tax credits of $11.0 billion and deferred tax liabilities of $2.8 billion ||| the company will continue to evaluate the amount of the valuation allowance, if any, by assessing the realizability of deferred tax assets.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para31", "text": "Recent accounting pronouncements Financial instruments in june 2016, the financial accounting standards board issued accounting standards update no. 2016-13, financial instruments credit losses (topic 326): measurement of credit losses on financial instruments (\"asu 2016-13\"), which modifies the measurement of expected credit losses on certain financial instruments. the company will adopt asu 2016-13 in its first quarter of 2021 utilizing the modified retrospective transition method. based on the composition of the company's investment portfolio, current market conditions, and historical credit loss activity, the adoption of asu 2016-13 will not have a material impact on its consolidated financial statements.", "highlight": "the company will adopt asu 2016-13 in its first quarter of 2021 utilizing the modified retrospective transition method.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para32", "text": "Liquidity and capital resources The following table presents selected financial information and statistics as of and for the years ended september 26, 2020, september 28, 2019 and september 29, 2018 (in millions): 2020 2019 2018 Cash, cash equivalents and marketable securities (1) $ 191,830 $ 205,898 $ 237,100 Property, plant and equipment, net $ 36,766 $ 37,378 $ 41,304 Commercial paper $ 4,996 $ 5,980 $ 11,964 Total term debt $ 107,440 $ 102,067 $ 102,519 Working capital $ 38,321 $ 57,101 $ 15,410 Cash generated by operating activities $ 80,674 $ 69,391 $ 77,434 Cash generated by/(used in) investing activities $ (4,289) $ 45,896 $ 16,066 Cash used in financing activities $ (86,820) $ (90,976) $ (87,876) -1) as of september 26, 2020 and september 28, 2019, total marketable securities included $18.6 billion and $18.9 billion, respectively, that was restricted from general use, related to the state aid decision (refer to note 5, \"income taxes\" in the notes to consolidated financial statements in part ii, item 8 of this form 10-k) and other agreements.", "highlight": "and for the years ended september 26, 2020, september 28, 2019 and september 29, 2018 (in millions): 2020 2019 2018 Cash, cash equivalents and marketable securities (1) $ 191,830 $ 205,898 $ 237,100 Property, plant and equipment, net $ 36,766 $ 37,378 $ 41,304 Commercial paper $ 4,996 $ 5,980 $ 11,964 Total term debt $ 107,440 $ 102,067 $ 102,519 Working capital $ 38,321 $ 57,101 $ 15,410 Cash generated by operating activities $ 80,674 $ 69,391 $ 77,434 Cash generated by/(used in) investing activities $ (4,289) $ 45,896 $ 16,066 Cash used in financing activities $ (86,820) $ (90,976) $ (87,876) -1)", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para33", "text": "the company believes its existing balances of cash, cash equivalents and marketable securities, along with commercial paper and other short-term liquidity arrangements, will be sufficient to satisfy its working capital needs, capital asset purchases, dividends, share repurchases, debt repayments and other liquidity requirements associated with its existing operations over the next 12 months.", "highlight": "believes its existing balances of cash, cash equivalents and marketable securities, along with commercial paper and other short-term liquidity arrangements, will be sufficient to satisfy its working capital needs", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para34", "text": "In connection with the state aid decision, as of september 26, 2020, the adjusted recovery amount of 12.9 billion plus interest of 1.2 billion was funded into escrow, where it will remain restricted from general use pending the conclusion of all legal proceedings. further information regarding the state aid decision can be found in part ii, item 8 of this form 10-k in the notes to consolidated financial statements in note 5, \"income taxes.\" the company's marketable securities investment portfolio is primarily invested in highly rated securities, with the primary objective of minimizing the potential risk of principal loss. the company's investment policy generally requires securities to be investment grade and limits the amount of credit exposure to any one issuer.", "highlight": "the adjusted recovery amount of 12.9 billion plus interest of 1.2 billion was funded into escrow |||  the company's marketable securities investment portfolio is primarily invested in highly rated securities, with the primary objective of minimizing the potential risk of principal loss", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para35", "text": "during 2020, cash generated by operating activities of $80.7 billion was a result of $57.4 billion of net income, non-cash adjustments to net income of $17.6 billion and an increase in the net change in operating assets and liabilities of $5.7 billion. cash used in investing activities of $4.3 billion during 2020 consisted primarily of cash used to acquire property, plant and equipment of $7.3 billion and cash paid for business acquisitions, net of cash acquired, of $1.5 billion, partially offset by proceeds from maturities and sales of marketable securities, net of purchases, of $5.5 billion. cash used in financing activities of $86.8 billion during 2020 consisted primarily of cash used to repurchase common stock of $72.4 billion, cash used to pay dividends and dividend equivalents of $14.1 billion, cash used to repay or redeem term debt of $12.6 billion and net repayments of commercial paper of $1.0 billion, partially offset by net proceeds from the issuance of term debt of $16.1 billion.", "highlight": "cash generated by operating activities of $80.7 billion was a result of $57.4 billion of net income, non-cash adjustments to net income of $17.6 billion and an increase in the net change in operating assets and liabilities of $5.7 billion ||| cash used in investing activities of $4.3 billion during 2020 consisted primarily of cash used to acquire property, plant and equipment of $7.3 billion ||| cash used in financing activities of $86.8 billion during 2020 consisted primarily of cash used to repurchase common stock of $72.4 billion", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para36", "text": "during 2019, cash generated by operating activities of $69.4 billion was a result of $55.3 billion of net income and non-cash adjustments to net income of $17.6 billion, partially offset by a decrease in the net change in operating assets and liabilities of $3.5 billion. cash generated by investing activities of $45.9 billion during 2019 consisted primarily of proceeds from sales and maturities of marketable securities, net of purchases, of $57.5 billion, partially offset by cash used to acquire property, plant and equipment of $10.5 billion. cash used in financing activities of $91.0 billion during 2019 consisted primarily of cash used to repurchase common stock of $66.9 billion, cash used to pay dividends and dividend equivalents of $14.1 billion, cash used to repay term debt of $8.8 billion and net repayments of commercial paper of $6.0 billion, partially offset by net proceeds from the issuance of term debt of $7.0 billion.", "highlight": "cash generated by operating activities of $69.4 billion was a result of $55.3 billion of net income and non-cash adjustments to net income of $17.6 billion |||  cash generated by investing activities of $45.9 billion during 2019 ||| from sales and maturities of marketable securities, net of purchases, of $57.5 billion ||| cash used in financing activities of $91.0 billion during 2019", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para37", "text": "Debt the company issues unsecured short-term promissory notes (\"commercial paper\") pursuant to a commercial paper program. the company uses the net proceeds from the commercial paper program for general corporate purposes, including dividends and share repurchases. as of september 26, 2020, the company had $5.0 billion of commercial paper outstanding, with a weighted-average interest rate of 0.62% and maturities generally less than nine months.", "highlight": "the company uses the net proceeds from the commercial paper program for general corporate purposes, including dividends and share repurchases.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para38", "text": "the company may enter into agreements to sell certain of its marketable securities with a promise to repurchase the securities at a specified time and amount as an additional short-term liquidity arrangement.", "highlight": "company may enter into agreements to sell certain of its marketable securities with a promise to repurchase the securities at a specified time and amount", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 1, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para39", "text": "as of september 26, 2020, the company had outstanding floating- and fixed-rate notes with varying maturities for an aggregate principal amount of $106.1 billion (collectively the \"notes\"). during 2020, the company issued $16.1 billion and repaid or redeemed $12.6 billion of notes. the company has entered, and in the future may enter, into interest rate swaps to manage interest rate risk on the notes. in addition, the company has entered, and in the future may enter, into foreign currency swaps to manage foreign currency risk on the notes.", "highlight": "the company had outstanding floating- and fixed-rate notes with varying maturities for an aggregate principal amount of $106.1 billion ||| the company issued $16.1 billion and repaid or redeemed $12.6 billion of notes", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para40", "text": "Further information regarding the company's debt issuances and related hedging activity can be found in part ii, item 8 of this form 10-k in the notes to consolidated financial statements in note 3, \"financial instruments\" and note 6, \"debt.\" Capital return program as of september 26, 2020, the company was authorized to purchase up to $225 billion of the company's common stock under a share repurchase program, of which $168.6 billion had been utilized. during 2020, the company repurchased 917 million shares of its common stock for $72.5 billion, including 141 million shares delivered under a $10.0 billion november 2019 asr and 64 million shares delivered under a $6.0 billion may 2020 asr. the company's share repurchase program does not obligate it to acquire any specific number of shares. under this program, shares may be repurchased in privately negotiated and/or open market transactions, including under plans complying with rule 10b5-1 under the exchange act.", "highlight": "the company was authorized to purchase up to $225 billion of the company's common stock under a share repurchase program, of which $168.6 billion had been utilized. during 2020, the company repurchased 917 million shares of its common stock for $72.5 billion, including 141 million shares delivered under a $10.0 billion november 2019 asr and 64 million shares delivered under a $6.0 billion may 2020 asr", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 2, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para41", "text": "as of september 26, 2020, the company's quarterly cash dividend was $0.205 per share. the company intends to increase its dividend on an annual basis, subject to declaration by the board of directors.", "highlight": "company's quarterly cash dividend was $0.205 per share", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para42", "text": "Contractual obligations The following table presents certain payments due by the company as of september 26, 2020, and includes amounts already recorded on the consolidated balance sheet, except for manufacturing purchase obligations, other purchase obligations and certain lease obligations (in millions): Payments due in 2021 Payments due in 2022 2023 Payments due in 2024 2025 Payments due after 2025 Total Term debt $ 8,750 $ 20,958 $ 21,029 $ 55,341 $ 106,078 Leases 1,622 3,097 2,352 5,888 12,959 Manufacturing purchase obligations (1) 47,961 1,849 61 40 49,911 Other purchase obligations 6,178 2,736 400 90 9,404 Deemed repatriation tax payable 1,533 5,923 12,955 9,254 29,665 Total $ 66,044 $ 34,563 $ 36,797 $ 70,613 $ 208,017 -1) represents amount expected to be paid under manufacturing-related supplier arrangements, which are primarily noncancelable.", "highlight": "Payments due after 2025 Total Term debt $ 8,750 $ 20,958 $ 21,029 $ 55,341 $ 106,078 Leases 1,622 3,097 2,352 5,888 12,959 Manufacturing purchase obligations (1) 47,961 1,849 61 40 49,911 Other purchase obligations 6,178 2,736 400 90 9,404 Deemed repatriation tax payable 1,533 5,923 12,955 9,254 29,665 Total $ 66,044 $ 34,563 $ 36,797 $ 70,613 $ 208,017 -1", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para43", "text": "Leases The company has lease arrangements for certain equipment and facilities, including retail, corporate, manufacturing and data center space. the company's retail store and other facility leases typically have original terms not exceeding 10 years and generally contain multi-year renewal options. the above contractual obligations table includes future payments under leases that had commenced as of september 26, 2020, and were therefore recorded on the company's consolidated balance sheet, as well as leases that had been signed but not yet commenced as of september 26, 2020. further information regarding the company's leases can be found in part ii, item 8 of this form 10-k in the notes to consolidated financial statements in note 12, \"leases.\" Manufacturing purchase obligations the company utilizes several outsourcing partners to manufacture sub-assemblies for the company's products and to perform final assembly and testing of finished products. these outsourcing partners acquire components and build product based on demand information supplied by the company, which typically covers periods up to 150 days. the company also obtains individual components for its products from a wide variety of individual suppliers.", "highlight": "The company has lease arrangements for certain equipment and facilities, including retail, corporate, manufacturing and data center space. the company's retail store and other facility leases typically have original terms not exceeding 10 years and generally contain multi-year renewal options ||| Manufacturing purchase obligations the company utilizes several outsourcing partners to manufacture sub-assemblies for the company's products and to perform final assembly and testing of finished products", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para44", "text": "Other purchase obligations the company's other purchase obligations consist of noncancelable obligations to acquire capital assets, including product tooling and manufacturing process equipment, and noncancelable obligations related to advertising, licensing, r&d, internet and telecommunications services, content creation and other activities.", "highlight": "other purchase obligations consist of noncancelable obligations to acquire capital assets, including product tooling and manufacturing process equipment, and noncancelable obligations related to advertising, licensing, r&d, internet and telecommunications services", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para45", "text": "Deemed repatriation tax payable as of september 26, 2020, a significant portion of the other non-current liabilities in the company's consolidated balance sheet consisted of the deemed repatriation tax payable imposed by the act. the company plans to pay the deemed repatriation tax payable in installments in accordance with the act.", "highlight": "a significant portion of the other non-current liabilities in the company's consolidated balance sheet consisted of the deemed repatriation tax payable imposed by the act", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para46", "text": "Other non-current liabilities the company's remaining other non-current liabilities primarily consist of items for which the company is unable to make a reasonably reliable estimate of the timing or amount of payments; therefore, such amounts are not included in the above contractual obligations table.", "highlight": "other non-current liabilities ||| is unable to make a reasonably reliable estimate", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para47", "text": "Critical accounting policies and estimates the preparation of financial statements and related disclosures in conformity with u.s. generally accepted accounting principles (\"gaap\") and the company's discussion and analysis of its financial condition and operating results require the company's management to make judgments, assumptions and estimates that affect the amounts reported. note 1, \"summary of significant accounting policies,\" of the notes to consolidated financial statements in part ii, item 8 of this form 10-k describes the significant accounting policies and methods used in the preparation of the company's consolidated financial statements. management bases its estimates on historical experience and on various other assumptions it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. actual results may differ from these estimates, and such differences may be material.", "highlight": "assumptions it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para48", "text": "management believes the company's critical accounting policies and estimates are those related to revenue recognition, valuation of manufacturing-related assets and estimation of inventory purchase commitment cancellation fees, warranty costs, income taxes, and legal and other contingencies. management considers these policies critical because they are both important to the portrayal of the company's financial condition and operating results, and they require management to make judgments and estimates about inherently uncertain matters. the company's senior management has reviewed these critical accounting policies and related disclosures with the audit and finance committee of the company's board of directors.", "highlight": "believes the company's critical accounting policies and estimates are those related to revenue recognition, valuation of manufacturing-related assets and estimation of inventory purchase commitment cancellation fees, warranty costs, income taxes, and legal and other contingencies ||| reviewed these critical accounting policies and related disclosures with the audit and finance committee of the company's board of directors", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para49", "text": "Revenue recognition the company has identified up to three performance obligations regularly included in arrangements involving the sale of iphone, mac, ipad and certain other products. the first performance obligation, which represents the substantial portion of the allocated sales price, is the hardware and bundled software delivered at the time of sale. the second performance obligation is the right to receive certain product-related bundled services, which include icloud, siri and maps. the third performance obligation is the right to receive, on a when-and-if-available basis, future unspecified software upgrades relating to the software bundled with each device. the company allocates revenue and any related discounts to these performance obligations based on their relative stand-alone selling prices (\"ssps\"). because the company lacks observable prices for the undelivered performance obligations, the allocation of revenue is based on the company's estimated ssps. revenue allocated to the product-related bundled services and unspecified software upgrade rights is deferred and recognized on a straight-line basis over the estimated period they are expected to be provided.", "highlight": "the first performance obligation, which represents the substantial portion of the allocated sales price, is the hardware and bundled software delivered at the time of sale. the second performance obligation is the right to receive certain product-related bundled services ||| revenue allocated to the product-related bundled services and unspecified software upgrade rights is deferred and recognized on a straight-line basis over the estimated period they are expected to be provided.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para50", "text": "the company's process for determining estimated ssps involves management's judgment and considers multiple factors that may vary over time depending upon the unique facts and circumstances related to each deliverable. should future facts and circumstances change, the company's ssps and the future rate of related amortization for product-related bundled services and unspecified software upgrade rights related to future sales of these devices could change. factors subject to change include the nature of the product-related bundled services and unspecified software upgrade rights offered, their estimated value and the estimated period they are expected to be provided.", "highlight": "involves management's judgment and considers multiple factors that may vary over time depending upon the unique facts and circumstances related to each deliverable", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para51", "text": "Valuation of manufacturing-related assets and estimation of inventory purchase commitment cancellation fees the company invests in manufacturing-related assets, including capital assets held at its suppliers' facilities and prepayments provided to certain of its suppliers associated with long-term agreements to secure the supply of inventory. the company also accrues estimated purchase commitment cancellation fees related to inventory orders that have been canceled or are expected to be canceled. the company's estimates of future product development plans and demand for its products are key inputs in determining the recoverability of manufacturing-related assets and assessing the adequacy of any purchase commitment cancellation fee accruals. if there is an abrupt and substantial decline in estimated demand for one or more of the company's products, a change in the company's product development plans, or an unanticipated change in technological requirements for any of the company's products, the company may be required to record write-downs or impairments of manufacturing-related assets or accrue purchase commitment cancellation fees.", "highlight": "accrues estimated purchase commitment cancellation fees related to inventory orders that have been canceled or are expected to be canceled ||| estimates of future product development plans and demand for its products are key inputs in determining the recoverability of manufacturing-related assets and assessing the adequacy of any purchase commitment cancellation fee accruals ||| the company may be required to record write-downs or impairments of manufacturing-related assets or accrue purchase commitment cancellation fees.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para52", "text": "Warranty costs the company offers limited warranties on its new and certified refurbished hardware products and on parts used to repair its hardware products, and customers may purchase extended service coverage, where available, on many of the company's hardware products. the company accrues the estimated cost of warranties in the period the related revenue is recognized based on historical and projected warranty claim rates, historical and projected cost per claim and knowledge of specific product failures outside the company's typical experience. if actual product failure rates or repair costs differ from estimates, revisions to the estimated warranty liabilities would be required.", "highlight": "the company accrues the estimated cost of warranties in the period the related revenue is recognized based on historical and projected warranty claim rates ||| if actual product failure rates or repair costs differ from estimates, revisions to the estimated warranty liabilities would be required.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para53", "text": "Income taxes the company recognizes tax benefits from uncertain tax positions if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. the tax benefits recognized in the financial statements from such positions are measured based on the largest benefit that has a greater-than-50% likelihood of being realized upon ultimate settlement. the calculation of tax liabilities involves significant judgment in estimating the impact of uncertainties in the application of gaap and complex tax laws. resolution of these uncertainties in a manner inconsistent with management's expectations could have a material impact on the company's financial condition and operating results.", "highlight": "resolution of these uncertainties in a manner inconsistent with management's expectations could have a material impact on the company's financial condition and operating results", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para54", "text": "Legal and other contingencies as discussed in part i, item 3 of this form 10-k under the heading \"legal proceedings\" and in part ii, item 8 of this form 10-k in the notes to consolidated financial statements in note 10, \"commitments and contingencies,\" the company is subject to various legal proceedings and claims that arise in the ordinary course of business. the company records a liability when it is probable that a loss has been incurred and the amount is reasonably estimable, the determination of which requires significant judgment. except as described in part ii, item 8 of this form 10-k in the notes to consolidated financial statements in note 10, \"commitments and contingencies\" under the heading \"contingencies,\" in the opinion of management, there was not at least a reasonable possibility the company may have incurred a material loss, or a material loss greater than a recorded accrual, concerning loss contingencies for asserted legal and other claims.", "highlight": "in part i, item 3 of this form 10-k under the heading \"legal proceedings\" and in part ii, item 8 of this form 10-k in the notes to consolidated financial statements in note 10, \"commitments and contingencies, ||| described in part ii, item 8 of this form 10-k in the notes to consolidated financial statements in note 10, \"commitments and contingencies\" under the heading \"contingencies,\" in the opinion of management", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20201030_10-K_320193_part2_item7_para55", "text": "the outcome of litigation is inherently uncertain. if one or more legal matters were resolved against the company in a reporting period for amounts above management's expectations, the company's financial condition and operating results for that reporting period could be materially adversely affected.", "highlight": "the outcome of litigation is inherently uncertain.", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para1", "text": "the following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and related notes included elsewhere in this annual report on form 10-k.", "highlight": "consolidated financial statements ||| elsewhere in this annual report on form 10-k.", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para2", "text": "For the discussion of the financial condition and results of operations for the year ended december 31, 2018 compared to the year ended december 31, 2017, refer to \"part ii item 7. management's discussion and analysis of financial condition and results of operations results of operations\" and \" liquidity and capital resources\" in our Annual report on form 10-k For the fiscal year ended December 31, 2018 filed with the sec on february 13, 2019, which discussion is incorporated herein by reference.", "highlight": "part ii item 7. management's discussion and analysis of financial condition and results of operations results of operations ||| liquidity and capital resources\" in our Annual report on form 10-k", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para3", "text": "Overview Our business hilton is one of the largest and fastest growing hospitality companies in the world, with 6,110 properties comprising 971,780 rooms in 119 countries and territories as of december 31, 2019. our premier brand portfolio includes: our luxury and lifestyle hotel brands, waldorf astoria hotels & resorts, lxr hotels & resorts, conrad hotels & resorts and canopy by hilton; our full service hotel brands, signia by hilton, hilton hotels & resorts, curio collection by hilton, doubletree by hilton, tapestry collection by hilton and embassy suites by hilton; our focused service hotel brands, motto by hilton, hilton garden inn, hampton by hilton, tru by hilton, homewood suites by hilton and home2 suites by hilton; and our timeshare brand, hilton grand vacations. as of december 31, 2019, we had more than 103 million members in our award-winning guest loyalty program, hilton honors, a 21 percent increase from december 31, 2018.", "highlight": "Our business hilton is one of the largest and fastest growing hospitality companies in the world", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para4", "text": "in january 2020, we launched our newest brand, tempo by hilton, an approachable lifestyle hotel brand dedicated to exceeding the expectations of an emerging, and discerning, class of traveler: the modern achiever. pioneering a new hospitality category, tempo by hilton offers accommodations thoughtfully designed to help guests relax and recharge.", "highlight": "we launched our newest brand, tempo by hilton ||| tempo by hilton offers accommodations thoughtfully designed to help guests relax and recharge.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para5", "text": "Segments and regions we analyze our operations and business by both operating segments and geographic regions. our operations consist of two reportable segments that are based on similar products or services: (i) management and franchise and (ii) ownership. the management and franchise segment provides services, including hotel management and licensing of our brands. this segment generates its revenue from: (i) management and franchise fees charged to third-party hotel owners; (ii) licensing fees from hgv and strategic partnerships for the right to use certain hilton marks and ip; and (iii) fees for managing our owned and leased hotels. as a manager of hotels, we typically are responsible for supervising or operating the property in exchange for management fees. as a franchisor of hotels, we charge franchise fees in exchange for the use of one of our brand names and related commercial services, such as our reservation system, marketing and information technology services. the ownership segment primarily derives earnings from providing nightly hotel room sales, food and beverage sales and other services at our owned and leased hotels.", "highlight": "the management and franchise segment provides services, including hotel management and licensing of our brands", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para6", "text": "geographically, we conduct business through three distinct geographic regions: (i) the americas; (ii) europe, middle east and africa (\"emea\"); and (iii) asia pacific. the americas region includes north america, south america and central america, including all caribbean nations. although the u.s. is included in the americas, it represented 72 percent of our system-wide hotel rooms as of december 31, 2019; therefore, the u.s. is often analyzed separately and apart from the americas geographic region and, as such, it is presented separately within the analysis herein. the emea region includes europe, which represents the western-most peninsula of eurasia stretching from iceland in the west to russia in the east, and the middle east and africa (\"mea\"), which represents the middle east region and all african nations, including the indian ocean island nations. europe and mea are often analyzed separately and, as such, are presented separately within the analysis herein. the asia pacific region includes the eastern and southeastern nations of asia, as well as india, australia, new zealand and the pacific island nations.", "highlight": "the u.s. is often analyzed separately and apart from the americas geographic region ||| europe and mea are often analyzed separately", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para7", "text": "System growth and development pipeline Our strategic objectives include the continued expansion of our global footprint and fee-based business. as we enter into new management and franchise contracts, we expand our business with minimal or no capital investment by us as the manager or franchisor, since the capital required to build and maintain hotels is typically provided by the third-party owner of the hotel with whom we contract to provide management services or license our brand names and ip. prior to approving the addition of new properties to our management and franchise development pipeline, we evaluate the economic viability of the property based on its geographic location, the credit quality of the third-party owner and other factors. by increasing the number of management and franchise contracts with third-party owners, we expect to increase overall return on invested capital and cash available for return to stockholders.", "highlight": "evaluate the economic viability of the property based on its geographic location, the credit quality of the third-party owner and other factors", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para8", "text": "as of december 31, 2019, we had more than 2,570 hotels in our development pipeline that we expect to add as open hotels in our system, representing over 387,000 rooms under construction or approved for development throughout 116 countries and territories, including 35 countries and territories where we do not currently have any open hotels. all of the rooms in the development pipeline are within our management and franchise segment. additionally, of the rooms in the development pipeline, 215,000 rooms were located outside the u.s., and 193,000 rooms were under construction. we do not consider any individual development project to be material to us.", "highlight": "we do not consider any individual development project to be material to us.", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para9", "text": "Brexit in june 2016, the u.k held a referendum in which voters approved an exit from the e.u. (commonly referred to as \"brexit\"), which occurred on january 31, 2020. the effects of brexit will depend on the final terms on which the u.k. will leave the e.u., including the terms of any trade agreements that will dictate the u.k.'s access to e.u. markets either during the transitional period, which has a deadline of december 31, 2020, or more permanently. while our results for the year ended december 31, 2019 were not materially affected by brexit, the final outcomes are not yet certain. brexit measures could potentially disrupt the markets we serve and cause tax and foreign currency volatility, which could have adverse effects on our business. we will continue to monitor the potential impact of brexit on our business as the transitional period deadline approaches and the final terms of the u.k.'s exit are determined.", "highlight": "the effects of brexit will depend on the final terms on which the u.k. will leave the e.u., including the terms of any trade agreements that will dictate the u.k.'s access to e.u. markets either during the transitional period ||| could potentially disrupt the markets we serve and cause tax and foreign currency volatility ||| monitor the potential impact of brexit on our business as the transitional period deadline", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para10", "text": "Other developments as of the date of this annual report on form 10-k, it appears the reported coronavirus outbreak has largely been concentrated in china, although cases have been confirmed in other countries. the extent to which our future results are affected by the coronavirus will largely depend on future developments, which are highly uncertain and cannot be accurately predicted, including new information which may emerge concerning the severity of the coronavirus and the actions to contain the coronavirus or treat its impact, among other.", "highlight": "the extent to which our future results are affected by the coronavirus will largely depend on future developments", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para11", "text": "Principal components and factors affecting our results of operations Revenues Principal components We primarily derive our revenues from the following sources: franchise and licensing fees . represents fees earned in connection with the licensing of one of our brands. under our franchise contracts, franchisees typically pay us franchise fees that include: (i) monthly royalty fees, generally based on a percentage of the hotel's monthly gross room revenue, and, in some cases, a percentage of gross food and beverage revenues and other revenues, as applicable; and (ii) application, initiation and other fees for when new hotels enter the system, when there is a change of ownership of a hotel or when contracts with properties already in our system are extended. we also earn licensing fees from a license agreement with hgv and strategic partnerships for the use of certain hilton marks and ip. consideration to incentivize hotel owners to enter into franchise contracts with us is amortized over the life of the applicable contract as a reduction to franchise and licensing fees.", "highlight": "We primarily derive our revenues from the following sources: franchise and licensing fees  ||| represents fees earned in connection with the licensing of one of our brands. under our franchise contracts ||| earn licensing fees from a license agreement with hgv and strategic partnerships for the use of certain hilton marks and ip", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para12", "text": "base and incentive management fees. represents fees earned in connection with the management of hotels. terms of our management contracts vary, but our fees generally consist of a base fee, which is typically based on a percentage of the hotel's monthly gross revenue and, when applicable, an incentive fee, which is typically based on the hotel's operating profits and may be subject to a stated return threshold to the owner, normally over a one-calendar year period. outside of the u.s., our fees are often more dependent on hotel profitability measures, either through a single management fee structure where the entire fee is based on a profitability measure, or because our two-tier fee structure is more heavily weighted toward the incentive fee than the base fee. consideration to incentivize hotel owners to enter into management contracts with us is amortized over the life of the applicable contract as a reduction to base and other management fees.", "highlight": "our fees are often more dependent on hotel profitability measures ||| consideration to incentivize hotel owners to enter into management contracts with us is amortized over the life of the applicable contract as a reduction to base and other management fees.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para13", "text": "owned and leased hotels. represents revenues derived from hotel operations, including nightly hotel room sales, accommodations sold in conjunction with other services, food and beverage sales and other ancillary goods and services. these revenues are primarily derived from two categories of customers: transient and group. transient guests are individual travelers who are traveling for business or leisure. group guests are traveling for group events that reserve rooms for meetings, conferences or social functions sponsored by corporate, social, military, educational, religious or other organizations or associations. group business usually includes a block of room accommodations, as well as other ancillary services, such as meeting facilities and catering and banquet services. a majority of our food and beverage sales and other ancillary services are provided to customers who are also occupying rooms at our hotels. as a result, occupancy affects all components of our owned and leased hotel revenues.", "highlight": "revenues are primarily derived from two categories of customers: transient and group.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para14", "text": "other revenues. represents revenues generated by the incidental support of hotel operations for owned, leased, managed and franchised hotels, including our purchasing operations, and other operating income.", "highlight": "incidental support of hotel operations for owned, leased, managed and franchised hotels, including our purchasing operations, and other operating income.", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para15", "text": "other revenues from managed and franchised properties. represents amounts that are contractually reimbursed to us by property owners, either directly as we incur costs or indirectly through program fees billed and collected each month that are associated with certain costs and expenses supporting the operations of the related properties. the direct reimbursements by property owners are for payroll and related costs if the property employees are legally our responsibility, and certain other operating costs of the managed and franchised properties' operations. we have no legal responsibility for the employees or the liabilities associated with operating franchised properties. revenues and expenses for these direct reimbursements have no net effect on operating income (loss) or net income (loss). the monthly program fee that hotel franchisees and property owners of hotels we manage pay is based on the underlying hotel's sales or usage and covers the costs of: (i) advertising, marketing and customer loyalty programs; (ii) internet, technology and reservation systems; and (iii) quality assurance programs. we are contractually required to use these fees solely for these programs.", "highlight": "we are contractually required to use these fees solely for these programs.\r\n ||| the direct reimbursements by property owners are for payroll and related costs if the property employees are legally our responsibility, and certain other operating costs of the managed and franchised properties' operations", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para16", "text": "Factors affecting our revenues The following factors affect the revenues we derive from our operations: consumer demand and global economic conditions . consumer demand for our products and services is closely linked to the performance of the general economy and is sensitive to business and personal discretionary spending levels. among other factors, declines in consumer demand due to adverse general economic conditions, risks affecting or reducing travel patterns, lower consumer confidence and adverse political conditions can lower the amount of management and franchise fee revenues we are able to generate and/or lower the revenues and profitability of our owned and leased operations. further, competition for hotel guests and the supply of hotel services affect our ability to sustain or increase rates charged to customers at our hotels. also, declines in hotel profitability during an economic downturn directly affect the incentive portion of our management fees, which is based on hotel profitability measures. as a result, changes in consumer demand and general business cycles have historically subjected and could in the future subject our revenues to significant volatility.", "highlight": "The following factors affect the revenues we derive from our operations: consumer demand and global economic conditions ||| declines in consumer demand due to adverse general economic conditions, risks affecting or reducing travel patterns, lower consumer confidence and adverse political conditions can lower the amount of management and franchise fee revenues we are able to generate and/or lower the revenues and profitability of our owned and leased operations", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para17", "text": "contracts with third-party owners and franchisees and relationships with developers . we depend on our long-term management and franchise contracts with third-party owners and franchisees for a significant portion of our management and franchise fee revenues. the success and sustainability of our management and franchise business depends on our ability to perform under our management and franchise contracts and maintain good relationships with third-party owners and franchisees. our relationships with these third parties also generate new incremental opportunities for property development that can support our growth. growth and maintenance of our hotel system and earning fees related to hotels in development are dependent on the ability of developers and owners to access capital for the development, maintenance and renovation of properties. we believe that we have good relationships with our third-party owners, franchisees and developers and are committed to the continued growth and development of these relationships. these relationships exist with a diverse group of owners, franchisees and developers and are not significantly concentrated with any one particular third party.", "highlight": "we depend on our long-term management and franchise contracts with third-party owners and franchisees for a significant portion of our management and franchise fee revenues ||| relationships with these third parties also generate new incremental opportunities for property development that can support our growth", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para18", "text": "Expenses Principal components We primarily incur the following expenses: owned and leased hotels. reflects the operating expenses of our consolidated owned and leased hotels, including room expense, food and beverage costs, other support costs and property expenses. room expense includes compensation costs for housekeeping, laundry and front desk staff, as well as supply costs for guest room amenities and laundry. food and beverage costs include costs for wait and kitchen staff and food and beverage inventory. other support expenses consist of costs associated with property-level management; utilities; sales and marketing; operating hotel spas, telephones, parking and other guest recreation; entertainment; and other services. property expenses include property taxes, repairs and maintenance, rent and insurance.", "highlight": "primarily incur the following expenses: owned and leased hotels. reflects the operating expenses of our consolidated owned and leased hotels, including room expense, food and beverage costs, other support costs and property expenses", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para19", "text": "depreciation and amortization. these are non-cash expenses that primarily consist of: (i) amortization of intangible assets that were recorded at their fair value at the time of the october 24, 2007 transaction whereby we became a wholly owned subsidiary of affiliates of the blackstone group inc. (formerly known as the blackstone group l.p.) (\"blackstone\"), which include management and franchise contracts, leases and our hilton honors guest loyalty program intangible; (ii) amortization of capitalized software costs; and (iii) depreciation of property and equipment, such as buildings and furniture and equipment that are used in corporate operations or at our consolidated owned and leased hotels.", "highlight": "these are non-cash expenses that primarily consist of: ||| amortization of intangible assets ||| amortization of capitalized software costs; ||| depreciation of property and equipment", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para20", "text": "general and administrative. consists primarily of compensation expense for our corporate staff and personnel supporting our business segments; professional fees, including consulting, audit and legal fees; travel and entertainment expenses; bad debt expenses for uncollected management, franchise and other fees; and administrative and related expenses.", "highlight": "general and administrative. consists primarily of compensation expense", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para21", "text": "other expenses . consists of expenses incurred by our purchasing operations and other ancillary businesses, along with other operating expenses of the business.", "highlight": "consists of expenses incurred by our purchasing operations and other ancillary businesses, along with other operating expenses of the business.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para22", "text": "other expenses from managed and franchised properties. represents certain costs and expenses that are contractually reimbursed to us by property owners for payroll and related costs for properties that we manage where the property employees are legally our responsibility, or paid from program fees collected from properties for certain other operating costs of the managed and franchised properties' operations, including those related to our brand and shared service programs. we are contractually required to use these fees solely for these programs. we have no legal responsibility for the employees or the liabilities associated with operating franchised properties or certain of our foreign managed properties.", "highlight": "we are contractually required to use these fees solely for these programs. we have no legal responsibility for the employees or the liabilities associated with operating franchised properties or certain of our foreign managed properties.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para23", "text": "Factors affecting our costs and expenses The following are principal factors that affect the costs and expenses we incur in the course of our operations: fixed expenses. many of the expenses associated with owning and leasing hotels are relatively fixed. these expenses include personnel costs, rent, property taxes, insurance and utilities. if we are unable to decrease these costs significantly or rapidly when demand for our hotels and other properties decreases, the resulting decline in our revenues can have an adverse effect on our net cash flows, margins and profits. this effect can be especially pronounced during periods of economic contraction or slow economic growth. economic downturns generally affect the results of our ownership segment more significantly than the results of our management and franchise segment due to the high fixed costs associated with operating an owned or leased hotel. employees at some of our owned and leased hotels are parties to collective bargaining agreements that may also limit our ability to make timely staffing or labor changes in response to declining revenues. in addition, any efforts to reduce costs, including the deferral or cancellation of capital improvements, could adversely affect the economic value of our hotels and brands. additionally, the general and administrative expenses of operating a global business also include fixed personnel costs, rent, property taxes, insurance and utilities. the effectiveness of any cost-cutting efforts related to owning and leasing hotels or corporate operations is limited by the amount of inherent fixed costs. however, we have taken steps to reduce our fixed costs to levels we believe are appropriate to maximize profitability and respond to market conditions, while continuing to optimize our customers' experience and the value of our hotels and brands.", "highlight": "The following are principal factors that affect the costs and expenses we incur in the course of our operations: fixed expenses ||| economic downturns generally affect the results of our ownership segment more significantly than the results of our management and franchise segment due to the high fixed costs associated with operating an owned or leased hotel ||| the general and administrative expenses of operating a global business also include fixed personnel costs, rent, property taxes, insurance and utilities.  ||| and leasing hotels or corporate operations is limited by the amount of inherent fixed costs ||| reduce our fixed costs to levels we believe are appropriate to maximize profitability and respond to market conditions, while continuing to optimize our customers' experience and the value of our hotels and brands.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para24", "text": "changes in depreciation and amortization expense. we capitalize costs associated with certain software development projects and, as those projects are completed and placed into service, amortization expense will increase. additionally, changes in depreciation expense may be driven by renovations of existing hotels, acquisition or development of new hotels, the disposition of existing hotels through sale or closure or changes in estimates of the useful lives of our assets. as we place new assets into service, we will be required to recognize additional depreciation expense on those assets.", "highlight": "we capitalize costs associated with certain software development projects and, as those projects are completed and placed into service, amortization expense will increase ||| as we place new assets into service, we will be required to recognize additional depreciation expense on those assets.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para25", "text": "Other items Effect of foreign currency exchange rate fluctuations significant portions of our operations are conducted in functional currencies other than our reporting currency, which is usd, and we have assets and liabilities, including those that are payable or receivable by consolidated subsidiaries, denominated in a variety of foreign currencies. as a result, we are required to translate the results of those operations, assets and liabilities from the functional currency into usd at market-based foreign currency exchange rates for each reporting period. when comparing our results of operations between periods, there may be material portions of the changes in our revenues or expenses that are derived from fluctuations in foreign currency exchange rates experienced between those periods. we hedge foreign exchange-based cash flow variability in certain of our fees using forward contracts designated as hedging instruments. we also hold short-term forward contracts to offset exposure to fluctuations in certain of our foreign currency denominated cash balances, primarily related to our intercompany financing arrangements and we elected not to designate these forward contracts as hedging instruments.", "highlight": "Effect of foreign currency exchange rate fluctuations significant portions of our operations are conducted in functional currencies other than our reporting currency ||| denominated in a variety of foreign currencies ||| we are required to translate the results of those operations, assets and liabilities from the functional currency into usd at market-based foreign currency exchange rates for each reporting period ||| we hedge foreign exchange-based cash flow variability in certain of our fees using forward contracts designated as hedging instruments. we also hold short-term forward contracts to offset exposure to fluctuations in certain of our foreign currency denominated cash balances, primarily related to our intercompany financing arrangements and we elected not to designate these forward contracts as hedging instruments.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 1, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para26", "text": "Seasonality the hospitality industry is seasonal in nature. the periods during which our properties experience higher or lower levels of demand vary from property to property, depending principally upon their location, type of property and competitive mix within the specific location. based on historical results, we generally expect our revenues to be lower in the first quarter of each year than in each of the three subsequent quarters.", "highlight": "the periods during which our properties experience higher or lower levels of demand vary from property to property", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para27", "text": "Key business and financial metrics used by management Comparable hotels we define our comparable hotels as those that: (i) were active and operating in our system for at least one full calendar year as of the end of the current period, and open january 1st of the previous year; (ii) have not undergone a change in brand or ownership type during the current or comparable periods reported; and (iii) have not sustained substantial property damage, business interruption, undergone large-scale capital projects or for which comparable results are not available. of the 6,055 hotels in our system as of december 31, 2019, 4,556 hotels were classified as comparable hotels. our 1,499 non-comparable hotels included 255 hotels, or approximately four percent of the total hotels in our system, that were removed from the comparable group during the last twelve months because they sustained substantial property damage, business interruption, underwent large-scale capital projects or comparable results were not available.", "highlight": "we define our comparable hotels as those that ||| were active and operating in our system ||| have not undergone a change in brand or ownership ||| have not sustained substantial property damage", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para28", "text": "Occupancy occupancy represents the total number of room nights sold divided by the total number of room nights available at a hotel or group of hotels for a given period. occupancy measures the utilization of our hotels' available capacity. management uses occupancy to gauge demand at a specific hotel or group of hotels in a given period. occupancy levels also help us determine achievable average daily rate pricing levels as demand for hotel rooms increases or decreases.", "highlight": "occupancy levels also help us determine achievable average daily rate pricing levels as demand for hotel rooms increases or decreases.\r\n\r\nOverview\r\n\r\nIndustry\r\n\r\nRisk\r\n\r\nLegal\r\n\r\nFinancial Status\r\n\r\nStrategy\r\n\r\nOperation", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para29", "text": "Average daily rate (\"adr\") adr represents hotel room revenue divided by the total number of room nights sold for a given period. adr measures average room price attained by a hotel, and adr trends provide useful information concerning the pricing environment and the nature of the customer base of a hotel or group of hotels. adr is a commonly used performance measure in the industry, and we use adr to assess pricing levels that we are able to generate by type of customer, as changes in rates charged to customers have a different effect on overall revenues and incremental profitability than changes in occupancy, as described above.", "highlight": "adr represents hotel room revenue divided by the total number of room nights sold for a given period", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para30", "text": "Revenue per available room (\"revpar\") revpar is calculated by dividing hotel room revenue by the total number of room nights available to guests for a given period. we consider revpar to be a meaningful indicator of our performance as it provides a metric correlated to two primary and key drivers of operations at a hotel or group of hotels, as previously described: occupancy and adr. revpar is also a useful indicator in measuring performance over comparable periods for comparable hotels.", "highlight": "revpar is calculated by dividing hotel room revenue by the total number of room nights available to guests for a given period", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para31", "text": "references to revpar, adr and occupancy are presented on a comparable basis, and references to revpar and adr are presented on a currency neutral basis, unless otherwise noted. as such, comparisons of these hotel operating statistics for the years ended december 31, 2019 and 2018 use the exchange rates for the year ended december 31, 2019.", "highlight": "references to revpar, adr and occupancy are presented on a comparable basis", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para32", "text": "Ebitda and adjusted ebitda ebitda reflects net income (loss), excluding interest expense, a provision for income taxes and depreciation and amortization.", "highlight": "Ebitda and adjusted ebitda ebitda reflects net income", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para33", "text": "adjusted ebitda is calculated as ebitda, as previously defined, further adjusted to exclude certain items, including gains, losses, revenues and expenses in connection with: (i) asset dispositions for both consolidated and unconsolidated equity investments; (ii) foreign currency transactions; (iii) debt restructurings and retirements; (iv) furniture, fixtures and equipment (\"ff&e\") replacement reserves required under certain lease agreements; (v) reorganization costs; (vi) share-based compensation expense; (vii) non-cash impairment losses; (viii) severance, relocation and other expenses; (ix) amortization of contract acquisition costs; (x) the net effect of reimbursable costs included in other revenues and expenses from managed and franchised properties; and (xi) other items.", "highlight": "ebitda, as previously defined, further adjusted to exclude certain items, including gains, losses, revenues and expenses", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para34", "text": "we believe that ebitda and adjusted ebitda provide useful information to investors about us and our financial condition and results of operations for the following reasons: (i) these measures are among the measures used by our management team to evaluate our operating performance and make day-to-day operating decisions and (ii) these measures are frequently used by securities analysts, investors and other interested parties as a common performance measure to compare results or estimate valuations across companies in our industry. additionally, these measures exclude certain items that can vary widely across different industries and among competitors within our industry. for instance, interest expense and the provision for income taxes are dependent on company specifics, including, among other things, capital structure and operating jurisdictions, respectively, and, therefore could vary significantly across companies. depreciation and amortization, as well as amortization of contract acquisition costs, are dependent upon company policies, including the method of acquiring and depreciating assets and the useful lives that are used. for adjusted ebitda, we also exclude items such as: (i) ff&e replacement reserves to be consistent with the treatment of ff&e for owned hotels where it is capitalized and depreciated over the life of the ff (ii) share-based compensation expense, as this could vary widely among companies due to the different plans in place and the usage of them; (iii) the net effect of our cost reimbursement revenues and reimbursed expenses, as we contractually do not operate the related programs to generate a profit over the terms of the respective contracts; and (iv) other items that are not core to our operations and are not reflective of our performance.", "highlight": "we believe that ebitda and adjusted ebitda provide useful information to investors about us and our financial condition and results of operations for the following reasons", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para35", "text": "Ebitda and adjusted ebitda are not recognized terms under u.s. generally accepted accounting principles (\"gaap\") and should not be considered as alternatives to net income (loss) or other measures of financial performance or liquidity derived in accordance with gaap. ebitda and adjusted ebitda have limitations as analytical tools and should not be considered as alternatives, either in isolation or as a substitute, for net income (loss), cash flow or other methods of analyzing our results as reported under gaap. some of these limitations are: Ebitda and adjusted ebitda do not reflect changes in, or cash requirements for, our working capital needs; Ebitda and adjusted ebitda do not reflect our interest expense, or the cash requirements necessary to service interest or principal payments, on our indebtedness; Ebitda and adjusted ebitda do not reflect a provision for income taxes or the cash requirements to pay our taxes; Ebitda and adjusted ebitda do not reflect historical cash expenditures or future requirements for capital expenditures or contractual commitments; Ebitda and adjusted ebitda do not reflect the effect on earnings or changes resulting from matters that we consider not to be indicative of our future operations; Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and ebitda and adjusted ebitda do not reflect any cash requirements for such replacements; and other companies in our industry may calculate ebitda and adjusted ebitda differently, limiting their usefulness as comparative measures.", "highlight": "Ebitda and adjusted ebitda are not recognized terms under u.s. generally accepted accounting principles (\"gaap\") and should not be considered as alternatives to net income (loss) or other measures of financial performance or liquidity derived in accordance with gaap ||| Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and ebitda and adjusted ebitda do not reflect any cash requirements for such replacements", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para36", "text": "because of these limitations, ebitda and adjusted ebitda should not be considered as discretionary cash available to us to reinvest in the growth of our business or as measures of cash that will be available to us to meet our obligations.", "highlight": "ebitda and adjusted ebitda should not be considered as discretionary cash available to us to reinvest in the growth of our business", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para37", "text": "Results of operations The hotel operating statistics by region for our system-wide comparable hotels were as follows: Year ended Variance December 31, 2019 2019 vs. 2018 u.s.", "highlight": "Year ended Variance December 31, 2019 2019 vs. 2018 u.s.", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para38", "text": "Occupancy 76.2 % 0.3 % pts.", "highlight": "Occupancy 76.2 % 0.3 % pts.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para39", "text": "Adr $ 148.70 0.3 % Revpar $ 113.36 0.7 % Americas (excluding u.s.) Occupancy 70.5 % 0.3 % pts.", "highlight": "Adr $ 148.70 0.3 % Revpar $ 113.36 0.7 % Americas (excluding u.s.) Occupancy 70.5 % 0.3 % pts.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para40", "text": "Adr $ 122.13 0.6 % Revpar $ 86.15 1.0 % Europe Occupancy 77.5 % 1.2 % pts.", "highlight": "Adr $ 122.13 0.6 % Revpar $ 86.15 1.0 % Europe Occupancy 77.5 % 1.2 % pts.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para41", "text": "Adr $ 139.97 1.4 % Revpar $ 108.46 3.0 % Mea Occupancy 73.8 % 1.9 % pts.", "highlight": "Adr $ 139.97 1.4 % Revpar $ 108.46 3.0 % Mea Occupancy 73.8 % 1.9 % pts.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para42", "text": "Adr $ 144.66 -5.5 % Revpar $ 106.70 -3.0 % Asia pacific Occupancy 72.4 % 0.6 % pts.", "highlight": "Adr $ 144.66 -5.5 % Revpar $ 106.70 -3.0 % Asia pacific Occupancy 72.4 % 0.6 % pts.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para43", "text": "Adr $ 123.72 -1.8 % Revpar $ 89.58 -0.9 % System-wide Occupancy 75.7 % 0.5 % pts.", "highlight": "Adr $ 123.72 -1.8 % Revpar $ 89.58 -0.9 % System-wide Occupancy 75.7 % 0.5 % pts.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para44", "text": "Adr $ 144.79 0.1 % Revpar $ 109.65 0.8 % for the year ended december 31, 2019, we experienced modest system-wide revpar growth, largely driven by occupancy growth. continued strength in europe resulted primarily from adr and occupancy growth in southern europe, particularly italy and turkey, which was partially offset by rate declines in russia. in the americas (excluding u.s.), results were attributable to both adr and occupancy growth in colombia and brazil, offset by decreases in revpar in canada and mexico. revpar growth in the u.s. was primarily a result of group performance. asia pacific results were primarily driven by declining revpar in china resulting from the continued economic slowdown, international trade challenges and the protests in hong kong. also contributing to asia pacific results was declining revpar in australia, which was offset by revpar growth in japan, malaysia and india. mea experienced a decline in revpar resulting from decreased adr in united arab emirates, partially offset by improved results in egypt and saudi arabia.", "highlight": "we experienced modest system-wide revpar growth, largely driven by occupancy growth.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para45", "text": "The table below provides a reconciliation of net income to ebitda and adjusted ebitda: Year ended december 31, 2019 2018 (in millions) Net income $ 886 $ 769 Interest expense 414 371 Income tax expense 358 309 Depreciation and amortization 346 325 Ebitda 2,004 1,774 Gain on sale of assets, net -81 Loss on foreign currency transactions 2 11 Ff&e replacement reserves 59 50 Share-based compensation expense 154 127 Amortization of contract acquisition costs 29 27 Net other expenses from managed and franchised properties 77 85 Other adjustment items -1 64 27 Adjusted ebitda $ 2,308 $ 2,101 ____________ -1 for the year ended december 31, 2019 includes impairment losses and, for all periods, includes expenses recognized in connection with the refinancings and repayments of the senior secured credit facilities, severance and other items.", "highlight": "includes impairment losses and, for all periods, includes expenses recognized in connection with the refinancings and repayments of the senior secured credit facilities, severance and other items.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para46", "text": "Revenues Year ended december 31, Percent change 2019 2018 2019 vs. 2018 (in millions) Franchise and licensing fees $ 1,681 $ 1,530 9.9 Base and other management fees $ 332 $ 321 3.4 Incentive management fees 230 235 -2.1 Total management fees $ 562 $ 556 1.1 our franchise and licensing fees and management fees increased primarily as a result of the addition of new properties to our management and franchise segment. including new development and ownership type transfers, from january 1, 2018 to december 31, 2019, we added 827 managed and franchised properties on a net basis, providing an additional 116,499 rooms to our management and franchise segment. as new hotels stabilize in our system, we expect the fees received from such hotels to increase as they are part of our system for full periods.", "highlight": "as new hotels stabilize in our system, we expect the fees received from such hotels to increase as they are part of our system for full periods.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para47", "text": "franchise fees from our comparable franchised properties increased as a result of increased revpar of 0.6 percent due to increases in both adr and occupancy. licensing and other fees increased $69 million, which included an increase in termination fees of $17 million, primarily related to the redevelopment of a franchised hotel.", "highlight": "franchise fees from our comparable franchised properties increased ||| licensing and other fees increased $69 million, which included an increase in termination fees of $17 million", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para48", "text": "management fees increased despite unfavorable foreign currency exchange rates, which decreased revenues by $8 million. on a currency neutral basis, base and other management fees increased as a result of an increase in revpar at our comparable managed hotels of 0.8 percent and termination fees that were recognized in 2019, while incentive management fees remained flat.", "highlight": "management fees increased despite unfavorable foreign currency exchange rates, |||  |||", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para49", "text": "Year ended december 31, Percent change 2019 2018 2019 vs. 2018 (in millions) Owned and leased hotels $ 1,422 $ 1,484 -4.2 Owned and leased hotel revenues decreased primarily as a result of unfavorable fluctuations in foreign currency exchange rates, which decreased revenues by $54 million. on a currency neutral basis, revenues at our comparable owned and leased hotels increased $31 million due to an increase in revpar of 3.5 percent, driven by increases in both adr and occupancy. on a currency neutral basis, revenues at our non-comparable owned and leased hotels decreased by $39 million on a net basis primarily due to leased hotels converting to managed or franchised hotels and the sale of the hilton odawara resort & spa (\"hilton odawara\"), which subsequently became a managed hotel, during the year, as well as hotels that were under renovation during 2019, partially offset by increases in revenues from hotels that were under renovation in 2018.", "highlight": "due to an increase in revpar of 3.5 percent, driven by increases in both adr and occupancy ||| due to leased hotels converting to managed or franchised hotels and the sale of the hilton odawara resort & spa (\"hilton odawara\"), which subsequently became a managed hotel", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para50", "text": "Year ended december 31, Percent change 2019 2018 2019 vs. 2018 (in millions) Other revenues $ 101 $ 98 3.1 other revenues increased primarily due to an increase in revenues from our purchasing operations.", "highlight": "primarily due to an increase in revenues from our purchasing operations.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para51", "text": "Operating expenses Year ended december 31, Percent change 2019 2018 2019 vs. 2018 (in millions) Owned and leased hotels $ 1,254 $ 1,332 -5.9 owned and leased hotel expenses decreased primarily as a result of fluctuations in foreign currency exchange rates, which decreased expenses by $54 million. on a currency neutral basis, owned and leased hotel expenses decreased due to a $27 million decrease in expenses at our non-comparable hotels resulting from leased hotels converting to managed or franchised hotels and the sale of the hilton odawara, partially offset by increases in expenses from hotels that were under renovation in 2018. the decrease in expenses at our non-comparable hotels was partially offset by a slight increase in expenses at our comparable hotels due to increased occupancy.", "highlight": "as a result of fluctuations in foreign currency exchange rates, which decreased expenses by $54 million ||| resulting from leased hotels converting to managed or franchised hotels and the sale of the hilton odawara, partially offset by increases in expenses from hotels that were under renovation in 2018", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para52", "text": "Year ended december 31, Percent change 2019 2018 2019 vs. 2018 (in millions) Depreciation and amortization $ 346 $ 325 6.5 General and administrative 441 443 -0.5 Other expenses 72 51 41.2 the increase in depreciation and amortization expense was primarily due to an increase in amortization expense, as a result of capitalized software costs that were placed into service from january 1, 2018 to december 31, 2019.", "highlight": "was primarily due to an increase in amortization expense, as a result of capitalized software costs that were placed into service", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 1, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para53", "text": "general and administrative expenses decreased primarily as a result of a decrease in general corporate expenses partially offset by an increase in share-based compensation costs driven by company performance.", "highlight": "primarily as a result of a decrease in general corporate expenses partially offset by an increase in share-based compensation costs driven by company performance.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para54", "text": "other expenses increased as a result of impairment losses recognized in 2019 and an increase in expenses from our purchasing operations.", "highlight": "as a result of impairment losses recognized in 2019 and an increase in expenses from our purchasing operations", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para55", "text": "Gain on sale of assets, net Year ended december 31, Percent change 2019 2018 2019 vs. 2018 (in millions) Gain on sale of assets, net $ 81 $Nm -1 ____________ -1 fluctuation in terms of percentage change is not meaningful.", "highlight": "fluctuation in terms of percentage change is not meaningful.", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para56", "text": "in september 2019, we recognized a gain upon completion of the sale of the hilton odawara. see note 3: \"disposal\" in our consolidated financial statements for additional information.", "highlight": "we recognized a gain upon completion of the sale of the hilton odawara.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para57", "text": "Non-operating income and expenses Year ended december 31, Percent change 2019 2018 2019 vs. 2018 (in millions) Interest expense $ (414) $ (371) 11.6 Loss on foreign currency transactions -2 -11 -81.8 Other non-operating income, net 3 28 -89.3 Income tax expense -358 -309 15.9 the increase in interest expense was primarily due to the issuances of the $1.0 billion 4.875% senior notes due 2030 (the \"2030 senior notes\") in june 2019 and the $1.5 billion 5.125% senior notes due 2026 (the \"2026 senior notes\") in april 2018. the increased interest expense due to debt issuances was partially offset by decreased interest expense related to our senior secured term loan facility (the \"term loans\"), as a result of the reduction of the interest rate in december 2018 and principal repayments of $500 million and $800 million during 2019 and 2018, respectively. see note 9: \"debt\" in our consolidated financial statements for additional information on our indebtedness.", "highlight": "increased interest expense due to debt issuances was partially offset by decreased interest expense related to our senior secured term loan facility", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para58", "text": "the losses on foreign currency transactions primarily resulted from certain intercompany financing arrangements, including short-term cross-currency intercompany loans, with the australian dollar (\"aud\") and the euro (\"eur\") having the most significant effect during the year ended december 31, 2019. for the year ended december 31, 2018, the changes were related to aud, eur and the british pound.", "highlight": "primarily resulted from certain intercompany financing arrangements, including short-term cross-currency intercompany loans, with the australian dollar (\"aud\") and the euro (\"eur\") having the most significant effect", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 1, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para59", "text": "other non-operating income, net decreased primarily due to a loss that was recognized during the year ended december 31, 2019 on the disposal of an unconsolidated real estate investment and a gain that was recognized during the year ended december 31, 2018 on the refinancing of a loan we issued to finance the construction of a hotel that we manage. additionally, other non-operating income, net during the years ended december 31, 2019 and 2018 included expenses recognized in connection with the refinancings and repayments of our senior secured credit facilities.", "highlight": "due to a loss that was recognized during the year ended december 31, 2019 ||| we issued to finance the construction of a hotel that we manage", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para60", "text": "the increase in income tax expense was primarily attributable to an increase in income before income taxes and the sale of the hilton odawara, which were partially offset by: (i) the adjustments to provisional amounts related to the tax cuts and jobs act of 2017 and (ii) the tax effect of a stock distribution of one of our subsidiaries, which were recognized in 2018. see note 13: \"income taxes\" in our consolidated financial statements for additional information.", "highlight": "see note 13: \"income taxes\" in our consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para61", "text": "Segment results refer to note 18: \"business segments\" in our consolidated financial statements for reconciliations of revenues for our reportable segments to consolidated amounts and of segment operating income to income before income taxes. we evaluate our business segment operating performance using operating income, without allocating other revenues and expenses or general and administrative expenses.", "highlight": "results refer to note 18: \"business segments\" in our consolidated financial statements for reconciliations of revenues", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para62", "text": "Refer to \" revenues\" for further discussion of the increases in revenues from our managed and franchised properties, which is correlated to our management and franchise segment revenues and segment operating income. refer to \" revenues\" and \" operating expenses\" for further discussion of the changes in revenues and operating expenses at our owned and leased hotels, which is correlated with our ownership segment revenues and operating income.", "highlight": "expenses at our owned and leased hotels, which is correlated with our ownership segment revenues and operating income.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para63", "text": "Liquidity and capital resources Overview as of december 31, 2019, we had total cash and cash equivalents of $630 million, including $92 million of restricted cash and cash equivalents. the majority of our restricted cash and cash equivalents balance related to cash collateral on our self-insurance programs and cash held for ff&e reserves.", "highlight": "we had total cash and cash equivalents of $630 million, including $92 million of restricted cash and cash equivalents", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para64", "text": "our known short-term liquidity requirements primarily consist of funds necessary to pay for operating and other expenditures, including costs associated with the management and franchising of hotels, corporate expenses, payroll and compensation costs, taxes and compliance costs, interest payments on our outstanding indebtedness, contract acquisition costs and capital expenditures for renovations and maintenance at the hotels within our ownership segment. our long-term liquidity requirements primarily consist of funds necessary to pay for scheduled debt maturities, capital improvements to the hotels within our ownership segment, commitments to owners in our management and franchise segment, dividends as declared, share repurchases and corporate capital and information technology expenditures.", "highlight": "", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para65", "text": "we have an investment policy that is focused on the preservation of capital and maximizing the return on new and existing investments and returning available capital to stockholders through dividends and share repurchases. within the framework of our investment policy, we finance our business activities primarily with existing cash and cash generated from our operations. we believe that this cash and, from time-to-time, the use of our senior secured revolving credit facility (the \"revolving credit facility\"), will be adequate to meet anticipated requirements for operating and other expenditures, including corporate expenses, payroll and related benefits, taxes and compliance costs and other commitments for the foreseeable future. the objectives of our cash management policy are to maintain existing leverage levels and the availability of liquidity, while minimizing operational costs.", "highlight": "have an investment policy that is focused on the preservation of capital and maximizing the return on new and existing investments and returning available capital to stockholders through dividends and share repurchases |||  the use of our senior secured revolving credi ||| will be adequate to meet anticipated requirements for operating and other expenditures", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para66", "text": "we may from time to time issue or incur or increase our capacity to incur new debt and/or purchase our outstanding debt through underwritten offerings, open market transactions, privately negotiated transactions or otherwise. issuances or incurrence of new debt (or an increase in our capacity to incur new debt) and/or purchases or retirement of outstanding debt, if any, will depend on prevailing market conditions, liquidity requirements, contractual restrictions and other factors. the amounts involved may be material.", "highlight": "issue or incur or increase our capacity to incur new debt and/or purchase our outstanding debt through underwritten offerings", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 1, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para67", "text": "during the year ended december 31, 2019, we returned over $1.7 billion to shareholders by repurchasing 16.9 million shares of our common stock for $1.5 billion and paying dividends of $172 million, which were both funded principally with borrowings and available cash. as of december 31, 2019, approximately $515 million remained available for share repurchases under our $3.5 billion stock repurchase program.", "highlight": "we returned over $1.7 billion to shareholders by repurchasing 16.9 million shares of our common stock for $1.5 billion and paying dividends of $172 million ||| approximately $515 million remained available for share repurchases under our $3.5 billion stock repurchase program.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 1, "7": 1, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para68", "text": "Sources and uses of our cash and cash equivalents The following table summarizes our net cash flows: Year ended december 31, Percent change 2019 2018 2019 vs. 2018 (in millions) Net cash provided by operating activities $ 1,384 $ 1,255 10.3 Net cash used in investing activities -123 -131 -6.1 Net cash used in financing activities -1,113 -1,300 -14.4 Operating activities cash flows from operating activities were primarily generated from management and franchise fee revenue and operating income from our owned and leased hotels.", "highlight": "Operating activities cash flows from operating activities were primarily generated from management and franchise fee revenue and operating income from our owned and leased hotels", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para69", "text": "the $129 million increase in net cash provided by operating activities was primarily the result of improved operating results from our management and franchise business, including net property additions and an increase in licensing and other fees. the increase was partially offset by increases in cash paid for interest and income taxes.", "highlight": "result of improved operating results from our management and franchise business, including net property additions and an increase in licensing and other fees", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para70", "text": "Investing activities for the years ended december 31, 2019 and 2018, net cash used in investing activities consisted primarily of capital expenditures for property and equipment and capitalized software costs. our capital expenditures for property and equipment primarily consisted of expenditures related to our corporate facilities and the renovation of hotels in our ownership segment. our capitalized software costs related to various systems initiatives, for the benefit of both our hotel owners and our overall corporate operations. additionally, cash used for investing activities during the year ended december 31, 2019 was offset by the proceeds from the sale of the hilton odawara and, during the year ended december 31, 2018, by the repayment of a loan we issued that financed the construction of a hotel that we manage.", "highlight": "net cash used in investing activities consisted primarily of capital expenditures for property and equipment and capitalized software costs. ||| cash used for investing activities during the year ended december 31, 2019 was offset by the proceeds from the sale of the hilton odawara and", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para71", "text": "Financing activities the decrease in net cash used in financing activities was primarily attributable to a decrease in repurchases of common stock due to the 2018 repurchases of shares from hna tourism group co., ltd and certain affiliates of blackstone as part of the full divestiture of their respective investments in hilton, as well as a decrease in repayments on the term loans of $300 million. the decrease in net cash used was partially offset by a $500 million decrease in proceeds received from the $1.0 billion senior notes issuance in june 2019 when compared to the $1.5 billion senior notes issuance in april 2018. additionally, the year ended december 31, 2019 included net proceeds of $195 million from borrowings under the revolving credit facility.", "highlight": "primarily attributable to a decrease in repurchases of common stock due to the 2018 repurchases of shares from hna tourism group co., ltd and certain affiliates of blackstone as part of the full divestiture of their respective investments in hilton, as well as a decrease in repayments on the term loans of $300 million", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para72", "text": "Debt and borrowing capacity as of december 31, 2019, our total indebtedness, excluding unamortized deferred financing costs and discount, was approximately $8.1 billion. for additional information on our total indebtedness, availability under our revolving credit facility and guarantees on our debt, refer to note 9: \"debt\" and note 22: \"condensed consolidating guarantor financial information\" in our consolidated financial statements.", "highlight": "our total indebtedness, excluding unamortized deferred financing costs and discount, was approximately $8.1 billion ||| refer to note 9: \"debt\" and note 22: \"condensed consolidating guarantor financial information", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para73", "text": "if we are unable to generate sufficient cash flow from operations in the future to service our debt, we may be required to reduce capital expenditures, issue additional equity securities or make draws on our revolving credit facility. our ability to make scheduled principal payments and to pay interest on our debt depends on our future operating performance, which is subject to general conditions in or affecting the hospitality industry that may be beyond our control.", "highlight": "if we are unable to generate sufficient cash flow from operations in the future to service our debt, we may be required to reduce capital expenditures, issue additional equity securities or make draws on our revolving credit facility", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para74", "text": "Contractual obligations The following table summarizes our significant contractual obligations as of december 31, 2019: Payments due by period Total Less than 1 year 1-3 years 3-5 years More than 5 years (in millions) Long-term debt -1 $ 10,107 $ 343 $ 686 $ 1,862 $ 7,216 Finance leases -2 319 51 75 59 134 Operating leases -3 1,518 178 315 235 790 Other commitments 257 59 133 43 22 Total contractual obligations $ 12,201 $ 631 $ 1,209 $ 2,199 $ 8,162 ____________ -1 includes principal, as well as estimated interest payments, and excludes finance lease liabilities. for our variable-rate debt, we have assumed a weighted average constant 30-day libor rate of 1.79 percent as of december 31, 2019.", "highlight": ", 2019: Payments due by period Total Less than 1 year 1-3 years 3-5 years More than 5 years (in millions) Long-term debt -1 $ 10,107 $ 343 $ 686 $ 1,862 $ 7,216 Finance leases -2 319 51 75 59 134 Operating leases -3 1,518 178 315 235 790 Other commitments 257 59 133 43 22 Total contractual obligations $ 12,201 $ 631 $ 1,209 $ 2,199 $ 8,162 ____________ -1 includes principal, as well as estimated interest payments, and excludes finance lease liabilities", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para75", "text": "-2 includes estimated interest payments using a weighted average interest rate of 5.83 percent as of december 31, 2019.", "highlight": "interest payments using a weighted average interest rate of 5.83 percent", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para76", "text": "-3 includes imputed interest using a weighted average interest rate of 3.76 percent as of december 31, 2019.", "highlight": "imputed interest using a weighted average interest rate of 3.76 percent", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para77", "text": "the total amount of unrecognized tax benefits as of december 31, 2019 was $395 million. this amount is excluded from the table above because these unrecognized tax benefits are uncertain and subject to the findings of the taxing authorities in the jurisdictions where we are subject to taxation. it is possible that the amount of the liability for unrecognized tax benefits could change. refer to note 13: \"income taxes\" in our consolidated financial statements for additional information.", "highlight": "the total amount of unrecognized tax benefits as of december 31, 2019 was $395 million", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para78", "text": "Off-balance sheet arrangements our off-balance sheet arrangements as of december 31, 2019 included letters of credit of $60 million and guarantees with possible cash outlays of approximately $20 million for estimated probable exposure. additionally, we enter into purchase commitments in the normal course of business for which we are reimbursed by the owners of our managed and franchised hotels to operate our marketing, sales and brand programs. these obligations have minimal or no net effect on our future cash flows. see note 19: \"commitments and contingencies\" in our consolidated financial statements for additional information.", "highlight": "Off-balance sheet arrangements our off-balance sheet arrangements as of december 31, 2019 included letters of credit of $60 million and guarantees with possible cash outlays of approximately $20 million for estimated probable exposure ||| enter into purchase commitments in the normal course of business for which we are reimbursed by the owners of our managed and franchised hotels to operate our marketing, sales and brand programs", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 1, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para79", "text": "Critical accounting policies and estimates the preparation of our consolidated financial statements in accordance with gaap requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements, the reported amounts of revenues and expenses during the reporting periods and the related disclosures in the consolidated financial statements and accompanying footnotes. we believe that of our significant accounting policies, which are described in note 2: \"basis of presentation and summary of significant accounting policies\" in our consolidated financial statements, the following accounting policies are critical because they involve a higher degree of judgment, and the estimates required to be made were based on assumptions that are inherently uncertain. as a result, these accounting policies could materially affect our financial position, results of operations, cash flows and related disclosures. on an ongoing basis, we evaluate these estimates and judgments based on historical experiences and various other factors that are believed to reflect the current circumstances. while we believe our estimates, assumptions and judgments are reasonable, they are based on information presently available. actual results may differ significantly from these estimates due to changes in judgments, assumptions and conditions as a result of unforeseen events or otherwise, which could have a material effect on our financial position or results of operations.", "highlight": "Critical accounting policies and estimates the preparation of our consolidated financial statements in accordance with gaap requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements ||| actual results may differ significantly from these estimates due to changes in judgments, assumptions and conditions as a result of unforeseen events or otherwise, which could have a material effect on our financial position or results of operations.\r\n\r\nOverview\r\n\r\nIndustry\r\n\r\nRisk\r\n\r\nLegal\r\n\r\nFinancial Status\r\n\r\nStrategy", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para80", "text": "management has discussed the development and selection of the following critical accounting policies and estimates with the audit committee of the board of directors.", "highlight": "management has discussed the development and selection", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para81", "text": "Impairment of certain finite-lived assets if we determine there are indicators of impairment, we evaluate the carrying value of our specifically identifiable lease intangible assets, rou assets and property and equipment for potential impairment, as an asset group, if we determine there are indicators of impairment by comparing the expected undiscounted future cash flows to the net carrying value of the assets.", "highlight": "we evaluate the carrying value of our specifically identifiable lease intangible assets, rou assets and property and equipment for potential impairment", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para82", "text": "As part of the process described above, we exercise judgment to: Determine if there are indicators of impairment present. factors we consider when making this determination include assessing the overall effect of trends in the hospitality industry and the general economy, regional performance and expectations, historical experience, capital costs and other asset-specific information; Determine the projected undiscounted future cash flows when indicators of impairment are present. judgment is required when developing projections of future revenues and expenses based on estimated growth rates over the expected useful life of the asset group. forward-looking growth rate estimates are based on historical operating results, as well as various internal projections and external sources; and determine the asset group fair value when required. in determining the fair value, we often use internally-developed discounted cash flow models, as well as appraisals, recent similar transactions in the market and, if appropriate and available, current estimated net sales proceeds from pending offers. assumptions used in the discounted cash flow models include estimating cash flows, which may require us to adjust for specific market conditions, as well as capitalization rates, which are based on location, property or asset type, market-specific dynamics and overall economic performance. the discount rate applied to forward-looking projections takes into account our weighted average cost of capital according to our capital structure and other market specific considerations.", "highlight": "we exercise judgment to: Determine if there are indicators of impairment present ||| Determine the projected undiscounted future cash flows when indicators of impairment are present ||| determine the asset group fair value when required. in determining the fair value, we often use internally-developed discounted cash flow models, as well as appraisals, recent similar transactions in the market ||| market-specific dynamics and overall economic performance. the discount rate applied to forward-looking projections takes into account our weighted average cost of capital according to our capital structure and other market specific considerations.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para83", "text": "as of december 31, 2019, we had $114 million, $867 million and $380 million of other lease intangible assets net, operating lease right-of-use assets and property and equipment, net, respectively. changes in estimates and assumptions used in our impairment testing could result in future impairment losses, which could be material.", "highlight": "we had $114 million, $867 million and $380 million of other lease intangible assets net, operating lease right-of-use assets and property and equipment, net, respectively", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para84", "text": "Leases we record lease liabilities as the present value of the future minimum lease payments using a discount rate that is either the rate implicit in the lease, if available, or our incremental borrowing rate, adjusted for collateral. the collateralized incremental borrowing rate is estimated on a portfolio basis and reflects factors such as the term of the lease and the currency in which the lease payments will be made. the determination of the estimate of lease liabilities utilizes various assumptions that require judgment, including our adjustment for collateral, economic factors, including currency data, and our credit risk. the rou asset is measured at the amount of the lease liability, with applicable adjustments. refer to note 2: \"basis of presentation and summary of significant accounting policies\" in our consolidated financial statements for additional information.", "highlight": "we record lease liabilities as the present value of the future minimum lease payments using a discount rate that is either the rate implicit in the lease, if available, or our incremental borrowing rate, adjusted for collateral. the collateralized incremental borrowing rate is estimated on a portfolio basis and reflects factors such as the term of the lease and the currency in which the lease payments will be made.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para85", "text": "as of december 31, 2019, we had $1.4 billion of lease liabilities. if circumstances arise, such as a modification of an existing lease, that require the reassessment of the collateralized incremental borrowing rate, changes in the estimates previously used for such a modified arrangement could result in material changes to our lease liabilities.", "highlight": "we had $1.4 billion of lease liabilities", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para86", "text": "Hilton honors hilton honors records a point redemption liability for amounts received from participating hotels and program partners in an amount equal to the estimated cost per point of the future redemption obligation. we engage outside actuaries to assist in determining the fair value of the future award redemption obligation using statistical formulas that project future point redemptions based on factors that require judgment, including an estimate of \"breakage\" (points that will never be redeemed), an estimate of the points that will eventually be redeemed and the cost of the points to be redeemed. the cost of the points to be redeemed includes further estimates of available room nights, occupancy rates, room rates and any devaluation or appreciation of points based on changes in reward prices or changes in points earned per stay. any amounts received from participating hotels and program partners in excess of the actuarial determined cost per point are recorded as deferred revenue and recognized as revenue upon point redemption.", "highlight": "hilton honors records a point redemption liability for amounts received from participating hotels and program partners in an amount equal to the estimated cost per point of the future redemption obligation", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para87", "text": "in addition to the hilton honors fees we receive from hotel owners to operate the program, we earn fees from co-brand credit card arrangements for the use of our ip license and the issuance of hilton honors points. the allocation of the overall fees from the co-brand credit card arrangements between the ip license and the hilton honors points is based on their estimated standalone selling prices. the estimated standalone selling price of the ip license is determined using a relief-from-royalty valuation method using statistical formulas based on factors that require significant judgment, including estimates of credit card usage, an appropriate royalty rate and a discount rate to be applied to the projected cash flows. the estimated standalone selling price of the future reward redemptions of hilton honors points under the co-brand credit card arrangements is calculated using a discounted cash flow analysis with the same assumptions as the point redemption liability discussed above, adjusted for an appropriate margin.", "highlight": "we earn fees from co-brand credit card arrangements for the use of our ip license and the issuance of hilton honors points ||| the estimated standalone selling price of the future reward redemptions of hilton honors points under the co-brand credit card arrangements is calculated using a discounted cash flow analysis with the same assumptions as the point redemption liability discussed above, adjusted for an appropriate margin.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 3, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para88", "text": "as of december 31, 2019, we had a $1,859 million liability for guest loyalty program, including $799 million reflected as a current liability, and deferred revenues related to hilton honors of $396 million, including $161 million reflected as a current liability. changes in the estimates used in developing our breakage rate or other expected future program operations could result in material changes to our liability for guest loyalty program and deferred revenues.", "highlight": "had a $1,859 million liability for guest loyalty program, including $799 million reflected as a current liability, and deferred revenues related to hilton honors of $396 million, including $161 million reflected as a current liability.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para89", "text": "Income taxes we recognize deferred tax assets and liabilities based on the differences between the financial statement carrying values and the tax basis of assets and liabilities using currently enacted tax rates. we regularly review our deferred tax assets to assess their potential realization and establish a valuation allowance for portions of such assets that we believe will not be ultimately realized. in performing this review, we make estimates and assumptions regarding projected future taxable income, the expected timing of reversals of existing temporary differences and the implementation of tax planning strategies. a change in these assumptions may increase or decrease our valuation allowance resulting in an increase or decrease in our effective tax rate, which could materially affect our consolidated financial statements.", "highlight": "we recognize deferred tax assets and liabilities based on the differences between the financial statement carrying values and the tax basis of assets and liabilities using currently enacted tax rates", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para90", "text": "We use a prescribed more-likely-than-not recognition threshold for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return if there is uncertainty in income taxes recognized in the consolidated financial statements. when determining the amount of tax benefit to be recognized, we assume, among other items, the position will be examined, the examiner will have all relevant information and the evaluation of the position should be based on its technical merits. further, estimates based on a tax position's technical merits and amounts we would ultimately accept in a negotiated settlement with the tax authorities are used to measure the largest amount of benefit that is greater than 50 percent likely of being realized upon settlement. changes to these assumptions and estimates can lead to an additional income tax benefit (expense), which could materially affect our consolidated financial statements.", "highlight": "We use a prescribed more-likely-than-not recognition threshold for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return if there is uncertainty in income taxes recognized in the consolidated financial statements", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para91", "text": "Legal contingencies we are subject to various legal proceedings and claims, the outcomes of which are subject to significant uncertainty. an estimated loss from a loss contingency will be accrued as a charge to income if it is probable and the amount of the loss can be reasonably estimated. significant judgment is required when we evaluate, among other factors, the degree of probability of an unfavorable outcome and the ability to make a reasonable estimate of the amount of loss. changes in these factors could materially affect our consolidated financial statements.", "highlight": "we are subject to various legal proceedings and claims, the outcomes of which are subject to significant uncertainty. an estimated loss from a loss contingency will be accrued as a charge to income if it is probable and the amount of the loss can be reasonably estimated", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200211_10-K_1585689_part2_item7_para92", "text": "Consolidation we use judgment when evaluating whether we have a controlling financial interest in an entity, including the assessment of the importance of rights and privileges of the partners based on voting rights, as well as financial interests in an entity that are not controllable through voting interests. if an entity in which we hold an interest is considered to be a vie, we use judgment evaluating whether we are the primary beneficiary, and then consolidate those vies for which we have determined we are the primary beneficiary. if the entity in which we hold an interest does not meet the definition of a vie, we evaluate whether we have a controlling financial interest through our voting interests in the entity. changes to judgments used in evaluating our partnerships and other investments could materially affect our consolidated financial statements.", "highlight": "we use judgment when evaluating whether we have a controlling financial interest in an entity, including the assessment of the importance of rights and privileges of the partners based on voting rights, as well as financial interests in an entity that are not controllable through voting interests", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para1", "text": "Management's discussion and analysis of results of operations and financial condition Organization and business segments Description of the company and business segments johnson & johnson and its subsidiaries (the company) have approximately 132,200 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. the company conducts business in virtually all countries of the world with the primary focus on products related to human health and well-being.", "highlight": ". the company conducts business in virtually all countries of the world with the primary focus on products related to human health and well-being.", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para2", "text": "the company is organized into three business segments: consumer, pharmaceutical and medical devices. the consumer segment includes a broad range of products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health and wound care markets. these products are marketed to the general public and sold both to retail outlets and distributors throughout the world. the pharmaceutical segment is focused on six therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. products in this segment are distributed directly to retailers, wholesalers, hospitals and health care professionals for prescription use. the medical devices segment includes a broad range of products used in the orthopaedic, surgery, interventional solutions (cardiovascular and neurovascular) and eye health fields. these products are distributed to wholesalers, hospitals and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics.", "highlight": "the company is organized into three business segments: consumer, pharmaceutical and medical devices", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para3", "text": "the executive committee of johnson & johnson is the principal management group responsible for the strategic operations and allocation of the resources of the company. this committee oversees and coordinates the activities of the consumer, pharmaceutical and medical devices business segments.", "highlight": "the executive committee of johnson & johnson is the principal management group responsible for the strategic operations and allocation of the resources of the company", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para4", "text": "in all of its product lines, the company competes with other companies both locally and globally, throughout the world. competition exists in all product lines without regard to the number and size of the competing companies involved. competition in research, involving the development and the improvement of new and existing products and processes, is particularly significant. the development of new and innovative products, as well as protecting the underlying intellectual property of the company's product portfolio, is important to the company's success in all areas of its business. the competitive environment requires substantial investments in continuing research. in addition, the development and maintenance of customer demand for the company's consumer products involves significant expenditures for advertising and promotion.", "highlight": "the company competes with other companies both locally and globally, throughout the world. ||| competition in research, involving the development and the improvement of new and existing products and processes, is particularly significant ||| development and maintenance of customer demand for the company's consumer products involves significant expenditures for advertising and promotion.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para5", "text": "Management's objectives with \"our credo\" as the foundation, the company's purpose is to blend heart, science and ingenuity to profoundly change the trajectory of health for humanity. the company is committed to bringing its full breadth and depth to ensure health for people today and for future generations. united around this common ambition, the company is poised to fulfill its purpose and successfully meet the demands of the rapidly evolving markets in which it competes.", "highlight": "the company is poised to fulfill its purpose and successfully meet the demands of the rapidly evolving markets in which it competes.\r\n\r\nOverview\r\n\r\nIndustry\r\n\r\nRisk\r\n\r\nLegal\r\n\r\nFinancial Status\r\n\r\nStrategy", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para6", "text": "the company is broadly based in human healthcare, and is committed to creating value by developing accessible, high quality, innovative products and services. new products introduced within the past five years accounted for approximately 25% of 2019 sales. in 2019, $11.4 billion was invested in research and development and $5.8 billion spent on acquisitions, reflecting management's commitment to create life-enhancing innovations and to create value through partnerships that will profoundly change the trajectory of health for humanity.", "highlight": "new products introduced within the past five years accounted for approximately 25% of 2019 sales. ||| 11.4 billion was invested in research and development and $5.8 billion spent on acquisitions", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para7", "text": "a critical driver of the company's success is the 132,200 diverse employees worldwide. employees are empowered and inspired to lead with the company's our credo and purpose as guides. this allows every employee to use the company's reach and size to advance the company's purpose, and to also lead with agility and urgency. leveraging the extensive resources across the enterprise, enables the company to innovate and execute with excellence. this ensures the company can remain focused on addressing the unmet needs of society every day and invest for an enduring impact, ultimately delivering value to its patients, consumers and healthcare professionals, employees, communities and shareholders.", "highlight": "this ensures the company can remain focused on addressing the unmet needs of society every day and invest for an enduring impact", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para8", "text": "Results of operations Analysis of consolidated sales for discussion on results of operations and financial condition pertaining to the fiscal years 2018 and 2017 see the company's annual report on form 10-k for the fiscal year ended december 30, 2018, item 7. management's discussion and analysis of results of operations and financial condition.", "highlight": "annual report on form 10-k for the fiscal year ended december 30, 2018, item 7. management's discussion", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para9", "text": "In 2019, worldwide sales increased 0.6% to $82.1 billion as compared to an increase of 6.7% in 2018. these sales changes consisted of the following: Sales increase/(decrease) due to: 2019 2018 Volume 3.7 % 8.5 % Price -0.9 )-2.2 )Currency -2.2 )0.4 Total 0.6 % 6.7 % the net impact of acquisitions and divestitures on the worldwide sales growth was a negative impact of 1.7% in 2019 and a positive impact of 0.8% in 2018.", "highlight": "the net impact of acquisitions and divestitures on the worldwide sales growth was a negative impact of 1.7% in 2019 and a positive impact of 0.8% in 2018.\r\n ||| worldwide sales increased 0.6% to $82.1 billion as compared to an increase of 6.7% in 2018", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para10", "text": "sales by u.s. companies were $42.1 billion in 2019 and $41.9 billion in 2018. this represents increases of 0.5% in 2019 and 5.1% in 2018. sales by international companies were $40.0 billion in 2019 and $39.7 billion in 2018. this represents an increase of 0.7% in 2019 and 8.5% in 2018.", "highlight": "sales by u.s. companies were $42.1 billion in 2019 and $41.9 billion in 2018 ||| sales by international companies were $40.0 billion in 2019 and $39.7 billion in 2018", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para11", "text": "the five-year compound annual growth rates for worldwide, u.s. and international sales were 2.0%, 3.9% and 0.2%, respectively. the ten-year compound annual growth rates for worldwide, u.s. and international sales were 2.9%, 3.1% and 2.6%, respectively.", "highlight": "the five-year compound annual growth rates for worldwide, u.s. and international sales were 2.0%, 3.9% and 0.2%, respectively. the ten-year compound annual growth rates for worldwide, u.s. and international sales were 2.9%, 3.1% and 2.6%, respectively.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para12", "text": "in 2019, sales by companies in europe experienced a sales decline of 1.5% as compared to the prior year, which included operational growth of 3.8% offset by a negative currency impact of 5.3%. sales by companies in the western hemisphere (excluding the u.s.) experienced a sales decline of 2.8% as compared to the prior year, which included operational growth of 5.7% offset by a negative currency impact of 8.5%. sales by companies in the asia-pacific, africa region achieved growth of 4.9% as compared to the prior year, including operational growth of 6.9% partially offset by a negative currency impact of 2.0%.", "highlight": "sales by companies in europe experienced a sales decline of 1.5% as compared to the prior year, which included operational growth of 3.8% offset by a negative currency impact of 5.3%.  ||| sales by companies in the western hemisphere  |||  sales decline of 2.8% ||| asia-pacific, africa region achieved growth of 4.9% as compared to the prior year, including operational growth of 6.9% partially offset by a negative currency impact of 2.0%.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para13", "text": "in 2019, the company utilized three wholesalers distributing products for all three segments that represented approximately 15.0%, 12.0% and 11.0% of the total consolidated revenues. in 2018, the company had three wholesalers distributing products for all three segments that represented approximately 14.0%, 11.0% and 11.0% of the total consolidated revenues.", "highlight": "2019, the company utilized three wholesalers distributing products for all three segments that represented approximately 15.0%, 12.0% and 11.0% of the total consolidated revenues", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para14", "text": "Analysis of sales by business segments Consumer segment consumer segment sales in 2019 were $13.9 billion , an increase of 0.3% from 2018, which included 3.0% operational growth and a negative currency impact of 2.7%. u.s. consumer segment sales were $5.8 billion , an increase of 1.4% . international sales were $8.1 billion , a decrease of 0.4% , which included 4.2% operational growth and a negative currency impact of 4.6%. in 2019, acquisitions and divestitures had a net positive impact of 1.6% on the operational sales growth of the worldwide consumer segment.", "highlight": "Analysis of sales by business segments Consumer segment consumer segment sales in 2019 were $13.9 billion ||| consumer segment sales were $5.8 billion ||| international sales were $8.1 billion", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para15", "text": "Major consumer franchise sales: % change (dollars in millions) 2019 2018 '19 vs. '18 Beauty $4,593 4,382 4.8 % Otc 4,444 4,334 2.5 Baby care 1,675 1,858 -9.9 )Oral care 1,528 1,555 -1.7 )Women's health 986 1,049 -6.0 )Wound care/other 671 675 -0.6 )Total consumer sales $13,898 13,853 0.3 % The beauty franchise sales of $4.6 billion increased 4.8% as compared to the prior year. growth was primarily driven by incremental sales from the acquisition of ci:z holdings co., ltd., (dr.ci:labo) in japan as well as market growth and share gains of neutrogena And aveeno Products. growth was partially offset by the divestitures of roc And nizoral in the fiscal year 2018.", "highlight": "driven by incremental sales from the acquisition of ci:z holdings co., ltd., (dr.ci:labo) in japan as well as market growth and share gains of neutrogena And aveeno Products. growth was partially offset by the divestitures of roc And nizoral in the fiscal year 2018.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para16", "text": "The over-the-counter (otc) franchise sales of $4.4 billion increased 2.5% as compared to the prior year. growth was primarily driven by incremental sales from the acquisition of zarbees Additional contributors to the growth Were tylenol , children's motrin , digestive health products and anti-smoking aids.", "highlight": "franchise sales of $4.4 billion increased 2.5% as compared to the prior year", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para17", "text": "The baby care franchise sales were $1.7 billion in 2019, a decrease of 9.9% compared to the prior year, primarily due to johnson's competitive pressures coupled with comparisons to prior year relaunch activities and the baby center divestiture.", "highlight": "due to johnson's competitive pressures coupled with comparisons to prior year relaunch activities and the baby center divestiture", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para18", "text": "The oral care franchise sales of $1.5 billion decreased 1.7% as compared to the prior year. growth in listerine mouthwash and ready tabs outside the u.s. was offset by share declines and retailer destocking in the u.s. and the negative impact of currency.", "highlight": "The oral care franchise sales of $1.5 billion decreased 1.7% as compared to the prior year", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para19", "text": "the women's health franchise sales were $1.0 billion in 2019, a decrease of 6.0% as compared to the prior year. the decline was primarily driven by the negative impact of currency and weakness in liners partially offset by strength in napkins in asia pacific and latin america.", "highlight": "primarily driven by the negative impact of currency and weakness in liners partially offset by strength in napkins in asia pacific and latin america", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para20", "text": "The wound care/other franchise sales were $0.7 billion in 2019, a decrease of 0.6% as compared to the prior year. the decline was primarily driven by the divestiture of compeed outside the u.s. and the negative impact of currency.", "highlight": "driven by the divestiture of compeed outside the u.s. and the negative impact of currency.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para21", "text": "Pharmaceutical segment pharmaceutical segment sales in 2019 were $42.2 billion , an increase of 3.6% from 2018, which included operational growth of 5.8% and a negative currency impact of 2.2%. u.s. sales were $23.9 billion , an increase of 2.5% . international sales were $18.3 billion , an increase of 5.0% , which included 10.1% operational growth and a negative currency impact of 5.1%. in 2019, the net impact of acquisitions and divestitures on the pharmaceutical segment operational sales growth was negligible. adjustments to previous reserve estimates, as compared to the prior year, positively impacted the pharmaceutical segment operational growth by approximately 1.3%, primarily in the immunology and cardiovascular/metabolism/other therapeutic areas.", "highlight": "Pharmaceutical segment pharmaceutical segment sales in 2019 were $42.2 billion  ||| .s. sales were $23.9 billion ||| international sales were $18.3 billion ||| the net impact of acquisitions and divestitures on the pharmaceutical segment operational sales growth was negligible", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para22", "text": "Major pharmaceutical therapeutic area sales: % change (dollars in millions) 2019 2018 '19 vs. '18 Total immunology $13,950 13,120 6.3 % Remicade 4,380 5,326 -17.8 )Simponi /simponi aria 2,188 2,084 5.0 Stelara 6,361 5,156 23.4 Tremfya 1,012 544 85.9 Other immunology 10 10 4.5 Total infectious diseases 3,413 3,304 3.3 Edurant /rilpivirine 861 816 5.6 Prezista / prezcobix /rezolsta /symtuza 2,110 1,955 8.0 Other infectious diseases 441 533 -17.3 )Total neuroscience 6,328 6,077 4.1 Concerta /methylphenidate 696 663 4.9 Invega sustenna /xeplion /invega trinza /trevicta 3,330 2,928 13.7 Risperdal consta 688 737 -6.7 )Other neuroscience 1,614 1,749 -7.7 )Total oncology 10,692 9,844 8.6 Darzalex 2,998 2,025 48.0 Imbruvica 3,411 2,615 30.4 Velcade 751 1,116 -32.7 )Zytiga /abiraterone acetate 2,795 3,498 -20.1 )Other oncology 739 590 25.0 Total pulmonary hypertension 2,623 2,573 1.9 Opsumit 1,327 1,215 9.2 Tracleer /bosentan 341 546 -37.5 )Uptravi 819 663 23.5 Other pulmonary hypertension 135 149 -9.4 )Total cardiovascular / metabolism / other 5,192 5,816 -10.7 )Xarelto 2,313 2,477 -6.6 )Invokana / invokamet 735 881 -16.5 )Procrit /eprex 790 988 -20.0 )Other 1,353 1,470 -8.0 )Total pharmaceutical sales $42,198 40,734 3.6 % Immunology products sales were $14.0 billion in 2019, representing an increase of 6.3% as compared to the prior year. growth was driven by strong uptake of stelara (ustekinumab) in crohn's disease, and tremfya (guselkumab) in psoriasis, expanded indications of simponi /simponi aria (golimumab), and the u.s. immunology market growth. immunology was negatively impacted by lower sales of remicade (infliximab) due to increased discounts/rebates and biosimilar competition.", "highlight": "was driven by strong uptake of stelara (ustekinumab) in crohn's disease, and tremfya (guselkumab) in psoriasis, expanded indications of simponi /simponi aria (golimumab), and the u.s. immunology market growth. immunology was negatively impacted by lower sales of remicade (infliximab) due to increased discounts/rebates and biosimilar competition.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para23", "text": "The patents for remicade (infliximab) In certain countries in europe expired in february 2015. biosimilar versions of remicade Have been introduced in certain markets outside the u.s., resulting in a reduction in sales of remicade In those markets. additional biosimilar competition will likely result in a further reduction in remicade Sales in markets outside the united states. in the u.s., a biosimilar version of remicade Was introduced in 2016, and additional competitors continue to enter the market. continued infliximab biosimilar competition in the u.s. market will result in a further reduction in u.s. sales of remicade . see note 21 to the consolidated financial statements for a description of legal matters regarding the remicade patents.", "highlight": "Have been introduced in certain markets outside the u.s., resulting in a reduction in sales of remicade In those markets ||| continued infliximab biosimilar competition in the u.s. market will result in a further reduction in u.s. sales of remicade", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para24", "text": "Infectious disease products sales were $3.4 billion in 2019, representing an increase of 3.3% as compared to the prior year. strong sales of symtuza And The launch of juluca (dolutegravir/rilpivirine) were partially offset by lower sales of prezista And prezcobix /rezolsta (darunavir/cobicistat) due to increased competition and loss of exclusivity of prezista in certain countries outside the u.s.", "highlight": "Infectious disease products sales were $3.4 billion in 2019, representing an increase of 3.3% as compared to the prior year", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para25", "text": "Neuroscience products sales were $6.3 billion , representing an increase of 4.1% as compared to the prior year. strong sales of long-acting injectables invega trinza /trevicta (paliperidone palmitate) and invega sustenna /xeplion Were partially offset by cannibalization of risperdal consta (risperidone).", "highlight": "Neuroscience products sales were $6.3 billion , representing an increase of 4.1% as compared to the prior year", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para26", "text": "Oncology products achieved sales of $10.7 billion in 2019, representing an increase of 8.6% as compared to the prior year. contributors to the growth were strong sales of darzalex (daratumumab) with continued market growth and share gain, imbruvica (ibrutinib) due to increased patient uptake globally. additionally, sales from the launch of erleada (apalutamide) contributed to the growth. growth was negatively impacted from a decline in u.s. sales of zytiga (abiraterone acetate) driven by generic competition partially offset by increased sales outside the u.s. lower sales of velcade (bortezomib) were also due to generic competition.", "highlight": "Oncology products achieved sales of $10.7 billion in 2019, representing an increase of 8.6% as compared to the prior year", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para27", "text": "Pulmonary hypertension products achieved sales of $2.6 billion , representing an increase of 1.9% as compared to the prior year. sales of opsumit (macitentan) and uptravi (selexipag) were due to continued market growth and increased share gains while sales of tracleer (bosentan) were negatively impacted by generics and cannibalization from opsumit Cardiovascular/metabolism/other products sales were $5.2 billion , a decline of 10.7% as compared to the prior year. xarelto (rivaroxaban) sales volume growth was offset by higher discounts and rebates. lower sales of invokana /invokamet (canagliflozin) were due to share loss from competitive pressure and a safety label update in the u.s. and lower sales of procrit / eprex (epoetin alfa) were due to biosimilar competition.", "highlight": "Pulmonary hypertension products achieved sales of $2.6 billion , representing an increase of 1.9% as compared to the prior year ||| Cardiovascular/metabolism/other products sales were $5.2 billion , a decline of 10.7% as compared to the prior year", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para28", "text": "During 2019, the company advanced its pipeline with several regulatory submissions and approvals for new drugs and additional indications for existing drugs as follows: Product name (chemical name) Indication Us approval Eu approval Us filing Eu filing Balversa (erdafitinib) Treatment of locally advanced or metastatic urothelial cancer Darzalex (daratumumab) Combination regimen for newly diagnosed, transplant-eligible patients with multiple myeloma Newly diagnosed patients with multiple myeloma in combination with lenalidomide and dexamethasone Split-dosing regimen Combination therapy for transplant ineligible multiple myeloma patients Subcutaneous formulation in multiple myeloma Erleada (apalutamide) Treatment of metastatic castration-sensitive prostate cancer Treatment of metastatic hormone-sensitive prostate cancer Imbruvica (ibrutinib) Expanded use in combination with obinutuzumab in adult patients with previously untreated chronic lymphocytic leukemia and in combination with rituximab in waldenstr m's macroglobulinemia Treatment for chronic lymphocytic leukemia in combination with obinutuzumab Invokana (canagliflozin) Treatment of diabetic kidney disease Rilpivirine and cabotegravir For monthly, injectable, two drug regimen for treatment of hiv Spravato (esketamine) Treatment-resistant depression Rapid reduction of depressive symptoms in adults with major depressive disorder who have active suicidal ideation with intent Stelara (ustekinumab) Extended use for the treatment of moderately to severely active ulcerative colitis Treatment of pediatric patients with moderate to severe plaque psoriasis Tremfya (guselkumab) One-press patient-controlled injector Treatment of adults with active psoriatic arthritis Xarelto (rivaroxaban) For the prevention of blood clots in acutely ill medical patients Medical devices segment the medical devices segment sales in 2019 were $26.0 billion , a decrease of 3.8% from 2018, which included an operational decrease of 1.7% and a negative currency impact of 2.1%. u.s. sales were $12.4 billion , a decrease of 3.5% as compared to the prior year. international sales were $13.6 billion , a decrease of 4.1% as compared to the prior year, with an operational decrease of 0.1% and a negative currency impact of 4.0%. in 2019, the net impact of acquisitions and divestitures on the medical devices segment worldwide operational sales growth was a negative 5.6% of which, the divestitures of lifescan and advanced sterilization products (asp) had an impact of approximately 3.8% and 1.6%, respectively.", "highlight": "the company advanced its pipeline with several regulatory submissions and approvals for new drugs and additional indications for existing drugs as follows ||| For the prevention of blood clots in acutely ill medical patients Medical devices segment the medical devices segment sales in 2019 were $26.0 billion , a decrease of 3.8% from 2018 ||| in 2019, the net impact of acquisitions and divestitures on the medical devices segment worldwide operational sales growth was a negative 5.6% of which, the divestitures of lifescan and advanced sterilization products (asp) had an impact of approximately 3.8% and 1.6%, respectively.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para29", "text": "Major medical devices franchise sales: % change (dollars in millions) 2019 2018 '19 vs. '18 Surgery $9,501 9,901 -4.0 )% Advanced 4,095 4,002 2.3 General 4,480 4,557 -1.7 )Specialty 926 1,342 -31.0 )Orthopaedics 8,839 8,885 -0.5 )Hips 1,438 1,418 1.4 Knees 1,480 1,502 -1.4 )Trauma 2,720 2,699 0.8 Spine & other 3,201 3,266 -2.0 )Vision 4,624 4,553 1.6 Contact lenses/other 3,392 3,302 2.7 Surgical 1,232 1,251 -1.6 )Interventional solutions 2,997 2,646 13.3 Diabetes care -1 1,009 * Total medical devices sales $25,963 26,994 -3.8 )% -1 lifescan was divested in the fiscal fourth quarter of 2018.", "highlight": "Major medical devices franchise sales: % change (dollars in millions) 2019 2018 '19 vs. '18 Surgery $9,501 9,901 -4.0 )% Advanced 4,095 4,002 2.3 General 4,480 4,557 -1.7 )Specialty 926 1,342 -31.0 )Orthopaedics 8,839 8,885 -0.5 )Hips 1,438 1,418 1.4 Knees 1,480 1,502 -1.4 )Trauma 2,720 2,699 0.8 Spine & other 3,201 3,266 -2.0 )Vision 4,624 4,553 1.6 Contact lenses/other 3,392 3,302 2.7 Surgical 1,232 1,251 -1.6 )Interventional solutions 2,997 2,646 13.3 Diabetes care -1 1,009 * Total medical devices sales $25,963 26,994 -3.8 )%", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para30", "text": "*percentage greater than 100% or not meaningful the surgery franchise sales were $9.5 billion in 2019, a decrease of 4.0% from 2018. growth in advanced surgery was primarily driven by endocutter, biosurgery and energy products. the decline in general surgery was primarily driven by the negative impact of currency partially offset by growth of wound closure products. the decline in specialty surgery was primarily driven by the divestiture of the sterilization business (asp) partially offset by growth of aesthetic products.", "highlight": "percentage greater than 100% or not meaningful the surgery franchise sales were $9.5 billion in 2019, a decrease of 4.0% from 2018. growth in advanced surgery was primarily driven by endocutter, biosurgery and energy products", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para31", "text": "The orthopaedics franchise sales were $8.8 billion in 2019, a decrease of 0.5% , including operational growth of 1.2% offset by a negative currency impact of 1.7% as compared to the prior year. the growth in hips was driven by leadership position in the anterior approach, strong market demand for the actis Stem and the kincise surgical automated system. knees grew outside the u.s. from new products coupled with continued global uptake of attune Revision, offset by a negative currency impact. growth in trauma was due to strong market growth coupled with continued uptake of new products. the decline in spine & other was primarily driven by base business declines in spine partially offset by growth in sports which was led by new products, monovisc in the u.s. and growth in asia pacific.", "highlight": "from new products coupled with continued global uptake of attune Revision, offset by a negative currency impact ||| strong market growth coupled with continued uptake of new products. the decline in spine & other was primarily driven by base business declines in spine partially offset by growth in sports which was led by new products, monovisc in the u.s. and growth in asia pacific.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para32", "text": "The vision franchise achieved sales of $4.6 billion in 2019, an increase of 1.6% from 2018. growth was primarily driven by the strength of daily disposable lenses in the acuvue oasys contact lenses category. the surgical operational growth was primarily driven by the strength of cataracts outside the u.s. partially offset by competitive pressures in the u.s.", "highlight": "driven by the strength of daily disposable lenses in the acuvue oasys contact lenses category. the surgical operational growth was primarily driven by the strength of cataracts outside the u.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para33", "text": "The interventional solutions franchise achieved sales of $3.0 billion in 2019, an increase of 13.3% from 2018. strong growth in the electrophysiology business was driven by atrial fibrillation procedure growth and with strong thermocool smarttouch sf contact force sensing catheter and diagnostic catheter sales.", "highlight": "driven by atrial fibrillation procedure growth and with strong thermocool smarttouch sf contact force sensing catheter and diagnostic catheter sales.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para34", "text": "Analysis of consolidated earnings before provision for taxes on income consolidated earnings before provision for taxes on income was $17.3 billion and $18.0 billion for the fiscal years ended 2019 and 2018, respectively. as a percent to sales, consolidated earnings before provision for taxes on income was 21.1% and 22.1%, in 2019 and 2018, respectively.", "highlight": "Analysis of consolidated earnings before provision for taxes on income consolidated earnings before provision for taxes on income was $17.3 billion and $18.0 billion", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para35", "text": "Cost of products sold and selling, marketing and administrative expenses: cost of products sold and selling, marketing and administrative expenses as a percent to sales were as follows: % of sales 2019 2018 Cost of products sold 33.6 % 33.2 Percent point increase/(decrease) over the prior year 0.4 -0.1 )Selling, marketing and administrative expenses 27.0 % 27.6 Percent point increase/(decrease) over the prior year -0.6 )-0.5 )in 2019, cost of products sold as a percent to sales increased to 33.6% from 33.2% as compared to the same period a year ago primarily driven by the negative impact of currency in the pharmaceutical business as well as increased intangible asset amortization expense. intangible asset amortization expense of $4.5 billion was included in cost of products sold for 2019 as compared to $4.4 billion in 2018. there was a decrease in the percent to sales of selling, marketing and administrative expenses in 2019 as compared to the prior year, primarily due to favorable segment mix with a higher percentage of sales coming from the pharmaceutical business, planned prioritization and reduced brand marketing expense in the consumer business partially offset by increased selling and marketing investments in the medical devices business.", "highlight": "primarily due to favorable segment mix with a higher percentage of sales coming from the pharmaceutical business, planned prioritization and reduced brand marketing expense in the consumer business partially offset by increased selling and marketing investments in the medical devices business.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 1, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para36", "text": "Research and development expense: research and development expense by segment of business was as follows: 2019 2018 (dollars in millions) Amount % of sales* Amount % of sales* Consumer $493 3.5 % 565 4.1 Pharmaceutical 8,834 20.9 8,446 20.7 Medical devices 2,028 7.8 1,764 6.5 Total research and development expense $11,355 13.8 % 10,775 13.2 Percent increase/(decrease) over the prior year 5.4 % 1.7 *as a percent to segment sales research and development activities represent a significant part of the company's business. these expenditures relate to the processes of discovering, testing and developing new products, upfront payments and developmental milestones, improving existing products, as well as ensuring product efficacy and regulatory compliance prior to launch. the company remains committed to investing in research and development with the aim of delivering high quality and innovative products. in 2019, worldwide costs of research and development activities increased by 5.4% compared to 2018 primarily driven by increased investment in the medical devices business related to robotics and digital surgery platforms along with higher upfront and developmental milestone payments, primarily from the argenx collaboration in the pharmaceutical business.", "highlight": "primarily driven by increased investment in the medical devices business related to robotics and digital surgery platforms along with higher upfront and developmental milestone payments, primarily from the argenx collaboration in the pharmaceutical business.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para37", "text": "research facilities are located in the u.s., belgium, brazil, china, france, germany, india, israel, the netherlands, poland, singapore, sweden, switzerland and the united kingdom with additional r&d support in over 30 other countries.", "highlight": "research facilities are located in the u.s., belgium, brazil, china, france, germany, india, israel, the netherlands, poland, singapore, sweden, switzerland and the united kingdom", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para38", "text": "in-process research and development (ipr&d): in the fiscal first quarter of 2019, the company recorded an ipr&d charge of $0.9 billion for the remaining intangible asset value related to the development program of al-8176, an investigational drug for the treatment of respiratory syncytial virus (rsv) and human metapneumovirus (hmpv) acquired with the 2014 acquisition of alios biopharma inc. the impairment charge was based on additional information, including clinical data, which became available and led to the company's decision to abandon the development of al-8176. in the fiscal third quarter of 2018, the company recorded an impairment charge of $1.1 billion which included a partial impairment charge of $0.8 billion related to the development program of al-8176 and an impairment charge of $0.3 billion for the discontinuation of the development project for an anti-thrombin antibody associated with the 2015 acquisition of xo1 limited.", "highlight": "the company recorded an ipr&d charge of $0.9 billion for the remaining intangible asset value related to the development program of al-8176, an investigational drug for the treatment of respiratory syncytial virus (rsv) and human metapneumovirus (hmpv) acquired with the 2014 acquisition of alios biopharma inc. the impairment charge was based on additional information, including clinical data, which became available and led to the company's decision to abandon the development of al-8176", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para39", "text": "other (income) expense, net: other (income) expense, net is the account where the company records gains and losses related to the sale and write-down of certain investments in equity securities held by johnson & johnson innovation - jjdc, inc. (jjdc), unrealized gains and losses on investments, gains and losses on divestitures, certain transactional currency gains and losses, acquisition-related costs, litigation accruals and settlements, as well as royalty income.", "highlight": "unrealized gains and losses on investments, gains and losses on divestitures, certain transactional currency gains and losses, acquisition-related costs, litigation accruals and settlements, as well as royalty income.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 3, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para40", "text": "The change in other (income) expense, net for the fiscal year 2019 was additional net expense of $1.1 billion primarily attributable to litigation expense of $5.1 billion in 2019, primarily related to the agreement in principle to settle opioid litigation of $4.0 billion, as compared to litigation expense of $2.0 billion in 2018. this was partially offset by divestiture gains in 2019 of $2.2 billion of which $2.0 billion related to the divestiture of the asp business. in addition, the fiscal year 2019 included higher unrealized gains on securities of $0.7 billion, an equity step-up gain of $0.3 billion related to the company's previously held equity investment in dr. ci:labo, and lower restructuring related expense of $0.2 billion as compared to the same period a year ago. divestiture gains were approximately $1.2 billion in 2018 and included the lifescan business, nizoral , roc and certain non-strategic pharmaceutical products. additionally, 2018 included a reversal of a contingent liability of $0.2 billion.", "highlight": "divestiture gains were approximately $1.2 billion in 2018 and included the lifescan business, nizoral , roc and certain non-strategic pharmaceutical products. additionally, 2018 included a reversal of a contingent liability of $0.2 billion.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para41", "text": "interest (income) expense: the fiscal year 2019 included net interest income as compared to an expense in the fiscal year 2018. this was primarily due to the positive effect of net investment hedging arrangements and certain cross currency swaps, and a lower average debt balance. cash, cash equivalents and marketable securities totaled $19.3 billion at the end of 2019, and averaged $19.5 billion as compared to the cash, cash equivalents and marketable securities total of $19.7 billion and $19.0 billion average cash balance in 2018. the total debt balance at the end of 2019 was $27.7 billion with an average debt balance of $29.1 billion as compared to $30.5 billion at the end of 2018 and an average debt balance of $32.5 billion. the decrease in debt was due to the retirement of long-term debt.", "highlight": "primarily due to the positive effect of net investment hedging arrangements and certain cross currency swaps, and a lower average debt balance", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para42", "text": "Income before tax by segment Income before tax by segment of business were as follows: Income before tax Segment sales Percent of segment sales (dollars in millions) 2019 2018 2019 2018 2019 2018 Consumer $2,061 2,320 13,898 13,853 14.8 % 16.7 Pharmaceutical 8,816 12,568 42,198 40,734 20.9 30.9 Medical devices 7,286 4,397 25,963 26,994 28.1 16.3 Total -1 18,163 19,285 82,059 81,581 22.1 23.6 Less: net expense not allocated to segments -2 835 1,286 Earnings before provision for taxes on income $17,328 17,999 82,059 81,581 21.1 % 22.1 -1 see note 18 to the consolidated financial statements for more details.", "highlight": "Income before tax Segment sales Percent of segment sales (dollars in millions) 2019 2018 2019 2018 2019 2018 Consumer $2,061 2,320 13,898 13,853 14.8 % 16.7 Pharmaceutical 8,816 12,568 42,198 40,734 20.9 30.9 Medical devices 7,286 4,397 25,963 26,994 28.1 16.3 Total -1 18,163 19,285 82,059 81,581 22.1 23.6 Less: net expense not allocated to segments -2 835 1,286 Earnings before provision for taxes on income $17,328 17,999 82,059 81,581 21.1 % 22.1 -1", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para43", "text": "-2 amounts not allocated to segments include interest (income) expense and general corporate (income) expense.", "highlight": "amounts not allocated to segments include interest (income) expense and general corporate (income) expense.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para44", "text": "Consumer segment: in 2019, the consumer segment income before tax as a percent to sales was 14.8% , versus 16.7% in 2018. the decrease in the income before tax as a percent of sales in 2019 as compared to 2018 was primarily attributable to higher expenses for litigation of $0.1 billion, intangible asset amortization of $0.1 billion and restructuring of $0.1 billion in the fiscal year 2019 as compared to the fiscal year 2018. this was partially offset by planned prioritization and brand marketing expense reductions. the fiscal year 2019 included a gain of $0.3 billion related to the company's previously held equity investment in dr. ci:labo. divestiture gains for the fiscal year of 2018 included a gain of $0.3 billion from the divestiture of nizoral pharmaceutical segment: in 2019, the pharmaceutical segment income before tax as a percent to sales was 20.9% versus 30.9% in 2018. the decrease in the income before tax as a percent of sales was primarily due to higher litigation expense of $4.3 billion, primarily due to the agreement in principle to settle opioid litigation of $4.0 billion, increased spending in research and development, including a $0.3 billion upfront payment to argenx. this was partially offset by $0.8 billion of higher unrealized gains on securities, a lower in-process research and development charge of $0.2 billion, and lower actelion acquisition and integration related costs as compared to the fiscal year 2018. in addition, the fiscal year 2018 included a contingent liability reversal of $0.2 billion and higher divestiture gains of $0.2 billion.", "highlight": "was primarily attributable to higher expenses for litigation of $0.1 billion, intangible asset amortization of $0.1 billion and restructuring of $0.1 billion in the fiscal year 2019 as compared to the fiscal year 2018 ||| primarily due to the agreement in principle to settle opioid litigation of $4.0 billion, increased spending in research and development, including a $0.3 billion upfront payment to argenx. this was partially offset by $0.8 billion of higher unrealized gains on securities, a lower in-process research and development charge of $0.2 billion, and lower actelion acquisition and integration related costs as compared to the fiscal year 2018", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para45", "text": "medical devices segment: in 2019, the medical devices segment income before tax as a percent to sales was 28.1% versus 16.3% in 2018. the increase in the income before tax as a percent to sales was primarily attributable to higher divestiture gains in 2019. divestiture gains in the fiscal 2019 included a gain of $2.0 billion related to the asp business. divestiture gains for the fiscal year of 2018 included a gain of $0.5 billion related to lifescan. additionally, the fiscal year 2019 included lower litigation expense of $1.3 billion, lower restructuring charges of $0.2 billion and lower intangible asset amortization expense of $0.1 billion as compared to the fiscal year 2018. this was partially offset by increased investment in robotics and digital solutions.", "highlight": "the medical devices segment income before tax as a percent to sales was 28.1% versus 16.3% in 2018 ||| divestiture gains in the fiscal 2019 included a gain of $2.0 billion related to the asp business ||| the fiscal year 2019 included lower litigation expense of $1.3 billion", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para46", "text": "restructuring: in the fiscal second quarter of 2018, the company announced plans to implement actions across its global supply chain that are intended to enable the company to focus resources and increase investments in critical capabilities, technologies and solutions necessary to manufacture and supply its product portfolio of the future, enhance agility and drive growth. the company expects these supply chain actions will include expanding its use of strategic collaborations, and bolstering its initiatives to reduce complexity, improving cost-competitiveness, enhancing capabilities and optimizing its network. discussions regarding specific future actions are ongoing and are subject to all relevant consultation requirements before they are finalized. in total, the company expects these actions to generate approximately $0.6 to $0.8 billion in annual pre-tax cost savings that will be substantially delivered by 2022. the company expects to record pre-tax restructuring charges of approximately $1.9 to $2.3 billion. the company estimates that approximately 70% of the cumulative pre-tax costs will result in cash outlays. in 2019, the company recorded a pre-tax charge of $0.6 billion, which is included on the following lines of the consolidated statement of earnings, $0.3 billion in restructuring, $0.2 billion in other (income) expense and $0.1 billion in cost of products sold. total project costs of approximately $0.8 billion have been recorded since the restructuring was announced.", "highlight": "announced plans to implement actions across its global supply chain that are intended to enable the company to focus resources and increase investments in critical capabilities, technologies and solutions necessary to manufacture and supply its product portfolio of the future, enhance agility and drive growth ||| company expects these actions to generate approximately $0.6 to $0.8 billion in annual pre-tax cost savings that will be substantially delivered by 2022 ||| estimates that approximately 70% of the cumulative pre-tax costs will result in cash outlays. in 2019, the company recorded a pre-tax charge of $0.6 billion", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 1, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para47", "text": "see note 22 to the consolidated financial statements for additional details related to the restructuring programs.", "highlight": "note 22 to the consolidated financial statements for", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para48", "text": "provision for taxes on income: the worldwide effective income tax rate was 12.7% in 2019 and 15.0% in 2018 .", "highlight": "provision for taxes on income: the worldwide effective income tax rate was 12.7%", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 2, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para49", "text": "for discussion related to the fiscal 2019 provision for taxes refer to note 8 to the consolidated financial statements.", "highlight": "refer to note 8 to the consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para50", "text": "on september 28, 2018 the swiss parliament approved the federal act on tax reform and ahv financing (traf). on may 19, 2019 a public referendum was held in switzerland that approved the federal reform proposals. in the fiscal third quarter of 2019, the swiss federal council enacted traf which became effective on january 1, 2020. on february 9, 2020 a public referendum on the legislative change was held in the last remaining canton where the company has significant operations. the legislation was approved by the voters and formal enactment is expected in the fiscal first half of 2020. the company has not yet elected the transitional provision in this canton. however, the net financial benefit is estimated to be between $0.2 billion and $0.5 billion in the fiscal first half of 2020. the company does not believe that traf will have a material impact to the company's ongoing consolidated effective tax rate beginning in fiscal year 2020.", "highlight": "swiss parliament approved the federal act on tax reform and ahv financing (traf ||| public referendum was held in switzerland that approved the federal reform proposals ||| the legislation was approved by the voters and formal enactment is expected in the fiscal first half of 2020.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para51", "text": "Liquidity and capital resources Liquidity & cash flows cash and cash equivalents were $17.3 billion at the end of 2019 as compared to $18.1 billion at the end of 2018. the primary sources and uses of cash that contributed to the $0.8 billion decrease were approximately $23.4 billion of cash generated from operating activities. this was offset by $6.2 billion net cash used by investing activities and $18.0 billion net cash used by financing activities. in addition, the company had $2.0 billion in marketable securities at the end of 2019 and $1.6 billion at the end of 2018. see note 1 to the consolidated financial statements for additional details on cash, cash equivalents and marketable securities.", "highlight": "cash and cash equivalents were $17.3 billion at the end of 2019 as compared to $18.1 billion at the end of 2018 ||| the company had $2.0 billion in marketable securities at the end of 2019 and $1.6 billion at the end of 2018", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para52", "text": "cash flow from operations of $23.4 billion was the result of $15.1 billion of net earnings and $9.1 billion of non-cash expenses and other adjustments for depreciation and amortization, stock-based compensation, assets write-downs (primarily related to the alios ipr&d asset), and favorable increases in accounts payable, accrued liabilities and other liabilities of $5.5 billion. this was reduced by $1.6 billion related to an increase in accounts receivable, inventories, other current and non-current assets. as well as non-cash expenses and other adjustments of $2.5 billion for the increase in the deferred tax provision and a net gain on sale of assets/businesses of $2.2 billion (primarily related to the asp divestiture).", "highlight": "cash flow from operations of $23.4 billion was the result of $15.1 billion of net earnings and $9.1 billion of non-cash expenses and other adjustments ||| this was reduced by $1.6 billion related to an increase in accounts receivable, inventories, other current and non-current assets. as well as non-cash expenses and other adjustments of $2.5 billion for the increase in the deferred tax provision and a net gain on sale of assets/businesses of $2.2 billion", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para53", "text": "investing activities use of $6.2 billion of cash was primarily used for acquisitions of $5.8 billion primarily related to the acquisitions of auris health, inc. and dr. ci:labo, additions to property, plant and equipment of $3.5 billion and $0.5 billion from the net purchases of investments. investing activities also included a source of $3.3 billion of proceeds from the disposal of assets/businesses, primarily the asp divestiture, and proceeds from credit support agreements of $0.3 billion.", "highlight": "investing activities use of $6.2 billion of cash was primarily used for acquisitions of $5.8 billion primarily related to the acquisitions of auris health, inc. and dr. ci:labo, ||| plant and equipment of $3.5 billion and $0.5 billion from the net purchases of investments ||| included a source of $3.3 billion of proceeds from the disposal of assets/businesses", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para54", "text": "financing activities use of $18.0 billion of cash was primarily used for dividends to shareholders of $9.9 billion, the repurchase of common stock of $6.7 billion and the net retirement of short and long term debt of $2.9 billion. financing activities also included sources of $1.5 billion from proceeds of stock options exercised/employee withholding tax on stock awards, and other financing activities.", "highlight": "financing activities use of $18.0 billion of cash was primarily used for dividends to shareholders of $9.9 billion, the repurchase of common stock of $6.7 billion and the net retirement of short and long term debt of $2.9 billion ||| $1.5 billion from proceeds of stock options exercised/employee withholding tax on stock awards", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para55", "text": "on december 17, 2018, the company announced that its board of directors approved a share repurchase program, authorizing the company to purchase up to $5.0 billion of the company's shares of common stock. shares acquired are available for general corporate purposes. the company financed the share repurchase program through available cash. as of september 29, 2019, $5.0 billion was repurchased under the program and the program was completed.", "highlight": "the company announced that its board of directors approved a share repurchase program, authorizing the company to purchase up to $5.0 billion of the company's shares of common stock ||| $5.0 billion was repurchased under the program and the program was completed.\r\n\r\nOverview\r\n\r\nIndustry\r\n\r\nRisk\r\n\r\nLegal\r\n\r\nFinancial Status", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para56", "text": "as of december 29, 2019, the company's notes payable and long-term debt was in excess of cash, cash equivalents and marketable securities. as of december 29, 2019, the net debt position was $8.4 billion as compared to the prior year of $10.8 billion. there was a decrease in the net debt position due to retirement of debt. the debt balance at the end of 2019 was $27.7 billion as compared to $30.5 billion in 2018. in 2019, the company continued to have access to liquidity through the commercial paper market. additionally, as a result of the tcja, the company has access to its cash outside the u.s. at a significantly reduced cost. the company anticipates that operating cash flows, the ability to raise funds from external sources, borrowing capacity from existing committed credit facilities and access to the commercial paper markets will continue to provide sufficient resources to fund operating needs, including the agreement in principle to settle opioid litigation to be potentially paid over the next two to three years. as discussed in note 8 to the consolidated financial statements, the internal revenue service (irs) has completed its audit for the tax years through 2009 and is currently auditing the tax years 2010-2012. the company currently expects completion of this audit and settlement of the related tax liabilities in the fiscal year 2020. as of december 29, 2019, the company has classified unrecognized tax benefits and related interest of approximately $0.9 billion as a current liability in the \"accrued taxes on income\" line in the consolidated balance sheet. this is the amount expected to be paid over the next 12 months with respect to the irs audit. subsequent to december 29, 2019, the company made a payment for approximately $0.6 billion to the u.s. treasury related to the estimated 2010-2012 tax audit liability in anticipation of the final settlement later in fiscal 2020. the completion of this tax audit may result in additional adjustments to the company's unrecognized tax benefit liability that may have a material impact on the company's future operating results or cash flows in the period that the audit is substantially completed.", "highlight": "the net debt position was $8.4 billion as compared to the prior year of $10.8 billion. ||| the debt balance at the end of 2019 was $27.7 billion as compared to $30.5 billion in 2018 ||| the internal revenue service (irs) has completed its audit for the tax years through 2009 and is currently auditing the tax years 2010-2012 ||| the company made a payment for approximately $0.6 billion to the u.s. treasury related to the estimated 2010-2012 tax audit liability in anticipation of the final settlement later in fiscal 2020", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para57", "text": "the company monitors the global capital markets on an ongoing basis and from time to time may raise capital when market conditions are favorable. the company filed a shelf registration on february 27, 2017, which will enable it to issue debt securities on a timely basis and will be updated as required. for additional details on borrowings, see note 7 to the consolidated financial statements.", "highlight": "the company filed a shelf registration on february 27, 2017, which will enable it to issue debt securities on a timely basis and will be updated as required.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para58", "text": "Financing and market risk The company uses financial instruments to manage the impact of foreign exchange rate changes on cash flows. accordingly, the company enters into forward foreign exchange contracts to protect the value of certain foreign currency assets and liabilities and to hedge future foreign currency transactions primarily related to product costs. gains or losses on these contracts are offset by the gains or losses on the underlying transactions. a 10% appreciation of the u.s. dollar from the december 29, 2019 market rates would increase the unrealized value of the company's forward contracts by $271 million. conversely, a 10% depreciation of the u.s. dollar from the december 29, 2019 market rates would decrease the unrealized value of the company's forward contracts by $331 million. in either scenario, the gain or loss on the forward contract would be offset by the gain or loss on the underlying transaction, and therefore, would have no impact on future anticipated earnings and cash flows.", "highlight": "The company uses financial instruments to manage the impact of foreign exchange rate changes on cash flows |||  a 10% appreciation of the u.s. dollar from the december 29, 2019 market rates would increase the unrealized value of the company's forward contracts by $271 million", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para59", "text": "the company hedges the exposure to fluctuations in currency exchange rates, and the effect on certain assets and liabilities in foreign currency, by entering into currency swap contracts. a 1% change in the spread between u.s. and foreign interest rates on the company's interest rate sensitive financial instruments would either increase or decrease the unrealized value of the company's swap contracts by approximately $1,043 million. in either scenario, at maturity, the gain or loss on the swap contract would be offset by the gain or loss on the underlying transaction, and therefore, would have no impact on future anticipated cash flows.", "highlight": "hedges the exposure to fluctuations in currency exchange rates ||| the gain or loss on the swap contract would be offset by the gain or loss on the underlying transaction", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para60", "text": "the company does not enter into financial instruments for trading or speculative purposes. further, the company has a policy of only entering into contracts with parties that have at least an investment grade credit rating. the counter-parties to these contracts are major financial institutions and there is no significant concentration of exposure with any one counter-party. management believes the risk of loss is remote. during the fiscal second quarter of 2017, the company entered into credit support agreements (csa) with certain derivative counterparties establishing collateral thresholds based on respective credit ratings and netting agreements. see note 6 to the consolidated financial statements for additional details on credit support agreements.", "highlight": "management believes the risk of loss is remote ||| the company entered into credit support agreements (csa) with certain derivative counterparties establishing collateral thresholds based on respective credit ratings and netting agreements", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para61", "text": "the company invests in both fixed rate and floating rate interest earning securities which carry a degree of interest rate risk. the fair market value of fixed rate securities may be adversely impacted due to a rise in interest rates, while floating rate securities may produce less income than predicted if interest rates fall. a 1% (100 basis points) change in spread on the company's interest rate sensitive investments would either increase or decrease the unrealized value of cash equivalents and current marketable securities by approximately $7 million.", "highlight": "the fair market value of fixed rate securities may be adversely impacted due to a rise in interest rates, while floating rate securities may produce less income than predicted if interest rates fall.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para62", "text": "the company has access to substantial sources of funds at numerous banks worldwide. in september 2019, the company secured a new 364-day credit facility. total credit available to the company approximates $10 billion, which expires on september 10, 2020. interest charged on borrowings under the credit line agreement is based on either bids provided by banks, the prime rate, london interbank offered rates (libor), or other applicable market rate as allowed under the terms of the agreement, plus applicable margins. commitment fees under the agreement are not material.", "highlight": "the company has access to substantial sources of funds at numerous banks worldwide ||| total credit available to the company approximates $10 billion, which expires on september 10, 2020", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para63", "text": "total borrowings at the end of 2019 and 2018 were $27.7 billion and $30.5 billion, respectively. the decrease in borrowings was due to the retirement of debt in 2019. in 2019, net debt (cash and current marketable securities, net of debt) was $8.4 billion compared to net debt of $10.8 billion in 2018. total debt represented 31.8% of total capital (shareholders' equity and total debt) in 2019 and 33.8% of total capital in 2018. shareholders' equity per share at the end of 2019 was $22.59 compared to $22.44 at year-end 2018 .", "highlight": "total borrowings at the end of 2019 and 2018 were $27.7 billion and $30.5 billion, respectively ||| total debt represented 31.8% of total capital (shareholders' equity and total debt) in 2019 and 33.8% of total capital in 2018. shareholders' equity per share at the end of 2019 was $22.59 compared to $22.44 at year-end 2018 .", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para64", "text": "a summary of borrowings can be found in note 7 to the consolidated financial statements.", "highlight": "note 7 to the consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para65", "text": "Contractual obligations and commitments The company's contractual obligations are primarily for the recently enacted tax legislation, leases, debt and unfunded retirement plans. there are no other significant obligations. to satisfy these obligations, the company will use cash from operations. the following table summarizes the company's contractual obligations and their aggregate maturities as of december 29, 2019 (see notes 7, 8, 10 and 16 to the consolidated financial statements for further details): (dollars in millions) Tax legislation (tcja) Debt obligations Interest on Debt obligations Unfunded Retirement plans Leases Total 2020 $528 1,100 886 103 215 2,832 2021 812 1,797 841 107 254 3,811 2022 812 2,106 796 113 197 4,024 2023 1,522 1,552 764 118 141 4,097 2024 2,029 1,474 729 127 86 4,445 After 2024 2,536 19,565 8,121 749 201 31,172 Total $8,239 27,594 12,137 1,317 1,094 50,381 for tax matters, see note 8 to the consolidated financial statements. for other retirement plan and post-employment medical benefit information, see note 10 to the consolidated financial statements. the table does not include activity related to business combinations.", "highlight": "The company's contractual obligations are primarily for the recently enacted tax legislation, leases, debt and unfunded retirement plans", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para66", "text": "Dividends the company increased its dividend in 2019 for the 57th consecutive year. cash dividends paid were $3.75 per share in 2019 and $3.54 per share in 2018 .", "highlight": "Dividends the company increased its dividend in 2019 for the 57th consecutive year", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para67", "text": "Other information Critical accounting policies and estimates management's discussion and analysis of results of operations and financial condition are based on the company's consolidated financial statements that have been prepared in accordance with accounting principles generally accepted in the u.s. (gaap). the preparation of these financial statements requires that management make estimates and assumptions that affect the amounts reported for revenues, expenses, assets, liabilities and other related disclosures. actual results may or may not differ from these estimates. the company believes that the understanding of certain key accounting policies and estimates are essential in achieving more insight into the company's operating results and financial condition. these key accounting policies include revenue recognition, income taxes, legal and self-insurance contingencies, valuation of long-lived assets, assumptions used to determine the amounts recorded for pensions and other employee benefit plans and accounting for stock based awards.", "highlight": "the company believes that the understanding of certain key accounting policies and estimates are essential in achieving more insight into the company's operating results and financial condition", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para68", "text": "revenue recognition: the company recognizes revenue from product sales when obligations under the terms of a contract with the customer are satisfied; generally, this occurs with the transfer of control of the goods to customers. the company's global payment terms are typically between 30 to 90 days. provisions for certain rebates, sales incentives, trade promotions, coupons, product returns and discounts to customers are accounted for as variable consideration and recorded as a reduction in sales. see note 1 to the consolidated financial statements for the accounting standards update related to revenue which was adopted in 2018.", "highlight": "the company recognizes revenue from product sales when obligations under the terms of a contract with the customer are satisfied; generally, this occurs with the transfer of control of the goods to customers", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para69", "text": "product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including consideration of competitor pricing. rebates are estimated based on contractual terms, historical experience, patient outcomes, trend analysis and projected market conditions in the various markets served. the company evaluates market conditions for products or groups of products primarily through the analysis of wholesaler and other third-party sell-through and market research data, as well as internally generated information.", "highlight": "product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para70", "text": "sales returns are estimated and recorded based on historical sales and returns information. products that exhibit unusual sales or return patterns due to dating, competition or other marketing matters are specifically investigated and analyzed as part of the accounting for sales return accruals.", "highlight": "sales returns are estimated and recorded based on historical sales and returns information", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para71", "text": "sales returns allowances represent a reserve for products that may be returned due to expiration, destruction in the field, or in specific areas, product recall. the sales returns reserve is based on historical return trends by product and by market as a percent to gross sales. in accordance with the company's accounting policies, the company generally issues credit to customers for returned goods. the company's sales returns reserves are accounted for in accordance with the u.s. gaap guidance for revenue recognition when right of return exists. sales returns reserves are recorded at full sales value. sales returns in the consumer and pharmaceutical segments are almost exclusively not resalable. sales returns for certain franchises in the medical devices segment are typically resalable but are not material. the company infrequently exchanges products from inventory for returned products. the sales returns reserve for the total company has been approximately 1.0% of annual net trade sales during the fiscal reporting years 2019 and 2018 .", "highlight": "sales returns allowances represent a reserve for products that may be returned due to expiration, destruction in the field, or in specific areas, product recall. the sales returns reserve is based on historical return trends by product and by market as a percent to gross sales ||| the sales returns reserve for the total company has been approximately 1.0% of annual net trade sales during the fiscal reporting years 2019 and 2018 .", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para72", "text": "promotional programs, such as product listing allowances and cooperative advertising arrangements, are recorded in the same period as related sales. continuing promotional programs include coupons and volume-based sales incentive programs. the redemption cost of consumer coupons is based on historical redemption experience by product and value. volume-based incentive programs are based on the estimated sales volumes for the incentive period and are recorded as products are sold. these arrangements are evaluated to determine the appropriate amounts to be deferred or recorded as a reduction of revenue. the company also earns profit-share payments through collaborative arrangements of certain products, which are included in sales to customers. for all years presented, profit-share payments were approximately 2.0% of the total revenues and are included in sales to customers.", "highlight": "promotional programs, such as product listing allowances and cooperative advertising arrangements, are recorded in the same period as related sales. ||| profit-share payments were approximately 2.0% of the total revenues and are included in sales to customers.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 3, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para73", "text": "in addition, the company enters into collaboration arrangements that contain multiple revenue generating activities. amounts due from collaborative partners for these arrangements are recognized as each activity is performed or delivered, based on the relative selling price. upfront fees received as part of these arrangements are deferred and recognized over the performance period. see note 1 to the consolidated financial statements for additional disclosures on collaborations.", "highlight": "the company enters into collaboration arrangements that contain multiple revenue generating activities", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 1, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para74", "text": "reasonably likely changes to assumptions used to calculate the accruals for rebates, returns and promotions are not anticipated to have a material effect on the financial statements. the company currently discloses the impact of changes to assumptions in the quarterly or annual filing in which there is a material financial statement impact.", "highlight": "the company currently discloses the impact of changes to assumptions in the quarterly or annual filing in which there is a material financial statement impact.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para75", "text": "below are tables that show the progression of accrued rebates, returns, promotions, reserve for doubtful accounts and reserve for cash discounts by segment of business for the fiscal years ended december 29, 2019 and december 30, 2018 .", "highlight": "show the progression of accrued rebates, returns, promotions, reserve for doubtful accounts and reserve for cash discounts by segment of business", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para76", "text": "Consumer segment (dollars in millions) Balance at Beginning of period Accruals Payments/credits Balance at End of period 2019 Accrued rebates -1 $271 841 -828 )284 Accrued returns 57 128 -122 )63 Accrued promotions 497 2,119 -2,129 )487 Subtotal $825 3,088 -3,079 )834 Reserve for doubtful accounts 32 21 -18 )35 Reserve for cash discounts 23 198 -204 )17 Total $880 3,307 -3,301 )886 2018 Accrued rebates -1 $186 836 -751 )271 Accrued returns 68 98 -109 )57 Accrued promotions 481 2,233 -2,217 )497 Subtotal $735 3,167 -3,077 )825 Reserve for doubtful accounts 31 10 -9 )32 Reserve for cash discounts 23 204 -204 )23 Total $789 3,381 -3,290 )880 -1 includes reserve for customer rebates of $54 million at december 29, 2019 and $57 million at december 30, 2018 , recorded as a contra asset.", "highlight": "Balance at Beginning of period Accruals Payments/credits Balance at End of period 2019 Accrued rebates -1 $271 841 -828 )284 Accrued returns 57 128 -122 )63 Accrued promotions 497 2,119 -2,129 )487 Subtotal $825 3,088 -3,079 )834 Reserve for doubtful accounts 32 21 -18 )35 Reserve for cash discounts 23 198 -204 )17 Total $880 3,307 -3,301 )886 2018 Accrued rebates -1 $186 836 -751 )271 Accrued returns 68 98 -109 )57 Accrued promotions 481 2,233 -2,217 )497 Subtotal $735 3,167 -3,077 )825 Reserve for doubtful accounts 31 10 -9 )32 Reserve for cash discounts 23 204 -204 )23 Total $789 3,381 -3,290 )880 -1 includes reserve for customer rebates of $54 million at december 29, 2019 and $57 million at december 30, 2018", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para77", "text": "Pharmaceutical segment (dollars in millions) Balance at Beginning of period Accruals Payments/credits -2 Balance at End of period 2019 Accrued rebates -1 $7,510 26,868 -25,365 )9,013 Accrued returns 436 354 -290 )500 Accrued promotions 13 17 -25 )5 Subtotal $7,959 27,239 -25,680 )9,518 Reserve for doubtful accounts 47 2 -13 )36 Reserve for cash discounts 53 936 -924 )65 Total $8,059 28,177 -26,617 )9,619 2018 Accrued rebates -1 $4,862 22,644 -19,996 )7,510 Accrued returns 362 385 -311 )436 Accrued promotions 35 46 -68 )13 Subtotal $5,259 23,075 -20,375 )7,959 Reserve for doubtful accounts 77 37 -67 )47 Reserve for cash discounts 55 860 -862 )53 Total $5,391 23,972 -21,304 )8,059 -1 includes reserve for customer rebates of $93 million at december 29, 2019 and $89 million at december 30, 2018 , recorded as a contra asset.", "highlight": "Balance at Beginning of period Accruals Payments/credits -2 Balance at End of period 2019 Accrued rebates -1 $7,510 26,868 -25,365 )9,013 Accrued returns 436 354 -290 )500 Accrued promotions 13 17 -25 )5 Subtotal $7,959 27,239 -25,680 )9,518 Reserve for doubtful accounts 47 2 -13 )36 Reserve for cash discounts 53 936 -924 )65 Total $8,059 28,177 -26,617 )9,619 2018 Accrued rebates -1 $4,862 22,644 -19,996 )7,510 Accrued returns 362 385 -311 )436 Accrued promotions 35 46 -68 )13 Subtotal $5,259 23,075 -20,375 )7,959 Reserve for doubtful accounts 77 37 -67 )47 Reserve for cash discounts 55 860 -862 )53 Total $5,391 23,972 -21,304 )8,059 -1 includes reserve for customer rebates of $93 million at december 29, 2019 and $89 million at december 30, 2018", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para78", "text": "-2 Includes adjustments Medical devices segment (dollars in millions) Balance at Beginning of period Accruals Payments/credits Balance at End of period 2019 Accrued rebates (1) $1,218 5,487 -5,692 )1,013 Accrued returns 114 673 -669 )118 Accrued promotions 42 106 -102 )46 Subtotal $1,374 6,266 -6,463 )1,177 Reserve for doubtful accounts 169 30 -44 )155 Reserve for cash discounts 106 -96 )10 Total $1,543 6,402 -6,603 )1,342 2018 -2 Accrued rebates -1 $1,620 6,344 -6,746 )1,218 Accrued returns 152 750 -788 )114 Accrued promotions 83 116 -157 )42 Subtotal $1,855 7,210 -7,691 )1,374 Reserve for doubtful accounts 183 29 -43 )169 Reserve for cash discounts 15 140 -155 )Total $2,053 7,379 -7,889 )1,543 -1 includes reserve for customer rebates of $499 million at december 29, 2019 and $632 million at december 30, 2018 , recorded as a contra asset.", "highlight": "nce at Beginning of period Accruals Payments/credits Balance at End of period 2019 Accrued rebates (1) $1,218 5,487 -5,692 )1,013 Accrued returns 114 673 -669 )118 Accrued promotions 42 106 -102 )46 Subtotal $1,374 6,266 -6,463 )1,177 Reserve for doubtful accounts 169 30 -44 )155 Reserve for cash discounts 106 -96 )10 Total $1,543 6,402 -6,603 )1,342 2018 -2 Accrued rebates -1 $1,620 6,344 -6,746 )1,218 Accrued returns 152 750 -788 )114 Accrued promotions 83 116 -157 )42 Subtotal $1,855 7,210 -7,691 )1,374 Reserve for doubtful accounts 183 29 -43 )169 Reserve for cash discounts 15 140 -155 )Total $2,053 7,379 -7,889 )1,543 -1 includes reserve for customer rebates of $499 million at december 29, 2019 and $632 million at december 30, 2018", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para79", "text": "-2 certain prior period amounts have been reclassified to conform to current year presentation.", "highlight": "certain prior period amounts have been reclassified to conform to current year presentation", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para80", "text": "income taxes: income taxes are recorded based on amounts refundable or payable for the current year and include the results of any difference between u.s. gaap accounting and tax reporting, recorded as deferred tax assets or liabilities. the company estimates deferred tax assets and liabilities based on enacted tax regulations and rates. future changes in tax laws and rates may affect recorded deferred tax assets and liabilities.", "highlight": "income taxes are recorded based on amounts refundable or payable for the current year and include the results of any difference between u.s. gaap accounting and tax reporting", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para81", "text": "the company has unrecognized tax benefits for uncertain tax positions. the company follows u.s. gaap, which prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. management believes that changes in these estimates would not have a material effect on the company's results of operations, cash flows or financial position.", "highlight": "the company has unrecognized tax benefits for uncertain tax positions.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para82", "text": "the company has recorded deferred tax liabilities on all undistributed earnings prior to december 31, 2017 from its international subsidiaries. the company has not provided deferred taxes on the undistributed earnings subsequent to january 1, 2018 from certain international subsidiaries where the earnings are considered to be indefinitely reinvested. the company intends to continue to reinvest these earnings in those international operations. if the company decides at a later date to repatriate these earnings to the u.s., the company would be required to provide for the net tax effects on these amounts. the company estimates that the total tax effect of this repatriation would be approximately $0.8 billion under current enacted tax laws and regulations and at current currency exchange rates.", "highlight": "the company has not provided deferred taxes on the undistributed earnings subsequent ||| the company has recorded deferred tax liabilities on all undistributed earnings ||| the company intends to continue to reinvest these earnings in those international operations ||| the company decides at a later date to repatriate these earnings to the u.s., the company would be required to provide for the net tax effects on these amounts", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 1, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para83", "text": "see note 8 to the consolidated financial statements for further information regarding income taxes.", "highlight": "note 8 to the consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para84", "text": "legal and self insurance contingencies: the company records accruals for various contingencies, including legal proceedings and product liability claims as these arise in the normal course of business. the accruals are based on management's judgment as to the probability of losses and, where applicable, actuarially determined estimates. the company has self insurance through a wholly-owned captive insurance company. in addition to accruals in the self insurance program, claims that exceed the insurance coverage are accrued when losses are probable and amounts can be reasonably estimated.", "highlight": "the company records accruals for various contingencies, including legal proceedings and product liability claims as these arise in the normal course of business", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para85", "text": "the company follows the provisions of u.s. gaap when recording litigation related contingencies. a liability is recorded when a loss is probable and can be reasonably estimated. the best estimate of a loss within a range is accrued; however, if no estimate in the range is better than any other, the minimum amount is accrued.", "highlight": "the company follows the provisions of u.s. gaap when recording litigation related contingencies", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para86", "text": "see notes 1 and 21 to the consolidated financial statements for further information regarding product liability and legal proceedings.", "highlight": "notes 1 and 21 to the consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para87", "text": "long-lived and intangible assets: the company assesses changes in economic conditions and makes assumptions regarding estimated future cash flows in evaluating the value of the company's property, plant and equipment, goodwill and intangible assets. as these assumptions and estimates may change over time, it may or may not be necessary for the company to record impairment charges.", "highlight": "the company assesses changes in economic conditions and makes assumptions regarding estimated future cash flows in evaluating the value of the company's property, plant and equipment, goodwill and intangible assets", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 3, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para88", "text": "employee benefit plans: the company sponsors various retirement and pension plans, including defined benefit, defined contribution and termination indemnity plans, which cover most employees worldwide. these plans are based on assumptions for the discount rate, expected return on plan assets, mortality rates, expected salary increases, health care cost trend rates and attrition rates. see note 10 to the consolidated financial statements for further details on these rates and the effect a rate change to the health care cost trend would have on the company's results of operations.", "highlight": "note 10 to the consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para89", "text": "stock based compensation: the company recognizes compensation expense associated with the issuance of equity instruments to employees for their services. based on the type of equity instrument, the fair value is estimated on the date of grant using either the black-scholes option valuation model or a combination of both the black-scholes option valuation model and monte carlo valuation model, and is expensed in the financial statements over the service period. the input assumptions used in determining fair value are the expected life, expected volatility, risk-free rate and expected dividend yield. for performance share units the fair market value is calculated for each of the three component goals at the date of grant. the fair values for the sales and earnings per share goals of each performance share unit were estimated on the date of grant using the fair market value of the shares at the time of the award, discounted for dividends, which are not paid on the performance share units during the vesting period. the fair value for the relative total shareholder return goal of each performance share unit was estimated on the date of grant using the monte carlo valuation model. see note 17 to the consolidated financial statements for additional information.", "highlight": "the company recognizes compensation expense associated with the issuance of equity instruments to employees for their services. ||| the fair value for the relative total shareholder return goal of each performance share unit was estimated on the date of grant using the monte carlo valuation model.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para90", "text": "New accounting pronouncements refer to note 1 to the consolidated financial statements for recently adopted accounting pronouncements and recently issued accounting pronouncements not yet adopted as of december 29, 2019 .", "highlight": "New accounting pronouncements ||| adopted accounting pronouncements and recently issued", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para91", "text": "Economic and market factors the company is aware that its products are used in an environment where, for more than a decade, policymakers, consumers and businesses have expressed concerns about the rising cost of health care. in response to these concerns, the company has a long-standing policy of pricing products responsibly. for the period 2009 - 2019, in the u.s., the weighted average compound annual growth rate of the company's net price increases for health care products (prescription and over-the-counter drugs, hospital and professional products) was below the u.s. consumer price index (cpi).", "highlight": "the weighted average compound annual growth rate of the company's net price increases for health care products (prescription and over-the-counter drugs, hospital and professional products) was below the u.s. consumer price index", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para92", "text": "the company operates in certain countries where the economic conditions continue to present significant challenges. the company continues to monitor these situations and take appropriate actions. inflation rates continue to have an effect on worldwide economies and, consequently, on the way companies operate. the company has accounted for operations in argentina (beginning in the fiscal third quarter of 2018) and venezuela as highly inflationary, as the prior three-year cumulative inflation rate surpassed 100%. this did not have a material impact to the company's results in the period. in the face of increasing costs, the company strives to maintain its profit margins through cost reduction programs, productivity improvements and periodic price increases.", "highlight": "the company operates in certain countries where the economic conditions continue to present significant challenges. ||| the company has accounted for operations in argentina ||| and venezuela as highly inflationary, as the prior three-year cumulative inflation rate surpassed 100%.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para93", "text": "in june 2016, the united kingdom (u.k.) held a referendum in which voters approved an exit from the european union (e.u. ), commonly referred to as \"brexit\" and on january 31, 2020, the u.k. formally exited the e.u. given the lack of comparable precedent, it is unclear what the ultimate financial, trade, regulatory and legal implications the withdrawal of the u.k. from the e.u. will have. brexit creates global political and economic uncertainty, which may cause, among other consequences, volatility in exchange rates and interest rates, additional cost containment by third-party payors and changes in regulations. however, the company currently does not believe that these and other related effects will have a material impact on the company's consolidated financial position or operating results. as of december 29, 2019, the business of the company's u.k. subsidiaries represented less than 3% of both the company's consolidated assets and fiscal twelve months revenues, respectively.", "highlight": "it is unclear what the ultimate financial, trade, regulatory and legal implications the withdrawal of the u.k. from the e.u. will have ||| however, the company currently does not believe that these and other related effects will have a material impact on the company's consolidated financial position or operating results", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 1, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para94", "text": "the company is exposed to fluctuations in currency exchange rates. a 1% change in the value of the u.s. dollar as compared to all foreign currencies in which the company had sales, income or expense in 2019 would have increased or decreased the translation of foreign sales by approximately $390 million and net income by approximately $120 million.", "highlight": "the company is exposed to fluctuations in currency exchange rates ||| increased or decreased the translation of foreign sales by approximately $390 million and net income by approximately $120 million.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para95", "text": "Governments around the world consider various proposals to make changes to tax laws, which may include increasing or decreasing existing statutory tax rates. a change in statutory tax rate in any country would result in the revaluation of the company's deferred tax assets and liabilities related to that particular jurisdiction in the period in which the new tax law is enacted. this change would result in an expense or benefit recorded to the company's consolidated statement of earnings. the company closely monitors these proposals as they arise in the countries where it operates. changes to the statutory tax rate may occur at any time, and any related expense or benefit recorded may be material to the fiscal quarter and year in which the law change is enacted. for discussion on federal act on tax reform and ahv financing (swiss tax reform) see provision for taxes on income in management's discussion and analysis of financial condition and results of operations.", "highlight": "Governments around the world consider various proposals to make changes to tax laws, which may include increasing or decreasing existing statutory tax rates ||| this change would result in an expense or benefit recorded to the company's consolidated statement of earnings", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 2, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para96", "text": "the company faces various worldwide health care changes that may continue to result in pricing pressures that include health care cost containment and government legislation relating to sales, promotions and reimbursement of health care products.", "highlight": "the company faces various worldwide health care changes", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para97", "text": "changes in the behavior and spending patterns of purchasers of health care products and services, including delaying medical procedures, rationing prescription medications, reducing the frequency of physician visits and foregoing health care insurance coverage, as a result of the current global economic downturn, may continue to impact the company's businesses.", "highlight": "changes in the behavior and spending patterns of purchasers of health care products and services ||| may continue to impact the company's businesses.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 1, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para98", "text": "The company also operates in an environment increasingly hostile to intellectual property rights. firms have filed abbreviated new drug applications or biosimilar biological product applications with the fda or otherwise challenged the coverage and/or validity of the company's patents, seeking to market generic or biosimilar forms of many of the company's key pharmaceutical products prior to expiration of the applicable patents covering those products. in the event the company is not successful in defending the patent claims challenged in the resulting lawsuits, generic or biosimilar versions of the products at issue will be introduced to the market, resulting in the potential for substantial market share and revenue losses for those products, and which may result in a non-cash impairment charge in any associated intangible asset. there is also a risk that one or more competitors could launch a generic or biosimilar version of the product at issue following regulatory approval even though one or more valid patents are in place. for further information, see the discussion on \"remicade related cases\" and \"litigation against filers of abbreviated new drug applications\" in note 21 to the consolidated financial statements.", "highlight": "The company also operates in an environment increasingly hostile to intellectual property rights ||| there is also a risk that one or more competitors could launch a generic or biosimilar version of the product at issue following regulatory approval even though one or more valid patents are in place", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para99", "text": "Legal proceedings johnson & johnson and certain of its subsidiaries are involved in various lawsuits and claims regarding product liability, intellectual property, commercial and other matters; governmental investigations; and other legal proceedings that arise from time to time in the ordinary course of business.", "highlight": "are involved in various lawsuits and claims regarding product liability, intellectual property, commercial and other matters; governmental investigations; and other legal proceedings", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 1, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para100", "text": "the company records accruals for loss contingencies associated with these legal matters when it is probable that a liability will be incurred and the amount of the loss can be reasonably estimated. as of december 29, 2019 , the company has determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated. the company has accrued for these matters and will continue to monitor each related legal issue and adjust accruals as might be warranted based on new information and further developments in accordance with asc 450-20-25. for these and other litigation and regulatory matters discussed below for which a loss is probable or reasonably possible, the company is unable to estimate the possible loss or range of loss beyond the amounts already accrued. amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely heavily on estimates and assumptions including timing of related payments. the ability to make such estimates and judgments can be affected by various factors including, among other things, whether damages sought in the proceedings are unsubstantiated or indeterminate; scientific and legal discovery has not commenced or is not complete; proceedings are in early stages; matters present legal uncertainties; there are significant facts in dispute; procedural or jurisdictional issues; the uncertainty and unpredictability of the number of potential claims; or there are numerous parties involved. to the extent adverse verdicts have been rendered against the company, the company does not record an accrual until a loss is determined to be probable and can be reasonably estimated.", "highlight": "the company records accruals for loss contingencies associated with these legal matters when it is probable that a liability will be incurred and the amount of the loss can be reasonably estimated. ||| the ability to make such estimates and judgments can be affected by various factors |||  the company does not record an accrual until a loss is determined to be probable and can be reasonably estimated.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para101", "text": "in the company's opinion, based on its examination of these matters, its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the company's balance sheet, is not expected to have a material adverse effect on the company's financial position. however, the resolution of, or increase in accruals for, one or more of these matters in any reporting period may have a material adverse effect on the company's results of operations and cash flows for that period.", "highlight": "its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the company's balance sheet, is not expected to have a material adverse effect on the company's financial position", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para102", "text": "see note 21 to the consolidated financial statements for further information regarding legal proceedings.", "highlight": "note 21 to the consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200218_10-K_200406_part2_item7_para103", "text": "Common stock the company's common stock is listed on the new york stock exchange under the symbol jnj. as of february 12, 2020, there were 135,953 record holders of common stock of the company.", "highlight": "there were 135,953 record holders of common stock of the company.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para1", "text": "the following discussion and analysis of our financial condition and results of operations should be read in conjunction with \"item 1a. risk factors\", \"item 6. selected financial data\", our consolidated financial statements and related notes thereto, as well as other cautionary statements and risks described elsewhere in this annual report on form 10-k, before deciding to purchase, hold or sell shares of our common stock.", "highlight": "\"item 1a. risk factors\", \"item 6", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para2", "text": "Overview Our company and our businesses nvidia pioneered accelerated computing to help solve the most challenging computational problems. starting with a focus on pc graphics, we extended our focus in recent years to the revolutionary field of ai. fueled by the sustained demand for exceptional 3d graphics and the scale of the gaming market, nvidia leveraged its gpu architecture to create platforms for vr, hpc, and ai.", "highlight": "nvidia leveraged its gpu architecture to create platforms for vr, hpc, and ai.", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para3", "text": "our two reportable segments - gpu and tegra processor - are based on a single underlying graphics architecture. from our proprietary processors, we have created platforms that address four large markets where our expertise is critical: gaming, professional visualization, data center, and automotive.", "highlight": "we have created platforms that address four large markets where our expertise is critical: gaming, professional visualization, data center, and automotive.", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para4", "text": "our gpu product brands are aimed at specialized markets including geforce for gamers; quadro for designers; tesla and dgx for ai data scientists and big data researchers; and grid for cloud-based visual computing users. our tegra brand incorporates gpus and multi-core cpus to drive supercomputing for autonomous robots, drones, and cars, as well as for game consoles and mobile gaming and entertainment devices.", "highlight": "our gpu product brands are aimed at specialized markets including geforce for gamers; quadro for designers; tesla and dgx for ai data scientists and big data researchers; and grid for cloud-based visual computing users. our tegra brand incorporates gpus and multi-core cpus to drive supercomputing for autonomous robots, drones, and cars, as well as for game consoles and mobile gaming and entertainment devices.", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para5", "text": "headquartered in santa clara, california, nvidia was incorporated in california in april 1993 and reincorporated in delaware in april 1998.", "highlight": "", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para6", "text": "Recent developments, future objectives and challenges Fiscal year 2020 summary Year ended January 26, 2020 January 27, 2019 Change ($ in millions, except per share data) Revenue $10,918 $11,716 Down 7% Gross margin 62.0 % 61.2 % Up 80 bps Operating expenses $3,922 $3,367 Up 16% Income from operations $2,846 $3,804 Down 25% Net income $2,796 $4,141 Down 32% Net income per diluted share $4.52 $6.63 Down 32% revenue for fiscal year 2020 was $10.92 billion, down 7% from a year earlier. gpu business revenue was $9.47 billion, down 7% from a year earlier. tegra processor business revenue - which includes automotive, socs for gaming platforms, and embedded edge ai platforms - was $1.45 billion, down 6% from a year earlier.", "highlight": "$10,918 $11,716 Down 7% Gross margin 62.0 % 61.2 % Up 80 bps Operating expenses $3,922 $3,367 Up 16% Income from operations $2,846 $3,804 Down 25% Net income $2,796 $4,141 Down 32% Net income per diluted share $4.52 $6.63 Down 32% revenue for fiscal year 2020 was $10.92 billion, down 7% from a year earlier. gpu business revenue was $9.47 billion, down 7% |||  tegra processor business revenue - which includes automotive, socs for gaming platforms, and embedded edge ai platforms - was $1.45 billion, down 6%", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para7", "text": "from a market platform perspective, gaming revenue was $5.52 billion, down 12% from a year ago, reflecting lower sales of geforce desktop gpus and socs for gaming platforms, partially offset by growth in geforce notebook gpus.", "highlight": "reflecting lower sales of geforce desktop gpus and socs for gaming platforms", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para8", "text": "professional visualization revenue was $1.21 billion, up 7% from a year ago, reflecting strength in desktop and notebook workstations.", "highlight": "reflecting strength in desktop and notebook workstations.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para9", "text": "data center revenue was $2.98 billion, up 2% from a year ago, driven by vertical industry growth partially offset by lower hyperscale sales.", "highlight": "driven by vertical industry growth", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para10", "text": "automotive revenue was $700 million, up 9% from a year ago, reflecting growth in ai cockpit solutions and development services agreements.", "highlight": "reflecting growth in ai cockpit solutions and development services agreements.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para11", "text": "24 oem and other revenue was $505 million, down 34% from a year ago, primarily due to the absence of cryptocurrency-specific product sales.", "highlight": "due to the absence of cryptocurrency-specific product sales.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para12", "text": "gross margin for fiscal year 2020 was 62.0%, up 80 basis points from a year ago, primarily driven by reduced inventory provisions and the sale of previously written-off components.", "highlight": "driven by reduced inventory provisions and the sale of previously written-off components.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para13", "text": "operating expenses for fiscal year 2020 were $3.92 billion, up 16% from a year ago, reflecting primarily employee additions and increases in employee compensation and other related costs, including stock-based compensation and infrastructure costs.", "highlight": "reflecting primarily employee additions and increases in employee compensation", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para14", "text": "income from operations for fiscal year 2020 was $2.85 billion, down 25% from a year earlier. net income and net income per diluted share for fiscal year 2020 were $2.80 billion and $4.52, respectively, both down 32% from a year earlier reflecting lower revenue and higher operating expenses.", "highlight": "income from operations for fiscal year 2020 was $2.85 billion ||| net income per diluted share for fiscal year 2020 were $2.80 billion and $4.52, respectively, both down 32% from a year earlier", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para15", "text": "on march 10, 2019, we entered into an agreement and plan of merger, or the merger agreement, with mellanox technologies ltd., or mellanox, pursuant to which we will acquire all of the issued and outstanding common shares of mellanox for $125 per share in cash, representing a total enterprise value of approximately $6.9 billion as of the date of the merger agreement. the merger agreement contains customary representations, warranties and covenants. the consummation of the merger is conditioned on the receipt of the approval of mellanox shareholders, as well as the satisfaction of other customary closing conditions, including domestic and foreign regulatory approvals and performance in all material respects by each party of its obligations under the merger agreement. in june 2019, mellanox shareholders approved the consummation of the merger and we received regulatory approvals for the deal from mexico in july 2019 and from the european commission in december 2019. in addition, the waiting period under the hart-scott-rodino antitrust improvements act of 1976, as amended, in connection with the proposed acquisition expired in may 2019. discussions with china's regulatory agency, the state administration for market regulation, are progressing and we believe the acquisition will likely close in the early part of calendar 2020. if the merger agreement is terminated under certain circumstances involving the failure to obtain the required regulatory approvals, we could be obligated to pay mellanox a termination fee of $350 million .", "highlight": "the merger agreement, with mellanox technologies ltd ||| common shares of mellanox for $125 per share in cash, representing a total enterprise value of approximately $6.9 billion ||| the consummation of the merger is conditioned on the receipt of the approval of mellanox shareholders, as well as the satisfaction of other customary closing conditions, including domestic and foreign regulatory approvals and performance in all material respects by each party of its obligations under the merger agreement ||| . if the merger agreement is terminated under certain circumstances involving the failure to obtain the required regulatory approvals, we could be obligated to pay mellanox a termination fee of $350 million .", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para16", "text": "in november 2018, we communicated our intent to return $3.00 billion to shareholders by the end of fiscal year 2020, including $700 million in share repurchases made during the fourth quarter of fiscal year 2019. in fiscal year 2020, we returned $390 million in quarterly cash dividends. we did not repurchase any shares during fiscal year 2020. we intend to return to repurchasing shares after closing the acquisition of mellanox.", "highlight": "return $3.00 billion to shareholders ||| including $700 million in share repurchases made ||| returned $390 million in quarterly cash dividends", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para17", "text": "cash, cash equivalents and marketable securities were $10.90 billion as of january 26, 2020 , compared with $7.42 billion as of january 27, 2019 . the increase primarily reflects growth in operating cash flow.", "highlight": "the increase primarily reflects growth in operating cash flow.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para18", "text": "in january 2020, a novel strain of coronavirus was identified in china, resulting in shutdowns of manufacturing and commerce, as well as global travel restrictions to contain the virus. the impact has extended to other regions. we have operations and employees in china, and the region represents an important end market for our products. our customers and suppliers within china and neighboring countries are also affected by the coronavirus related restrictions and closures. the coronavirus is expected to have a negative effect on our financial results, though the full extent and duration is uncertain and could have a material negative impact on our business.", "highlight": "the coronavirus is expected to have a negative effect on our financial results, though the full extent and duration is uncertain and could have a material negative impact on our business.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para19", "text": "Gpu business in gaming, we extended nvidia's family of turing-based gpus with the geforce gtx 1660 ti, gtx 1660 and gtx 1650, as well as with our new super line, including the geforce rtx 2080 super, rtx 2070 super, rtx 2060 super, gtx 1660 super, and gtx 1650 super; and accelerated momentum of ray-tracing games by supporting a growing list of titles; introduced new rtx studio laptops powered by geforce rtx and quadro rtx gpus for online and studio-based creatives and prosumer customers; unveiled two new models of the shield tv streaming media player; and introduced two new service offerings for geforce now cloud gaming service.", "highlight": "extended nvidia's family of turing-based gpus with the geforce gtx 1660 ti, gtx 1660 and gtx 1650, ||| geforce rtx 2080 super, rtx 2070 super, rtx 2060 super, gtx 1660 super, and gtx 1650 super ||| new rtx studio laptops powered by geforce rtx and quadro rtx gpus ||| two new models of the shield tv streaming media player ||| new service offerings for geforce now cloud gaming service", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para20", "text": "in professional visualization, we expanded adoption of nvidia rtx ray-tracing technology by 3d application providers; rolled out a full range of turing-based quadro gpus for mobile workstations, incorporating ray tracing for product design, architecture, effects and scientific visualization; and unveiled the nvidia omniverse open-collaboration platform to simplify creative workflows for content creation.", "highlight": "nvidia rtx ray-tracing technology by 3d application providers ||| turing-based quadro gpus for mobile workstations |||  ray tracing for product design, architecture, effects and scientific visualization ||| nvidia omniverse open-collaboration platform", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para21", "text": "In data center, we introduced the nvidia cuda-x ai platform for accelerating data science; announced availability of nvidia t4 tensor core gpus from leading oems and cloud service providers; unveiled the dgx superpod; and announced support for arm cpus, providing a new path to build ai-enabled exascale supercomputers, as well as a collaboration with arm and others on a reference design for gpu accelerated arm-based servers. we launched the nvidia egx intelligent edge computing platform, bringing accelerated ai to vertical industries; and announced a collaboration to integrate microsoft 25 azure with egx, as well as plans for a scalable gpu-accelerated supercomputer in the microsoft azure cloud. additionally, we entered the 5g telecom market, enabling telcos to build efficient, virtualized 5g rans; announced a collaboration to deliver software-defined 5g ran; and announced that alibaba and baidu's recommendation engines run on nvidia ai.", "highlight": "nvidia cuda-x ai platform for accelerating data science ||| nvidia t4 tensor core gpus ||| unveiled the dgx superpod; and announced support for arm cpus ||| nvidia egx intelligent edge computing platform, ||| plans for a scalable gpu-accelerated supercomputer in the microsoft azure cloud ||| 5g telecom market", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para22", "text": "Tegra processor business in our automotive platform, we announced a partnership with toyota research institute-advanced development to develop, train and validate self-driving vehicles; unveiled the nvidia drive ap2x automated driving solution, encompassing drive autopilot software, drive agx and drive validation tools; introduced the nvidia drive av safety force field to enable safe, comfortable driving experiences; and announced availability of the nvidia drive constellation autonomous vehicle simulation platform.", "highlight": "nvidia drive ap2x automated driving solution ||| drive autopilot software, drive agx and drive validation tools", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para23", "text": "Critical accounting policies and estimates management's discussion and analysis of financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the united states, or u.s. gaap. the preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, cost of revenue, expenses and related disclosure of contingencies. on an on-going basis, we evaluate our estimates, including those related to inventories, revenue recognition, income taxes, and goodwill. we base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities.", "highlight": "requires us to make estimates and judgments that affect the reported amounts ||| on an on-going basis, we evaluate our estimates, ||| we base our estimates on historical experience and on various other assumptions", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para24", "text": "we believe the following critical accounting policies affect our significant judgments and estimates used in the preparation of our consolidated financial statements. our management has discussed the development and selection of these critical accounting policies and estimates with the audit committee of our board of directors. the audit committee has reviewed our disclosures relating to our critical accounting policies and estimates in this annual report on form 10-k.", "highlight": "the audit committee has reviewed our disclosures relating to our critical accounting policies", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para25", "text": "Inventories inventory cost is computed on an adjusted standard basis, which approximates actual cost on an average or first-in, first-out basis. we charge cost of sales for inventory provisions to write down our inventory to the lower of cost or net realizable value or to completely write off obsolete or excess inventory. most of our inventory provisions relate to the write-off of excess quantities of products or components, based on our inventory levels and future product purchase commitments compared to assumptions about future demand and m arket conditions.", "highlight": "we charge cost of sales for inventory provisions to write down our inventory to the lower of cost or net realizable value or to completely write off obsolete or excess inventory", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para26", "text": "situations that may result in excess or obsolete inventory include changes in business and economic conditions, changes in market conditions, sudden and significant decreases in demand for our products, inventory obsolescence because of changing technology and customer requirements, failure to estimate customer demand properly, or unexpected competitive pricing actions by our competition. in addition, cancellation or deferral of customer purchase orders could result in our holding excess inventory.", "highlight": "cancellation or deferral of customer purchase orders could result in our holding excess inventory", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para27", "text": "the overall net effect on our gross margin from inventory provisions and sales of items previously written down was insignificant in fiscal year 2020 and an unfavorable impact of 2.0% in fiscal year 2019 . the charges we took to cost of sales for inventory provisions during fiscal year 2019 were primarily related to excess dram, other components, and prior architecture components and chips. as a fabless semiconductor company, we must make commitments to purchase inventory based on forecasts of future customer demand. in doing so, we must account for our third-party manufacturers' lead times and constraints. we also adjust to other market factors, such as product offerings and pricing actions by our competitors, new product transitions, and macroeconomic conditions - all of which may impact demand for our products.", "highlight": "we must make commitments to purchase inventory based on forecasts of future customer demand ||| we must account for our third-party manufacturers' lead times and constraints ||| all of which may impact demand for our products.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para28", "text": "refer to the gross profit and gross margin discussion below in this management's discussion and analysis for further discussion.", "highlight": "", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para29", "text": "Revenue recognition we derive our revenue from product sales, including hardware and systems, license and development arrangements, and software licensing. we determine revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, we satisfy a performance obligation.", "highlight": "we derive our revenue from product sales, including hardware and systems, license and development arrangements, and software licensing", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para30", "text": "26 Product sales revenue revenue from product sales is recognized upon transfer of control of promised products to customers in an amount that reflects the consideration we expect to receive in exchange for those products. revenue is recognized net of allowances for returns, customer programs and any taxes collected from customers.", "highlight": "is recognized upon transfer of control of promised products to customers ||| is recognized net of allowances for returns, customer programs and any taxes collected from customers.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para31", "text": "for products sold with a right of return, we record a reduction to revenue by establishing a sales return allowance for estimated product returns at the time revenue is recognized, based primarily on historical return rates. however, if product returns for a fiscal period are anticipated to exceed historical return rates, we may determine that additional sales return allowances are required to properly reflect our estimated exposure for product returns.", "highlight": "we record a reduction to revenue by establishing a sales return allowance ||| if product returns for a fiscal period are anticipated to exceed historical return rates, we may determine that additional sales return allowances are required", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para32", "text": "our customer programs involve rebates, which are designed to serve as sales incentives to resellers of our products in various target markets, and marketing development funds, or mdfs, which represent monies paid to our partners that are earmarked for market segment development and are designed to support our partners' activities while also promoting nvidia products. we account for customer programs as a reduction to revenue and accrue for potential rebates and mdfs based on the amount we expect to be claimed by customers.", "highlight": "we account for customer programs as a reduction to revenue and accrue for potential rebates and mdfs based on the amount we expect to be claimed by customers.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para33", "text": "License and development arrangements our license and development arrangements with customers typically require significant customization of our intellectual property components. as a result, we recognize the revenue from the license and the revenue from the development services as a single performance obligation over the period in which the development services are performed. we measure progress to completion based on actual cost incurred to date as a percentage of the estimated total cost required to complete each project. if a loss on an arrangement becomes probable during a period, we record a provision for such loss in that period.", "highlight": "if a loss on an arrangement becomes probable during a period, we record a provision for such loss in that period.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para34", "text": "refer to note 1 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k for additional information.", "highlight": "in part iv, item 15 of this annual report on form 10-k", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para35", "text": "Income taxes we recognize federal, state and foreign current tax liabilities or assets based on our estimate of taxes payable or refundable in the current fiscal year by tax jurisdiction. we recognize federal, state and foreign deferred tax assets or liabilities, as appropriate, for our estimate of future tax effects attributable to temporary differences and carryforwards; and we record a valuation allowance to reduce any deferred tax assets by the amount of any tax benefits that, based on available evidence and judgment, are not expected to be realized.", "highlight": "we recognize federal, state and foreign deferred tax assets or liabilities, as appropriate ||| we record a valuation allowance to reduce any deferred tax assets by the amount of any tax benefits", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para36", "text": "our calculation of deferred tax assets and liabilities is based on certain estimates and judgments and involves dealing with uncertainties in the application of complex tax laws. our estimates of deferred tax assets and liabilities may change based, in part, on added certainty or finality to an anticipated outcome, changes in accounting standards or tax laws in the united states, or foreign jurisdictions where we operate, or changes in other facts or circumstances. in addition, we recognize liabilities for potential united states and foreign income tax contingencies based on our estimate of whether, and the extent to which, additional taxes may be due. if we determine that payment of these amounts is unnecessary or if the recorded tax liability is less than our current assessment, we may be required to recognize an income tax benefit or additional income tax expense in our financial statements accordingly.", "highlight": "if we determine that payment of these amounts is unnecessary or if the recorded tax liability is less than our current assessment, we may be required to recognize an income tax benefit or additional income tax expense in our financial statements accordingly", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para37", "text": "as of january 26, 2020 , we had a valuation allowance of $621 million related to state and certain foreign deferred tax assets that management determined are not likely to be realized due to jurisdictional projections of future taxable income and potential utilization limitations of tax attributes acquired as a result of stock ownership changes. to the extent realization of the deferred tax assets becomes more-likely-than-not, we would recognize such deferred tax asset as an income tax benefit during the period.", "highlight": ", we would recognize such deferred tax asset as an income tax benefit during the period.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para38", "text": "we recognize the benefit from a tax position only if it is more-likely-than-not that the position would be sustained upon audit based solely on the technical merits of the tax position. our policy is to include interest and penalties related to unrecognized tax benefits as a component of income tax expense.", "highlight": "our policy is to include interest and penalties related to unrecognized tax benefits", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 2, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para39", "text": "refer to note 14 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k for additional information.", "highlight": "part iv, item 15 of this annual report on form 10-k", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para40", "text": "Goodwill Goodwill is subject to our annual impairment test during the fourth quarter of our fiscal year, or earlier, if indicators of potential impairment exist, using either a qualitative or a quantitative assessment. our impairment review process compares the fair value of the reporting unit in which the goodwill resides to its carrying value. we have identified two reporting units, 27 gpu and tegra processor, for the purposes of completing our goodwill analysis. goodwill assigned to the gpu and tegra processor reporting units as of january 26, 2020 was $210 million and $408 million , respectively. determining the fair value of a reporting unit requires us to make judgments and involves the use of significant estimates and assumptions. we also make judgments and assumptions in allocating assets and liabilities to each of our reporting units. we base our fair value estimates on assumptions we believe to be reasonable but that are unpredictable and inherently uncertain.", "highlight": "Goodwill is subject to our annual impairment test during the fourth quarter of our fiscal year, or earlier, if indicators of potential impairment exist, using either a qualitative or a quantitative assessment", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para41", "text": "we performed our annual goodwill assessment during the fourth quarter of fiscal year 2020 using a qualitative assessment and concluded there was no goodwill impairment.", "highlight": "there was no goodwill impairment.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para42", "text": "refer to note 6 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k for additional information.", "highlight": "in part iv, item 15 of this annual report on form 10-k", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para43", "text": "Results of operations a discussion regarding our financial condition and results of operations for fiscal year 2020 compared to fiscal year 2019 is presented below. a discussion regarding our financial condition and results of operations for fiscal year 2019 compared to fiscal year 2018 can be found under item 7 in our annual report on form 10-k for the fiscal year ended january 27, 2019, filed with the sec on february 21, 2019, which is available free of charge on the sec's website at http://www.sec.gov and at our investor relations website, http://investor.nvidia.com.", "highlight": "which is available free of charge on the sec's website at http://www.sec.gov and at our investor relations website, http://investor.nvidia.com.", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para44", "text": "the following table sets forth, for the periods indicated, certain items in our consolidated statements of income expressed as a percentage of revenue.", "highlight": "", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para45", "text": "Year ended January 26, 2020 January 27, 2019 Revenue 100.0 % 100.0 % Cost of revenue 38.0 38.8 Gross profit 62.0 61.2 Operating expenses: Research and development 25.9 20.3 Sales, general and administrative 10.0 8.5 Total operating expenses 35.9 28.7 Income from operations 26.1 32.5 Interest income 1.6 1.2 Interest expense -0.5 )-0.5 )Other, net 0.1 Total other income 1.1 0.8 Income before income tax expense 27.2 33.3 Income tax expense (benefit) 1.6 -2.1 )Net income 25.6 % 35.3 % Revenue Revenue by reportable segments Year ended January 26, 2020 January 27, 2019 $Change % Change ($ in millions) Gpu $9,465 $10,175 $-710 )-7 )% Tegra processor 1,453 1,541 -88 )-6 )% Total $10,918 $11,716 $-798 )-7 )% Gpu business. gpu business revenue decreased by 7% in fiscal year 2020 compared to fiscal year 2019 , which reflects a decline in gpus sold for gaming. geforce gpu product sales for gaming decreased by 10%, reflecting lower sales of geforce 28 desktop gpus and socs for gaming platforms, partially offset by growth in geforce notebook gpus. revenue from quadro gpus for professional visualization increased by 7%, reflecting strength in desktop and notebook workstations. data center revenue, which includes tesla, grid and dgx, increased by 2%, driven by vertical industry growth partially offset by lower hyperscale sales.", "highlight": "reflects a decline in gpus sold for gaming ||| reflecting lower sales of geforce 28 desktop gpus and socs for gaming platforms, partially offset by growth in geforce notebook gpus ||| reflecting strength in desktop and notebook workstations ||| driven by vertical industry growth partially offset by lower hyperscale sales.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para46", "text": "tegra processor business. tegra processor business revenue decreased by 6% in fiscal year 2020 compared to fiscal year 2019 . this was driven by a decline in revenue from socs for gaming platforms, which was partially offset by an increase of 9% in automotive revenue, reflecting growth in ai cockpit solutions and development services agreements.", "highlight": "driven by a decline in revenue from socs for gaming platforms ||| reflecting growth in ai cockpit solutions and development services agreements.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para47", "text": "Concentration of revenue revenue from sales to customers outside of the united states accounted for 92% and 87% of total revenue for fiscal years 2020 and 2019 , respectively . revenue by geographic region is allocated to individual countries based on the location to which the products are initially billed even if the revenue is attributable to end customers in a different location.", "highlight": "revenue from sales to customers outside of the united states accounted for 92% and 87% of total revenue for fiscal years 2020 and 2019 , respectively", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para48", "text": "dell represented approximately 11% of our total revenue for fiscal year 2020 and was attributable to the gpu business. no customer represented 10% or more of total revenue for fiscal year 2019 .", "highlight": "dell represented approximately 11% of our total revenue for fiscal year 2020", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para49", "text": "Gross profit and gross margin gross profit consists of total revenue, net of allowances, less cost of revenue. cost of revenue consists primarily of the cost of semiconductors purchased from subcontractors, including wafer fabrication, assembly, testing and packaging, board and device costs, manufacturing support costs, including labor and overhead associated with such purchases, final test yield fallout, inventory and warranty provisions, memory and component costs, and shipping costs. cost of revenue also includes development costs for license and service arrangements and stock-based compensation related to personnel associated with manufacturing.", "highlight": "gross margin gross profit consists of total revenue, net of allowances, less cost of revenue", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para50", "text": "our overall gross margin was 62.0% and 61.2% for fiscal years 2020 and 2019 , respectively. the increase in fiscal year 2020 was driven by reduced inventory provisions and the sale of previously written-off components.", "highlight": "driven by reduced inventory provisions and the sale of previously written-off components", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para51", "text": "inventory provisions totaled $161 million and $270 million for fiscal years 2020 and 2019, respectively. sales of inventory that was previously written-off or written-down totaled $145 million and $41 million for fiscal years 2020 and 2019, respectively. as a result, the overall net effect on our gross margin was insignificant in fiscal year 2020 and an unfavorable impact of 2.0% in fiscal year 2019.", "highlight": "inventory provisions totaled $161 million and $270 million ||| previously written-off or written-down totaled $145 million and $41 million", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para52", "text": "A discussion of our gross margin results for each of our reportable segments is as follows: gpu business. the gross margin of our gpu business increased during fiscal year 2020 when compared to fiscal year 2019, primarily driven by reduced inventory provisions and the sale of previously written-off components.", "highlight": "primarily driven by reduced inventory provisions and the sale of previously written-off components", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para53", "text": "tegra processor business. the gross margin of our tegra processor business was relatively flat during fiscal year 2020 when compared to fiscal year 2019.", "highlight": "was relatively flat", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para54", "text": "Operating expenses Year ended January 26, 2020 January 27, 2019 $Change % Change ($ in millions) Research and development expenses $2,829 $2,376 $453 19 % % of net revenue 25.9 % 20.3 % Sales, general and administrative expenses 1,093 991 102 10 % % of net revenue 10.0 % 8.5 % Total operating expenses $3,922 $3,367 $555 16 % Research and development research and development expenses increased by 19% in fiscal year 2020 compared to fiscal year 2019 , driven primarily by employee additions and increases in employee compensation and other related costs, including infrastructure costs and stock-based compensation expense.", "highlight": "driven primarily by employee additions and increases in employee compensation and other related costs, including infrastructure costs and stock-based compensation expense", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para55", "text": "29 Sales, general and administrative sales, general and administrative expenses increased by 10% in fiscal year 2020 compared to fiscal year 2019 , driven primarily by employee additions and increases in employee compensation and other related costs, including infrastructure costs and stock-based compensation expense.", "highlight": "driven primarily by employee additions and increases in employee compensation and other related costs", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para56", "text": "Total other income, net Interest income and interest expense interest income consists of interest earned on cash, cash equivalents and marketable securities. interest income was $178 million and $ 136 million in fiscal years 2020 and 2019 , respectively. the increase in interest income was primarily due to higher average invested balances.", "highlight": "was primarily due to higher average invested balances.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para57", "text": "interest expense is primarily comprised of coupon interest and debt discount amortization related to the 2.20% notes due 2021 and 3.20% notes due 2026 issued in september 2016. interest expense was $52 million and $58 million in fiscal years 2020 and 2019 , respectively.", "highlight": "coupon interest and debt discount amortization related to the 2.20% notes due 2021 and 3.20% notes due 2026 ||| interest expense was $52 million and $58 million", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para58", "text": "Other, net other, net, consists primarily of realized or unrealized gains and losses from non-affiliated investments and the impact of changes in foreign currency rates. other, net, was not significant during fiscal year 2020 and was $14 million of income during fiscal year 2019, consisting primarily of $12 million unrealized gains from non-affiliated investments.", "highlight": "was not significant during fiscal year 2020 and was $14 million of income during fiscal year 2019", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para59", "text": "Income taxes we recognized income tax expense of $174 million for fiscal year 2020 and income tax benefit of $245 million for fiscal year 2019. our annual effective tax rate was 5.9% and (6.3)% for fiscal years 2020 and 2019, respectively. the increase in our effective tax rate in fiscal year 2020 as compared to fiscal year 2019 was primarily due to a decrease of tax benefits from stock-based compensation and an absence of tax benefits related to the enactment of the tcja.", "highlight": "primarily due to a decrease of tax benefits from stock-based compensation and an absence of tax benefits related to the enactment of the tcja.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para60", "text": "our effective tax rate for fiscal years 2020 and 2019 was lower than the u.s. federal statutory rate of 21% due primarily to income earned in jurisdictions, including the british virgin islands and hong kong, where the tax rate was lower than the u.s. federal statutory tax rates, favorable recognition of u.s. federal research tax credits, excess tax benefits related to stock-based compensation, and the finalization of the enactment-date income tax effects of the tcja in 2019.", "highlight": "income earned in jurisdictions, including the british virgin islands and hong kong, where the tax rate was lower than the u.s. federal statutory tax rates, favorable recognition of u.s. federal research tax credits, excess tax benefits related to stock-based compensation, and the finalization of the enactment-date income tax effects", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 2, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para61", "text": "refer to note 14 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k for additional information.", "highlight": "in part iv, item 15 of this annual report on form 10-k", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para62", "text": "Liquidity and capital resources January 26, 2020 January 27, 2019 (in millions) Cash and cash equivalents $10,896 $782 Marketable securities 1 6,640 Cash, cash equivalents, and marketable securities $10,897 $7,422 Year ended January 26, 2020 January 27, 2019 (in millions) Net cash provided by operating activities $4,761 $3,743 Net cash provided by (used in) investing activities $6,145 $-4,097 )Net cash used in financing activities $-792 )$-2,866 )as of january 26, 2020 , we had $10.90 billion in cash, cash equivalents and marketable securities, an increase of $3.48 billion from the end of fiscal year 2019 . our investment policy requires the purchase of highly rated fixed income securities, the diversification of investment types and credit exposures, and certain limits on our portfolio duration.", "highlight": "as of january 26, 2020 , we had $10.90 billion in cash, cash equivalents and marketable securities, an increase of $3.48 billion from the end of fiscal year 2019", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para63", "text": "30 cash provided by operating activities increased in fiscal year 2020 compared to fiscal year 2019, primarily due to changes in working capital driven by a reduction in inventory, partially offset by a decrease in operating income.", "highlight": "primarily due to changes in working capital driven by a reduction in inventory", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para64", "text": "cash used in investing activities decreased in fiscal year 2020 compared to fiscal year 2019, primarily due to lower purchases, higher sales, and lower maturities of marketable securities in preparation for the acquisition of mellanox.", "highlight": "primarily due to lower purchases, higher sales, and lower maturities of marketable securities", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para65", "text": "cash used in financing activities decreased in fiscal year 2020 compared to fiscal year 2019, primarily due to no share repurchases in fiscal year 2020 and lower tax payments related to employee stock plans.", "highlight": "primarily due to no share repurchases in fiscal year 2020 and lower tax payments related to employee stock plans.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para66", "text": "Liquidity our primary sources of liquidity are our cash and cash equivalents, our marketable securities, and the cash generated by our operations. as of january 26, 2020 , we had $ 10.90 billion in cash, cash equivalents and marketable securities. we believe that we have sufficient liquidity to meet our operating requirements for at least the next twelve months, including our proposed acquisition of mellanox. refer to note 2 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k for additional information.", "highlight": "we believe that we have sufficient liquidity to meet our operating requirements for at least the next twelve months, including our proposed acquisition of mellanox", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 1, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para67", "text": "our marketable securities consist of debt securities issued by the united states government and its agencies, highly rated corporations and financial institutions, asset-backed issuers, and foreign government entities. these marketable securities are denominated in united states dollars. refer to note 8 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k for additional information.", "highlight": "marketable securities consist of debt securities issued by the united states government and its agencies, highly rated corporations and financial institutions, asset-backed issuers, and foreign government entities", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para68", "text": "during fiscal year 2021, we expect our capital investment to be approximately $700 million to $900 million to fund property and equipment including construction of a new building at our santa clara campus.", "highlight": "we expect our capital investment to be approximately $700 million to $900 million", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para69", "text": "as a result of the tcja, substantially all of our cash, cash equivalents and marketable securities held outside of the united states as of january 26, 2020 are available for use in the united states without incurring additional u.s. federal income taxes. refer to note 14 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k for additional information.", "highlight": "are available for use in the united states without incurring additional u.s. federal income taxes", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para70", "text": "Capital return to shareholders in november 2018, we communicated our intent to return $3.00 billion to shareholders by the end of fiscal year 2020, including $700 million in share repurchases made during the fourth quarter of fiscal year 2019. in fiscal year 2020, we returned $390 million in quarterly cash dividends. we did not repurchase any shares during fiscal year 2020. we intend to return to repurchasing shares after closing the acquisition of mellanox. as of january 26, 2020, we are authorized, subject to certain specifications, to repurchase shares of our common stock up to $7.24 billion through december 2022.", "highlight": "we communicated our intent to return $3.00 billion to shareholders ||| we returned $390 million in quarterly cash dividends. we did not repurchase any shares during fiscal year 2020. we intend to return to repurchasing shares after closing the acquisition of mellanox", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 1, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para71", "text": "our cash dividend program and the payment of future cash dividends under that program are subject to our board's continuing determination that the dividend program and the declaration of dividends thereunder are in the best interests of our shareholders. refer to note 15 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k for further discussion.", "highlight": "our cash dividend program and the payment of future cash dividends under that program are subject to our board's continuing determination", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para72", "text": "Outstanding indebtedness and credit facilities we have outstanding $1.00 billion of notes due 2021 and $1.00 billion of notes due 2026, collectively, the notes.", "highlight": "we have outstanding $1.00 billion of notes due 2021 and $1.00 billion of notes due 2026", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para73", "text": "we have a credit agreement under which we may borrow up to $575 million for general corporate purposes and can obtain revolving loan commitments up to $425 million. as of january 26, 2020 , we had not borrowed any amounts under this agreement.", "highlight": "we may borrow up to $575 million for general corporate purposes and can obtain revolving loan commitments up to $425 million", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para74", "text": "we have a $575 million commercial paper program to support general corporate purposes. as of january 26, 2020 , we had not issued any commercial paper.", "highlight": "we have a $575 million commercial paper program", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para75", "text": "refer to note 12 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k for further discussion.", "highlight": "in part iv, item 15 of this annual report on form 10-k", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para76", "text": "Off-balance sheet arrangements as of january 26, 2020, we had no material off-balance sheet arrangements as defined by applicable sec regulations.", "highlight": "we had no material off-balance sheet arrangements", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para77", "text": "31 Contractual obligations The following table summarizes our contractual obligations as of january 26, 2020 : Payment due by period Contractual obligations Total Less than 1 year 1-3 years 4-5 years More than 5 years (in millions) Long-term debt (1) $2,248 $54 $1,078 $64 $1,052 Inventory purchase obligations 1,156 1,156 Transition tax payable (2) 351 33 67 146 105 Operating leases (3) 773 121 219 141 292 Capital purchase obligations 186 186 Total contractual obligations $4,714 $1,550 $1,364 $351 $1,449 -1 represents the aggregate principal amount of $2.00 billion and anticipated interest payments of $248 million for the notes. refer to note 12 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k.", "highlight": "as of january 26, 2020 : Payment due by period Contractual obligations Total Less than 1 year 1-3 years 4-5 years More than 5 years (in millions) Long-term debt (1) $2,248 $54 $1,078 $64 $1,052 Inventory purchase obligations 1,156 1,156 Transition tax payable (2) 351 33 67 146 105 Operating leases (3) 773 121 219 141 292 Capital purchase obligations 186 186 Total contractual obligations $4,714 $1,550 $1,364 $351 $1,449 -1 represents the aggregate principal amount of $2.00 billion and anticipated interest payments of $248 million for the notes", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para78", "text": "-2 represents our remaining tax payable of the one-time transition tax that resulted from enactment of the tcja in fiscal year 2018. as of january 26, 2020, we have paid the first two installments totaling $67 million. the remaining will be payable in six annual installments. the next installment of $33 million is classified as a current income tax payable. the installment amounts are equal to 8% of the total liability, payable in fiscal years 2019 through 2023, 15% in fiscal year 2024, 20% in fiscal year 2025 and 25% in fiscal year 2026. refer to note 14 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k.", "highlight": "represents our remaining tax payable of the one-time transition tax that resulted from enactment of the tcja in fiscal year 2018", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para79", "text": "-3 for further information, refer to note 3 of the notes to consolidated financial statements included in part iv, item 15 of this annual report on form 10-k.", "highlight": "refer to note 3 of the notes to consolidated financial statements included in part iv, item 15 of this annual report on form 10-k.", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para80", "text": "excluded from the table above are unrecognized tax benefits of $211 million which consists of $180 million and the related interest and penalties of $31 million recorded in non-current income tax payable as of january 26, 2020. we are unable to reasonably estimate the timing of any potential tax liability or interest/penalty payments in individual years due to uncertainties in the underlying income tax positions and the timing of the effective settlement of such tax positions. refer to note 14 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k.", "highlight": "we are unable to reasonably estimate the timing of any potential tax liability or interest/penalty payments in individual years due to uncertainties in the underlying income tax positions and the timing of the effective settlement of such tax positions", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 1, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1045810_part2_item7_para81", "text": "Adoption of new and recently issued accounting pronouncements refer to note 1 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k for a discussion of adoption of new and recently issued accounting pronouncements.", "highlight": "refer to note 1 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para1", "text": "Management's discussion and analysis of financial condition and results of operations Overview Highlights of our annual results follow: Year ended december 31, $ change % change 2019 2018 2019/2018 2019/2018 Revenue (in millions) $74,094 $71,861 $2,233 3.1 % Operating expenses (in millions) 66,296 64,837 1,459 2.3 % Operating profit (in millions) $7,798 $7,024 $774 11.0 % Operating margin 10.5 % 9.8 % Net income (in millions) $4,440 $4,791 $-351 )-7.3 )% Basic earnings per share $5.14 $5.53 $-0.39 )-7.1 )% Diluted earnings per share $5.11 $5.51 $-0.40 )-7.3 )% Average daily package volume (in thousands) 21,880 20,677 5.8 % Average revenue per piece $10.87 $10.98 $-0.11 )-1.0 )% consolidated revenue increased 3.1% .", "highlight": "Overview Highlights of our annual results follow: Year ended december 31, $ change % change 2019 2018 2019/2018 2019/2018 Revenue (in millions) $74,094 $71,861 $2,233 3.1 % Operating expenses (in millions) 66,296 64,837 1,459 2.3 % Operating profit (in millions) $7,798 $7,024 $774 11.0 % Operating margin 10.5 % 9.8 % Net income (in millions) $4,440 $4,791 $-351 )-7.3 )% Basic earnings per share $5.14 $5.53 $-0.39 )-7.1 )% Diluted earnings per share $5.11 $5.51 $-0.40 )-7.3 )% Average daily package volume (in thousands) 21,880 20,677 5.8 % Average revenue per piece $10.87 $10.98 $-0.11 )-1.0 )% consolidated revenue increased 3.1% .", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para2", "text": "average daily package volume increased 5.8% primarily driven by our u.s. domestic package segment, which experienced growth from smbs as well as several large customers, led by our largest customer, amazon.", "highlight": "average daily package volume increased 5.8%", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para3", "text": "average revenue per piece is dependent upon base rates, customer and product mix, average billable weight per piece, fuel surcharge rates and currency. average revenue per piece decreased as a result of changes in customer and product mix, and lower average billable weight per piece in our u.s. domestic package segment. currency movements negatively impacted revenue per piece in our international package segment.", "highlight": "currency movements negatively impacted revenue per piece in our international package segment.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para4", "text": "operating profit and operating margin increased with growth and margin expansion in all segments.", "highlight": "operating profit and operating margin increased", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para5", "text": "We reported net income of $4.440 billion and diluted earnings per share of $5.11 . adjusted diluted earnings per share was $7.53 after adjusting for the after-tax impacts of the following: Transformation strategy costs of $196 million; Legal contingencies and expenses of $91 million; and pension mark-to-market losses recognized outside of a 10% corridor of $1.816 billion.", "highlight": "reported net income of $4.440 billion and diluted earnings per share of $5.11 . adjusted diluted earnings per share was $7.53 ||| Transformation strategy costs of $196 million; Legal contingencies and expenses of $91 million; and pension mark-to-market losses recognized outside of a 10% corridor of $1.816 billion", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para6", "text": "2018 compared to 2017 see item 7. management's discussion and analysis of financial condition and results of operations of the company's annual report on form 10-k for the year ended december 31, 2018 filed with the securities and exchange commission on february 21, 2019.", "highlight": "2018 compared to 2017 see item 7", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para7", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Supplemental information - items affecting comparability we supplement the reporting of our financial information determined under generally accepted accounting principles in the united states (\"gaap\") with certain non-gaap financial measures including, as applicable, \"adjusted\" compensation and benefits, operating expenses, operating profit, operating margin, other income and (expense), income before income taxes, income tax expense, effective tax rate, net income and earnings per share. adjusted financial measures may exclude the impact of period over period exchange rate changes and hedging activities, amounts related to mark-to-market gains or losses, recognition of contingencies and transformation strategy costs, as described below. we believe that these adjusted financial measures provide meaningful information to assist investors and analysts in understanding our financial results and assessing our prospects for future performance. we believe these adjusted financial measures are important indicators of our recurring results of operations because they exclude items that may not be indicative of, or are unrelated to, our underlying operating results, and provide a useful baseline for analyzing trends in our underlying businesses. additionally, these adjusted financial measures are used internally by management for the determination of incentive compensation awards, business unit operating performance analysis and business unit resource allocation.", "highlight": "we believe that these adjusted financial measures provide meaningful information to assist investors and analysts in understanding our financial results and assessing our prospects for future performance.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para8", "text": "non-gaap financial measures should be considered in addition to, and not as an alternative for, our reported results prepared in accordance with gaap. our non-gaap financial information does not represent a comprehensive basis of accounting. therefore, our non-gaap financial information may not be comparable to similarly titled measures reported by other companies.", "highlight": "therefore, our non-gaap financial information may not be comparable to similarly titled measures reported by other companies.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para9", "text": "The year over year comparisons of our financial results are affected by the following items (in millions): Year ended december 31, Non-gaap adjustments 2019 2018 Operating expenses: Transformation strategy costs $255 $360 Legal contingencies and expenses 97 Total adjustments to operating expenses $352 $360 Other income and (expense): Defined benefit plans mark-to-market charges $2,387 $1,627 Total adjustments to other income and (expense) $2,387 $1,627 Total adjustments to income before income taxes $2,739 $1,987 Income tax benefit from the mark-to-market charges $-571 )$-390 )Income tax benefit from transformation strategy costs -59 )-87 )Income tax benefit from legal contingencies and expenses -6 )Total adjustments to income tax expense $-636 )$-477 )Total adjustments to net income $2,103 $1,510 these items have been excluded from comparisons of \"adjusted\" compensation and benefits, operating expenses, operating profit, operating margin, other income and (expense), income tax expense and effective tax rate in the discussion that follows. the income tax benefit from transformation strategy costs, legal contingencies and expenses and the mark-to-market charges are calculated by multiplying the statutory tax rates applicable in each tax jurisdiction, including the u.s. federal jurisdiction and various u.s. state and non-u.s. jurisdictions, by the tax deductible adjustments. the blended average of the effective tax rates in 2019 and 2018 were 23.2% and 24.0%, respectively.", "highlight": "Transformation strategy costs $255 $360 Legal contingencies and expenses 97 Total adjustments to operating expenses $352 $360 Other income and (expense): Defined benefit plans mark-to-market charges $2,387 $1,627 Total adjustments to other income and (expense) $2,387 $1,627 Total adjustments to income before income taxes $2,739 $1,987 Income tax benefit from the mark-to-market charges $-571 )$-390 )Income tax benefit from transformation strategy costs -59 )-87 )Income tax benefit from legal contingencies and expenses -6 )Total adjustments to income tax expense $-636 )$-477 )Total adjustments to net income $2,103 $1,510  ||| . the blended average of the effective tax rates in 2019 and 2018 were 23.2% and 24.0%, respectively.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para10", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Impact of changes in foreign currency exchange rates and hedging activities we supplement the reporting of our revenue, revenue per piece and operating profit with non-gaap measures that exclude the period over period impact of foreign currency exchange rate changes and hedging activities.", "highlight": "we supplement the reporting of our revenue, revenue per piece and operating profit with non-gaap measures that exclude the period over period impact of foreign currency exchange rate changes and hedging activities.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para11", "text": "currency-neutral revenue, revenue per piece and operating profit are calculated by dividing current period reported u.s. dollar revenue, revenue per piece and operating profit by the current period average exchange rates to derive current period local currency revenue, revenue per piece and operating profit. the derived amounts are then multiplied by the average foreign exchange rates used to translate the comparable results for each month in the prior year period (including the period over period impact of foreign currency hedging activities). the difference between the current period reported u.s. dollar revenue, revenue per piece and operating profit and the derived current period u.s. dollar revenue, revenue per piece and operating profit is the period over period impact of currency fluctuations.", "highlight": "the derived amounts are then multiplied by the average foreign exchange rates used to translate the comparable results for each month in the prior year period", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para12", "text": "Transformation strategy costs we supplement the presentation of our operating profit, operating margin, income before income taxes, net income and earnings per share with similar non-gaap measures that exclude the impact of costs related to restructuring programs, including transformation strategy costs. for information regarding transformation strategy costs, see note 17 to the audited, consolidated financial statements.", "highlight": "Transformation strategy costs we supplement the presentation of our operating profit, operating margin, income before income taxes, net income and earnings per share with similar non-gaap measures that exclude the impact of costs related to restructuring programs, including transformation strategy costs", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para13", "text": "Costs related to legal contingencies and expenses we supplement the presentation of our operating profit, operating margin, income before income taxes, net income and earnings per share with similar non-gaap measures that exclude the impact of costs related to certain of our legal contingencies and expenses. for information regarding legal contingencies and expenses, see note 9 to the audited, consolidated financial statements.", "highlight": "Costs related to legal contingencies and expenses we supplement the presentation of our operating profit, operating margin, income before income taxes, net income and earnings per share with similar non-gaap measures that exclude the impact of costs related to certain of our legal contingencies and expenses", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para14", "text": "Defined benefit plans mark-to-market charges we recognize changes in the fair value of plan assets and net actuarial gains and losses in excess of a 10% corridor for our pension and postretirement defined benefit plans immediately as part of net periodic benefit cost other than service cost. we supplement the presentation of our income before income taxes, net income and earnings per share with \"adjusted\" measures that exclude the impact of the portion of net periodic benefit cost other than service cost represented by the gains and losses recognized in excess of the 10% corridor and the related income tax effects. we believe excluding these mark-to-market impacts from our adjusted results provides important supplemental information to remove the volatility caused by short-term changes in market interest rates, equity prices and similar factors.", "highlight": "we believe excluding these mark-to-market impacts from our adjusted results provides important supplemental information to remove the volatility caused by short-term changes in market interest rates, equity prices and similar factors.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para15", "text": "this adjusted net periodic benefit cost ($754 million in 2019 and $615 million in 2018) utilizes the expected return on plan assets (7.68% in 2019 and 2018) and the discount rate used to determine net periodic benefit cost (4.45% in 2019 and 3.81% in 2018). the unadjusted net periodic benefit cost reflects the actual return on plan assets (17.57% in 2019 and -2.38% in 2018) and the discount rate used to measure the projected benefit obligation at the december 31 measurement date (3.55% in 2019 and 4.45% in 2018).", "highlight": "this adjusted net periodic benefit cost ($754 million in 2019 and $615 million in 2018) utilizes the expected return on plan assets (7.68% in 2019 and 2018) and the discount rate used to determine net periodic benefit cost (4.45% in 2019 and 3.81% in 2018). the unadjusted net periodic benefit cost reflects the actual return on plan assets (17.57% in 2019 and -2.38% in 2018) ||| e (3.55% in 2019 and 4.45% in 2018).", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para16", "text": "we recognized pre-tax mark-to-market losses outside of a 10% corridor related to the remeasurement of our pension and postretirement defined benefit plans' assets and liabilities in \"other income and (expense)\" of $2.387 and $1.627 billion for 2019 and 2018, respectively. in october 2019, we refined the bond matching approach used to determine the discount rate for our u.s. pension and postretirement plans by implementing advances in technology and modeling techniques. this refinement decreased the projected benefit obligation on our consolidated balance sheet by approximately $900 million as of december 31, 2019, decreased the pre-tax mark-to-market charge by approximately $810 million and increased net income by $616 million, or $0.71 per share on a basic and diluted basis. this change did not have an impact on adjusted net income or adjusted earnings per share.", "highlight": "we recognized pre-tax mark-to-market losses outside of a 10% corridor related to the remeasurement |||  of $2.387 and $1.627 billion for 2019 and 2018, ||| this refinement decreased the projected benefit obligation on our consolidated balance sheet by approximately $900 million ||| decreased the pre-tax mark-to-market charge by approximately $810 million and increased net income by $616 million ||| this change did not have an impact on adjusted net income or adjusted earnings per share", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para17", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations The table below indicates the amounts associated with each component of the pre-tax mark-to-market losses, as well as the weighted-average actuarial assumptions used to determine our net periodic benefit cost, for each year: Year ended december 31, Components of mark-to-market gain (loss) (in millions): 2019 2018 Discount rates $-5,670 )$845 Return on assets 3,850 -1,057 )Demographic and other assumption changes -24 )-22 )Coordinating benefits attributable to the central states pension fund -543 )-1,393 )Total mark-to-market gain (loss) $-2,387 )$-1,627 )Year ended december 31, Weighted-average actuarial assumptions used to determine net periodic benefit cost: 2019 2018 Expected rate of return on plan assets 7.68 % 7.68 % Actual rate of return on plan assets 17.57 % -2.38 )% Discount rate used for net periodic benefit cost 4.45 % 3.81 % Discount rate at measurement date 3.55 % 4.45 % The pre-tax mark-to-market losses for the years ended december 31, 2019 and 2018 , respectively, were comprised of the following components: 2019 - $2.387 billion pre-tax mark-to-market loss: return on assets ($3.850 billion pre-tax gain): in 2019, the actual rate of return on plan assets was higher than our expected rate of return, primarily due to strong global equity and u.s. bond markets.", "highlight": "Components of mark-to-market gain (loss) (in millions): 2019 2018 Discount rates $-5,670 )$845 Return on assets 3,850 -1,057 )Demographic and other assumption changes -24 )-22 )Coordinating benefits attributable to the central states pension fund -543 )-1,393 )Total mark-to-market gain (loss) $-2,387 )$-1,627 )Year ended december 31, Weighted-average actuarial assumptions used to determine net periodic benefit cost: 2019 2018 Expected rate of return on plan assets 7.68 % 7.68 % Actual rate of return on plan assets 17.57 % -2.38 )% Discount rate used for net periodic benefit cost 4.45 % 3.81 % Discount rate at measurement date 3.55 % 4.45 % The pre-tax mark-to-market losses for the years ended december 31, 2019 and 2018 , respectively ||| components: 2019 - $2.387 billion pre-tax mark-to-market loss", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para18", "text": "coordinating benefits attributable to the central states pension fund ($543 million pre-tax loss): this represents our current best estimate of the additional potential coordinating benefits that may be required to be paid related to the central states pension fund.", "highlight": "coordinating benefits attributable to the central states pension fund ($543 million pre-tax loss):", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para19", "text": "discount rates ($5.670 billion pre-tax loss): the weighted-average discount rate for our pension and postretirement medical plans decreased from 4.45% at december 31, 2018 to 3.55% at december 31, 2019, primarily due to both a decline in u.s. treasury yields and a decrease in credit spreads on aa-rated corporate bonds in 2019.", "highlight": "primarily due to both a decline in u.s. treasury yields and a decrease in credit spreads on aa-rated corporate bonds in 2019.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para20", "text": "demographic and other assumption changes ($24 million pre-tax loss): this represents the difference between actual and estimated participant data and demographic factors, including items such as healthcare cost trends, compensation rate increases and rates of termination, retirement and mortality.", "highlight": "this represents the difference between actual and estimated participant data and demographic factors", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para21", "text": "2018 - $1.627 billion pre-tax mark-to-market loss: return on assets ($1.057 billion pre-tax loss): in 2018, the actual rate of return on plan assets was lower than our expected rate of return, primarily due to weak global equity markets.", "highlight": "in 2018, the actual rate of return on plan assets was lower than our expected rate of return", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para22", "text": "coordinating benefits attributable to the central states pension fund ($1.393 billion pre-tax loss): this represented our then-current best estimate of potential coordinating benefits that may be required to be paid related to the central states pension fund.", "highlight": "this represented our then-current best estimate of potential coordinating benefits that may be required to be paid related to the central states pension fund.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para23", "text": "discount rates ($845 million pre-tax gain): the weighted-average discount rate for our pension and postretirement medical plans increased from 3.81% at december 31, 2017 to 4.45% at december 31, 2018, primarily due to both an increase in u.s. treasury yields and an increase in credit spreads on aa-rated corporate bonds in 2018.", "highlight": "primarily due to both an increase in u.s. treasury yields and an increase in credit spreads on aa-rated corporate bonds in 2018.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para24", "text": "demographic and other assumption changes ($22 million pre-tax loss): this represents the difference between actual and estimated participant data and demographic factors, including items such as healthcare cost trends, compensation rate increases and rates of termination, retirement and mortality.", "highlight": "this represents the difference between actual and estimated participant data and demographic factors, including items such as healthcare cost trends, compensation rate increases and rates of termination, retirement and mortality.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para25", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Expense allocations certain operating expenses are allocated between our reporting segments using activity-based costing methods. these activity-based costing methods require us to make estimates that impact the amount of each expense category that is attributed to each segment. changes in these estimates will directly impact the amount of expense allocated to each segment, and therefore the operating profit of each reporting segment. our allocation methodologies are refined periodically, as necessary, to reflect changes in our businesses. there were no significant changes in our expense allocation methodologies during 2019 , 2018 or 2017 .", "highlight": "to reflect changes in our businesses. there were no significant changes in our expense allocation methodologies", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para26", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations U.s. domestic package operations Year ended december 31, $ change % change 2019 2018 2019/2018 2019/2018 Average daily package volume (in thousands): Next day air 1,889 1,542 22.5 % Deferred 1,622 1,432 13.3 % Ground 15,176 14,498 4.7 % Total average daily package volume 18,687 17,472 7.0 % Average revenue per piece: Next day air $17.74 $19.53 $-1.79 )-9.2 )% Deferred 12.62 13.12 -0.50 )-3.8 )% Ground 8.55 8.51 0.04 0.5 % Total average revenue per piece $9.83 $9.86 $-0.03 )-0.3 )% Operating days in period 253 253 Revenue (in millions): Next day air $8,479 $7,618 $861 11.3 % Deferred 5,180 4,752 428 9.0 % Ground 32,834 31,223 1,611 5.2 % Total revenue $46,493 $43,593 $2,900 6.7 % Operating expenses (in millions): Operating expenses $42,329 $39,950 $2,379 6.0 % Transformation strategy costs -108 )-235 )127 -54.0 )% Legal contingencies and expenses -97 )-97 )N/m Adjusted operating expenses $42,124 $39,715 $2,409 6.1 % Operating profit (in millions) and operating margin: Operating profit $4,164 $3,643 $521 14.3 % Adjusted operating profit $4,369 $3,878 $491 12.7 % Operating margin 9.0 % 8.4 % Adjusted operating margin 9.4 % 8.9 % Revenue The change in overall revenue was due to the following factors for the year ended december 31, 2019 versus 2018 : Volume Rates / Product mix Fuel Surcharge Total revenue Change Revenue change drivers: 2019/2018 7.0 % -0.6 )% 0.3 % 6.7 % United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Volume 2019 compared to 2018 our overall volume increased across all products, led by strong growth in our next day air and deferred driven by the structural shift to faster delivery in retail and e-commerce, and from additional customer volume. we experienced growth from a number of large customers and smbs, with volume growth led by our largest customer, amazon. this growth was enabled by our on-going investment in automated facilities and other transformation initiatives.", "highlight": "ended december 31, $ change % change 2019 2018 2019/2018 2019/2018 Average daily package volume (in thousands): Next day air 1,889 1,542 22.5 % Deferred 1,622 1,432 13.3 % Ground 15,176 14,498 4.7 % Total average daily package volume 18,687 17,472 7.0 % Average revenue per piece: Next day air $17.74 $19.53 $-1.79 )-9.2 )% Deferred 12.62 13.12 -0.50 )-3.8 )% Ground 8.55 8.51 0.04 0.5 % Total average revenue per piece $9.83 $9.86 $-0.03 )-0.3 )% Operating days in period 253 253 Revenue (in millions): Next day air $8,479 $7,618 $861 11.3 % Deferred 5,180 4,752 428 9.0 % Ground 32,834 31,223 1,611 5.2 % Total revenue $46,493 $43,593 $2,900 6.7 % Operating expenses (in millions): Operating expenses $42,329 $39,950 $2,379 6.0 % Transformation strategy costs -108 )-235 )127 -54.0 )% Legal contingencies and expenses -97 )-97 )N/m Adjusted operating expenses $42,124 $39,715 $2,409 6.1 % Operating profit (in millions) and operating margin: Operating profit $4,164 $3,643 $521 14.3 % Adjusted operating profit $4,369 $3,878 $491 12.7 % Operating margin 9.0 % 8.4 % Adjusted operating margin 9.4 % 8.9 % Revenue The change in overall revenue was due to the following factors for the year ended december 31, 2019 versus 2018 : Volume Rates / Product mix Fuel Surcharge Total revenue Change Revenue change drivers: 2019/2018 7.0 % -0.6 )% 0.3 % 6.7 %", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para27", "text": "business-to-consumer shipments, which represented approximately 54% of the total u.s. domestic package average daily volume, grew 11.3% for the year driven by the growth in e-commerce and retail. volume grew across all products, with particularly strong growth in our air products. business-to-business shipments increased 2.2% for the year with volume increases in both air and ground services.", "highlight": "which represented approximately 54% of the total u.s. domestic package average daily volume, grew 11.3% ||| , with particularly strong growth in our air products. business-to-business shipments increased 2.2", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para28", "text": "within our air products, overall average daily volume increased in both next day air and deferred. strong air volume growth continued primarily in residential next day air and second day package products, as consumers and businesses continue to demand faster delivery options, which we expect will persist. this growth was slightly offset by declines in next day air letter and second day letter volume due to shifts in customer preferences.", "highlight": "within our air products, overall average daily volume increased in both next day air and deferred. strong air volume growth continued primarily in residential next day air and second day package products, as consumers and businesses continue to demand faster delivery options, which we expect will persist", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para29", "text": "we experienced year over year growth in both residential and commercial ground products. growth in residential ground volume was driven by changes in customer mix resulting from the continued growth in e-commerce, while growth in commercial ground products was primarily driven by an increase in retail return services.", "highlight": "we experienced year over year growth in both residential and commercial ground products ||| growth in residential ground volume was driven by changes in customer mix resulting from the continued growth in e-commerce", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para30", "text": "Rates and product mix 2019 compared to 2018 overall revenue per piece decreased due to customer and product mix and fuel surcharge rates, partially offset by changes in base rates.", "highlight": "due to customer and product mix and fuel surcharge rates, partially offset by changes in base rates", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para31", "text": "revenue per piece for ground and air products was positively impacted by a base rate increase on december 26, 2018. ups ground and ups air services rates increased an average net 4.9%.", "highlight": "revenue per piece for ground and air products was positively impacted by a base rate increase", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para32", "text": "revenue per piece for our next day air and deferred products decreased primarily due to a shift in customer and product mix and a decrease in average billable weight per piece, which was partially offset by the increase in base rates.", "highlight": "due to a shift in customer and product mix and a decrease in average billable weight per piece, which was partially offset by the increase in base rates.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para33", "text": "revenue per piece for our ground products increased primarily due to base rate increases and customer and product mix, partially offset by a decrease in average billable weight per piece.", "highlight": "due to base rate increases and customer and product mix, partially offset by a decrease in average billable weight per piece.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para34", "text": "Fuel surcharges We apply a fuel surcharge on our domestic air and ground services. the air fuel surcharge is based on the u.s. department of energy's (\"doe\") gulf coast spot price for a gallon of kerosene-type jet fuel, while the ground fuel surcharge is based on the doe's on-highway diesel fuel price. based on published rates, the average fuel surcharge rates for domestic air and ground products were as follows: Year ended december 31, % point change 2019 2018 2019/2018 Next day air / deferred 7.3 % 7.7 % -0.4 )% Ground 7.2 % 7.0 % 0.2 % effective april 2, 2018, we created separate fuel surcharges for domestic air shipments and international air export shipments. these surcharges are based on the u.s. gulf coast jet fuel price and are adjusted weekly. in june and october 2018, ground fuel surcharge rates were raised for all thresholds, and in october and december 2018, domestic air fuel surcharge rates were increased for all thresholds. ground surcharges continue to be based on the national u.s. average on-highway diesel fuel price and adjusted weekly.", "highlight": "we created separate fuel surcharges for domestic air shipments and international air export shipments ||| Fuel surcharges We apply a fuel surcharge on our domestic air and ground services. the air fuel surcharge is based on the u.s. department of energy's (\"doe\") gulf coast spot price for a gallon of kerosene-type jet fuel, while the ground fuel surcharge is based on the doe's on-highway diesel fuel price", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para35", "text": "while fluctuations in fuel surcharges can be significant from period to period, fuel surcharges represent one of the many individual components of our pricing structure that impact our overall revenue and yield. additional components include the mix of products sold, the base price and any additional charges or discounts on these services.", "highlight": "fuel surcharges represent one of the many individual components of our pricing structure that impact our overall revenue and yield", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para36", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations revenue per piece for ground products was positively impacted by fuel surcharge rate increases during 2018, while fuel surcharge rates for air products decreased slightly for the year.", "highlight": "United parcel service ||| was positively impacted by fuel surcharge rate increases during 2018, while fuel surcharge rates for air products decreased slightly for the year.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para37", "text": "total domestic fuel surcharge revenue increased by $140 million for the year as a result of increases in package volume and shifts in product mix, partially offset by lower fuel surcharge rates on our air products.", "highlight": "increases in package volume and shifts in product mix, partially offset by lower fuel surcharge rates on our air products", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para38", "text": "Operating expenses 2019 compared to 2018 operating expenses, and operating expenses excluding the impact of transformation strategy costs and legal contingencies and expenses, increased largely due to pickup and delivery costs (up $1.385 billion), costs of operating our domestic integrated air and ground network (up $631 million), costs of package sorting (up $301 million) and other indirect operating costs (up $92 million).", "highlight": "increased largely due to pickup and delivery costs (up $1.385 billion), costs of operating our domestic integrated air and ground network (up $631 million), costs of package sorting (up $301 million) and other indirect operating costs (up $92 million).", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para39", "text": "In order to manage costs, we continually adjust our air and ground network to better match higher volume levels. in addition, we continue to deploy and utilize technology to increase package sorting and delivery productivity by reducing manual touchpoints. the growth in pickup and delivery and network operational costs was impacted by several factors: Higher employee compensation and benefit costs largely resulting from: Volume growth, which resulted in an increase in average daily union labor hours of 4.7%; Union pay rate and benefit increases; and growth in the overall size of the workforce due to facility expansions.", "highlight": "we continually adjust our air and ground network to better match higher volume levels ||| we continue to deploy and utilize technology to increase package sorting and delivery productivity by reducing manual touchpoints. ||| Higher employee compensation and benefit costs largely resulting from: Volume growth", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para40", "text": "we incurred higher employee benefit expenses due to additional headcount, contractual contribution rate increases to union multiemployer plans and changes in benefit eligibility for certain union employees. these increases were slightly offset by lower pension expense for our company-sponsored plans due to higher discount rates used to measure the projected benefit obligations which reduced service costs, and lower premiums due to improved funded status.", "highlight": "we incurred higher employee benefit expenses due to additional headcount ||| union multiemployer plans and changes in benefit eligibility for certain union employees", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para41", "text": "we incurred slightly lower fuel expense for the year, driven by declines in fuel prices and higher alternative fuel tax credits in 2019 due to the passage of additional legislation. these reductions were partially offset by increased network volume, which resulted in higher fuel usage. aircraft block hours increased 10.3%, daily package delivery stops increased 10.9% and daily delivery miles increased 7.9%.", "highlight": "driven by declines in fuel prices and higher alternative fuel tax credits in 2019 due to the passage of additional legislation ||| partially offset by increased network volume, which resulted in higher fuel usage", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para42", "text": "lower costs for outside contract carriers were the result of retaining additional volume within our network.", "highlight": "lower costs for outside contract carriers were the result of retaining additional volume", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para43", "text": "total cost per piece, which includes transformation strategy costs and legal contingencies and expenses, decreased 0.9% for the year. excluding the year over year impact of transformation strategy costs and legal contingencies and expenses, adjusted cost per piece decreased 0.8% for the year. year over year cost per piece decreased due to the incremental impact of our new automated facilities and other transformation initiatives.", "highlight": "total cost per piece, which includes transformation strategy costs and legal contingencies and expenses, decreased 0.9%  ||| transformation strategy costs and legal contingencies and expenses, adjusted cost per piece decreased 0.8%", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para44", "text": "Operating profit and margin 2019 compared to 2018 operating profit increased $521 million with operating margins increasing 60 basis points to 9.0%. excluding the year over year impact of transformation strategy costs and legal contingencies and expenses, adjusted operating profit increased $491 million with operating margins increasing 50 basis points to 9.4%. operating profit increased as a result of the items described above.", "highlight": "operating profit increased $521 million with operating margins increasing 60 basis points to 9.0% ||| adjusted operating profit increased $491 million with operating margins increasing 50 basis points to 9.4%. operating profit increased", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para45", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations International package operations Year ended december 31, $ change % change 2019 2018 2019/2018 2019/2018 Average daily package volume (in thousands): Domestic 1,721 1,723 -0.1 )% Export 1,472 1,482 -0.7 )% Total average daily package volume 3,193 3,205 -0.4 )% Average revenue per piece: Domestic $6.51 $6.59 $-0.08 )-1.2 )% Export 29.10 29.27 -0.17 )-0.6 )% Total average revenue per piece $16.93 $17.08 $-0.15 )-0.9 )% Operating days in period 253 253 Revenue (in millions): Domestic $2,836 $2,874 $-38 )-1.3 )% Export 10,837 10,973 -136 )-1.2 )% Cargo & other 547 595 -48 )-8.1 )% Total revenue $14,220 $14,442 $-222 )-1.5 )% Operating expenses (in millions): Operating expenses $11,563 $11,913 $-350 )-2.9 )% Transformation strategy costs -122 )-76 )-46 )60.5 % Adjusted operating expenses $11,441 $11,837 $-396 )-3.3 )% Operating profit (in millions) and operating margin: Operating profit $2,657 $2,529 $128 5.1 % Adjusted operating profit $2,779 $2,605 $174 6.7 % Operating margin 18.7 % 17.5 % Adjusted operating margin 19.5 % 18.0 % Currency translation benefit / (cost) (in millions)*: Revenue $-232 )Operating expenses 302 Operating profit $70 * net of currency hedging; amount represents the change compared to the prior year.", "highlight": ", $ change % change 2019 2018 2019/2018 2019/2018 Average daily package volume (in thousands): Domestic 1,721 1,723 -0.1 )% Export 1,472 1,482 -0.7 )% Total average daily package volume 3,193 3,205 -0.4 )% Average revenue per piece: Domestic $6.51 $6.59 $-0.08 )-1.2 )% Export 29.10 29.27 -0.17 )-0.6 )% Total average revenue per piece $16.93 $17.08 $-0.15 )-0.9 )% Operating days in period 253 253 Revenue (in millions): Domestic $2,836 $2,874 $-38 )-1.3 )% Export 10,837 10,973 -136 )-1.2 )% Cargo & other 547 595 -48 )-8.1 )% Total revenue $14,220 $14,442 $-222 )-1.5 )% Operating expenses (in millions): Operating expenses $11,563 $11,913 $-350 )-2.9 )% Transformation strategy costs -122 )-76 )-46 )60.5 % Adjusted operating expenses $11,441 $11,837 $-396 )-3.3 )% Operating profit (in millions) and operating margin: Operating profit $2,657 $2,529 $128 5.1 % Adjusted operating profit $2,779 $2,605 $174 6.7 % Operating margin 18.7 % 17.5 % Adjusted operating margin 19.5 % 18.0 % Currency translation benefit / (cost) (in millions)*: Revenue $-232 )Operating expenses 302 Operating profit $70 * net of currency hedging; amount represents the change compared to the prior year.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para46", "text": "Revenue The change in overall revenue was due to the following factors for the year ended december 31, 2019 versus 2018 : Volume Rates / Product mix Fuel Surcharge Currency Total revenue Change Revenue change drivers: 2019/2018 -0.4 )% 0.4 % 0.1 % -1.6 )% -1.5 )% United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Volume 2019 compared to 2018 our overall average daily volume decreased slightly due to weak demand from several sectors including high tech, manufacturing, professional services, automotive and government, partially offset by higher demand in healthcare, retail and other sectors.", "highlight": "Volume Rates / Product mix Fuel Surcharge Currency Total revenue Change Revenue change drivers: 2019/2018 -0.4 )% 0.4 % 0.1 % -1.6 )% -1.5 )% ||| our overall average daily volume decreased slightly", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para47", "text": "export volume decreased slightly in 2019. european export volume declined across all trade lanes, while intra-european volume grew slightly. total u.s. export volume decreased, with declines in the europe and asia trade lanes partially offset by growth in the u.s. to americas and u.s. to ismea trade lanes. asia exports grew in all major trade lanes, with the exception of the united states. export volume for the year was strongest in our non-premium transborder standard product, offset by declines in our premium worldwide and transborder express services.", "highlight": "export volume decreased slightly ||| total u.s. export volume decreased, with declines in the europe and asia trade lanes partially offset by growth in the u.s. to americas and u.s. to ismea trade lanes ||| export volume for the year was strongest in our non-premium transborder standard product", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para48", "text": "domestic volume also decreased slightly for the year as growth in several domestic markets was more than offset by challenging economic conditions, particularly in the united kingdom and other european countries. additionally, a postal strike in canada in 2018 drove additional domestic volume which did not repeat in 2019.", "highlight": "domestic volume also decreased slightly ||| particularly in the united kingdom and other european countries ||| a postal strike in canada in 2018 drove additional domestic volume", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para49", "text": "Rates and product mix 2019 compared to 2018 on december 26, 2018, we implemented an average 4.9% net increase in base and accessorial rates for international shipments originating in the united states. rate changes for shipments originating outside the u.s. are made throughout the year and vary by geographic market. on august 26, 2019, we implemented a 1.0% increase in international air-import fuel surcharge.", "highlight": "we implemented an average 4.9% net increase in base and accessorial rates for international shipments originating in the united states ||| we implemented a 1.0% increase in international air-import fuel surcharge.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para50", "text": "total average revenue per piece decreased in 2019 due entirely to a 170 basis point decrease from currency. excluding the impact of currency, revenue per piece increased 0.8% due to increases in base rates, partially offset by declines in fuel surcharge indices.", "highlight": "due entirely to a 170 basis point decrease from currency |||  due to increases in base rates, partially offset by declines in fuel surcharge indices.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para51", "text": "domestic revenue per piece decreased 120 basis points, driven entirely by a 390 basis point decrease from currency. excluding the impact of currency, revenue per piece increased 2.7% due to base rate increases.", "highlight": "domestic revenue per piece decreased 120 basis points, driven entirely by a 390 basis point decrease from currency |||  revenue per piece increased 2.7%", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para52", "text": "export revenue per piece decreased 60 basis points, also driven entirely by a 110 basis point decrease from currency. excluding the impact of currency, revenue per piece increased 0.5% as the trend toward our lower priced non-premium services was more than offset by base rate increases.", "highlight": "export revenue per piece decreased 60 basis points, also driven entirely by a 110 basis point decrease ||| revenue per piece increased 0.5%", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para53", "text": "Fuel surcharges we apply fuel surcharges on our international air and ground services. the fuel surcharge for international air products originating inside or outside the united states is largely indexed to the doe's gulf coast spot price for a gallon of kerosene-type jet fuel. fuel surcharges for ground products originating outside the united states are indexed to fuel prices in the region or country where the shipments originate.", "highlight": "fuel surcharges for ground products originating outside the united states are indexed to fuel prices in the region or country where the shipments originate.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para54", "text": "while fluctuations in fuel surcharges can be significant from period to period, fuel surcharges represent one of the many individual components of our pricing structure that impact our overall revenue and yield. additional components include the mix of products sold, the base price and any additional charges or discounts on these services.", "highlight": "fuel surcharges represent one of the many individual components of our pricing structure that impact our overall revenue and yield. additional components include the mix of products sold,", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para55", "text": "total international fuel surcharge revenue decreased by $33 million in 2019, primarily due to decreases in fuel surcharge indices and decreases in volume.", "highlight": "due to decreases in fuel surcharge indices and decreases in volume.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para56", "text": "Operating expenses 2019 compared to 2018 operating expenses, and operating expenses excluding the year over year impact of transformation strategy costs, decreased for 2019. these decreases are the results of effective management of network capacity and cost in response to lower volumes within our air, ground and local pickup and delivery networks, combined with lower fuel prices and currency exchange rate movements.", "highlight": "the results of effective management of network capacity and cost in response to lower volumes within our air, ground and local pickup and delivery networks, combined with lower fuel prices and currency exchange rate movements.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para57", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations in addition to variability in usage and market prices, the manner in which we purchase fuel also influences the net impact of fuel on our results. the majority of our contracts for fuel purchases utilize index-based pricing formulas plus or minus a fixed locational/supplier differential. while many of the indices are aligned, each index may fluctuate at a different pace, driving variability in the prices paid for fuel. because of this, our operating results may be affected should the market price of fuel suddenly change by a significant amount or change by amounts that do not result in an adjustment in our fuel surcharges, which can affect our earnings either positively or negatively in the short-term.", "highlight": "the majority of our contracts for fuel purchases utilize index-based pricing formulas plus or minus a fixed locational/supplier differential ||| our operating results may be affected should the market price of fuel suddenly change by a significant amount or change by amounts that do not result in an adjustment in our fuel surcharges", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para58", "text": "the cost of operating our integrated international air and ground network decreased $130 million for 2019. the decrease in network costs was primarily driven by a 2.1% decrease in aircraft block hours, due in large part to our ability to adjust our global air network to match capacity with demand, and lower package volume for the year, together with lower fuel prices. pickup and delivery costs decreased $105 million in 2019. the remaining decrease in operating expenses was driven by a $40 million gain from the sale of surplus property in canada, as well as decreases in the costs of package sorting and other indirect operating costs.", "highlight": "the cost of operating our integrated international air and ground network decreased $130 million ||| decrease in network costs was primarily driven by a 2.1% decrease in aircraft block hours ||| pickup and delivery costs decreased $105 million in 2019. ||| remaining decrease in operating expenses was driven by a $40 million gain from the sale of surplus", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para59", "text": "Operating profit and margin 2019 compared to 2018 operating profit increased $128 million for the year, with operating margin increasing 120 basis points to 18.7%. excluding the year over year impact of transformation strategy costs, adjusted operating profit increased, with adjusted operating margin up 150 basis points to 19.5%. operating profit increased as a result of the items described above.", "highlight": "operating profit increased $128 million for the year, with operating margin increasing 120 basis points to 18.7%. ||| adjusted operating profit increased, with adjusted operating margin up 150 basis points to 19.5%. operating profit increased", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para60", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Supply chain & freight operations Year ended december 31, $ change % change 2019 2018 2019/2018 2019/2018 Freight ltl statistics: Revenue (in millions) $2,679 $2,706 $-27 )-1.0 )% Revenue per hundredweight $26.54 $25.52 $1.02 4.0 % Shipments (in thousands) 9,281 9,720 -4.5 )% Shipments per day (in thousands) 36.7 38.4 -4.5 )% Gross weight hauled (in millions of lbs) 10,096 10,605 -4.8 )% Weight per shipment (in lbs) 1,088 1,091 -0.3 )% Operating days in period 253 253 Revenue (in millions): Forwarding $5,867 $6,580 $-713 )-10.8 )% Logistics 3,435 3,234 201 6.2 % Freight 3,265 3,218 47 1.5 % Other 814 794 20 2.5 % Total revenue $13,381 $13,826 $-445 )-3.2 )% Operating expenses (in millions): Operating expenses $12,404 $12,974 $-570 )-4.4 )% Transformation strategy costs -25 )-49 )24 -49.0 )% Adjusted operating expenses $12,379 $12,925 $-546 )-4.2 )% Operating profit (in millions) and operating margins: Operating profit $977 $852 $125 14.7 % Adjusted operating profit $1,002 $901 $101 11.2 % Operating margin 7.3 % 6.2 % Adjusted operating margin 7.5 % 6.5 % Currency translation benefit / (cost) (in millions)*: Revenue $-75 )Operating expenses 67 Operating profit $-8 )* amount represents the change compared to the prior year.", "highlight": "$ change % change 2019 2018 2019/2018 2019/2018 Freight ltl statistics: Revenue (in millions) $2,679 $2,706 $-27 )-1.0 )% Revenue per hundredweight $26.54 $25.52 $1.02 4.0 % Shipments (in thousands) 9,281 9,720 -4.5 )% Shipments per day (in thousands) 36.7 38.4 -4.5 )% Gross weight hauled (in millions of lbs) 10,096 10,605 -4.8 )% Weight per shipment (in lbs) 1,088 1,091 -0.3 )% Operating days in period 253 253 Revenue (in millions): Forwarding $5,867 $6,580 $-713 )-10.8 )% Logistics 3,435 3,234 201 6.2 % Freight 3,265 3,218 47 1.5 % Other 814 794 20 2.5 % Total revenue $13,381 $13,826 $-445 )-3.2 )% Operating expenses (in millions): Operating expenses $12,404 $12,974 $-570 )-4.4 )% Transformation strategy costs -25 )-49 )24 -49.0 )% Adjusted operating expenses $12,379 $12,925 $-546 )-4.2 )% Operating profit (in millions) and operating margins: Operating profit $977 $852 $125 14.7 % Adjusted operating profit $1,002 $901 $101 11.2 % Operating margin 7.3 % 6.2 % Adjusted operating margin 7.5 % 6.5 % Currency translation benefit / (cost) (in millions)*: Revenue $-75 )", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para61", "text": "Year ended december 31, $ change % change 2019 2018 2019/2018 2019/2018 Transformation strategy costs (in millions): Forwarding $12 $16 $-4 )-25.0 )% Logistics 13 22 -9 )-40.9 )% Freight 6 -6 )-100.0 )% Other 5 -5 )-100.0 )% Total transformation strategy costs $25 $49 $-24 )-49.0 )% United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Revenue 2019 compared to 2018 total revenue for the supply chain & freight segment decreased $445 million in 2019 compared with 2018 .", "highlight": "$ change % change 2019 2018 2019/2018 2019/2018 Transformation strategy costs (in millions): Forwarding $12 $16 $-4 )-25.0 )% Logistics 13 22 -9 )-40.9 )% Freight 6 -6 )-100.0 )% Other 5 -5 )-100.0 )% Total transformation strategy costs $25 $49 $-24 )-49.0 )%", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para62", "text": "forwarding revenue decreased primarily due to an overall decline in market demand that was impacted by global trade uncertainties. this led to lower volume and declines in market rates in our international air and ocean freight forwarding businesses. in addition, excess capacity in the truckload brokerage market depressed rates, contributing to the year over year decrease in revenue. these decreases were partially offset by yield management initiatives in our air and ocean freight businesses.", "highlight": "primarily due to an overall decline in market demand that was impacted by global trade uncertainties ||| contributing to the year over year decrease in revenue. these decreases were partially offset by yield management initiatives in our air and ocean freight businesses.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para63", "text": "logistics revenue increased as we experienced growth in the healthcare, mail services, retail and manufacturing sectors.", "highlight": "revenue increased as we experienced growth in the healthcare, mail services, retail and manufacturing sectors", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para64", "text": "overall ups freight revenue increased, as declines in ltl tonnage and shipment volume which were largely attributable to market demand and the residual impacts of the fourth quarter 2018 network disruption were more than offset by yield management initiatives and volume growth in our ground freight pricing product.", "highlight": "overall ups freight revenue increased ||| largely attributable to market demand and the residual impacts of the fourth quarter 2018 network disruption", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para65", "text": "Operating expenses 2019 compared to 2018 total operating expenses for the supply chain & freight segment, and operating expenses excluding the year over year impact of transformation strategy costs, decreased in 2019 compared with 2018 .", "highlight": "total operating expenses for the supply chain & freight segment, and ||| operating expenses excluding the year over year impact of transformation strategy costs, decreased in 2019 compared with 2018", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para66", "text": "forwarding operating expenses decreased $685 million largely due to reductions in purchased transportation. purchased transportation expense decreased $655 million primarily due to lower tonnage and declines in market rates in our international air and ocean freight forwarding businesses as well as a decrease in volume and market rates in truckload brokerage. cost management initiatives in our freight forwarding businesses also contributed to the reduction in operating expenses.", "highlight": "due to reductions in purchased transportation ||| due to lower tonnage and declines in market rates in our international air and ocean freight forwarding businesses as well as a decrease in volume and market rates in truckload brokerage", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para67", "text": "logistics operating expenses increased $172 million, primarily due to increases in purchased transportation driven by increased volume and rates, particularly in our mail services business. additionally, business investments in healthcare quality assurance and technology increased costs.", "highlight": "primarily due to increases in purchased transportation driven by increased volume and rates, particularly in our mail services business. ||| business investments in healthcare quality assurance and technology increased costs", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para68", "text": "ups freight operating expenses decreased $54 million. decreases in costs associated with operating our linehaul network ($49 million) and decreases in pickup and delivery costs ($40 million) were driven by lower expenses from outside transportation carriers as a result of a decline in tonnage, lower fuel surcharges and the residual impacts of the fourth quarter 2018 network disruption. these decreases were offset by increases in transportation expense for our ground freight pricing product due to higher volume. cost management initiatives and production improvements largely contributed to the overall reduction in operating expenses.", "highlight": "freight operating expenses decreased $54 million. decreases in costs associated with operating our linehaul network ($49 million) and decreases in pickup and delivery costs ($40 million)  ||| cost management initiatives and production improvements largely contributed to the overall reduction in operating expenses", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para69", "text": "Operating profit and margin 2019 compared to 2018 total operating profit for the supply chain & freight segment increased $125 million in 2019 compared with 2018 . excluding the year over year impact of transformation strategy costs, adjusted operating profit increased $101 million. operating margin increased 110 basis points to 7.3% , while the adjusted operating margin increased 100 basis points to 7.5% . operating profit and margin were impacted by the items described above.", "highlight": "total operating profit for the supply chain & freight segment increased $125 million in 2019 ||| adjusted operating profit increased $101 million ||| operating margin increased 110 basis points to 7.3% , while the adjusted operating margin increased 100 basis points to 7.5% .", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para70", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Consolidated operating expenses Year ended december 31, $ change % change 2019 2018 2019/2018 2019/2018 Operating expenses (in millions): Compensation and benefits: $38,908 $37,235 $1,673 4.5 % Transformation strategy costs -166 )-262 )96 -36.6 )% Adjusted compensation and benefits 38,742 36,973 1,769 4.8 % Repairs and maintenance 1,838 1,732 106 6.1 % Depreciation and amortization 2,360 2,207 153 6.9 % Purchased transportation 12,590 13,409 -819 )-6.1 )% Fuel 3,289 3,427 -138 )-4.0 )% Other occupancy 1,392 1,362 30 2.2 % Other expenses 5,919 5,465 454 8.3 % Total other expenses 27,388 27,602 -214 )-0.8 )% Other transformation strategy costs -89 )-98 )9 -9.2 )% Legal contingencies and expenses -97 )-97 )N/m Adjusted total other expenses $27,202 $27,504 $-302 )-1.1 )% Total operating expenses $66,296 $64,837 $1,459 2.3 % Adjusted total operating expenses $65,944 $64,477 $1,467 2.3 % Currency translation cost / (benefit)* $-369 )Year ended december 31, $ change % change 2019 2018 2019/2018 2019/2018 Adjustments to operating expenses (in millions): Transformation strategy costs: Compensation $21 $$21 N/m Benefits 145 262 -117 )-44.7 )% Depreciation and amortization 3 12 -9 )-75.0 )% Other occupancy 8 8 N/m Other expenses 78 86 -8 )-9.3 )% Total transformation strategy costs $255 $360 $-105 )-29.2 )% Legal contingencies and expenses: Other expenses $97 $$97 N/m Total adjustments to operating expenses $352 $360 $-8 )-2.2 )% Compensation and benefits 2019 compared to 2018 total compensation and benefits, and total compensation and benefits excluding the year over year impact of transformation strategy costs, increased for 2019.", "highlight": ", $ change % change 2019 2018 2019/2018 2019/2018 Operating expenses (in millions): Compensation and benefits: $38,908 $37,235 $1,673 4.5 % Transformation strategy costs -166 )-262 )96 -36.6 )% Adjusted compensation and benefits 38,742 36,973 1,769 4.8 % Repairs and maintenance 1,838 1,732 106 6.1 % Depreciation and amortization 2,360 2,207 153 6.9 % Purchased transportation 12,590 13,409 -819 )-6.1 )% Fuel 3,289 3,427 -138 )-4.0 )% Other occupancy 1,392 1,362 30 2.2 % Other expenses 5,919 5,465 454 8.3 % Total other expenses 27,388 27,602 -214 )-0.8 )% Other transformation strategy costs -89 )-98 )9 -9.2 )% Legal contingencies and expenses -97 )-97 )N/m Adjusted total other expenses $27,202 $27,504 $-302 )-1.1 )% Total operating expenses $66,296 $64,837 $1,459 2.3 % Adjusted total operating expenses $65,944 $64,477 $1,467 2.3 % Currency translation cost / (benefit)* $-369 )Year ended december 31, $ change % change 2019 2018 2019/2018 2019/2018 Adjustments to operating expenses (in millions): Transformation strategy costs: Compensation $21 $$21 N/m Benefits 145 262 -117 )-44.7 )% Depreciation and amortization 3 12 -9 )-75.0 )% Other occupancy 8 8 N/m Other expenses 78 86 -8 )-9.3 )% Total transformation strategy costs $255 $360 $-105 )-29.2 )% Legal contingencies and expenses: Other expenses $97 $$97 N/m Total adjustments to operating expenses $352 $360 $-8 )-2.2 )% C", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para71", "text": "total compensation costs increased $1.028 billion or 4.6%. excluding the year over year impact of transformation strategy costs, adjusted compensation increased $1.007 billion largely due to higher u.s. domestic direct labor costs. these costs increased as a result of additional headcount, driven by u.s. domestic average daily volume growth that resulted in an increase in average daily union hours of 4.7%. contractual union wage increases also contributed to the increase in compensation for hourly employees.", "highlight": "total compensation costs increased $1.028 billion or 4.6% ||| adjusted compensation increased $1.007 billion ||| domestic average daily volume growth that resulted in an increase in average daily union hours of 4.7% ||| contractual union wage increases", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para72", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Benefits costs increased $645 million. excluding the year over year impact of transformation strategy costs, adjusted benefits costs increased $762 million due to the following: health and welfare costs increased $570 million, driven by higher contributions to multiemployer plans due to contractual rate increases, an overall increase in the size of the workforce and changes in eligibility for certain union employees.", "highlight": "financial condition and Results of operations Benefits costs increased $645 million. ||| adjusted benefits costs increased $762 million due to the following ||| health and welfare costs increased $570 million ||| an overall increase in the size of the workforce", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para73", "text": "pension and retirement benefits increased $18 million. the impacts of contractually-mandated contribution increases to multiemployer plans, as well as an increase in the size of the overall workforce, were substantially offset by lower service cost for company-sponsored plans as a result of higher discount rates.", "highlight": "pension and retirement benefits increased $18 million ||| were substantially offset by lower service cost for company-sponsored plans as a result of higher discount rates.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para74", "text": "vacation, excused absence, payroll taxes and other expenses increased $211 million, primarily driven by salary increases and growth in the overall size of the workforce.", "highlight": "driven by salary increases and growth in the overall size of the workforce.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para75", "text": "workers' compensation expense decreased $37 million as we experienced more favorable actuarial adjustments. we evaluate the total range of actuarial outcomes when estimating losses that will ultimately occur. see note 1 to the audited, consolidated financial statements for a further description of this policy.", "highlight": "workers' compensation expense decreased $37 million", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para76", "text": "Repairs and maintenance 2019 compared to 2018 the increase in repairs and maintenance expense was driven by maintenance of our aircraft, routine repairs to buildings and facilities and maintenance of our other transportation equipment, due to additional investments we have made in recent periods.", "highlight": "was driven by maintenance of our aircraft, routine repairs to buildings and facilities and maintenance of our other transportation equipment, due to additional investments we have made in recent periods.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para77", "text": "Depreciation and amortization 2019 compared to 2018 we evaluate the useful lives of all our property, plant and equipment based on our usage, maintenance and replacement policies, and taking into account physical and economic factors that may affect the useful lives of the assets. see note 1 to the audited, consolidated financial statements for a further description of the policy.", "highlight": "we evaluate the useful lives of all our property, plant and equipment based on our usage, maintenance and replacement policies, and taking into account physical and economic factors that may affect the useful lives of the assets", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para78", "text": "for 2019, depreciation expense increased $365 million, and net income decreased by $287 million, or $0.33 per share on a basic and diluted basis, as a result of investments in property, plant and equipment, net of disposals and assets becoming fully depreciated. depreciation expense decreased $212 million, and net income increased $167 million, or $0.19 per share on a basic and diluted basis, as a result of lengthening our estimated useful lives for various asset categories in the latter half of 2018. the combined effect of the foregoing was a net increase in depreciation expense of $153 million and a decrease in net income of $120 million, or $0.14 per share on a basic and diluted basis, for the year.", "highlight": "depreciation expense increased $365 million, and net income decreased by $287 million, or $0.33 per share on a basic and diluted basis ||| depreciation expense decreased $212 million, and net income increased $167 million, or $0.19 per share on a basic and diluted basis ||| combined effect of the foregoing was a net increase in depreciation expense of $153 million and a decrease in net income of $120 million, or $0.14 per share on a basic and diluted basis", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para79", "text": "Purchased transportation 2019 compared to 2018 The decrease in purchased transportation expense charged to us by third-party air, rail, ocean and truck carriers was primarily driven by the following factors: expense in our freight forwarding and logistics business decreased $530 million due to decreases in both market rates and volume in our air and ocean freight forwarding businesses. our truckload brokerage business also experienced declines in rates, primarily driven by market overcapacity. these decreases were partially offset by increases due to volume growth and rate increases in our mail services business.", "highlight": "due to decreases in both market rates and volume in our air and ocean freight forwarding businesses ||| primarily driven by market overcapacity. these decreases were partially offset by increases due to volume growth and rate increases in our mail services business.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para80", "text": "u.s. domestic package expense decreased $186 million primarily due to lower overall usage of third-party transportation carriers.", "highlight": "primarily due to lower overall usage of third-party transportation carriers.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para81", "text": "international package expense decreased $100 million primarily due to favorable currency exchange rate movements.", "highlight": "primarily due to favorable currency exchange rate movements.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para82", "text": "other purchased transportation expense decreased $3 million due to changes in the number of leased and chartered aircraft and lower fuel surcharges passed on to us by outside carriers.", "highlight": "due to changes in the number of leased and chartered aircraft and lower fuel surcharges passed", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para83", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Fuel 2019 compared to 2018 the decrease in fuel expense was driven by lower jet fuel, diesel and gasoline prices as well as higher alternative fuel tax credits as a result of legislation passed in 2019. these decreases were partially offset by higher consumption due to additional aircraft block hours and vehicle miles driven by higher u.s. domestic package volume.", "highlight": "driven by lower jet fuel, diesel and gasoline prices as well as higher alternative fuel tax credits as a result of legislation passed in 2019 ||| partially offset by higher consumption due to additional aircraft block hours and vehicle miles driven by higher u.s. domestic package volume", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para84", "text": "Other occupancy 2019 compared to 2018 the increase in other occupancy expense and other occupancy expense excluding the year over year impact of transformation strategy costs was primarily driven by additional operating facilities coming into service.", "highlight": "was primarily driven by additional operating facilities coming into service.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para85", "text": "Other expenses 2019 compared to 2018 other expenses, and other expenses excluding the year over year impact of transformation strategy costs and legal contingencies and expenses, increased for 2019. the increase was attributable to various items, including adjustments to reserves for self-insured automobile liability claims, bad debt expense, technology equipment and software licenses, professional service fees and advertising. these increases were partially offset by a $40 million gain on the sale of surplus property in canada and lower travel and entertainment expenses.", "highlight": "including adjustments to reserves for self-insured automobile liability claims, bad debt expense, technology equipment and software licenses, professional service fees and advertising ||| offset by a $40 million gain on the sale of surplus property in canada and lower travel and entertainment expenses.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para86", "text": "Other income and (expense) The following table sets forth investment income (expense) and other and interest expense for the years ended december 31, 2019 and 2018 (in millions): Year ended december 31, $ change % change 2019 2018 2019/2018 2019/2018 Investment income (expense) and other $-1,493 )$-400 )$-1,093 )273.3 % Defined benefit plans mark-to-market charges 2,387 1,627 760 46.7 % Adjusted investment income (expense) and other $894 $1,227 $-333 )-27.1 )% Interest expense -653 )-605 )-48 )7.9 % Total other income and (expense) $-2,146 )$-1,005 )$-1,141 )113.5 % Adjusted other income and (expense) $241 $622 $-381 )-61.3 )% Investment income (expense) and other 2019 compared to 2018 investment income (expense) and other for the period increased $1.093 billion, which included a $760 million increase in mark-to-market pension charges. excluding the impact of the defined benefit plan mark-to-market charges, adjusted investment income (expense) and other for the period, which includes expected investment returns on pension assets, net of interest cost on projected benefit obligations, prior service cost and investment income, decreased $333 million. expected returns on plan assets decreased as a result of the lower asset base driven by negative asset returns in 2018, partially offset by the effects of higher discretionary contributions in 2019. pension interest cost increased with higher year-end discount rates, ongoing plan growth and an increase in the projected benefit obligation as a result of the 2018 year-end measurement of our plans. investment income increased as a result of higher yields on invested assets, higher overall investment balances and foreign currency exchange rate movements.", "highlight": "Year ended december 31, $ change % change 2019 2018 2019/2018 2019/2018 Investment income (expense) and other $-1,493 )$-400 )$-1,093 )273.3 % Defined benefit plans mark-to-market charges 2,387 1,627 760 46.7 % Adjusted investment income (expense) and other $894 $1,227 $-333 )-27.1 )% Interest expense -653 )-605 )-48 )7.9 % Total other income and (expense) $-2,146 )$-1,005 )$-1,141 )113.5 % Adjusted other income and (expense) $241 $622 $-381 )-61.3 )% ||| prior service cost and investment income, decreased $333 million", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para87", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Interest expense 2019 compared to 2018 interest expense increased primarily due to higher average outstanding debt balances and higher effective interest rates, combined with lower capitalized interest for 2019.", "highlight": "primarily due to higher average outstanding debt balances and higher effective interest rates, combined with lower capitalized interest for 2019.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para88", "text": "Income tax expense The following table sets forth income tax expense and our effective tax rate for the years ended december 31, 2019 and 2018 (in millions): Year ended december 31, $ change % change 2019 2018 2019/2018 2019/2018 Income tax expense: $1,212 $1,228 $-16 )-1.3 )% Income tax impact of: Defined benefit plans mark-to-market charges 571 390 181 46.4 % Transformation strategy costs 59 87 -28 )-32.2 )% Legal contingencies and expenses 6 6 N/m Adjusted income tax expense $1,848 $1,705 $143 8.4 % Effective tax rate 21.4 % 20.4 % Adjusted effective tax rate 22.0 % 21.3 % for additional information on income tax expense and our effective tax rate, see note 14 to the audited, consolidated financial statements.", "highlight": "Year ended december 31, $ change % change 2019 2018 2019/2018 2019/2018 Income tax expense: $1,212 $1,228 $-16 )-1.3 )% Income tax impact of: Defined benefit plans mark-to-market charges 571 390 181 46.4 % Transformation strategy costs 59 87 -28 )-32.2 )% Legal contingencies and expenses 6 6 N/m Adjusted income tax expense $1,848 $1,705 $143 8.4 % Effective tax rate 21.4 % 20.4 % Adjusted effective tax rate 22.0 % 21.3 %", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para89", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Liquidity and capital resources as of december 31, 2019 , we had $ 5.741 billion in cash, cash equivalents and marketable securities. we believe that our current cash position, access to commercial paper programs and debt capital markets and cash flow generated from operations should be adequate not only for operating requirements, but also to enable us to complete our capital expenditure programs, transformation strategy and to fund dividend payments, share repurchases, pension contributions and long-term debt payments through the next several years. we regularly evaluate opportunities to optimize our capital structure, including through issuances of debt or equity to refinance existing debt and to fund ongoing cash needs.", "highlight": "we believe that our current cash position, access to commercial paper programs and debt capital markets and cash flow generated from operations should be adequate not only for operating requirements, but also to enable us to complete our capital expenditure programs, transformation strategy and to fund dividend payments, share repurchases, pension contributions and long-term debt payments through the next several years ||| evaluate opportunities to optimize our capital structure", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para90", "text": "Cash flows from operating activities The following is a summary of the significant sources (uses) of cash from operating activities (in millions): 2019 2018 Net income $4,440 $4,791 Non-cash operating activities -1 6,405 6,048 Pension and postretirement benefit plan contributions (company-sponsored plans) -2,362 )-186 )Hedge margin receivables and payables 171 482 Income tax receivables and payables 599 469 Changes in working capital and other non-current assets and liabilities -634 )1,091 Other operating activities 20 16 Net cash from operating activities $8,639 $12,711 -1 represents depreciation and amortization, gains and losses on derivative transactions and foreign exchange, deferred income taxes, provisions for uncollectible accounts receivable, amortization on operating lease assets, pension and postretirement benefit expense, stock compensation expense and other non-cash items.", "highlight": "2019 2018 Net income $4,440 $4,791 Non-cash operating activities -1 6,405 6,048 Pension and postretirement benefit plan contributions (company-sponsored plans) -2,362 )-186 )Hedge margin receivables and payables 171 482 Income tax receivables and payables 599 469 Changes in working capital and other non-current assets and liabilities -634 )1,091 Other operating activities 20 16 Net cash from operating activities $8,639 $12,711 -", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para91", "text": "cash from operating activities remained strong throughout 2018 and 2019. most of the variability in operating cash flows during this period related to funding company-sponsored pension and postretirement benefit plans (and related cash tax deductions). except for discretionary or accelerated fundings of our plans, contributions to our company-sponsored pension plans have largely varied in accordance with minimum funding requirements. we made discretionary contributions to our three primary, company-sponsored u.s. pension plans totaling $2.0 billion in 2019. no discretionary contributions were made in 2018. the remaining contributions in 2018 and 2019 were to our international pension plans and u.s. postretirement medical benefit plans.", "highlight": ". the remaining contributions in 2018 and 2019 were to our international pension plans and u.s. postretirement medical benefit plans. |||  made discretionary contributions to our three primary, company-sponsored u.s. pension plans totaling $2.0 billion in 2019", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para92", "text": "operating cash flows were impacted by changes in our working capital management whereby certain payments from the fourth quarter of 2018 shifted into the first quarter of 2019. in addition, accelerated growth in the business lifted overall working capital demand. the net hedge margin collateral received from our derivative counterparties was $171 and $482 million during 2019 and 2018, respectively, due to the change in net fair value of the derivative contracts used in our currency and interest rate hedging programs. cash payments for income taxes were $514 million and $2 million for 2019 and 2018, respectively, primarily due to timing of deductions related to pension contributions.", "highlight": "net hedge margin collateral received from our derivative counterparties was $171 and $482 million during 2019 and 2018 ||| cash payments for income taxes were $514 million and $2 million for 2019 and 2018, respectively", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para93", "text": "as of december 31, 2019 , our total worldwide holdings of cash, cash equivalents and marketable securities were $ 5.741 billion , of which approximately $2.564 billion was held by foreign subsidiaries. the amount of cash, cash equivalents and marketable securities held by our u.s. and foreign subsidiaries fluctuates throughout the year due to a variety of factors, including the timing of cash receipts and disbursements in the normal course of business. cash provided by operating activities in the u.s. continues to be our primary source of funds to finance domestic operating needs, capital expenditures, share repurchases, pension contributions and dividend payments to shareowners. all cash, cash equivalents and marketable securities held by foreign subsidiaries are generally available for distribution to the u.s. without any u.s. federal income taxes. any such distributions may be subject to foreign withholding and u.s. state taxes. when amounts earned by foreign subsidiaries are expected to be indefinitely reinvested, no accrual for taxes is provided.", "highlight": "our total worldwide holdings of cash, cash equivalents and marketable securities were $ 5.741 billion , of which approximately $2.564 billion was held by foreign subsidiaries ||| cash provided by operating activities in the u.s. continues to be our primary source of funds to finance domestic operating needs, capital expenditures, share repurchases, pension contributions and dividend payments to shareowners ||| when amounts earned by foreign subsidiaries are expected to be indefinitely reinvested, no accrual for taxes is provided", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para94", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Cash flows from investing activities Our primary sources (uses) of cash for investing activities were as follows (amounts in millions): 2019 2018 Net cash used in investing activities $-6,061 )$-6,330 )Capital expenditures: Buildings, facilities and plant equipment $-2,729 )$-3,147 )Aircraft and parts -1,890 )-1,496 )Vehicles -987 )-931 )Information technology -774 )-709 )Total capital expenditures -1 : $-6,380 )$-6,283 )Capital expenditures as a % of revenue 8.6 % 8.7 % Other investing activities: Proceeds from disposals of property, plant and equipment $65 $37 Net change in finance receivables $13 $4 Net (purchases), sales and maturities of marketable securities $322 $-87 )Cash paid for business acquisitions, net of cash and cash equivalents acquired $-6 )$-2 )Other investing activities $-75 )$1 -1 in addition to capital expenditures of $6.380 and $6.283 billion in 2019 and 2018, respectively, there were capital expenditures relating to the principal repayments of finance lease obligations of $140 and $340 million. these are included in cash flows from financing activities.", "highlight": "2019 2018 Net cash used in investing activities $-6,061 )$-6,330 )Capital expenditures: Buildings, facilities and plant equipment $-2,729 )$-3,147 )Aircraft and parts -1,890 )-1,496 )Vehicles -987 )-931 )Information technology -774 )-709 )Total capital expenditures -1 : $-6,380 )$-6,283 )Capital expenditures as a % of revenue 8.6 % 8.7 % Other investing activities: Proceeds from disposals of property, plant and equipment $65 $37 Net change in finance receivables $13 $4 Net (purchases), sales and maturities of marketable securities $322 $-87 )Cash paid for business acquisitions, net of cash and cash equivalents acquired $-6 )$-2 )Other investing activities $-75 )$1 -1 in addition to capital expenditures of $6.380 and $6.283 billion in 2019 and 2018, respectively ||| principal repayments of finance lease obligations of $140 and $340 million", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para95", "text": "we have commitments for the purchase of aircraft, vehicles, equipment and real estate to provide for the replacement of existing capacity and anticipated future growth. we generally fund our capital expenditures with cash from operations. future capital spending for anticipated growth and replacement assets will depend on a variety of factors, including economic and industry conditions. in 2017 we began a multi-year investment program in our smart global logistics network which impacts all asset categories, with the largest investments in buildings, facilities and plant equipment. this investment program will continue in 2020, and we anticipate that our capital expenditures will be approximately $6.5 to $7.0 billion.", "highlight": "we have commitments for the purchase of aircraft, vehicles, equipment and real estate to provide for the replacement of existing capacity and anticipated future growth ||| we began a multi-year investment program in our smart global logistics network which impacts all asset categories,", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para96", "text": "capital expenditures on buildings, facilities and plant equipment decreased in 2019 compared to 2018 in our u.s. and international package businesses, as we completed several facility automation and capacity expansion projects in 2018. capital spending on aircraft increased in 2019 compared 2018 due to a net increase in contract deposits on open aircraft orders and final payments associated with the delivery of aircraft. capital spending on information technology increased in 2019 compared to 2018 due to continuing development of technology enabled solutions and capitalized software projects. capital spending on vehicles increased in 2019 relative to 2018, largely due to the timing of vehicle replacements and expansion of the overall fleet to support volume growth.", "highlight": "capital spending on aircraft increased in 2019 compared 2018 due to a net increase in contract deposits on open aircraft orders and final payments associated with the delivery of aircraft ||| capital spending on vehicles increased in 2019 relative to 2018, largely due to the timing of vehicle replacements and expansion of the overall fleet to support volume growth", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para97", "text": "proceeds from the disposal of property, plant and equipment were largely attributable to the sale of an international property in 2019 and disposal of equipment in 2018. the net change in finance receivables was due to reductions in our finance portfolios in 2019 compared with 2018. purchases and sales of marketable securities are largely determined by liquidity needs and the periodic rebalancing of investment types, and will fluctuate from period to period.", "highlight": "proceeds from the disposal of property, plant and equipment were largely attributable to the sale of an international property in 2019 and disposal of equipment in  ||| purchases and sales of marketable securities are largely determined by liquidity needs and the periodic rebalancing of investment types", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para98", "text": "cash paid for business acquisitions in 2019 and 2018 related to our acquisition of area franchise rights for the ups store, as well as other, small acquisitions in our international small package and logistics business units in 2019. other investing activities are impacted by changes in our non-current investments and various other items.", "highlight": "cash paid for business acquisitions in 2019 and 2018 related to our acquisition of area franchise rights for the ups store ||| small acquisitions in our international small package and logistics business units in 2019. ||| impacted by changes in our non-current investments", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para99", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Cash flows from financing activities Our primary sources (uses) of cash for financing activities were as follows (amounts in millions, except per share data): 2019 2018 Net cash used in financing activities $-1,727 )$-5,692 )Share repurchases: Cash expended for shares repurchased $-1,004 )$-1,011 )Number of shares repurchased -9.1 )-8.9 )Shares outstanding at period end 857 858 Percent increase (decrease) in shares outstanding -0.1 )% -0.1 )% Dividends: Dividends declared per share $3.84 $3.64 Cash expended for dividend payments $-3,194 )$-3,011 )Borrowings: Net borrowings (repayments) of debt principal $2,419 $-1,622 )Other financing activities: Cash received for common stock issuances $218 $240 Other financing activities $-166 )$-288 )Capitalization: Total debt outstanding at year end $25,238 $22,736 Total shareowners' equity at year end 3,283 3,037 Total capitalization $28,521 $25,773 for the years ended december 31, 2019 and 2018 , we repurchased a total of 9.1 and 8.9 million shares of class a and class b common stock for $ 1.005 and $ 1.000 billion, respectively ($ 1.004 and $ 1.011 billion in repurchases for 2019 and 2018 , respectively, are reported on the cash flow statement due to the timing of settlements). for additional information on our share repurchase activities, see note 11 to the audited, consolidated financial statements.", "highlight": "2019 2018 Net cash used in financing activities $-1,727 )$-5,692 )Share repurchases: Cash expended for shares repurchased $-1,004 )$-1,011 )Number of shares repurchased -9.1 )-8.9 )Shares outstanding at period end 857 858 Percent increase (decrease) in shares outstanding -0.1 )% -0.1 )% Dividends: Dividends declared per share $3.84 $3.64 Cash expended for dividend payments $-3,194 )$-3,011 )Borrowings: Net borrowings (repayments) of debt principal $2,419 $-1,622 )Other financing activities: Cash received for common stock issuances $218 $240 Other financing activities $-166 )$-288 )Capitalization: Total debt outstanding at year end $25,238 $22,736 Total shareowners' equity at year end 3,283 3,037 Total capitalization $28,521 $25,773 for the years ended december 31, 2019 and 2018 , we repurchased a total of 9.1 and 8.9 million shares of class a and class b common stock for $ 1.005 and $ 1.000 billion, respectively ($ 1.004 and $ 1.011 billion in repurchases for 2019 and 2018 , respectively", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para100", "text": "for the years ended december 31, 2019 and 2018, dividends reported within shareowners' equity include $147 and $178 million, respectively, of non-cash dividends that were settled in shares of class a common stock.", "highlight": "dividends reported within shareowners' equity include $147 and $178 million", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para101", "text": "the declaration of dividends is subject to the discretion of the board of directors and depends on various factors, including our net income, financial condition, cash requirements, future prospects and other relevant factors. we expect to continue the practice of paying regular cash dividends. in february 2020, we increased our quarterly dividend payment from $0.96 to $1.01 per share, a 5.2% increase.", "highlight": "we expect to continue the practice of paying regular cash dividends.  ||| we increased our quarterly dividend payment from $0.96 to $1.01 per share, a 5.2% increase.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para102", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Issuances of debt in 2019 consisted of fixed-rate senior notes totaling $3.0 billion and commercial paper. in 2018, issuances of debt consisted primarily of commercial paper. the following is a summary of debt issuances in 2019 (in millions): Principal amount in usd 2019 Fixed-rate senior notes: 2.200% senior notes $400 2.500% senior notes 400 3.400% senior notes (multiple issuances) 1,450 4.250% senior notes 750 Total $3,000 repayments of debt in 2019 and 2018 consisted primarily of our $1.0 billion 5.125% fixed-rate senior notes that matured in april 2019 and our $750 million 5.50% fixed-rate senior notes that matured in january 2018. the remaining repayments of debt during the period included paydowns of commercial paper and scheduled principal payments on our finance lease obligations. we consider the overall fixed and floating interest rate mix of our portfolio and the related overall cost of borrowing when planning for future issuances and non-scheduled repayments of debt.", "highlight": "Principal amount in usd 2019 Fixed-rate senior notes: 2.200% senior notes $400 2.500% senior notes 400 3.400% senior notes (multiple issuances) 1,450 4.250% senior notes 750 Total $3,000 repayments of debt in 2019 and 2018 consisted primarily of our $1.0 billion 5.125% fixed-rate senior notes that matured in april 2019 and our $750 million 5.50% fixed-rate senior notes that matured in january 2018 ||| fixed-rate senior notes totaling $3.0 billion and commercial paper", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para103", "text": "The amount of commercial paper outstanding fluctuates throughout the year based on daily liquidity needs. the following is a summary of our commercial paper program (in millions): Functional currency outstanding balance at year end Outstanding balance at year end ($) Average balance outstanding Average balance outstanding ($) Average interest rate 2019 Usd $2,172 $2,172 $1,665 $1,665 2.24 % Eur 949 $1,062 903 $1,011 -0.39 )% Total $3,234 Functional currency outstanding balance at year end Outstanding balance at year end ($) Average balance outstanding Average balance outstanding ($) Average interest rate 2018 Usd $1,968 $1,968 $2,137 $2,137 1.81 % Eur 606 $694 360 $425 -0.38 )% Total $2,662 the variation in cash received from common stock issuances was primarily due to the amount of stock option exercises by employees in 2018 and 2019.", "highlight": "($) Average balance outstanding Average balance outstanding ($) Average interest rate 2019 Usd $2,172 $2,172 $1,665 $1,665 2.24 % Eur 949 $1,062 903 $1,011 -0.39 )% Total $3,234 Functional currency outstanding balance at year end Outstanding balance at year end ($) Average balance outstanding Average balance outstanding ($) Average interest rate 2018 Usd $1,968 $1,968 $2,137 $2,137 1.81 % Eur 606 $694 360 $425 -0.38 )% Total $2,662", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para104", "text": "other financing activities includes cash used to repurchase shares from employees sold to satisfy tax withholding obligations on vested stock awards of $180 and $259 million in 2019 and 2018 , respectively. net cash inflows from premium payments and settlements of capped call options for the purchase of ups class b shares were $21 and $34 million in 2019 and 2018, respectively.", "highlight": "cash used to repurchase shares from employees sold to satisfy tax withholding obligations on vested stock awards of $180 and $259 million in 2019 and 2018 ||| net cash inflows from premium payments and settlements of capped call options for the purchase of ups class b shares were $21 and $34 million", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para105", "text": "Sources of credit see note 8 to the audited, consolidated financial statements for a discussion of our available credit and debt covenants.", "highlight": "see note 8 to the audited, consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para106", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Guarantees and other off-balance sheet arrangements except as disclosed in note 8 to the audited, consolidated financial statements, we do not have guarantees or other off-balance sheet financing arrangements, including variable interest entities, which we believe could have a material impact on financial condition or liquidity.", "highlight": "we do not have guarantees or other off-balance sheet financing arrangements", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para107", "text": "Contractual commitments We have contractual obligations and commitments in the form of finance leases, operating leases, debt obligations, purchase commitments and certain other liabilities. we intend to satisfy these obligations primarily through the use of cash flow from operations. the following table summarizes the expected cash outflow to satisfy our contractual obligations and commitments as of december 31, 2019 (in millions): Commitment type 2020 2021 2022 2023 2024 After 2024 Total Finance leases $199 44 39 37 35 259 $613 Operating leases 619 536 451 360 256 1,267 3,489 Debt principal 4,232 2,551 2,001 2,284 1,474 12,349 24,891 Debt interest 749 661 601 521 481 6,522 9,535 Purchase commitments -1 3,569 1,982 966 323 261 201 7,302 Tax act repatriation liability 13 49 61 123 Pension funding 1,180 1,180 Total $10,548 $5,774 $4,058 $3,538 $2,556 $20,659 $47,133 -1 purchase commitments includes amounts due under aircraft leases that we entered into in 2019 and our january 29, 2020 announced commitment to purchase 10,000 electric vehicles.", "highlight": "Commitment type 2020 2021 2022 2023 2024 After 2024 Total Finance leases $199 44 39 37 35 259 $613 Operating leases 619 536 451 360 256 1,267 3,489 Debt principal 4,232 2,551 2,001 2,284 1,474 12,349 24,891 Debt interest 749 661 601 521 481 6,522 9,535 Purchase commitments -1 3,569 1,982 966 323 261 201 7,302 Tax act repatriation liability 13 49 61 123 Pension funding 1,180 1,180 Total $10,548 $5,774 $4,058 $3,538 $2,556 $20,659 $47,133 -1 purchase commitments includes amounts due under aircraft leases that we entered into in 2019 and our january 29, 2020", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para108", "text": "our finance lease obligations relate primarily to leases on aircraft and real estate. finance leases and operating leases are discussed further in note 10 to the audited, consolidated financial statements. purchase commitments, as well as our debt principal obligations, are discussed further in note 8 to the audited, consolidated financial statements. the amount of interest on our debt was calculated as the contractual interest payments due on our fixed-rate debt and variable rate debt based on interest rates as of december 31, 2019 . the calculations of debt interest take into account the effect of interest rate swap agreements. for debt denominated in a foreign currency, the u.s. dollar equivalent principal amount of the debt at the end of the year was used as the basis to calculate future interest payments.", "highlight": "our finance lease obligations relate primarily to leases on aircraft and real estate. ||| the amount of interest on our debt was calculated as the contractual interest payments due on our fixed-rate debt and variable rate debt based on interest rates as of december 31, 2019", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para109", "text": "purchase commitments represent contractual agreements to purchase assets, goods or services that are legally binding, including contracts for aircraft, construction of new or expanded facilities and orders for technology equipment and vehicles. as of december 31, 2019 , we had firm commitments to lease three used and purchase eight new boeing 767-300 aircraft, to be delivered between 2020 and 2021 and to purchase 13 new boeing 747-8f aircraft to be delivered between 2020 and 2022. we also had a firm commitment to purchase five boeing md-11 aircraft to be delivered between 2020 and 2021. we paid the full purchase price for these md-11 aircraft in december 2019; therefore these amounts are not included in the table above.", "highlight": "we had firm commitments to lease three used and purchase eight new boeing 767-300 aircraft, to be delivered between 2020 and 2021 and to purchase 13 new boeing 747-8f aircraft to be delivered between 2020 and 2022. ||| had a firm commitment to purchase five boeing md-11 aircraft to be delivered between 2020 and 2021. we ||| paid the full purchase price for these md-11 aircraft in december 2019; therefore these amounts are not included in the table above.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 1, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para110", "text": "on december 22, 2017, the united states enacted into law the tax act requiring a one-time transition tax on certain unrepatriated earnings of foreign subsidiaries. companies may elect to pay the tax over eight years based on an installment schedule outlined in the tax act but are required under current internal revenue service guidance to offset certain overpayments of tax against the liability. we made this election and have reflected our remaining transition tax due by year as a contractual obligation.", "highlight": "companies may elect to pay the tax over eight years based on an installment schedule outlined in the tax act but are required under current internal revenue service guidance to offset certain overpayments of tax against the liability", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para111", "text": "there are no anticipated required minimum cash contributions to our qualified u.s. pension plans (these plans are discussed further in note 5 to the audited, consolidated financial statements). the amount of any minimum funding requirement, as applicable, for these plans could change significantly in future periods depending on many factors, including future plan asset returns, discount rates, other actuarial assumptions and changes to pension plan funding regulations. a decline in discount rates or a sustained significant decline in equity or bond returns could result in our domestic pension plans being subject to significantly higher minimum funding requirements. actual contributions made in future years could materially differ and consequently required minimum contributions beyond 2020 cannot be reasonably estimated.", "highlight": "there are no anticipated required minimum cash contributions to our qualified u.s. pension plans |||  a decline in discount rates or a sustained significant decline in equity or bond returns could result in our domestic pension plans being subject to significantly higher minimum funding requirements", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para112", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations as discussed in note 6 to the audited, consolidated financial statements, we are not currently subject to any minimum contributions or surcharges with respect to the multiemployer pension and health and welfare plans in which we participate. contribution rates to these multiemployer pension and health and welfare plans are established through the collective bargaining process. as we are not subject to any minimum contribution levels, we have not included any amounts in the contractual commitments table with respect to these multiemployer plans.", "highlight": "we are not currently subject to any minimum contributions or surcharges with respect to the multiemployer pension and health and welfare plans in which we participate |||  are not subject to any minimum contribution levels, we have not included any amounts in the contractual commitments table with respect to these multiemployer plans", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para113", "text": "the table above does not include approximately $ 228 million of liabilities for uncertain tax positions because we are uncertain if or when such amounts will ultimately be settled in cash. uncertain tax positions are further discussed in note 14 to the audited, consolidated financial statements.", "highlight": "the table above does not include approximately $ 228 million of liabilities for uncertain tax positions", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para114", "text": "as of december 31, 2019 , we had outstanding letters of credit totaling approximately $ 1.267 billion issued in connection with our self-insurance reserves and other routine business requirements. we also issue surety bonds as an alternative to letters of credit in certain instances, and as of december 31, 2019 , we had $ 1.327 billion of surety bonds written. as of december 31, 2019 , we had unfunded loan commitments totaling $ 131 million associated with ups capital.", "highlight": "we had outstanding letters of credit totaling approximately $ 1.267 billion ||| we had $ 1.327 billion of surety bonds written ||| we had unfunded loan commitments totaling $ 131 million associated with ups capital.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para115", "text": "we believe that funds from operations and borrowing programs will provide adequate sources of liquidity and capital resources to meet our expected long-term needs for the operation of our business, including anticipated capital expenditures, transformation strategy and pension contributions for the foreseeable future.", "highlight": "we believe that funds from operations and borrowing programs will provide adequate sources of liquidity and capital resources to meet our expected long-term needs for the operation of our business", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para116", "text": "Contingencies see note 5 to the audited, consolidated financial statements for a discussion of pension related matters and note 9 for a discussion of judicial proceedings and other matters arising from the conduct of our business activities.", "highlight": "Contingencies see note 5 to the audited, consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para117", "text": "Collective bargaining agreements Status of collective bargaining agreements see note 6 to the audited, consolidated financial statements for a discussion of the status of collective bargaining agreements.", "highlight": "note 6 to the audited, consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para118", "text": "Multiemployer benefit plans we contribute to a number of multiemployer pension and health and welfare plans under the terms of collective bargaining agreements that cover our union represented employees. our current collective bargaining agreements set forth the annual contribution increases allotted to the plans that we participate in, and we are in compliance with these contribution rates. these limitations will remain in effect throughout the terms of the existing collective bargaining agreements.", "highlight": ". these limitations will remain in effect throughout the terms of the existing collective bargaining agreements. ||| Multiemployer benefit plans we contribute to a number of multiemployer pension and health and welfare plans under the terms of collective bargaining agreements that cover our union represented employees", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para119", "text": "New accounting pronouncements Recently adopted accounting standards see note 1 to the audited, consolidated financial statements for a discussion of recently adopted accounting standards.", "highlight": "see note 1 to the audited, consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para120", "text": "Accounting standards issued but not yet effective see note 1 to the audited, consolidated financial statements for a discussion of accounting standards issued, but not yet effective.", "highlight": "see note 1 to the audited, consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para121", "text": "Rate adjustments effective december 29, 2019, the rates and accessorial charges for ups ground, ups air and international services increased by an average net 4.9%. ups air freight rates within and between the u.s., canada and puerto rico increased an average net 4.2%. density-based ups freight non-contractual ltl rates using tariff 580 increased an average net 3.9%.", "highlight": "ups air and international services increased by an average net 4.9% ||| canada and puerto rico increased an average net 4.2% ||| freight non-contractual ltl rates using tariff 580 increased an average net 3.9%.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para122", "text": "these rate changes are customary and occur on an annual basis. rate changes for shipments originating outside the u.s. are made throughout the year and vary by geographic market.", "highlight": "these rate changes are customary and occur on an annual ba", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 1}}
{"id": "20200220_10-K_1090727_part2_item7_para123", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Critical accounting policies and estimates this discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which are prepared in accordance with gaap. as indicated in note 1 to the audited, consolidated financial statements, the amounts of assets, liabilities, revenue and expenses reported in our financial statements are affected by estimates and judgments that are necessary to comply with gaap. we base our estimates on prior experience and assumptions and third-party input that we consider reasonable to our circumstances. actual results could differ materially from our estimates, which would affect the related amounts reported in our consolidated financial statements. while estimates and judgments are applied in arriving at many reported amounts, we believe that the following critical accounting policies involve a higher degree of judgment and complexity.", "highlight": "the amounts of assets, liabilities, revenue and expenses reported in our financial statements are affected by estimates and judgments that are necessary to comply with gaap ||| while estimates and judgments are applied in arriving at many reported amounts, we believe that the following critical accounting policies involve a higher degree of judgment and complexity.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para124", "text": "Contingencies as discussed in note 9 to the audited, consolidated financial statements, we are involved in various legal proceedings and subject to various contingencies. the events that may impact our contingent liabilities are often unique and generally are not predictable. at the time a contingency is identified, we consider all relevant facts as part of our evaluation. we record a liability for a loss when the loss is probable of occurring and reasonably estimable. events may arise that were not anticipated and the outcome of a contingency may result in a loss to us that differs from our previously estimated liability. this difference could be material. income taxes and self-insurance are discussed below. except as disclosed in note 9 to the audited, consolidated financial statements, other contingent losses that were probable and estimable were not material to our financial position or results of operations as of, or for the year ended, december 31, 2019 . in addition, we have certain contingent liabilities that have not been recognized as of, or for the year ended, december 31, 2019 , because a loss was not reasonably estimable.", "highlight": "we are involved in various legal proceedings and subject to various contingencies. ||| we record a liability for a loss when the loss is probable of occurring and reasonably estimable ||| we have certain contingent liabilities that have not been recognized as of, or for the year ended, december 31, 2019 , because a loss was not reasonably estimable.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para125", "text": "Goodwill and intangible impairment We test goodwill for impairment in each of our reporting units on an annual basis. our u.s. domestic package segment is a reporting unit. in our international package reporting segment, we have the following reporting units: europe, asia, americas and ismea. in our supply chain & freight segment we have the following reporting units: forwarding, logistics, ups mail innovations, ups freight, the ups store, ups capital, marken and coyote logistics. our annual goodwill impairment testing date is july 1 St for each reporting unit owned at the testing date. in assessing goodwill for impairment, we initially evaluate qualitative factors to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. if the qualitative assessment is not conclusive and it is necessary to calculate the fair value of a reporting unit, then we utilize a two-step process to test goodwill for impairment. first, a comparison of the fair value of the applicable reporting unit with the aggregate carrying value, including goodwill, is performed. if the carrying amount of a reporting unit exceeds the reporting unit's fair value, we perform the second step of the goodwill impairment test to determine the amount of impairment loss. the second step includes comparing the implied fair value of the affected reporting unit's goodwill with the carrying value of that goodwill.", "highlight": "We test goodwill for impairment in each of our reporting units on an annual basis ||| we have the following reporting units: europe, asia, americas and ismea ||| we have the following reporting units: forwarding, logistics, ups mail innovations, ups freight, the ups store, ups capital, marken and coyote logistics ||| we initially evaluate qualitative factors to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount ||| we utilize a two-step process to test goodwill for impairment ||| we perform the second step of the goodwill impairment test to determine the amount of impairment loss", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para126", "text": "we primarily determine the fair value of our reporting units using a discounted cash flow (\"dcf\") model and supplement this with observable valuation multiples for comparable companies, as appropriate. the completion of the dcf model requires that we make a number of significant assumptions to produce an estimate of future cash flows. these assumptions include projections of future revenue, costs, capital expenditures and working capital changes, as well as assumptions about the estimated cost of capital and other relevant variables. the projections that we use in our dcf model are updated annually and will change over time based on the historical performance and changing business conditions for each of our reporting units. the determination of whether goodwill is impaired involves a significant level of judgment in these assumptions, and changes in our business strategy, government regulations, or economic or market conditions could significantly impact these judgments. we routinely monitor market conditions and other factors to determine if interim impairment tests are necessary. if impairment indicators are present in future periods, the resulting impairment charges could have a material impact on our results of operations.", "highlight": "we primarily determine the fair value of our reporting units using a discounted cash flow (\"dcf\") model and supplement this with observable valuation multiples for comparable companies, ||| we make a number of significant assumptions to produce an estimate of future cash flows ||| the projections that we use in our dcf model are updated annually and will change over time based on the historical performance and changing business conditions for each of our reporting units ||| we routinely monitor market conditions and other factors to determine if interim impairment tests are necessary", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para127", "text": "none of the reporting units incurred any goodwill impairment charges in 2019 or 2018 . changes in our forecasts could cause carrying values of our reporting units to exceed their fair values in future periods, potentially resulting in a goodwill impairment charge. during the year, management monitored the actual performance of the business relative to the fair value assumptions used during our annual goodwill impairment test. for the periods presented, no triggering events were identified that required an interim impairment test. based on most recent tests, the fair value of all our reporting units exceed their carrying value.", "highlight": "none of the reporting units incurred any goodwill impairment charges ||| changes in our forecasts could cause carrying values of our reporting units to exceed their fair values in future periods, potentially resulting in a goodwill impairment charge ||| the fair value of all our reporting units exceed their carrying value.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para128", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations a trade name with a carrying value of $200 million and licenses with a carrying value of $ 4 million as of december 31, 2019 are considered to be indefinite-lived intangibles, and therefore are not amortized. impairment tests for indefinite-lived intangibles are performed on an annual basis. we determined that the income approach, specifically the relief from royalty method, is the most appropriate valuation method for the trade name. the estimated fair value of the trade name is compared to the carrying value of the asset. if the carrying value of the trade name exceeds its estimated fair value, an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds its fair value. this valuation approach requires that we make a number of assumptions to estimate fair value. these assumptions include projections of future revenues, market royalty rates, tax rates, discount rates and other relevant variables. the projections we use in the model are updated annually and will change over time based on the historical performance and changing business conditions.", "highlight": "we determined that the income approach, specifically the relief from royalty method, is the most appropriate valuation method for the trade name ||| this valuation approach requires that we make a number of assumptions to estimate fair value. these assumptions include projections of future revenues ||| the projections we use in the model are updated annually and will change over time based on the historical performance and changing business conditions.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para129", "text": "all of our remaining recorded intangible assets are deemed to be finite-lived intangibles, and are amortized over their estimated useful lives. impairment tests for these intangible assets are only performed when a triggering event occurs that indicates that the carrying value of the intangible may not be recoverable based on the undiscounted future cash flows of the intangible. if the carrying amount of the intangible is determined not to be recoverable, a write-down to fair value is recorded. fair values are determined based on a dcf model. if impairment indicators are present in future periods, the resulting impairment charges could have a material impact on our results of operations. impairments of finite-lived intangible assets were $ 2 and $ 12 million in 2019 and 2018 , respectively. there were no impairments of indefinite-lived intangible assets in 2019 or 2018 .", "highlight": "remaining recorded intangible assets are deemed to be finite-lived intangibles, and are amortized over their estimated useful lives. impairment tests for these intangible assets are only performed when a triggering event occurs that indicates that the carrying value of the intangible may not be recoverable based on the undiscounted future cash flows of the intangible", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para130", "text": "Self-insurance accruals we self-insure costs associated with workers' compensation claims, automobile liability, health and welfare and general business liabilities, up to certain limits. insurance reserves are established for estimates of the loss that we will ultimately incur on reported claims, as well as loss estimates for claims that have been incurred but not yet reported. recorded balances are based on third-party actuarial estimates, which incorporate historical loss experience and judgments about the present and expected cost per claim. trends in actual experience are a significant factor in the determination of our reserves.", "highlight": "we self-insure costs associated with workers' compensation claims, automobile liability, health and welfare and general business liabilities, up to certain limits ||| trends in actual experience are a significant factor in the determination of our reserves.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para131", "text": "workers' compensation, automobile liability and general liability insurance claims may take several years to completely settle. consequently, actuarial estimates are required to project the ultimate cost that will be incurred to fully resolve a claim. a number of factors can affect the actual cost of a claim, including the length of time the claim remains open, trends in healthcare costs, the results of any related litigation and with respect to workers' compensation claims and changes in legislation. furthermore, claims may emerge in a future year for events that occurred in a prior year at a rate that differs from actuarial projections. all of these factors can result in revisions to actuarial projections and produce a material difference between estimated and actual operating results. based on our historical experience, during 2019 we changed our self-insurance reserves from the central estimate to the low end of the actuarial range of losses. we believe our estimated reserves for such claims are adequate; actual experience in claim frequency and/or severity could materially differ from our estimates and affect our results of operations. for additional information on our self-insurance reserves, refer to note 1 of the audited, consolidated financial statements.", "highlight": "workers' compensation, automobile liability and general liability insurance claims may take several years to completely settle ||| based on our historical experience, during 2019 we changed our self-insurance reserves from the central estimate to the low end of the actuarial range of losses ||| we believe our estimated reserves for such claims are adequate; actual experience in claim frequency and/or severity could materially differ from our estimates and affect our results of operations", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para132", "text": "we sponsor a number of health and welfare insurance plans for our employees. liabilities and expenses related to these plans are based on estimates of, among other things, the number of employees and eligible dependents covered under the plans, anticipated medical usage by participants and overall trends in medical costs and inflation. we believe our estimates are reasonable/appropriate. actual experience may differ from these estimates and, therefore, produce a material difference between estimated and actual operating results.", "highlight": "we sponsor a number of health and welfare insurance plans for our employees. ||| we believe our estimates are reasonable/appropriate. actual experience may differ from these estimates and, therefore, produce a material difference between estimated and actual operating results.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para133", "text": "Pension and postretirement medical benefits our pension and other postretirement benefit costs are calculated using various actuarial assumptions and methodologies. these assumptions include discount rates, healthcare cost trend rates, inflation, compensation increase rates, expected returns on plan assets, mortality rates and other factors. the assumptions utilized in recording the obligations under our plans represent our best estimates, and we believe that they are reasonable, based on information as to historical experience and performance as well as other factors that might cause future expectations to differ from past trends.", "highlight": "Pension and postretirement medical benefits our pension and other postretirement benefit costs are calculated using various actuarial assumptions and methodologies. |||  we believe that they are reasonable, based on information as to historical experience and performance as well as other factors that might cause future expectations to differ from past trends", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para134", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations differences in actual experience or changes in assumptions may affect our pension and other postretirement obligations and future expenses. the primary factors contributing to actuarial gains and losses each year are (1) changes in the discount rate used to value pension and postretirement benefit obligations as of the measurement date, (2) differences between the expected and the actual return on plan assets, (3) changes in demographic assumptions including mortality, (4) participant experience different from demographic assumptions and (5) changes in coordinating benefits with plans not sponsored by ups. in october 2019, we refined the bond matching approach used to determine the discount rate for our u.s. pension and postretirement plans by implementing advances in technology and modeling techniques. this refinement decreased the projected benefit obligation on our consolidated balance sheet by approximately $900 million as of december 31, 2019, decreased the pre-tax mark-to-market charge by approximately $810 million and increased net income by $616 million, or $0.71 per share on a basic and diluted basis.", "highlight": "our consolidated balance sheet by approximately $900 million as of december ||| decreased the pre-tax mark-to-market charge by approximately $810 million and increased net income by $616 million, or $0.71 per share on a basic and diluted basis.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para135", "text": "we recognize changes in the fair value of plan assets and net actuarial gains or losses in excess of a corridor (defined as 10% of the greater of the fair value of plan assets or the plans' projected benefit obligations) in pension expense annually at december 31st each year. the remaining components of pension expense (herein referred to as \"ongoing net periodic benefit cost\"), primarily service and interest costs and the expected return on plan assets, are reported on a quarterly basis.", "highlight": "we recognize changes in the fair value of plan assets and net actuarial gains or losses in excess of a corridor ||| in pension expense annually at december 31st each year ||| primarily service and interest costs and the expected return on plan assets, are reported on a quarterly basis", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para136", "text": "the following sensitivity analysis shows the impact of a 25 basis point change in the assumed discount rate and return on assets for our pension and postretirement benefit plans, and the resulting increase/(decrease) on our obligations and expense as of, and for the year ended, december 31, 2019 (in millions).", "highlight": "shows the impact of a 25 basis point change in the assumed discount rate and return on assets for our pension and postretirement benefit plans", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para137", "text": "Pension plans 25 basis point Increase 25 basis point Decrease Discount rate: Effect on ongoing net periodic benefit cost $-37 )$38 Effect on net periodic benefit cost for amounts recognized outside the 10% corridor -1,390 )2,043 Effect on projected benefit obligation -2,156 )2,294 Return on assets: Effect on ongoing net periodic benefit cost -1 -100 )100 Effect on net periodic benefit cost for amounts recognized outside the 10% corridor -2 -100 )100 Postretirement medical plans Discount rate: Effect on ongoing net periodic benefit cost 3 -3 )Effect on net periodic benefit cost for amounts recognized outside the 10% corridor -37 )48 Effect on accumulated postretirement benefit obligation -55 )65 Healthcare cost trend rate: Effect on ongoing net periodic benefit cost 1 -1 )Effect on net periodic benefit cost for amounts recognized outside the 10% corridor 4 -5 )Effect on accumulated postretirement benefit obligation 14 -16 )-1 amount calculated based on 25 basis point increase / decrease in the expected return on assets.", "highlight": "Effect on ongoing net periodic benefit cost $-37 )$38 Effect on net periodic benefit cost for amounts recognized outside the 10% corridor -1,390 )2,043 Effect on projected benefit obligation -2,156 )2,294 Return on assets: Effect on ongoing net periodic benefit cost -1 -100 )100 Effect on net periodic benefit cost for amounts recognized outside the 10% corridor -2 -100 )100 Postretirement medical plans Discount rate: Effect on ongoing net periodic benefit cost 3 -3 )Effect on net periodic benefit cost for amounts recognized outside the 10% corridor -37 )48 Effect on accumulated postretirement benefit obligation -55 )65 Healthcare cost trend rate: Effect on ongoing net periodic benefit cost 1 -1 )Effect on net periodic benefit cost for amounts recognized outside the 10% corridor 4 -5 )Effect on accumulated postretirement benefit obligation 14 -16 )-", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para138", "text": "-2 amount calculated based on 25 basis point increase / decrease in the actual return on assets.", "highlight": "based on 25 basis point increase / decrease in the actual return on assets.", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para139", "text": "refer to note 5 to the audited, consolidated financial statements for information on our potential liability for coordinating benefits related to the central states pension fund.", "highlight": "note 5 to the audited, consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para140", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Depreciation, residual value and impairment of fixed assets as of december 31, 2019 , we had $ 30.482 billion of net fixed assets, the most significant category of which is aircraft. in accounting for fixed assets, we make estimates of the expected useful lives, the expected residual values and the potential for impairment based on the fair values of the assets and the cash flows which they generate.", "highlight": "we had $ 30.482 billion of net fixed assets", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para141", "text": "in estimating the lives and expected residual values of aircraft, we rely upon actual experience with the same or similar aircraft types. revisions to these estimates could be caused by changes to our maintenance programs, changes in the utilization of the aircraft, governmental regulations on aging aircraft and changing market prices of new and used aircraft of the same or similar types. we periodically evaluate these estimates and assumptions, and adjust them as necessary. adjustments are accounted for on a prospective basis through depreciation expense. in 2019, we revised our estimates of the useful lives and residual values for certain airframes, engines and related rotable parts. this change increased the useful lives of certain fleet types and reduced the useful lives and residual values of the majority of our used aircraft. the net impact to 2019 depreciation expense was not material. in estimating cash flows, we project future volume levels for our different air products in all geographic regions in which we do business. adverse changes in these volume forecasts, or a shortfall of our actual volume compared with our projections, could result in our current aircraft capacity exceeding current or projected demand. this situation could lead to an excess of a particular aircraft, resulting in an aircraft impairment charge or a reduction of the expected life of an aircraft (thus resulting in increased depreciation expense).", "highlight": "we rely upon actual experience with the same or similar aircraft types ||| we periodically evaluate these estimates and assumptions, and adjust them as necessary ||| we revised our estimates of the useful lives and residual values for certain airframes, engines and related rotable parts ||| adverse changes in these volume forecasts, or a shortfall of our actual volume compared with our projections, could result in our current aircraft capacity exceeding current or projected demand. this situation could lead to an excess of a particular aircraft", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 2, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para142", "text": "we evaluate the useful lives of our property, plant and equipment based on our usage, maintenance and replacement policies, and taking into account physical and economic factors that may affect the useful lives of the assets. as part of our ongoing investment in transformation in 2018, we revised our estimates of useful lives for building improvements, vehicles and plant equipment based on our current assessment of these factors. in general, these changes in estimate had the effect of lengthening the useful lives of vehicles, building improvements and plant equipment, and were applied prospectively beginning in 2018 through depreciation expense. see \"consolidated operating expenses\" of this \"management's discussion and analysis of financial condition and results of operations\" for the discussion of the impacts to \"depreciation and amortization.\" see note 1 to the audited, consolidated financial statements for a discussion of our accounting policies and note 4 for a discussion of the change in estimated useful lives.", "highlight": "we evaluate the useful lives of our property, plant and equipment based on our usage, maintenance and replacement policies, and taking into account physical and economic factors that may affect the useful lives of the assets", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para143", "text": "we review long-lived assets for impairment when circumstances indicate the carrying amount of an asset may not be recoverable based on the undiscounted future cash flows of the asset. if the carrying amount of the asset is determined not to be recoverable, a write-down to fair value is recorded. fair values are determined based on quoted market values, discounted cash flows or external appraisals, as appropriate. we review long-lived assets for impairment at the individual asset or the asset group level for which the lowest level of independent cash flows can be identified. the circumstances that would indicate potential impairment may include, but are not limited to, a significant change in the extent to which an asset is utilized and operating or cash flow losses associated with the use of the asset.", "highlight": "we review long-lived assets for impairment when circumstances indicate the carrying amount of an asset may not be recoverable based on the undiscounted future cash flows of the asset. ||| we review long-lived assets for impairment at the individual asset or the asset group level for which the lowest level of independent cash flows can be identified", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para144", "text": "there were no impairment charges on our property, plant and equipment during 2019 or 2018 .", "highlight": "no impairment charges", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para145", "text": "Fair value measurements in the normal course of business, we hold and issue financial instruments that contain elements of market risk, including derivatives, marketable securities, finance receivables, pension assets, other investments and debt. certain of these financial instruments are required to be recorded at fair value, principally derivatives, marketable securities, pension assets and certain other investments. fair values are based on listed market prices, when such prices are available. to the extent that listed market prices are not available, fair value is determined based on other relevant factors, including dealer price quotations. if listed market prices or other relevant factors are not available, inputs are developed from unobservable data reflecting our own assumptions and include situations where there is little or no market activity for the asset or liability. certain financial instruments, including over-the-counter derivative instruments, are valued using pricing models that consider, among other factors, contractual and market prices, correlations, time value, credit spreads and yield curve volatility factors. changes in the fixed income, foreign exchange and commodity markets will impact our estimates of fair value in the future, potentially affecting our results of operations. a quantitative sensitivity analysis of our exposure to changes in commodity prices, foreign currency exchange rates and interest rates is presented in the \"quantitative and qualitative disclosures about market risk\" section of this report.", "highlight": "we hold and issue financial instruments that contain elements of market risk ||| to the extent that listed market prices are not available, fair value is determined based on other relevant factors ||| changes in the fixed income, foreign exchange and commodity markets will impact our estimates of fair value in the future, potentially affecting our results of operations", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para146", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations certain non-financial assets and liabilities are measured at fair value on a nonrecurring basis, including property, plant, and equipment, goodwill and intangible assets. these assets are not measured at fair value on a recurring basis; however, they are subject to fair value adjustments in certain circumstances, such as when there is evidence of an impairment.", "highlight": "are measured at fair value on a nonrecurring basis ||| these assets are not measured at fair value on a recurring basis ||| subject to fair value adjustments in certain circumstances", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para147", "text": "for acquisitions, we allocate the fair value of purchase consideration to the tangible assets acquired, liabilities assumed and intangible assets acquired based on their estimated fair values. the excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. such valuations require management to make significant estimates and assumptions, especially with respect to intangible assets. significant estimates in valuing certain intangible assets include, but are not limited to, future expected cash flows from acquired customers, technology and trade names from a market participant perspective, useful lives and discount rates. management's estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable. as a result, actual results may differ from estimates. during the measurement period, which is one year from the acquisition date, we may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. upon the conclusion of the measurement period, any subsequent adjustments are recorded to earnings.", "highlight": "the excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. such ||| management's estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para148", "text": "Income taxes we make certain estimates and judgments in determining income tax expense for financial statement purposes. these estimates and judgments occur in the calculation of income by legal entity and jurisdiction, tax credits, benefits and deductions, and in the calculation of deferred tax assets and liabilities, which arise from differences in the timing of recognition of revenue and expense for tax and financial statement purposes, as well as tax, interest and penalties related to uncertain tax positions. significant changes to these estimates may result in an increase or decrease to our tax provision in a subsequent period.", "highlight": "we make certain estimates and judgments in determining income tax expense for financial statement purposes ||| significant changes to these estimates may result in an increase or decrease to our tax provision in a subsequent period.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para149", "text": "we assess the likelihood that we will be able to recover our deferred tax assets. if recovery is not likely, we must increase our provision for taxes by recording a valuation allowance against the deferred tax assets that we estimate will not ultimately be recoverable. we believe that we will ultimately recover a substantial majority of the deferred tax assets recorded on our consolidated balance sheets. however, should there be a change in our ability to recover our deferred tax assets, our tax provision would increase in the period in which we determined that the recovery was not likely.", "highlight": "we believe that we will ultimately recover a substantial majority of the deferred tax assets recorded on our consolidated balance sheets ||| however, should there be a change in our ability to recover our deferred tax assets, our tax provision would increase", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para150", "text": "the calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax regulations. we recognize liabilities for uncertain tax positions based on a two-step process. the first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. once it is determined that the position meets the recognition threshold, the second step requires us to estimate and measure the largest amount of tax benefit that is more likely than not to be realized upon ultimate settlement. the difference between the amount of recognizable tax benefit and the total amount of tax benefit from positions filed or to be filed with the tax authorities is recorded as a liability for uncertain tax benefits. it is inherently difficult and subjective to estimate such amounts, as we have to determine the probability of various possible outcomes. we reevaluate uncertain tax positions on a quarterly basis. this evaluation is based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit and new audit activity. such a change in recognition or measurement could result in the recognition of a tax benefit or an additional charge to the tax provision.", "highlight": "the calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax regulations ||| recognize liabilities for uncertain tax positions based on a two-step process ||| reevaluate uncertain tax positions on a quarterly basis. this evaluation is based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit and new audit activity", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20200220_10-K_1090727_part2_item7_para151", "text": "see note 14 to the audited consolidated financial statements for a discussion of impacts of the tax act.", "highlight": "note 14 to the audited consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para1", "text": "the following discussion should be read in conjunction with the consolidated financial statements and accompanying notes included in part ii, item 8 of this form 10-k. this section of this form 10-k generally discusses 2022 and 2021 items and year-to-year comparisons between 2022 and 2021. discussions of 2020 items and year-to-year comparisons between 2021 and 2020 are not included in this form 10-k, and can be found in \"management's discussion and analysis of financial condition and results of operations\" in part ii, item 7 of the company's annual report on form 10-k for the fiscal year ended september 25, 2021.", "highlight": "consolidated financial statements and accompanying notes included in part ii, item 8 of this form 10-k. this section of this form 10-k generally ||| operations\" in part ii, item 7 of the company's annual report on form 10-k", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para2", "text": "Fiscal year highlights Fiscal 2022 highlights total net sales increased 8% or $28.5 billion during 2022 compared to 2021, driven primarily by higher net sales of iphone, services and mac. the weakness in foreign currencies relative to the u.s. dollar had an unfavorable year-over-year impact on all products and services net sales during 2022.", "highlight": "driven primarily by higher net sales of iphone, services and mac. the weakness in foreign currencies relative to the u.s. dollar had an unfavorable year-over-year impact on all products and services net sales during 2022.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para3", "text": "The company announces new product, service and software offerings at various times during the year. significant announcements during fiscal 2022 included the following: First quarter 2022: Updated macbook pro 14\" and macbook pro 16\", powered by the apple m1 pro or m1 max chip; and third generation of airpods.", "highlight": "included the following: First quarter 2022: Updated macbook pro 14\" and macbook pro 16\", powered by the apple m1 pro or m1 max chip; and third generation of airpods", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para4", "text": "Second quarter 2022: Updated iphone se with 5g technology; All-new mac studio, powered by the apple m1 max or m1 ultra chip; All-new studio display ; and updated ipad air with 5g technology, powered by the apple m1 chip.", "highlight": "All-new mac studio, powered by the apple m1 max or m1 ultra chip; All-new studio display ; and updated ipad air with 5g technology, powered by the apple m1 chip", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para5", "text": "Third quarter 2022: Updated macbook air and macbook pro 13\", both powered by the apple m2 chip; Ios 16, macos ventura, ipados 16 and watchos 9, updates to the company's operating systems; and apple pay later, a buy now, pay later service.", "highlight": "Updated macbook air and macbook pro 13\", both powered by the apple m2 chip; Ios 16, macos ventura, ipados 16 and watchos 9, updates to the company's operating systems; and apple pay later, a buy now, pay later service.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para6", "text": "Fourth quarter 2022: Iphone 14, iphone 14 plus, iphone 14 pro and iphone 14 pro max; Second generation of airpods pro; and apple watch series 8, updated apple watch se and all-new apple watch ultra.", "highlight": "Iphone 14, iphone 14 plus, iphone 14 pro and iphone 14 pro max; Second generation of airpods pro; and apple watch series 8, updated apple watch se and all-new apple watch ultra.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para7", "text": "in april 2022, the company announced an increase to its program authorization from $315 billion to $405 billion and raised its quarterly dividend from $0.22 to $0.23 per share beginning in may 2022. during 2022, the company repurchased $90.2 billion of its common stock and paid dividends and dividend equivalents of $14.8 billion.", "highlight": "announced an increase to its program authorization from $315 billion to $405 billion and raised its quarterly dividend from $0.22 to $0.23 per share beginning in may 2022. during 2022, the company repurchased $90.2 billion of its common stock and paid dividends and dividend equivalents of $14.8 billion.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para8", "text": "Covid-19 the covid-19 pandemic has had, and continues to have, a significant impact around the world, prompting governments and businesses to take unprecedented measures, such as restrictions on travel and business operations, temporary closures of businesses, and quarantine and shelter-in-place orders. the covid-19 pandemic has at times significantly curtailed global economic activity and caused significant volatility and disruption in global financial markets. the covid-19 pandemic and the measures taken by many countries in response have affected and could in the future materially impact the company's business, results of operations and financial condition.", "highlight": "the covid-19 pandemic and the measures taken by many countries in response have affected and could in the future materially impact the company's business, results of operations and financial condition.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 1, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para9", "text": "certain of the company's outsourcing partners, component suppliers and logistical service providers have experienced disruptions during the covid-19 pandemic, resulting in supply shortages. similar disruptions could occur in the future.", "highlight": "component suppliers and logistical service providers have experienced disruptions during the covid-19 pandemic, resulting in supply shortages", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 1, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para10", "text": "Products and services performance The following table shows net sales by category for 2022, 2021 and 2020 (dollars in millions): 2022 Change 2021 Change 2020 Net sales by category: Iphone (1) $ 205,489 7 % $ 191,973 39 % $ 137,781 Mac (1) 40,177 14 % 35,190 23 % 28,622 Ipad (1) 29,292 -8 % 31,862 34 % 23,724 Wearables, home and accessories (1)(2) 41,241 7 % 38,367 25 % 30,620 Services (3) 78,129 14 % 68,425 27 % 53,768 Total net sales $ 394,328 8 % $ 365,817 33 % $ 274,515 -1) products net sales include amortization of the deferred value of unspecified software upgrade rights, which are bundled in the sales price of the respective product.", "highlight": "Iphone (1) $ 205,489 7 % $ 191,973 39 % $ 137,781 Mac (1) 40,177 14 % 35,190 23 % 28,622 Ipad (1) 29,292 -8 % 31,862 34 % 23,724 Wearables, home and accessories (1)(2) 41,241 7 % 38,367 25 % 30,620 Services (3) 78,129 14 % 68,425 27 % 53,768 Total net sales $ 394,328 8 % $ 365,817 33 % $ 274,515 -1)", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para11", "text": "-2) wearables, home and accessories net sales include sales of airpods, apple tv, apple watch, beats products, homepod mini and accessories.", "highlight": "include sales of airpods, apple tv, apple watch, beats products, homepod mini and accessories.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para12", "text": "-3) services net sales include sales from the company's advertising, applecare, cloud, digital content, payment and other services. services net sales also include amortization of the deferred value of services bundled in the sales price of certain products.", "highlight": "net sales include sales from the company's advertising, applecare, cloud, digital content, payment and other services", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para13", "text": "Iphone iphone net sales increased during 2022 compared to 2021 due primarily to higher net sales from the company's new iphone models released since the beginning of the fourth quarter of 2021.", "highlight": "due primarily to higher net sales from the company's new iphone models released since the beginning of the fourth quarter of 2021.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para14", "text": "Mac mac net sales increased during 2022 compared to 2021 due primarily to higher net sales of laptops.", "highlight": "due primarily to higher net sales of laptops.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para15", "text": "Ipad ipad net sales decreased during 2022 compared to 2021 due primarily to lower net sales of ipad pro.", "highlight": "due primarily to lower net sales of ipad pro.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para16", "text": "Wearables, home and accessories wearables, home and accessories net sales increased during 2022 compared to 2021 due primarily to higher net sales of apple watch and airpods.", "highlight": "due primarily to higher net sales of apple watch and airpods.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para17", "text": "Services services net sales increased during 2022 compared to 2021 due primarily to higher net sales from advertising, cloud services and the app store.", "highlight": "due primarily to higher net sales from advertising, cloud services and the app store.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para18", "text": "Segment operating performance The company manages its business primarily on a geographic basis. the company's reportable segments consist of the americas, europe, greater china, japan and rest of asia pacific. americas includes both north and south america. europe includes european countries, as well as india, the middle east and africa. greater china includes china mainland, hong kong and taiwan. rest of asia pacific includes australia and those asian countries not included in the company's other reportable segments. although the reportable segments provide similar hardware and software products and similar services, each one is managed separately to better align with the location of the company's customers and distribution partners and the unique market dynamics of each geographic region. further information regarding the company's reportable segments can be found in part ii, item 8 of this form 10-k in the notes to consolidated financial statements in note 11, \"segment information and geographic data.\" The following table shows net sales by reportable segment for 2022, 2021 and 2020 (dollars in millions): 2022 Change 2021 Change 2020 Net sales by reportable segment: Americas $ 169,658 11 % $ 153,306 23 % $ 124,556 Europe 95,118 7 % 89,307 30 % 68,640 Greater china 74,200 9 % 68,366 70 % 40,308 Japan 25,977 -9 % 28,482 33 % 21,418 Rest of asia pacific 29,375 11 % 26,356 35 % 19,593 Total net sales $ 394,328 8 % $ 365,817 33 % $ 274,515 Americas americas net sales increased during 2022 compared to 2021 due primarily to higher net sales of iphone, services and mac.", "highlight": "The following table shows net sales by reportable segment for 2022, 2021 and 2020 (dollars in millions): 2022 Change 2021 Change 2020 Net sales by reportable segment: Americas $ 169,658 11 % $ 153,306 23 % $ 124,556 Europe 95,118 7 % 89,307 30 % 68,640 Greater china 74,200 9 % 68,366 70 % 40,308 Japan 25,977 -9 % 28,482 33 % 21,418 Rest of asia pacific 29,375 11 % 26,356 35 % 19,593 Total net sales $ 394,328 8 % $ 365,817 33 % $ 274,515 Americas americas net sales increased during 2022 compared to 2021 due primarily to higher net sales of iphone, services and mac.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para19", "text": "Europe europe net sales increased during 2022 compared to 2021 due primarily to higher net sales of iphone and services. the weakness in foreign currencies relative to the u.s. dollar had a net unfavorable year-over-year impact on europe net sales during 2022.", "highlight": "due primarily to higher net sales of iphone and services. the weakness in foreign currencies relative to the u.s. dollar had a net unfavorable year-over-year impact on europe net sales during 2022", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 1, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para20", "text": "Greater china greater china net sales increased during 2022 compared to 2021 due primarily to higher net sales of iphone and services. the strength of the renminbi relative to the u.s. dollar had a favorable year-over-year impact on greater china net sales during 2022.", "highlight": "due primarily to higher net sales of iphone and services ||| had a favorable year-over-year impact on greater china net sales during 2022.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 1, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para21", "text": "Japan japan net sales decreased during 2022 compared to 2021 due to the weakness of the yen relative to the u.s. dollar.", "highlight": "due to the weakness of the yen relative to the u.s. dollar.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para22", "text": "Rest of asia pacific rest of asia pacific net sales increased during 2022 compared to 2021 due primarily to higher net sales of iphone, mac and services. the weakness in foreign currencies relative to the u.s. dollar had an unfavorable year-over-year impact on rest of asia pacific net sales during 2022.", "highlight": "due primarily to higher net sales of iphone, mac and services. the weakness in foreign currencies relative to the u.s. dollar had an unfavorable year-over-year impact", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para23", "text": "Gross margin Products and services gross margin and gross margin percentage for 2022, 2021 and 2020 were as follows (dollars in millions): 2022 2021 2020 Gross margin: Products $ 114,728 $ 105,126 $ 69,461 Services 56,054 47,710 35,495 Total gross margin $ 170,782 $ 152,836 $ 104,956 Gross margin percentage: Products 36.3 % 35.3 % 31.5 % Services 71.7 % 69.7 % 66.0 % Total gross margin percentage 43.3 % 41.8 % 38.2 % Products gross margin products gross margin increased during 2022 compared to 2021 due primarily to a different products mix and higher products volume, partially offset by the weakness in foreign currencies relative to the u.s. dollar.", "highlight": "2022 2021 2020 Gross margin: Products $ 114,728 $ 105,126 $ 69,461 Services 56,054 47,710 35,495 Total gross margin $ 170,782 $ 152,836 $ 104,956 Gross margin percentage: Products 36.3 % 35.3 % 31.5 % Services 71.7 % 69.7 % 66.0 % Total gross margin percentage 43.3 % 41.8 % 38.2 %  ||| Products gross margin products gross margin increased", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para24", "text": "products gross margin percentage increased during 2022 compared to 2021 due primarily to a different products mix, partially offset by the weakness in foreign currencies relative to the u.s. dollar.", "highlight": "due primarily to a different products mix, partially offset by the weakness in foreign currencies relative to the u.s. dollar.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para25", "text": "Services gross margin services gross margin increased during 2022 compared to 2021 due primarily to higher services net sales, partially offset by the weakness in foreign currencies relative to the u.s. dollar.", "highlight": "due primarily to higher services net sales, partially offset by the weakness in foreign currencies relative to the u.s. dollar.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para26", "text": "services gross margin percentage increased during 2022 compared to 2021 due primarily to improved leverage and a different services mix, partially offset by the weakness in foreign currencies relative to the u.s. dollar.", "highlight": "due primarily to improved leverage and a different services mix, partially offset by the weakness in foreign currencies relative to the u.s. dollar.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para27", "text": "the company's future gross margins can be impacted by a variety of factors, as discussed in part i, item 1a of this form 10-k under the heading \"risk factors.\" as a result, the company believes, in general, gross margins will be subject to volatility and downward pressure.", "highlight": "the company believes, in general, gross margins will be subject to volatility and downward pressure.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para28", "text": "Operating expenses Operating expenses for 2022, 2021 and 2020 were as follows (dollars in millions): 2022 Change 2021 Change 2020 Research and development $ 26,251 20 % $ 21,914 17 % $ 18,752 Percentage of total net sales 7 % 6 % 7 % Selling, general and administrative $ 25,094 14 % $ 21,973 10 % $ 19,916 Percentage of total net sales 6 % 6 % 7 % Total operating expenses $ 51,345 17 % $ 43,887 13 % $ 38,668 Percentage of total net sales 13 % 12 % 14 % Research and development the year-over-year growth in r&d expense in 2022 was driven primarily by increases in headcount-related expenses and engineering program costs.", "highlight": "2022 Change 2021 Change 2020 Research and development $ 26,251 20 % $ 21,914 17 % $ 18,752 Percentage of total net sales 7 % 6 % 7 % Selling, general and administrative $ 25,094 14 % $ 21,973 10 % $ 19,916 Percentage of total net sales 6 % 6 % 7 % Total operating expenses $ 51,345 17 % $ 43,887 13 % $ 38,668 Percentage of total net sales 13 % 12 % 14 ||| Research and development the year-over-year growth", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para29", "text": "Selling, general and administrative the year-over-year growth in selling, general and administrative expense in 2022 was driven primarily by increases in headcount-related expenses, advertising and professional services.", "highlight": "was driven primarily by increases in headcount-related expenses, advertising and professional services.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para30", "text": "Other income/(expense), net Other income/(expense), net (\"oi&e\") for 2022, 2021 and 2020 was as follows (dollars in millions): 2022 Change 2021 Change 2020 Interest and dividend income $ 2,825 $ 2,843 $ 3,763 Interest expense -2,931 -2,645 -2,873 Other income/(expense), net -228 60 -87 Total other income/(expense), net $ (334) -229 % $ 258 -68 % $ 803 the decrease in oi&e during 2022 compared to 2021 was due primarily to higher realized losses on debt securities, unfavorable fair value adjustments on equity securities and higher interest expense, partially offset by higher foreign exchange gains.", "highlight": "net (\"oi&e\") for 2022, 2021 and 2020 was as follows (dollars in millions): 2022 Change 2021 Change 2020 Interest and dividend income $ 2,825 $ 2,843 $ 3,763 Interest expense -2,931 -2,645 -2,873 Other income/(expense), net -228 60 -87 Total other income/(expense), net $ (334) -229 % $ 258 -68 % $ 803 the decrease in oi&e", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para31", "text": "Provision for income taxes Provision for income taxes, effective tax rate and statutory federal income tax rate for 2022, 2021 and 2020 were as follows (dollars in millions): 2022 2021 2020 Provision for income taxes $ 19,300 $ 14,527 $ 9,680 Effective tax rate 16.2 % 13.3 % 14.4 % Statutory federal income tax rate 21 % 21 % 21 % the company's effective tax rate for 2022 was lower than the statutory federal income tax rate due primarily to a lower effective tax rate on foreign earnings, tax benefits from share-based compensation and the impact of the u.s. federal r&d credit, partially offset by state income taxes. the company's effective tax rate for 2021 was lower than the statutory federal income tax rate due primarily to a lower effective tax rate on foreign earnings, tax benefits from share-based compensation and foreign-derived intangible income deductions.", "highlight": "2022 2021 2020 Provision for income taxes $ 19,300 $ 14,527 $ 9,680 Effective tax rate 16.2 % 13.3 % 14.4 % Statutory federal income tax rate 21 % 21 % 21 % the company's effective tax rate for 2022 was lower than the statutory federal income tax rate", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para32", "text": "the company's effective tax rate for 2022 was higher compared to 2021 due primarily to a higher effective tax rate on foreign earnings, including the impact to u.s. foreign tax credits as a result of regulatory guidance issued by the u.s. department of the treasury in 2022, and lower tax benefits from foreign-derived intangible income deductions and share-based compensation.", "highlight": "due primarily to a higher effective tax rate on foreign earnings, including the impact to u.s. foreign tax credits as a result of regulatory guidance issued by the u.s. department of the treasury in", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para33", "text": "Liquidity and capital resources the company believes its balances of cash, cash equivalents and unrestricted marketable securities, which totaled $156.4 billion as of september 24, 2022, along with cash generated by ongoing operations and continued access to debt markets, will be sufficient to satisfy its cash requirements and capital return program over the next 12 months and beyond.", "highlight": "the company believes its balances of cash, cash equivalents and unrestricted marketable securities ||| will be sufficient to satisfy its cash requirements and capital return program over the next 12 months and beyond.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para34", "text": "the company's material cash requirements include the following contractual obligations.", "highlight": "the company's material cash requirements include the following contractual obligations.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para35", "text": "Debt as of september 24, 2022, the company had outstanding fixed-rate notes with varying maturities for an aggregate principal amount of $111.8 billion (collectively the \"notes\"), with $11.1 billion payable within 12 months. future interest payments associated with the notes total $41.3 billion, with $2.9 billion payable within 12 months.", "highlight": "future interest payments associated with the notes total $41.3 billion, with $2.9 billion payable within 12 months.\r\n ||| fixed-rate notes with varying maturities for an aggregate principal amount of $111.8 billion", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para36", "text": "the company also issues unsecured short-term promissory notes (\"commercial paper\") pursuant to a commercial paper program. as of september 24, 2022, the company had $10.0 billion of commercial paper outstanding, all of which was payable within 12 months.", "highlight": "company had $10.0 billion of commercial paper outstanding, all of which was payable within 12 months.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para37", "text": "Leases the company has lease arrangements for certain equipment and facilities, including corporate, data center, manufacturing and retail space. as of september 24, 2022, the company had fixed lease payment obligations of $15.3 billion, with $2.0 billion payable within 12 months.", "highlight": "the company had fixed lease payment obligations of $15.3 billion, with $2.0 billion payable within 12 months.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para38", "text": "Manufacturing purchase obligations the company utilizes several outsourcing partners to manufacture subassemblies for the company's products and to perform final assembly and testing of finished products. the company also obtains individual components for its products from a wide variety of individual suppliers. outsourcing partners acquire components and build product based on demand information supplied by the company, which typically covers periods up to 150 days. as of september 24, 2022, the company had manufacturing purchase obligations of $71.1 billion, with $68.4 billion payable within 12 months. the company's manufacturing purchase obligations are primarily noncancelable.", "highlight": "the company had manufacturing purchase obligations of $71.1 billion, with $68.4 billion payable within 12 months. the company's manufacturing purchase obligations are primarily noncancelable.\r\n ||| the company also obtains individual components for its products from a wide variety of individual suppliers", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para39", "text": "Other purchase obligations the company's other purchase obligations primarily consist of noncancelable obligations to acquire capital assets, including assets related to product manufacturing, and noncancelable obligations related to internet services and content creation. as of september 24, 2022, the company had other purchase obligations of $17.8 billion, with $6.8 billion payable within 12 months.", "highlight": "the company had other purchase obligations of $17.8 billion, with $6.8 billion payable within 12 months.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para40", "text": "Deemed repatriation tax payable as of september 24, 2022, the balance of the deemed repatriation tax payable imposed by the u.s. tax cuts and jobs act of 2017 (the \"act\") was $22.0 billion, with $5.3 billion expected to be paid within 12 months.", "highlight": "the balance of the deemed repatriation tax payable imposed by the u.s. tax cuts and jobs act ||| was $22.0 billion, with $5.3 billion expected to be paid within 12 months.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para41", "text": "in addition to its contractual cash requirements, the company has a capital return program authorized by the board of directors. the program does not obligate the company to acquire a minimum amount of shares. as of september 24, 2022, the company's quarterly cash dividend was $0.23 per share. the company intends to increase its dividend on an annual basis, subject to declaration by the board of directors.", "highlight": "the company has a capital return program authorized by the board of directors |||  the company's quarterly cash dividend was $0.23 per share", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para42", "text": "Critical accounting estimates the preparation of financial statements and related disclosures in conformity with u.s. generally accepted accounting principles (\"gaap\") and the company's discussion and analysis of its financial condition and operating results require the company's management to make judgments, assumptions and estimates that affect the amounts reported. note 1, \"summary of significant accounting policies\" of the notes to consolidated financial statements in part ii, item 8 of this form 10-k describes the significant accounting policies and methods used in the preparation of the company's consolidated financial statements. management bases its estimates on historical experience and on various other assumptions it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities.", "highlight": "its estimates on historical experience and on various other assumptions it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para43", "text": "Uncertain tax positions the company is subject to income taxes in the u.s. and numerous foreign jurisdictions. the evaluation of the company's uncertain tax positions involves significant judgment in the interpretation and application of gaap and complex domestic and international tax laws, including the act and matters related to the allocation of international taxation rights between countries. although management believes the company's reserves are reasonable, no assurance can be given that the final outcome of these uncertainties will not be different from that which is reflected in the company's reserves. reserves are adjusted considering changing facts and circumstances, such as the closing of a tax examination. resolution of these uncertainties in a manner inconsistent with management's expectations could have a material impact on the company's financial condition and operating results.", "highlight": "the evaluation of the company's uncertain tax positions involves significant judgment in the interpretation and application of gaap and complex domestic and international tax  ||| believes the company's reserves are reasonable, no assurance can be given that the final outcome of these uncertainties will not be different from that which is reflected in the company's reserves", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20221028_10-K_320193_part2_item7_para44", "text": "Legal and other contingencies the company is subject to various legal proceedings and claims that arise in the ordinary course of business, the outcomes of which are inherently uncertain. the company records a liability when it is probable that a loss has been incurred and the amount is reasonably estimable, the determination of which requires significant judgment. resolution of legal matters in a manner inconsistent with management's expectations could have a material impact on the company's financial condition and operating results.", "highlight": "the outcomes of which are inherently uncertain ||| records a liability when it is probable that a loss has been incurred and the amount is reasonably estimable ||| management's expectations could have a material impact on the company's financial condition and operating results.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para1", "text": "the following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and related notes included elsewhere in this annual report on form 10-k.", "highlight": "consolidated financial statements ||| elsewhere in this annual report on form 10-k.", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para2", "text": "For the discussion of the financial condition and results of operations for the year ended december 31, 2020 compared to the year ended december 31, 2019, refer to \"part ii item 7. management's discussion and analysis of financial condition and results of operations\" in our Annual report on form 10-k for the fiscal year ended december 31, 2020 filed with the sec on february 17, 2021, which is incorporated herein by reference.", "highlight": "part ii item 7. management's discussion and analysis of financial condition and results of operations", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para3", "text": "Covid-19 pandemic the covid-19 pandemic has significantly impacted the global economy and strained the hospitality industry since the beginning of 2020. our asia pacific region began experiencing the effects of the covid-19 pandemic in january 2020, while the pronounced negative results and suspensions of hotel operations in the americas and europe, middle east and africa (\"emea\") regions did not begin until mid-march 2020. since the beginning of the pandemic, the pervasiveness and severity of travel restrictions and stay-at-home directives have varied by country and state and fluctuated based on a number of factors, including: (i) covid-19 infection surges and contractions; (ii) the emergence of new strains and variants of the virus; and (iii) the distribution of covid-19 vaccinations, which commenced in late 2020. the pandemic had a material adverse impact on our results for the years ended december 31, 2021 and 2020 when compared to periods prior to the onset of the pandemic, and although all periods were significantly impacted by the pandemic, none of these periods are considered comparable, and no periods affected by the pandemic are expected to be comparable to future periods. although we have observed signs of economic recovery, we cannot determine when the global economy will fully recover. accordingly, given the ongoing nature of the pandemic, the ultimate impact that it will have on the company's business, financial performance and results of operations remains uncertain.", "highlight": "(i) covid-19 infection surges and contractions; (ii) the emergence of new strains and variants of the virus; and (iii) the distribution of covid-19 vaccinations, which commenced in late 2020. the pandemic had a material adverse impact on our results ||| the ultimate impact that it will have on the company's business, financial performance and results of operations remains uncertain.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para4", "text": "although certain restrictions have been reinstated with the spread of new variants of the virus, the broader distribution of covid-19 vaccinations beginning in early 2021 and the overall easing of travel and other restrictions generated renewed interest in travel and tourism activities in many markets around the globe in 2021. however, the continued spreading of covid-19 and its related variants could result in travel and other restrictions being implemented or reinstated in the affected areas, where our hotels may be located, in future periods, yielding further negative effects on our operations.", "highlight": "however, the continued spreading of covid-19 and its related variants could result in travel and other restrictions being implemented or reinstated in the affected areas, where our hotels may be located, in future periods, yielding further negative effects on our operations.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para5", "text": "while the restrictions and the reduction in travel resulted in the suspensions of operations at certain hotels throughout 2020, reopenings significantly outpaced new suspensions and resuspensions during 2021, with approximately 360 hotels suspended for some period of time during the year ended december 31, 2021. nearly all of the hotels that suspended operations at some point since the start of the pandemic had reopened as of december 31, 2021.", "highlight": "nearly all of the hotels that suspended operations at some point since the start of the pandemic had reopened as of december 31, 2021.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para6", "text": "Overview Our business hilton is one of the largest hospitality companies in the world, with 6,837 properties comprising 1,074,791 rooms in 122 countries and territories as of december 31, 2021. our premier brand portfolio includes: our luxury hotel brands, waldorf astoria hotels & resorts, lxr hotels & resorts and conrad hotels & resorts; our emerging lifestyle hotel brands, canopy by hilton, tempo by hilton and motto by hilton; our full service hotel brands, signia by hilton, hilton hotels & resorts, curio collection by hilton, doubletree by hilton and tapestry collection by hilton; our focused service hotel brands, hilton garden inn, hampton by hilton and tru by hilton; our all-suites hotel brands, embassy suites by hilton, homewood suites by hilton and home2 suites by hilton; and our timeshare brand, hilton grand vacations. as of december 31, 2021, we had 128 million members in our award-winning guest loyalty program, hilton honors, a 13 percent increase from december 31, 2020.", "highlight": "Our business hilton is one of the largest hospitality companies in the world, with 6,837 properties comprising 1,074,791 rooms in 122 countries and territories as of december 31, 2021 ||| we had 128 million members in our award-winning guest loyalty program, hilton honors, a 13 percent increase from december 31, 2020.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para7", "text": "Segments and regions We analyze our operations and business by both operating segments and geographic regions. our operations consist of two reportable segments that are based on similar products or services: (i) management and franchise and (ii) ownership. the management and franchise segment provides services, including hotel management and licensing of our ip. this segment generates its revenue from: (i) management and franchise fees charged to third-party hotel owners; (ii) licensing fees from hgv and strategic partnerships, including co-branded credit card arrangements, for the right to use our ip; and (iii) fees for managing hotels in our ownership segment. as a manager of hotels, we typically are responsible for supervising or operating the hotel in exchange for management fees. as a franchisor of hotels, we charge franchise fees in exchange for the use of one of our brand names and related commercial services, such as our reservation system, marketing and information technology services, while a third party manages or operates such franchised hotels. the ownership segment primarily derives earnings from providing nightly hotel room sales, food and beverage sales and other services at our consolidated owned and leased hotels.", "highlight": "our operations consist of two reportable segments that are based on similar products or services: (i) management and franchise and (ii) ownership ||| this segment generates its revenue from: (i) management and franchise fees charged to third-party hotel owners; (ii) licensing fees from hgv and strategic partnerships, including co-branded credit card arrangements, for the right to use our ip; and (iii) fees for managing hotels in our ownership segment.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para8", "text": "geographically, we conduct business through three distinct geographic regions: (i) the americas; (ii) emea; and (iii) asia pacific. the americas region includes north america, south america and central america, including all caribbean nations. although the u.s., which represented 70 percent of our system-wide hotel rooms as of december 31, 2021, is included in the americas region, it is often analyzed separately and apart from the americas region and, as such, it is presented separately within the analysis herein. the emea region includes europe, which represents the western-most peninsula of eurasia stretching from iceland in the west to russia in the east, and the middle east and africa (\"mea\"), which represents the middle east region and all african nations, including the indian ocean island nations. europe and mea are often analyzed separately and, as such, are presented separately within the analysis herein. the asia pacific region includes the eastern and southeastern nations of asia, as well as india, australia, new zealand and the pacific island nations.", "highlight": ", we conduct business through three distinct geographic regions: (i) the americas; (ii) emea; and (iii) asia pacific", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para9", "text": "System growth and development pipeline Our strategic objectives include the continued expansion of our global portfolio and fee-based business. as we enter into new management and franchise contracts, we expand our business with minimal or no capital investment by us as the manager or franchisor, since the capital required to build and maintain hotels is typically provided by the third-party owner of the hotel with whom we contract to provide management services or license our ip. prior to approving the addition of new hotels to our management and franchise development pipeline, we evaluate the economic viability of the hotel based on its geographic location, the credit quality of the third-party owner and other factors. by increasing the number of management and franchise contracts with third-party owners, over time we expect to increase revenues, overall return on invested capital and cash available to support our business needs. while these objectives have not changed as a result of the covid-19 pandemic, the current economic environment has posed certain challenges to the execution of our strategy, which have included and may continue to include delays in openings and new development. see further discussion on our cash management policy, as detailed in \" liquidity and capital resources.\" We are focused on the growth of our business by expanding our share of the global hospitality industry through our development pipeline, which includes hotels that we expect to add to our system in the future. the following table summarizes our development activity: As of or for the year ended december 31, 2021 Hotels Rooms (1) Hotel system Additions 414 67,100 Net additions (2) 355 55,100 Development pipeline (3) Additions 645 96,200 Count as of period end (4) 2,668 407,900 ____________ -1) rounded to the nearest hundred.", "highlight": "Our strategic objectives include the continued expansion of our global portfolio and fee-based business ||| we evaluate the economic viability of the hotel based on its geographic location, the credit quality of the third-party owner and other factors. |||  We are focused on the growth of our business by expanding our share of the global hospitality industry through our development pipeline, which includes hotels that we expect to add to our system in the future.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para10", "text": "-2) represents net unit growth for the year ended december 31, 2021 of 5.6 percent.", "highlight": "represents net unit growth for the year ended december 31, 2021 of 5.6 percent.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para11", "text": "-3) hotels in our system are under development throughout 115 countries and territories, including 28 countries and territories where we do not currently have any existing hotels.", "highlight": "hotels in our system are under development throughout 115 countries and territories", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para12", "text": "-4) in our development pipeline, as of december 31, 2021, 198,000 of the rooms were under construction and 249,600 of the rooms were located outside of the u.s. nearly all of the rooms in our development pipeline are within our management and franchise segment. we do not consider any individual development project to be material to us.", "highlight": "198,000 of the rooms were under construction and 249,600 of the rooms were located outside of the u.s. nearly", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para13", "text": "Brexit In june 2016, the u.k. held a referendum in which voters approved an exit from the e.u. (commonly referred to as \"brexit\"). in december 2020, the u.k. and the e.u. reached a new bilateral trade and cooperation deal governing their future relationship (the \"eu-uk trade and cooperation agreement\"), which was fully implemented from may 1, 2021. while the eu-uk trade and cooperation agreement provides clarity in respect of the intended future relationship between the u.k. and the e.u. and some detailed matters of trade and cooperation, it remains unclear what general long-term economic, financial, trade and legal implications the u.k. withdrawal from the e.u. will have and how it will ultimately affect our business. while our results as of and for the year ended december 31, 2021 were not materially affected by brexit specifically, we will continue to monitor the potential impact of brexit on our business in future periods.", "highlight": "it remains unclear what general long-term economic, financial, trade and legal implications the u.k. withdrawal from the e.u. will have and how it will ultimately affect our business.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para14", "text": "Principal components and factors affecting our results of operations Revenues Principal components We primarily derive our revenues from the following sources: franchise and licensing fees . represents fees earned in connection with the licensing of one of our brands, as well as fees from licensing agreements to use our ip. under our long-term franchise contracts with hotel owners, franchisees typically pay us franchise fees that include: (i) monthly royalty fees, generally based on a percentage of the hotel's monthly gross room revenue, and, in some cases, a percentage of gross food and beverage revenues and other revenues, as applicable and (ii) application, initiation and other fees for when new hotels enter the system, when there is a change of ownership of a hotel or when contracts with properties already in our system are extended. consideration to incentivize hotel owners to enter into franchise contracts with us is amortized over the life of the applicable contract as a reduction to franchise and licensing fees. our non-hotel licensing agreements are predominantly with hgv and strategic partners, including co-branded credit card providers.", "highlight": "We primarily derive our revenues from the following sources: franchise and licensing fees ||| represents fees earned in connection with the licensing of one of our brands, as well as fees from licensing agreements to use our ip.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para15", "text": "base and incentive management fees. represents fees earned in connection with the management of hotels. terms of our management contracts vary, but our fees generally consist of a base fee, which is typically based on a percentage of the hotel's monthly gross revenue and, when applicable, an incentive fee, which is typically based on the hotel's operating profits, normally over a one-calendar year period, and, in some cases, may be subject to a stated return threshold to the hotel owner. outside of the u.s., our fees are often more dependent on hotel profitability measures, either because of a single management fee structure where the entire fee is an incentive fee, or because our two-tier fee structure is more heavily weighted toward the incentive fee than the base fee. consideration to incentivize hotel owners to enter into management contracts with us is amortized over the life of the applicable contract as a reduction to base and other management fees.", "highlight": "terms of our management contracts vary, but our fees generally consist of a base fee, which is typically based on a percentage of the hotel's monthly gross revenue and, when applicable, an incentive fee, which is typically based on the hotel's operating profits", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para16", "text": "owned and leased hotels. represents revenues derived from the operations of our consolidated owned and leased hotels, including hotel room sales, accommodations sold in conjunction with other services, food and beverage sales and other ancillary goods and services. these revenues are primarily derived from two categories of customers: transient and group. transient guests are individual travelers who are traveling for business or leisure. group guests are traveling for group events that reserve rooms for meetings, conferences or social functions, which may be sponsored by corporate, social, military, educational, religious or other organizations or associations. group business usually includes a block of room accommodations, as well as other ancillary services, such as meetings facilities and catering and banquet services. a majority of our food and beverage sales and other ancillary goods and services are provided to customers who are also occupying rooms at our hotels. as a result, occupancy affects all components of our owned and leased hotel revenues.", "highlight": "these revenues are primarily derived from two categories of customers: transient and group ||| transient guests are individual travelers who are traveling for business or leisure. group guests are traveling for group events that reserve rooms for meetings, conferences or social functions", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para17", "text": "other revenues. represents revenues generated by the incidental support of hotel operations for owned, leased, managed and franchised hotels, including our purchasing operations, and other operating income.", "highlight": "represents revenues generated by the incidental support of hotel operations for owned, leased, managed and franchised hotels", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para18", "text": "Other revenues from managed and franchised properties. represents amounts that are contractually reimbursed to us by property owners, either directly as costs are incurred or indirectly through program fees billed and collected in advance related to certain costs and expenses supporting the operations of the related properties. the direct reimbursements by property owners are for payroll and related costs if the property employees are legally our responsibility, and certain other operating costs of the managed and franchised properties' operations. we have no legal responsibility for the employees or the liabilities associated with operating franchised properties or certain of our managed properties. revenues and expenses for these direct reimbursements have no net effect on operating income (loss) or net income (loss). the monthly program fee that is paid by hotel franchisees and property owners of hotels that we manage is based on the underlying hotel's sales or usage and relates to the costs of our brands and shared services, including: (i) advertising and marketing programs; (ii) internet, technology and reservation systems; and (iii) quality assurance programs. other revenues from managed and franchised properties also includes revenues related to our hilton honors guest loyalty program, which are primarily derived from payments from hotel franchisees and third- party owners of hotels we manage that participate in the program, as well as co-branded credit card providers. we are contractually required to use these fees that we collect solely for these programs.", "highlight": "the monthly program fee that is paid by hotel franchisees and property owners of hotels that we manage is based on the underlying hotel's sales or usage and relates to the costs of our brands and shared services, including: (i) advertising and marketing programs; (ii) internet, technology and reservation systems; and (iii) quality assurance programs ||| Other revenues from managed and franchised properties. represents amounts that are contractually reimbursed to us by property owners", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para19", "text": "Factors affecting our revenues The following factors affect the revenues we derive from our operations: consumer demand and global economic conditions . consumer demand for our products and services is closely linked to the performance of the general economy and is sensitive to business and personal discretionary spending levels. among other factors, declines in consumer demand due to adverse general economic conditions, risks reducing or otherwise negatively affecting travel patterns, lower consumer confidence and adverse political conditions can reduce the amount of management and franchise fee revenues we are able to generate and/or reduce the revenues and profitability of the operations of our owned and leased hotels. further, competition for hotel guests and the supply of hotel services affect our ability to sustain or increase rates charged to customers of our hotels. as a result of the covid-19 pandemic, several of these factors, as well as health and safety concerns, had a significant effect on global economic conditions and consumer demand for our products and services. also, declines in hotel profitability during an economic downturn directly affect the incentive portion of our management fees, which is based on hotel profitability measures. as a result, changes in consumer demand and general business cycles have historically subjected, are currently subjecting and could in the future subject our revenues to significant volatility.", "highlight": "The following factors affect the revenues we derive from our operations: consumer demand and global economic conditions ||| consumer demand for our products and services is closely linked to the performance of the general economy and is sensitive to business and personal discretionary spending levels |||  as a result of the covid-19 pandemic, several of these factors, as well as health and safety concerns, had a significant effect on global economic conditions and consumer demand for our products and services", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para20", "text": "contracts with third-party owners and franchisees and relationships with developers . we depend on our long-term management and franchise contracts with third-party hotel owners and hotel franchisees for our management and franchise fee revenues. the success and sustainability of our management and franchise business depends on our ability to perform under our management and franchise contracts and maintain good relationships with third-party owners and franchisees. our relationships with these third parties allow us to maintain our current presence as contracts mature and also generate new incremental opportunities for property development that can support our growth. growth and maintenance of our hotel system and earning fees related to hotels in development are dependent on the ability of developers and owners to access capital for the development, maintenance and renovation of properties. we believe that we have good relationships with our third-party owners, franchisees and developers and are committed to the continued growth and development of these relationships. these relationships exist with a diverse group of owners, franchisees and developers and are not significantly concentrated with any one particular third party.", "highlight": "we depend on our long-term management and franchise contracts with third-party hotel owners and hotel franchisees for our management and franchise fee revenues. |||  these relationships exist with a diverse group of owners, franchisees and developers and are not significantly concentrated with any one particular third party.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para21", "text": "Expenses Principal components We primarily incur the following expenses: owned and leased hotels. reflects the operating expenses of our consolidated owned and leased hotels, including room expenses, food and beverage costs, other support costs and property expenses. room expenses include compensation costs for housekeeping, laundry and front desk staff, as well as supply costs for guest room amenities and laundry. food and beverage costs include costs for wait and kitchen staff and food and beverage inventory. other support expenses include: costs associated with property-level management; utilities; sales and marketing; operating hotel spas; operating telephones, parking and other guest recreation; entertainment; and other services. property expenses include property taxes, repairs and maintenance, rent and insurance.", "highlight": "We primarily incur the following expenses: owned and leased hotels. reflects the operating expenses of our consolidated owned and leased hotels, including room expenses, food and beverage costs, other support costs and property expenses", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para22", "text": "depreciation and amortization. these are non-cash expenses that primarily consist of: (i) amortization of intangible assets that were recorded at their fair value at the time of the 2007 transaction whereby we became a wholly owned subsidiary of affiliates of blackstone inc. (the \"merger\"), which primarily include values assigned to management and franchise contracts, leases and our hilton honors guest loyalty program intangible asset; (ii) amortization of capitalized software costs; and (iii) depreciation and amortization of property and equipment, including our finance lease right-of-use (\"rou\") assets, such as buildings and furniture and equipment that are used in corporate operations or at our consolidated owned and leased hotels.", "highlight": "these are non-cash expenses that primarily consist of: (i) amortization of intangible assets that were recorded at their fair value |||  (ii) amortization of capitalized software costs; and (iii) depreciation and amortization of property and equipment", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para23", "text": "general and administrative. consists primarily of compensation costs for our corporate employees, including share-based compensation; professional fees, including consulting, audit and legal fees; travel and entertainment expenses; bad debt expenses for uncollectible management, franchise and other fees; and administrative and related expenses.", "highlight": "consists primarily of compensation costs for our corporate employees, including share-based compensation; professional fees, including consulting, audit and legal fees; travel and entertainment expenses; bad debt expenses for uncollectible management, franchise and other fees; and administrative and related expenses.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para24", "text": "other expenses . consists of expenses incurred by our purchasing operations and other ancillary businesses, along with other operating expenses of the business.", "highlight": "consists of expenses incurred by our purchasing operations and other ancillary businesses", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para25", "text": "other expenses from managed and franchised properties. represents certain costs and expenses that are contractually reimbursed to us by property owners for payroll and related costs for properties that we manage where the property employees are legally our responsibility, or paid from program fees collected from properties for certain other operating costs of the managed and franchised properties' operations, including those related to our brands and shared services programs. we are contractually required to use these fees solely for these programs. we have no legal responsibility for the employees or the liabilities associated with operating franchised properties or certain of our managed hotels. other expenses from managed and franchised properties also includes expenses for the operation of our hilton honors guest loyalty program.", "highlight": "represents certain costs and expenses that are contractually reimbursed to us by property owners for payroll and related costs for properties that we manage where the property employees are legally our responsibility, or paid from program fees collected from properties for certain other operating costs of the managed and franchised properties' operations,", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para26", "text": "Factors affecting our costs and expenses The following are principal factors that affect the costs and expenses we incur in the course of our operations: fixed expenses. many of the expenses associated with owning and leasing hotels are relatively fixed. these expenses include personnel costs, rent, property taxes, insurance and utilities. if we are unable to decrease these costs significantly or rapidly when demand for our hotels decreases, the resulting decline in our revenues can have an adverse effect on our net cash flows, margins and profits. this effect can be especially pronounced during periods of economic contraction or slow economic growth, including that which resulted from the covid-19 pandemic. economic downturns generally affect the results of our ownership segment more significantly than the results of our management and franchise segment due to the high fixed costs associated with operating an owned or leased hotel. employees at some of our owned and leased hotels are parties to collective bargaining agreements that may also limit our ability to make timely staffing or labor changes in response to declining revenues. in addition, any efforts to reduce costs, including the deferral or cancellation of capital improvements, could adversely affect the economic value of our hotels and brands. additionally, the general and administrative expenses of operating a global business also include fixed personnel costs, rent, property taxes, insurance and utilities. the effectiveness of any cost-cutting efforts related to owning and leasing hotels or corporate operations is limited by the amount of inherent fixed costs. however, we have taken steps to reduce our fixed costs to levels we believe are appropriate to maximize profitability and respond to expected future market conditions, while continuing to optimize value for the experiences of our customers, owners and hilton employees, supporting the long-term sustainability of our brands and business.", "highlight": "The following are principal factors that affect the costs and expenses we incur in the course of our operations: fixed expenses. many of the expenses associated with owning and leasing hotels are relatively fixed |||  if we are unable to decrease these costs significantly or rapidly when demand for our hotels decreases, the resulting decline in our revenues can have an adverse effect ||| economic downturns generally affect the results of our ownership segment more significantly than the results of our management and franchise segment", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para27", "text": "changes in depreciation and amortization expenses. we capitalize costs associated with certain software development projects and, as those projects are completed and placed into service, amortization expenses will increase. as the finite-lived intangible assets that were recorded at the merger become fully amortized, amortization expenses will decrease. additionally, changes in depreciation expenses may be driven by renovations of existing hotels, acquisition or development of new hotels, the disposition of existing hotels or corporate facilities through sale, closure or lease termination, lease renewals, expenditures related to our corporate facilities or changes in estimates of the useful lives of our assets. as we place new assets into service, we will be required to recognize additional depreciation expenses on those assets. if we are required to recognize impairment losses related to our depreciable assets or finite-lived intangible assets, the related depreciation or amortization expenses, respectively, will decrease.", "highlight": "we capitalize costs associated with certain software development projects and, as those projects are completed and placed into service, amortization expenses will increase. ||| as the finite-lived intangible assets that were recorded at the merger become fully amortized, amortization expenses will decrease", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para28", "text": "Other items Effect of foreign currency exchange rate fluctuations significant portions of our operations are conducted in functional currencies other than our reporting currency, which is usd, and we have assets and liabilities, including those that are payable or receivable by consolidated subsidiaries, denominated in a variety of foreign currencies. as a result, we are required to translate the results of those operations, assets and liabilities from their functional currency into usd at market-based foreign currency exchange rates for each reporting period. when comparing our results of operations between periods, there may be material portions of the changes in our revenues or expenses that are derived from fluctuations in foreign currency exchange rates experienced between those periods. we hedge foreign currency exchange-based cash flow variability of certain of our fees using forward contracts designated as hedging instruments. we also hold short-term forward contracts to offset exposure to fluctuations in certain of our foreign currency denominated cash balances, primarily related to our intercompany financing arrangements, and we have not currently elected to designate these forward contracts as hedging instruments.", "highlight": "Effect of foreign currency exchange rate fluctuations significant portions of our operations are conducted in functional currencies other than our reporting currency, which is usd ||| we hedge foreign currency exchange-based cash flow variability of certain of our fees using forward contracts designated as hedging instruments", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para29", "text": "Seasonality the hospitality industry is seasonal in nature. the periods during which our properties experience higher or lower levels of demand vary from property to property, depending principally upon their location, type of property and competitive mix within the specific location. based on historical results, we generally expect our revenues to be lower in the first quarter of each year than in each of the three subsequent quarters.", "highlight": "Seasonality the hospitality industry is seasonal in nature. the periods during which our properties experience higher or lower levels of demand vary from property to property", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para30", "text": "Key business and financial metrics used by management Comparable hotels we define our comparable hotels as those that: (i) were active and operating in our system for at least one full calendar year as of the end of the current period, and open january 1st of the previous year; (ii) have not undergone a change in brand or ownership type during the current or comparable periods reported; and (iii) have not sustained substantial property damage, business interruption, undergone large-scale capital projects or for which comparable results were not available. of the 6,777 hotels in our system as of december 31, 2021, 5,524 hotels were classified as comparable hotels. our 1,253 non-comparable hotels included 70 hotels, or approximately one percent of the total hotels in our system, that were removed from the comparable group during the last twelve months because they sustained substantial property damage, business interruption, underwent large-scale capital projects or comparable results were otherwise not available.", "highlight": "Key business and financial metrics used by management Comparable hotels we define our comparable hotels as those that: (i) were active and operating in our system for at least one full calendar year as of the end of the current period |||  (ii) have not undergone a change in brand or ownership type during the current or comparable periods reported |||  (iii) have not sustained substantial property damage, business interruption, undergone large-scale capital projects ||| that were removed from the comparable group during the last twelve months because they sustained substantial property damage, business interruption, underwent large-scale capital projects or comparable results were otherwise not available.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para31", "text": "when considering business interruption in the context of our definition of comparable hotels, no hotel that had completely or partially suspended operations on a temporary basis at any time as a result of the covid-19 pandemic was excluded from the definition of comparable hotels on that basis alone. despite these temporary suspensions of hotel operations, we believe that including these hotels within our hotel operating statistics of occupancy, average daily rate (\"adr\") and revenue per available room (\"revpar\"), if they would have otherwise been included, reflects the underlying results of our business for the years ended december 31, 2021 and 2020.", "highlight": "we believe that including these hotels within our hotel operating statistics of occupancy, average daily rate (\"adr\") and revenue per available room (\"revpar\"), if they would have otherwise been included, reflects the underlying results of our business", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para32", "text": "Occupancy occupancy represents the total number of room nights sold divided by the total number of room nights available at a hotel or group of hotels for a given period. occupancy measures the utilization of our hotels' available capacity. management uses occupancy to gauge demand at a specific hotel or group of hotels in a given period. occupancy levels also help us determine achievable adr pricing levels as demand for hotel rooms increases or decreases.", "highlight": "occupancy represents the total number of room nights sold divided by the total number of room nights available at a hotel or group of hotels for a given period", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para33", "text": "Adr adr represents hotel room revenue divided by the total number of room nights sold for a given period. adr measures the average room price attained by a hotel, and adr trends provide useful information concerning the pricing environment and the nature of the customer base of a hotel or group of hotels. adr is a commonly used performance measure in the industry, and we use adr to assess pricing levels that we are able to generate by type of customer, as changes in rates charged to customers have different effects on overall revenues and incremental profitability than changes in occupancy, as described above.", "highlight": "adr represents hotel room revenue divided by the total number of room nights sold for a given period. adr measures the average room price attained by a hotel, and adr trends provide useful information concerning the pricing environment and the nature of the customer base of a hotel or group of hotels", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para34", "text": "Revpar revpar is calculated by dividing hotel room revenue by the total number of room nights available to guests for a given period. we consider revpar to be a meaningful indicator of our performance as it provides a metric correlated to two primary and key drivers of operations at a hotel or group of hotels, as previously described: occupancy and adr. revpar is also a useful indicator in measuring performance over comparable periods for comparable hotels.", "highlight": "revpar is calculated by dividing hotel room revenue by the total number of room nights available to guests for a given period", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para35", "text": "references to occupancy, adr and revpar are presented on a comparable basis, based on the comparable hotels as of december 31, 2021, and references to adr and revpar are presented on a currency neutral basis, unless otherwise noted. as such, comparisons of these hotel operating statistics for the years ended december 31, 2021 and 2020 or 2019, use the foreign currency exchange rates used to translate the results of the company's foreign operations within its financial statements for the year ended december 31, 2021.", "highlight": "references to occupancy, adr and revpar are presented on a comparable basis, based on the comparable hotels as of december 31, 2021", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para36", "text": "Ebitda and adjusted ebitda ebitda reflects net income (loss), excluding interest expense, a provision for income tax benefit (expense) and depreciation and amortization expenses. adjusted ebitda is calculated as ebitda, as previously defined, further adjusted to exclude certain items, including gains, losses, revenues and expenses in connection with: (i) asset dispositions for both consolidated and unconsolidated equity investments; (ii) foreign currency transactions; (iii) debt restructurings and retirements; (iv) furniture, fixtures and equipment (\"ff&e\") replacement reserves required under certain lease agreements; (v) share-based compensation; (vi) reorganization, severance, relocation and other expenses; (vii) non-cash impairment; (viii) amortization of contract acquisition costs; (ix) the net effect of reimbursable costs included in other revenues and other expenses from managed and franchised properties; and (x) other items.", "highlight": "Ebitda and adjusted ebitda ebitda reflects net income (loss), excluding interest expense, a provision for income tax benefit (expense) and depreciation and amortization expenses", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para37", "text": "we believe that ebitda and adjusted ebitda provide useful information to investors about us and our financial condition and results of operations for the following reasons: (i) these measures are among the measures used by our management team to evaluate our operating performance and make day-to-day operating decisions and (ii) these measures are frequently used by securities analysts, investors and other interested parties as a common performance measure to compare results or estimate valuations across companies in our industry. additionally, these measures exclude certain items that can vary widely across different industries and among competitors within our industry. for instance, interest expense and income taxes are dependent on company specifics, including, among other things, capital structure and operating jurisdictions, respectively, and, therefore, could vary significantly across companies. depreciation and amortization expenses, as well as amortization of contract acquisition costs, are dependent upon company policies, including the method of acquiring and depreciating assets and the useful lives that are used. for adjusted ebitda, we also exclude items such as: (i) ff&e replacement reserves for leased hotels to be consistent with the treatment of capital expenditures for property and equipment, where payments for such capitalized assets are depreciated over their useful lives; (ii) share-based compensation, as this could vary widely among companies due to the different plans in place and the usage of them; (iii) the net effect of our cost reimbursement revenues and reimbursed expenses, as we contractually do not operate the related programs to generate a profit over the terms of the respective contracts; and (iv) other items, such as amounts related to debt restructurings and debt retirements and reorganization and related severance costs, that are not core to our operations and are not reflective of our operating performance.", "highlight": "we believe that ebitda and adjusted ebitda provide useful information to investors about us and our financial condition and results of operations ||| these measures exclude certain items that can vary widely across different industries and among competitors within our industry", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para38", "text": "Ebitda and adjusted ebitda are not recognized terms under u.s. generally accepted accounting principles (\"gaap\") and should not be considered as alternatives, either in isolation or as a substitute, for net income (loss) or other measures of financial performance or liquidity, including cash flows, derived in accordance with gaap. further, ebitda and adjusted ebitda have limitations as analytical tools, including: Ebitda and adjusted ebitda do not reflect changes in, or cash requirements for, our working capital needs; Ebitda and adjusted ebitda do not reflect our interest expense, or the cash requirements necessary to service interest or principal payments, on our indebtedness; Ebitda and adjusted ebitda do not reflect income tax expenses or the cash requirements to pay our taxes; Ebitda and adjusted ebitda do not reflect historical cash expenditures or future requirements for capital expenditures or contractual commitments; Ebitda and adjusted ebitda do not reflect the effect on earnings or changes resulting from matters that we consider not to be indicative of our future operations; Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and ebitda and adjusted ebitda do not reflect any cash requirements for such replacements; and other companies in our industry may calculate ebitda and adjusted ebitda differently, limiting their usefulness as comparative measures.", "highlight": "Ebitda and adjusted ebitda are not recognized terms under u.s. generally accepted accounting principles (\"gaap\") and should not be considered as alternatives ||| ebitda and adjusted ebitda have limitations as analytical tools", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para39", "text": "because of these limitations, ebitda and adjusted ebitda should not be considered as discretionary cash available to us to reinvest in the growth of our business or as measures of cash that will be available to us to meet our obligations.", "highlight": "ebitda and adjusted ebitda should not be considered as discretionary cash available to us to reinvest in the growth of our business or as measures of cash that will be available to us to meet our obligations.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para40", "text": "Results of operations The hotel operating statistics by region for our system-wide comparable hotels were as follows: Year ended Change December 31, 2021 2021 vs. 2020 u.s.", "highlight": "The hotel operating statistics by region for our system-wide comparable hotels were as follows", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para41", "text": "Occupancy 60.8 % 18.8 % pts.", "highlight": "Occupancy 60.8 % 18.8 %", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para42", "text": "Adr $132.94 13.8 % Revpar $80.88 64.5 % Americas (excluding u.s.) Occupancy 44.0 % 15.8 % pts.", "highlight": "Adr $132.94 13.8 % Revpar $80.88 64.5 % Americas (excluding u.s.) Occupancy 44.0 % 15.8 % pts.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para43", "text": "Adr $111.68 3.7 % Revpar $49.17 61.7 % Europe Occupancy 41.9 % 13.6 % pts.", "highlight": "Adr $111.68 3.7 % Revpar $49.17 61.7 % Europe Occupancy 41.9 % 13.6 % pts.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para44", "text": "Adr $121.84 12.6 % Revpar $51.10 66.7 % Mea Occupancy 52.6 % 18.1 % pts.", "highlight": "Adr $121.84 12.6 % Revpar $51.10 66.7 % Mea Occupancy 52.6 % 18.1 % pts.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para45", "text": "Adr $139.02 10.0 % Revpar $73.08 67.7 % Asia pacific Occupancy 50.5 % 6.0 % pts.", "highlight": "Adr $139.02 10.0 % Revpar $73.08 67.7 % Asia pacific Occupancy 50.5 % 6.0 % pts.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para46", "text": "Adr $101.08 4.0 % Revpar $51.06 18.1 % System-wide Occupancy 57.2 % 16.9 % pts.", "highlight": "Adr $101.08 4.0 % Revpar $51.06 18.1 % System-wide Occupancy 57.2 % 16.9 % pts", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para47", "text": "Adr $128.82 12.9 % Revpar $73.65 60.4 % during the year ended december 31, 2021, while the covid-19 pandemic continued to negatively impact our business and our hotel operating statistics, we experienced significant improvement in our results as compared to the prior year, due to an upward trend in travel and tourism with the easing of many covid-19 restrictions and the distribution of covid-19 vaccinations. all regions showed improvement in revpar during the year ended december 31, 2021 as compared to the year ended december 31, 2020. the u.s. experienced relatively consistent recovery throughout 2021, with occupancy for the year down 13.8 percentage points from 2019. while the recoveries of the europe and americas (excluding u.s.) regions were outpaced by other regions early in 2021, the easing of travel restrictions, and, in europe, a more expansive vaccination program, accelerated their recovery later in the year, resulting in improvement in operating statistics consistent with system-wide results for the full year. of all regions, mea recovered the most during the year with regard to revpar when compared to 2019. in asia pacific, a fluctuating recovery due to prolonged covid-19 and travel restrictions in certain countries on both domestic and international travel resulted in a more modest increase in revpar for the year when compared to the other regions. our system-wide revpar and adr for the year ended december 31, 2021 were down 30.0 percent and 9.9 percent, respectively, compared to the same period in 2019 on a comparable and currency neutral basis.", "highlight": "we experienced significant improvement in our results as compared to the prior year, due to an upward trend in travel and tourism with the easing of many covid-19 restrictions and the distribution of covid-19 vaccinations ||| the easing of travel restrictions, and, in europe, a more expansive vaccination program, accelerated their recovery later in the year, resulting in improvement in operating statistics consistent with system-wide results for the full year", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para48", "text": "Further, as a result of the pandemic, certain hotels suspended operations at various times throughout 2020, but the majority of those hotels were reopened by the beginning of 2021. in line with our recovery, although some hotels did suspend operations during the year ended december 31, 2021, reopenings significantly outpaced suspensions. as such, the operations of only approximately 360 hotels, primarily located in the u.s. and europe, were suspended for some period of time during the year ended december 31, 2021, as compared to approximately 1,280 hotels during the year ended december 31, 2020. nearly all of the hotels that suspended operations at some point since the start of the pandemic had reopened as of december 31, 2021. additionally, while most hotels, including those that reopened following suspensions of their operations, experienced significantly lower occupancy during 2020 and early 2021 as compared to periods prior to the onset of the pandemic, system- wide occupancy improved during 2021 and system-wide occupancy during the three months ended december 31, 2021 increased 20.7 percentage points as compared to the same period in 2020.", "highlight": "the majority of those hotels were reopened by the beginning of 2021 ||| nearly all of the hotels that suspended operations at some point since the start of the pandemic had reopened as of december 31, 2021. ||| 2021 increased 20.7 percentage points as compared to the same period in 2020.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para49", "text": "The table below provides a reconciliation of net income (loss) to ebitda and adjusted ebitda: Year ended december 31, 2021 2020 (in millions) Net income (loss) $ 407 $ (720) Interest expense 397 429 Income tax expense (benefit) 153 -204 Depreciation and amortization expenses 188 331 Ebitda 1,145 -164 Loss on sales of assets, net 7 Loss on foreign currency transactions 7 27 Loss on debt extinguishments 69 48 Ff&e replacement reserves 48 57 Share-based compensation expense 193 97 Reorganization costs 41 Impairment losses 258 Amortization of contract acquisition costs 32 29 Net other expenses from managed and franchised properties 110 397 Other adjustments (1) 18 52 Adjusted ebitda $ 1,629 $ 842 ____________ -1) amounts for the years ended december 31, 2021 and 2020 include costs recognized for certain legal settlements, severance not related to the reorganization activities undertaken in response to the covid-19 pandemic and other items. the amount for the year ended december 31, 2020 also includes losses related to the disposal of an investment and the settlement of a debt guarantee for a franchised hotel and a gain related to the reimbursement by a third party for taxes owed resulting from the sale of a hotel in a prior period.", "highlight": "Year ended december 31, 2021 2020 (in millions) Net income (loss) $ 407 $ (720) Interest expense 397 429 Income tax expense (benefit) 153 -204 Depreciation and amortization expenses 188 331 Ebitda 1,145 -164 Loss on sales of assets, net 7 Loss on foreign currency transactions 7 27 Loss on debt extinguishments 69 48 Ff&e replacement reserves 48 57 Share-based compensation expense 193 97 Reorganization costs 41 Impairment losses 258 Amortization of contract acquisition costs 32 29 Net other expenses from managed and franchised properties 110 397 Other adjustments (1) 18 52 Adjusted ebitda $ 1,629 $ 842 ____________ -1)", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para50", "text": "Revenues Year ended december 31, Percent change 2021 2020 2021 vs. 2020 (in millions) Franchise and licensing fees $ 1,493 $ 945 58.0 Base and other management fees $ 176 $ 123 43.1 Incentive management fees 98 38 Nm (1) Total management fees $ 274 $ 161 70.2 ____________ -1) fluctuation in terms of percentage change is not meaningful.", "highlight": "ercent change 2021 2020 2021 vs. 2020 (in millions) Franchise and licensing fees $ 1,493 $ 945 58.0 Base and other management fees $ 176 $ 123 43.1 Incentive management fees 98 38 Nm (1) Total management fees $ 274 $ 161 70.2 ____________ -1)", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para51", "text": "the covid-19 pandemic began to negatively affect our franchise and licensing fees and total management fees in march 2020. however, during 2021, we experienced increases in fees recognized, as compared to fees recognized during 2020, driven by an upward trend in travel and tourism resulting from increased desire to travel by our customers, as covid-19 vaccinations were distributed more broadly and covid-19 restrictions eased in many areas. additionally, there were decreases in the number of hotels that had suspended operations as a result of the pandemic during the respective periods, with approximately 1,245 managed and franchised hotels with suspended operations for some period of time during the year ended december 31, 2020, compared to approximately 345 managed and franchised hotels during the year ended december 31, 2021. nearly all of the managed and franchised hotels that suspended operations at some point since the start of the pandemic were reopened as of december 31, 2021.", "highlight": "driven by an upward trend in travel and tourism resulting from increased desire to travel by our customers, as covid-19 vaccinations were distributed more broadly and covid-19 restrictions eased in many areas ||| decreases in the number of hotels that had suspended operations as a result of the pandemic during the respective periods", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para52", "text": "for the year ended december 31, 2021, revpar increased 62.3 percent at our comparable franchised properties and 55.2 percent at our comparable managed properties as a result of increased occupancy of 18.3 percentage points and 12.7 percentage points, respectively, and increased adr of 13.4 percent and 12.3 percent, respectively.", "highlight": "revpar increased 62.3 percent at our comparable franchised properties and 55.2 percent at our comparable managed properties ||| increased occupancy of 18.3 percentage points and 12.7 percentage points ||| increased adr of 13.4 percent and 12.3 percent, respectively.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para53", "text": "including new development and ownership type transfers, from january 1, 2020 to december 31, 2021, we added over 730 managed and franchised properties on a net basis, providing an additional 105,000 rooms to our management and franchise segment. as new hotels were part of our system for full periods and were part of the recovery from the negative impact of the covid-19 pandemic, such hotels increased our franchise and management fees during the periods, and we expect this trend to continue in future periods.", "highlight": "such hotels increased our franchise and management fees during the periods, and we expect this trend to continue in future periods.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para54", "text": "additionally, licensing and other fees increased $97 million during the year ended december 31, 2021, primarily due to increases in licensing fees from our strategic partnerships and hgv, which were the result of increased co-branded credit cardholder spend and timeshare revenues, respectively, both resulting from the rise in consumer spending and travel and tourism during the period.", "highlight": "due to increases in licensing fees from our strategic partnerships and hgv, which were the result of increased co-branded credit cardholder spend and timeshare revenues", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para55", "text": "incentive management fees increased during the period as they are based on hotels' operating profits, which have improved significantly from the prior year as a result of increased demand at our properties.", "highlight": "improved significantly from the prior year as a result of increased demand at our properties", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para56", "text": "Year ended december 31, Percent change 2021 2020 2021 vs. 2020 (in millions) Owned and leased hotels $ 598 $ 421 42.0 the increase in owned and leased hotel revenues during the year ended december 31, 2021 was primarily attributable to the ongoing recovery from the covid-19 pandemic and the resulting increase in occupancy across our owned and leased hotels. although the operations of approximately 15 and 35 of our owned and leased hotels were suspended for some period of time during the years ended december 31, 2021 and 2020, respectively, as a result of the covid-19 pandemic, all of these hotels were reopened before december 31, 2021.", "highlight": "primarily attributable to the ongoing recovery from the covid-19 pandemic and the resulting increase in occupancy across our owned and leased hotels.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para57", "text": "the increase in owned and leased hotel revenues during the year ended december 31, 2021 included a $7 million increase as a result of favorable fluctuations in foreign currency exchange rates and, on a currency neutral basis, a $130 million increase and $40 million increase from our comparable and non-comparable owned and leased hotels, respectively. the increase in revenues from our comparable owned and leased hotels was the result of increased revpar of 45.3 percent, primarily due to increased occupancy of 9.5 percentage points and adr of 4.7 percent, as well as a $27 million increase in covid-19 relief subsidies from international governments that were recognized as revenues. the increase in revenues from our non-comparable owned and leased hotels, which included five leased hotels that exited our system or transferred to our management and franchise segment on december 31, 2021, included a $10 million increase, on a currency neutral basis, in covid-19 relief subsidies from international governments. additionally, the overall increase, on a currency neutral basis, of $40 million in revenues from our non-comparable owned and leased hotels was net of an $11 million decrease from properties that were sold or for which the lease agreements were terminated in 2020 and mid-2021, with most of these properties transferring to our management and franchise segment.", "highlight": "the increase in revenues from our comparable owned and leased hotels was the result of increased revpar of 45.3 percent, primarily due to increased occupancy of 9.5 percentage points and adr of 4.7 percent, as well as a $27 million increase in covid-19 relief subsidies from international governments that were recognized as revenues", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para58", "text": "Year ended december 31, Percent change 2021 2020 2021 vs. 2020 (in millions) Other revenues $ 79 $ 73 8.2 the increase in other revenues during the year ended december 31, 2021 was primarily due to increased revenues from our purchasing operations related to improved hotel demand resulting from the rise in travel and tourism during 2021.", "highlight": "due to increased revenues from our purchasing operations related to improved hotel demand resulting from the rise in travel and tourism during 2021.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para59", "text": "Operating expenses Year ended december 31, Percent change 2021 2020 2021 vs. 2020 (in millions) Owned and leased hotels $ 679 $ 620 9.5 The increase in owned and leased hotel expenses during the year ended december 31, 2021 included a $19 million increase as a result of unfavorable fluctuations in foreign currency exchange rates and, on a currency neutral basis, a $46 million increase and a $6 million decrease from our comparable and non-comparable owned and leased hotels, respectively. our owned and leased hotels had increases in certain operating expenses as a result of increased occupancy during 2021, including variable rent costs, which are generally based on a percentage of hotel revenues or profits, partially offset by decreased expenses related to ff&e replacement reserves due to timing of costs and spending on improvement projects incurred at our leased properties. the decrease in expenses from our non-comparable owned and leased hotels, which included five leased hotels that exited our system or transferred to our management and franchise segment on december 31, 2021, also included a $16 million decrease, on a currency neutral basis, from properties that were sold or for which the lease agreements were terminated in 2020 and mid-2021, with most of these properties transferring to our management and franchise segment.", "highlight": "as a result of unfavorable fluctuations in foreign currency exchange rates and, on a currency neutral basis ||| as a result of increased occupancy during 2021, including variable rent costs, which are generally based on a percentage of hotel revenues or profits, partially offset by decreased expenses related to ff&e replacement reserves due to timing of costs and spending on improvement projects incurred at our leased properties ||| were sold or for which the lease agreements were terminated", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para60", "text": "Year ended december 31, Percent change 2021 2020 2021 vs. 2020 (in millions) Depreciation and amortization expenses $ 188 $ 331 -43.2 General and administrative expenses 405 311 30.2 Reorganization costs 41 -100.0 Impairment losses 258 -100.0 Other expenses 45 60 -25.0 the decrease in depreciation and amortization expenses was due to a decrease in amortization expenses, primarily resulting from the full amortization of: (i) certain management and franchise contract intangible assets that were recorded at the time of the merger during 2020 and (ii) certain capitalized software costs during both periods.", "highlight": "due to a decrease in amortization expenses, primarily resulting from the full amortization of: (i) certain management and franchise contract intangible assets that were recorded at the time of the merger during 2020 and (ii) certain capitalized software costs during both periods.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para61", "text": "the increase in general and administrative expenses was primarily due to increased share-based compensation expense as a result of expenses recognized during the year ended december 31, 2021 for all of the outstanding performance shares, which were probable of achievement as of december 31, 2021. share-based compensation expense recognized during the year ended december 31, 2020 included the reversal of expense recognized in prior years as a result of the determination that the performance conditions of our then-outstanding performance shares were no longer probable of achievement, partially offset by expense recorded in december 2020 as a result of the modification of our then-outstanding performance shares. see note 15: \"share-based compensation\" in our consolidated financial statements for additional information. also, for the year ended december 31, 2021, payroll expenses for our corporate workforce increased, as furloughs and reduced pay in 2020 yielded lower comparable costs reflected in general and administrative expenses. partially offsetting these increases was a decrease in bad debt expense, which was in line with the improvement we experienced with respect to the timing and volume of payments from hotel owners throughout 2021, as compared to 2020.", "highlight": "due to increased share-based compensation expense as a result of expenses recognized during the year ended december 31, 2021 for all of the outstanding performance shares, which were probable of achievement as of december 31, 2021 ||| as a result of the determination that the performance conditions of our then-outstanding performance shares were no longer probable of achievement ||| yielded lower comparable costs reflected in general and administrative expenses", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para62", "text": "during the year ended december 31, 2020, we recognized reorganization costs related to activities undertaken in response to the covid-19 pandemic, primarily relating to reductions in our workforce and the associated costs.", "highlight": "we recognized reorganization costs related to activities undertaken in response to the covid-19 pandemic", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para63", "text": "during the year ended december 31, 2020, we recognized $258 million of impairment losses, primarily related to our ownership segment, including $104 million on our ownership reporting unit's goodwill, along with certain assets associated with specific owned and leased hotels. additionally, $15 million was on management contract acquisition costs as a result of actual and expected early terminations of the related management contracts.", "highlight": "we recognized $258 million of impairment losses, primarily related to our ownership segment", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para64", "text": "other expenses decreased primarily as a result of expenses related to the settlement of a dispute with an owner of a managed hotel and expenses related to performance guarantees that were recognized during the year ended december 31, 2020.", "highlight": "as a result of expenses related to the settlement of a dispute with an owner of a managed hotel and expenses related to performance guarantees that were recognized", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para65", "text": "Non-operating income and expenses Year ended december 31, Percent change 2021 2020 2021 vs. 2020 (in millions) Interest expense $ (397) $ (429) -7.5 Loss on foreign currency transactions -7 -27 -74.1 Loss on debt extinguishments -69 -48 43.8 Other non-operating income (loss), net 23 -2 Nm (1) Income tax benefit (expense) -153 204 Nm (1) ____________ -1) fluctuation in terms of percentage change is not meaningful.", "highlight": "Percent change 2021 2020 2021 vs. 2020 (in millions) Interest expense $ (397) $ (429) -7.5 Loss on foreign currency transactions -7 -27 -74.1 Loss on debt extinguishments -69 -48 43.8 Other non-operating income (loss), net 23 -2 Nm (1) Income tax benefit (expense) -153 204 Nm", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para66", "text": "the decrease in interest expense during the year ended december 31, 2021 included the decrease resulting from the issuances of new senior unsecured notes and the use of such proceeds for the redemptions of existing senior unsecured notes in december 2020 and february 2021, which reduced the weighted average interest rates on our outstanding senior unsecured notes. additionally, we repaid the entire outstanding balance on the senior secured revolving credit facility (the \"revolving credit facility\") by june 2021, while it was fully drawn for the period from march 2020 to december 2020. for the year ended december 31, 2021, our variable interest expense also decreased due to declines in the variable interest rate on our senior secured term loan facility (the \"term loan\"). these decreases in interest expense during the year ended december 31, 2021 were partially offset by an increase due to the issuances of new senior unsecured notes in april 2020. see note 9: \"debt\" in our consolidated financial statements for additional information on our indebtedness and the associated interest rates.", "highlight": "we repaid the entire outstanding balance on the senior secured revolving credit facility ||| our variable interest expense also decreased due to declines in the variable interest rate on our senior secured term loan facility", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para67", "text": "the loss on foreign currency transactions during both the years ended december 31, 2021 and 2020 included the impact of changes in foreign currency exchange rates related to our operations conducted in functional currencies other than our reported currency, as well as changes in foreign currency exchange rates on certain intercompany financing arrangements, including short-term cross-currency intercompany loans. additionally, the loss recognized during the year ended december 31, 2020, included losses related to the liquidation of investments in foreign entities that were reclassified out of accumulated other comprehensive loss.", "highlight": "the loss recognized during the year ended december 31, 2020, included losses related to the liquidation of investments in foreign entities that were reclassified out of accumulated other comprehensive loss.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para68", "text": "loss on debt extinguishments for the years ended december 31, 2021 and 2020 related to the redemptions of senior notes and included redemption premiums of $55 million and $31 million, respectively, and the accelerated recognition of unamortized deferred financing costs of $14 million and $17 million, respectively. see note 9: \"debt\" in our consolidated financial statements for additional information on these redemptions.", "highlight": "loss on debt extinguishments for the years ended december 31, 2021 and 2020 related to the redemptions of senior notes and included redemption premiums of $55 million and $31 million, ||| accelerated recognition of unamortized deferred financing costs of $14 million and $17 million, respectively", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para69", "text": "other non-operating income (loss), net consists of interest income, equity in earnings (losses) from unconsolidated affiliates, certain income and costs related to our defined employee benefit plans and other non-operating gains and losses. the change in other non-operating income (loss), net during the year ended december 31, 2021 included an $8 million increase related to our employee benefit plans, primarily as a result of a decrease in interest cost and an increase in the expected investment gains from our plan assets. the year ended december 31, 2020 included other non-operating losses related to a debt guarantee for a franchised hotel and the disposal of an investment, offset by a gain related to the reimbursement by a third party for taxes owed resulting from the sale of a hotel in a prior period.", "highlight": "primarily as a result of a decrease in interest cost and an increase in the expected investment gains from our plan assets ||| debt guarantee for a franchised hotel and the disposal of an investment, offset by a gain related to the reimbursement by a third party for taxes", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para70", "text": "the increase in income tax expense during the year ended december 31, 2021 was primarily attributable to the increase in income before income taxes, which was partially offset by benefits recognized as a result of tax rate changes. for additional information, see note 13: \"income taxes\" in our consolidated financial statements.", "highlight": "attributable to the increase in income before income taxes, which was partially offset by benefits recognized as a result of tax rate changes", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para71", "text": "Segment results refer to note 18: \"business segments\" in our consolidated financial statements for reconciliations of revenues for our reportable segments to consolidated amounts and of segment operating income to consolidated income (loss) before income taxes.", "highlight": "business segments\" in our consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para72", "text": "Refer to \" revenues\" for further discussion of the increase in revenues from our managed and franchised properties, which is correlated to our management and franchise segment revenues and segment operating income. refer to \" revenues\" and \" operating expenses\" for further discussion of the increases in revenues and operating expenses at our owned and leased hotels, which are correlated with our ownership segment revenues and segment operating losses. although, we saw significant improvement in revenues from our ownership segment during 2021 as compared to 2020, due to the nature of the fixed rent commitments and other fixed operating costs at our leased hotels, our ownership segment continued to experience an operating loss for the year ended december 31, 2021.", "highlight": "we saw significant improvement in revenues from our ownership segment during 2021 as compared to 2020 ||| our ownership segment continued to experience an operating loss for the year ended december 31, 2021.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 1, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para73", "text": "Liquidity and capital resources Overview as of december 31, 2021, we had total cash and cash equivalents of $1,512 million, including $85 million of restricted cash and cash equivalents. the majority of our restricted cash and cash equivalents is related to cash collateral and cash held for ff&e reserves.", "highlight": "we had total cash and cash equivalents of $1,512 million", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para74", "text": "in response to the global crisis resulting from the covid-19 pandemic, we took certain proactive measures in 2020 to help our business withstand the negative impact on our business from the crisis. these measures included securing our liquidity position to be able to meet our obligations for the foreseeable future, including issuing senior notes, drawing down the available borrowing capacity of our $1.75 billion revolving credit facility and consummating the april 2020 pre-sale of hilton honors points to american express for $1.0 billion in cash (the \"honors points pre-sale\"). further, in february 2021, we issued the 3.625% senior notes due 2032 to continue to extend debt maturities and reduce our cost of debt by repaying the outstanding 5.125% senior notes due 2026. based on our continued recovery and expectations of the foreseeable demands on our available cash and our liquidity in future periods, we had fully repaid the outstanding debt balance on the revolving credit facility by june 2021.", "highlight": "securing our liquidity position to be able to meet our obligations for the foreseeable future ||| we issued the 3.625% senior notes due 2032 to continue to extend debt maturities and reduce our cost of debt by repaying the outstanding 5.125% senior notes due 2026 ||| we had fully repaid the outstanding debt balance on the revolving credit facility by june 2021.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para75", "text": "while our accounts receivable balance as of december 31, 2021 is somewhat less than periods prior to the start of the pandemic, we are generally experiencing slower payment of certain fees due to us and we have considered these payment trends in developing our estimates of expected future credit losses. however, during the year ended december 31, 2021, we experienced relative improvement with respect to the timing of customer payments and overall cash flow from operations when compared to 2020.", "highlight": "we are generally experiencing slower payment of certain fees due to us and we have considered these payment trends in developing our estimates of expected future credit losses ||| we experienced relative improvement with respect to the timing of customer payments and overall cash flow from operations when compared to 2020.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para76", "text": "Our known short-term liquidity requirements primarily consist of funds necessary to pay for operating and other expenditures, including: Costs associated with the management and franchising of hotels; Costs, other than compensation and rent as noted separately below, associated with the operations of owned and leased hotels, including, but not limited to, utilities and operating supplies; Corporate expenses; Payroll and compensation costs; Taxes and compliance costs; Scheduled debt maturities and interest payments on our outstanding indebtedness, which, excluding finance lease liabilities, are estimated to be approximately $316 million in 2022; Lease payments under our finance and operating leases, which include minimum lease payments that are estimated to be approximately $61 million and $177 million, respectively, in 2022; Committed contract acquisition costs; and capital expenditures for required renovations and maintenance at the hotels within our ownership segment.", "highlight": "Scheduled debt maturities and interest payments on our outstanding indebtedness ||| are estimated to be approximately $316 million in 2022 ||| Lease payments under our finance and operating leases, which include minimum lease payments that are estimated to be approximately $61 million and $177 million,", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para77", "text": "Our known long-term liquidity requirements primarily consist of funds necessary to pay for: Scheduled debt maturities and interest payments on our outstanding indebtedness, which, excluding finance lease liabilities, are estimated to total an aggregate of $10.5 billion after december 31, 2022; Lease payments under our finance and operating leases, which include minimum lease payments that are estimated to total an aggregate of $194 million and $1,081 million, respectively, after december 31, 2022; Committed contract acquisition costs; Capital improvements to the hotels within our ownership segment; Corporate capital and information technology expenditures; and commitments to owners in our management and franchise segment made in the normal course of business for which we are reimbursed by these owners through program fees to operate our marketing, sales and brands programs.", "highlight": "Scheduled debt maturities and interest payments on our outstanding indebtedness ||| are estimated to total an aggregate of $10.5 billion after december 31, 2022 ||| Lease payments under our finance and operating leases ||| aggregate of $194 million and $1,081 million", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para78", "text": "additionally, in circumstances where we have the opportunity to support our strategic objectives by growing our global footprint, we may provide performance or debt guarantees or loan commitments, as necessary, for hotels that we currently or plan to manage or franchise, as applicable, as well as letters of credit that support hotel financing or other obligations of hotel owners. see note 19: \"commitments and contingencies\" in our consolidated financial statements for additional information on these commitments that were outstanding as of december 31, 2021.", "highlight": "we may provide performance or debt guarantees or loan commitments, as necessary", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 1, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para79", "text": "we formally suspended share repurchases in march 2020, given the economic environment and our efforts to preserve cash, and no share repurchases have been made since then. however, the stock repurchase program remains authorized by our board of directors, with approximately $2.2 billion remaining available for share repurchases under the program, and we may resume share repurchases in the future at any time, depending on market conditions, our capital needs and other factors. additionally, we suspended dividend payments in 2020, but we expect that both share repurchases and dividend payments will be reinstated in future periods and result in uses of liquidity.", "highlight": "we formally suspended share repurchases in march 2020, given the economic environment and our efforts to preserve cash ||| the stock repurchase program remains authorized by our board of directors, with approximately $2.2 billion remaining available for share repurchases under the program, and we may resume share repurchases in the future at any time,", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para80", "text": "although the covid-19 pandemic has caused us to temporarily change our cash management strategy, we have a long-term investment policy that is focused on the preservation of capital and maximizing the return on new and existing investments and returning available capital to stockholders through dividends and share repurchases, which we expect to reimplement at some time in the future. within the framework of our investment policy, we currently intend to continue to finance our business activities primarily with cash on our balance sheet as of december 31, 2021, cash generated from our operations and, as needed, the use of the available capacity of our revolving credit facility. additionally, we have continued access to debt markets and expect to be able to obtain financing, if necessary.", "highlight": "we have a long-term investment policy that is focused on the preservation of capital and maximizing the return on new and existing investments and returning available capital to stockholders through dividends and share repurchases ||| we have continued access to debt markets and expect to be able to obtain financing", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para81", "text": "after considering our approach to liquidity and our available sources of cash, we believe that our cash position and sources of liquidity will meet anticipated requirements for operating and other expenditures, including corporate expenses, payroll and other compensation costs, taxes and compliance costs and other commitments for the foreseeable future based on current conditions. the objectives of our cash management policy are to maintain the availability of liquidity while minimizing operational costs.", "highlight": "we believe that our cash position and sources of liquidity will meet anticipated requirements for operating and other expenditures", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para82", "text": "we may from time to time issue or incur or increase our capacity to incur new debt and/or purchase our outstanding debt through underwritten offerings, open market transactions, privately negotiated transactions or otherwise. issuances or incurrence of new debt (or an increase in our capacity to incur new debt) and/or purchases or retirements of outstanding debt, if any, will depend on prevailing market conditions, liquidity requirements, contractual restrictions and other factors. the amounts involved may be material.", "highlight": "issue or incur or increase our capacity to incur new debt and/or purchase our outstanding debt through underwritten offerings, open market transactions, privately negotiated transactions or otherwise. issuances or incurrence of new debt ||| purchases or retirements of outstanding debt", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 1, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para83", "text": "Sources and uses of our cash and cash equivalents The following table summarizes our net cash flows: Year ended december 31, Percent change 2021 2020 2021 vs. 2020 (in millions) Net cash provided by operating activities $ 109 $ 708 Nm (1) Net cash used in investing activities -57 -107 -46.7 Net cash provided by (used in) financing activities -1,793 2,032 Nm (1) ____________ -1) fluctuation in terms of percentage change is not meaningful; see additional details below.", "highlight": "Net cash provided by operating activities $ 109 $ 708 Nm (1) Net cash used in investing activities -57 -107 -46.7 Net cash provided by (used in) financing activities -1,793 2,032", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para84", "text": "Operating activities as we recover from the negative impacts of the pandemic and our system-wide revpar increases, we are returning to a position where cash flows are being generated from our operations.", "highlight": "we are returning to a position where cash flows are being generated from our operations", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para85", "text": "the decrease in cash flows from operating activities during the year ended december 31, 2021 as compared to the year ended december 31, 2020, was primarily attributable to the $1.0 billion of cash received in connection with the honors points pre-sale during 2020. excluding the impact of this transaction, cash flows from operating activities increased during the year ended december 31, 2021 when compared to 2020, primarily due to the increase in cash inflows generated from our management and franchise segment, largely as a result of an increase in managed and franchised revpar of 60.8 percent due to the recovery from the covid-19 pandemic, as well as the decrease in cash paid for interest of $74 million, primarily as a result of the senior notes issuances and redemptions in december 2020 and february 2021; see note 9: \"debt\" in our consolidated financial statements for additional information. this increase was partially offset by a $150 million increase in payments of contract acquisition costs, which reflects our strategic investment in growing our system by adding hotels to our management and franchise segment, as well as an increase in cash paid for income taxes of $102 million, primarily due to an increase in income before income taxes.", "highlight": "primarily due to an increase in income before income taxes.\r\n ||| primarily attributable to the $1.0 billion of cash received in connection with the honors points pre-sale during 2020 ||| primarily due to the increase in cash inflows generated from our management and franchise segment ||| which reflects our strategic investment in growing our system by adding hotels to our management and franchise segment", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para86", "text": "Investing activities net cash used in investing activities primarily related to capitalized software costs that were related to various systems initiatives for the benefit of both our hotel owners and our overall corporate operations and to capital expenditures for property and equipment related to our corporate facilities and the renovation of certain hotels in our ownership segment. beginning in march 2020, we took steps to temporarily reduce such expenditures in response to the covid-19 pandemic and continued to limit investment spending throughout 2021; however, we expect such costs to continue to increase in future periods, aligned to our recovery from the pandemic.", "highlight": "Investing activities net cash used in investing activities primarily related to capitalized software costs ||| took steps to temporarily reduce such expenditures in response to the covid-19 pandemic and continued to limit investment spending throughout 2021", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para87", "text": "Financing activities the change in cash flows from financing activities was primarily attributable to our revolving credit facility, which we fully drew down during the year ended december 31, 2020 in response to the covid-19 pandemic, resulting in net cash inflows of $1.5 billion, while we fully repaid the $1.7 billion outstanding debt balance during the year ended december 31, 2021. additionally, during the year ended december 31, 2020, we had a net additional $1.0 billion of senior notes borrowings, as compared to the year ended december 31, 2021. further, cash outflows decreased $338 million in 2021 as a result of decreases in share repurchases and dividend payments, as both programs remained suspended after their suspension was initiated in 2020.", "highlight": "resulting in net cash inflows of $1.5 billion, while we fully repaid the $1.7 billion outstanding debt balance during the year ended december 31, 2021 ||| we had a net additional $1.0 billion of senior notes borrowings ||| cash outflows decreased $338 million in 2021", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para88", "text": "Debt and borrowing capacity as of december 31, 2021, our total indebtedness, excluding unamortized deferred financing costs and discount, was approximately $8.9 billion, and we had letters of credit of $60 million outstanding on our revolving credit facility. for additional information on our total indebtedness, including financing transactions executed during the years ended december 31, 2021 and 2020, availability under our revolving credit facility and guarantees on our debt, refer to note 9: \"debt\" in our consolidated financial statements.", "highlight": "our total indebtedness, ||| was approximately $8.9 billion, and we had letters of credit of $60 million outstanding on our revolving credit facility", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para89", "text": "if we are unable to generate sufficient cash flow from operations in the future to service our debt, we may be required to reduce capital expenditures or issue additional equity securities. our ability to make scheduled principal payments and to pay interest on our debt depends on our future operating performance, which is subject to general conditions in or affecting the hospitality industry that may be beyond our control. the covid-19 pandemic negatively impacted our cash flows from operations as compared to periods prior to the onset of the pandemic, and is expected to continue to do so for an indeterminate period of time; however, during the year ended december 31, 2021, we returned to a position where we were generating cash flows from our core operations. during 2020, we took precautions to secure our cash position, as discussed above, and, with our business recovering during 2021, we were able to repay outstanding debt borrowings on our revolving credit facility and we expect to be able to meet our current obligations. furthermore, we do not have any material indebtedness outstanding that matures prior to may 2025.", "highlight": "if we are unable to generate sufficient cash flow from operations in the future to service our debt, we may be required to reduce capital expenditures or issue additional equity securities ||| the covid-19 pandemic negatively impacted our cash flows from operations as compared to periods prior to the onset of the pandemic, and is expected to continue to do so for an indeterminate period of time", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para90", "text": "Summarized guarantor financial information Hilton domestic operating company inc. (\"hoc\") is the issuer of the following senior notes, collectively referred to as the senior notes: 5.375% senior notes due 2025; 4.875% senior notes due 2027; 5.750% senior notes due 2028; 3.750% senior notes due 2029; 4.875% senior notes due 2030; 4.000% senior notes due 2031; and 3.625% senior notes due 2032. hoc is 100 percent owned directly by hilton worldwide parent llc (\"hwp\"), which, in turn, is 100 percent owned directly by hilton worldwide holdings inc. (the \"parent\"). the senior notes are guaranteed jointly and severally on a senior unsecured basis by the parent, hwp and substantially all of the parent's direct and indirect wholly owned domestic restricted subsidiaries, except for hoc (together, the \"guarantors\"). the indentures that govern the senior notes provide that any subsidiary of the company that provides a guarantee of our senior secured credit facilities will guarantee the senior notes. as of december 31, 2021, none of our foreign subsidiaries or domestic subsidiaries owned by foreign subsidiaries or our non-wholly owned subsidiaries guaranteed the senior notes.", "highlight": "5.375% senior notes due 2025; 4.875% senior notes due 2027; 5.750% senior notes due 2028; 3.750% senior notes due 2029; 4.875% senior notes due 2030; 4.000% senior notes due 2031; and 3.625% senior notes due 2032", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para91", "text": "the guarantees are full and unconditional, subject to certain customary release provisions. the indentures that govern the senior notes provide that any guarantor may be released from its guarantee so long as: (i) the subsidiary is sold or sells all of its assets; (ii) the subsidiary is released from its guarantee under our senior secured credit facilities; (iii) the subsidiary is declared \"unrestricted\" for covenant purposes; or (iv) the requirements for legal defeasance or covenant defeasance or to discharge the indenture have been satisfied, in each case in compliance with applicable provisions of the indentures.", "highlight": "the indentures that govern the senior notes provide that any guarantor may be released from its guarantee so long as: (i) the subsidiary is sold or sells all of its assets; (ii) the subsidiary is released from its guarantee under our senior secured credit facilities; (iii) the subsidiary is declared \"unrestricted\" for covenant purposes; or (iv) the requirements for legal defeasance or covenant defeasance or to discharge the indenture", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para92", "text": "Neither hoc nor any of the guarantors has any reporting obligation under the exchange act in respect of the senior notes; however, we are supplementally providing the information set forth below. the following tables present summarized financial information for hoc, along with the parent and all other guarantors, on a combined basis: As of December 31, 2021 (in millions) (unaudited) Assets Total current assets $ 1,041 Intangible assets, net 8,794 Total intangibles and other assets 9,301 Total assets 10,342 Liabilities and equity (deficit) Total current liabilities 2,397 Long-term debt 8,541 Total liabilities 14,176 Total hilton stockholders' deficit -3,834 Total liabilities and equity (deficit) 10,342 Year ended december 31, 2021 (in millions) (unaudited) Revenues Revenues $ 1,483 Other revenues from managed and franchised properties 2,847 Total revenues $ 4,330 Expenses Expenses $ 449 Other expenses from managed and franchised properties 3,039 Total expenses $ 3,488 Operating income $ 844 Interest expense -380 Income tax expense -128 Net income 285 Net income attributable to hilton stockholders 285 Critical accounting estimates the preparation of our consolidated financial statements in accordance with gaap requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements, the reported amounts of revenues and expenses during the reporting periods and the related disclosures in the consolidated financial statements and accompanying footnotes. on an ongoing basis, we evaluate these estimates and judgments based on historical experiences and various other factors that we believe reflect the current circumstances. while we believe our estimates, assumptions and judgments are reasonable, they are based on information presently available. actual results may differ significantly from these estimates due to changes in judgments, assumptions and conditions as a result of unforeseen events or otherwise, which could have a material effect on our financial position or results of operations.", "highlight": "As of December 31, 2021 (in millions) (unaudited) Assets Total current assets $ 1,041 Intangible assets, net 8,794 Total intangibles and other assets 9,301 Total assets 10,342 Liabilities and equity (deficit) Total current liabilities 2,397 Long-term debt 8,541 Total liabilities 14,176 Total hilton stockholders' deficit -3,834 Total liabilities and equity (deficit) 10,342 Year ended december 31, 2021 (in millions) (unaudited) Revenues Revenues $ 1,483 Other revenues from managed and franchised properties 2,847 Total revenues $ 4,330 Expenses Expenses $ 449 Other expenses from managed and franchised properties 3,039 Total expenses $ 3,488 Operating income $ 844 Interest expense -380 Income tax expense -128 Net income 285", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para93", "text": "We believe that the following estimates, which are used in conjunction with our significant accounting policies, are critical because they involve a higher degree of judgment and are based on information that is inherently uncertain; refer to note 2: \"basis of presentation and summary of significant accounting policies\" in our consolidated financial statements for information on our significant accounting policies. management has discussed the development and selection of the following critical accounting estimates with the audit committee of the board of directors: Impairment of goodwill and brands intangible assets we evaluate goodwill and brands intangible assets for potential impairment on an annual basis or at other times during the year if indicators of impairment exist. our reporting units are the same as our operating segments as described in note 18: \"business segments\" in our consolidated financial statements.", "highlight": "We believe that the following estimates, which are used in conjunction with our significant accounting policies, are critical because they involve a higher degree of judgment and are based on information that is inherently uncertain;", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para94", "text": "As part of the evaluation of goodwill and brands intangible assets for potential impairment, we exercise judgment to: Perform a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit or brand intangible asset is less than its carrying value. factors we consider when making this determination include assessing the overall effect of trends in the hospitality industry and the general economy, regional performance and expectations and historical experience; Decide whether to bypass the qualitative assessment and perform a quantitative assessment. factors we consider when making this determination include changes in the company or general economic conditions since the previous quantitative assessment was performed, the amount by which the fair value exceeded the carrying value at that time and the period of time that has passed since such quantitative assessment; and perform a quantitative analysis to identify both the existence of impairment and the amount of the impairment loss. the estimated fair value is based on internal projections of expected future cash flows and operating plans, as well as market conditions relative to the operations of our reporting units and brands.", "highlight": "we exercise judgment to: Perform a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit or brand intangible asset is less than its carrying value ||| Decide whether to bypass the qualitative assessment and perform a quantitative assessment", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para95", "text": "changes in our estimates and assumptions, or changes in the factors that we consider that would affect them, such as those described above, that were used in our impairment testing could result in impairment losses, which could be material.", "highlight": "that were used in our impairment testing could result in impairment losses, which could be material.", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para96", "text": "Impairment of certain finite-lived assets we evaluate the carrying value of our specifically identifiable lease intangible assets, operating and finance lease rou assets and property and equipment for indicators of impairment, and, if such indicators exist, we perform an analysis to determine the recoverability of the determined asset group, by comparing the expected undiscounted future cash flows to the net carrying value of the asset group.", "highlight": "we evaluate the carrying value of our specifically identifiable lease intangible assets, operating and finance lease rou assets and property and equipment for indicators of impairment, and, if such indicators exist ||| we perform an analysis to determine the recoverability of the determined asset group", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para97", "text": "As part of the process, we exercise judgment to: Determine if there are indicators of impairment present. factors we consider when making this determination include assessing the overall effect of trends in the hospitality industry and the general economy, regional performance and expectations, historical experience, capital costs and other asset-specific information; Determine the projected undiscounted future cash flows when indicators of impairment are present. judgment is required when developing projections of future revenues and expenses based on estimated performance over the expected useful life of the asset group. forward-looking estimates of future performance are based on historical operating results, as well as various internal projections and external sources; and determine the asset group fair value when required. in determining the fair value, we often use internally-developed discounted cash flow models, appraisals, recent similar transactions in the market and, if appropriate and available for a specific asset group, current estimated net sales proceeds from pending offers. assumptions used in the discounted cash flow models include estimating cash flows, which may require us to adjust for specific market conditions, as well as capitalization rates, which are based on location, property or asset type, market-specific dynamics and overall economic performance. the discount rate applied to forward-looking projections takes into account market-specific considerations.", "highlight": "Determine if there are indicators of impairment present ||| Determine the projected undiscounted future cash flows when indicators of impairment are present ||| determine the asset group fair value when required. in determining the fair value", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para98", "text": "changes in our estimates and assumptions, or changes in the factors that we consider that would affect them, such as those described above, that were used in our impairment testing could result in impairment losses, which could be material.", "highlight": "that were used in our impairment testing could result in impairment losses, which could be material.\r\n\r\nOverview\r\n\r\nIndustry\r\n\r\nRisk\r\n\r\nLegal\r\n\r\nFinancial Status\r\n\r\nStrategy\r\n\r\nOperation\r\n\r\nOthers", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para99", "text": "Hilton honors we record a point redemption liability for amounts received from properties participating in our hilton honors guest loyalty program and strategic partners in an amount equal to the estimated cost per point of the future redemption obligation. we engage third-party actuaries annually to assist in determining the fair value of the future reward redemption obligation using statistical formulas that project future point redemptions based on factors that require judgment, including an estimate of points that will eventually be redeemed, which includes an estimate of breakage (i.e., points that will never be redeemed), and the cost of reimbursing properties and other third parties. the cost of the points expected to be redeemed includes further estimates of available room nights, occupancy rates, room rates and any changes to the program, including devaluation or appreciation of points based on changes in the number of points required to redeem a reward. any amounts received from strategic partners related to the issuance of points that are in excess of the actuarial determined cost per point are recorded as deferred revenue in our consolidated balance sheets and recognized as revenue upon point redemption. we recognize revenue for point redemptions in the amount we expect to retain in excess of the cost per point, inclusive of estimated breakage, and limit the revenue recognized to an amount that is probable to not result in a significant reversal in the cumulative revenue recognized when breakage occurs.", "highlight": "we engage third-party actuaries annually to assist in determining the fair value of the future reward redemption obligation using statistical formulas ||| we recognize revenue for point redemptions in the amount we expect to retain in excess of the cost per point, inclusive of estimated breakage, and limit the revenue recognized to an amount that is probable to not result in a significant reversal in the cumulative revenue recognized when breakage occurs.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para100", "text": "in addition to the hilton honors fees we receive from hotel owners to operate the program, we earn fees from strategic partnerships, including co-branded credit card arrangements, for the use of our ip license and the issuance of hilton honors points. the allocation of the overall fees from the strategic partnerships between the ip license and the hilton honors points is based on their estimated standalone selling prices. the estimated standalone selling price of the ip license is determined using a relief-from-royalty valuation method incorporating statistical formulas based on factors that require significant judgment, including estimates of credit card usage, an appropriate royalty rate and a discount rate to be applied to the projected cash flows. the estimated standalone selling price of the future reward redemptions of hilton honors points under the strategic partnerships is calculated using a discounted cash flow analysis with the same assumptions as the point redemption liability discussed above, adjusted for an appropriate margin.", "highlight": "the allocation of the overall fees from the strategic partnerships between the ip license and the hilton honors points is based on their estimated standalone selling prices ||| estimated standalone selling price of the ip license is determined using a relief-from-royalty valuation method incorporating statistical formulas based on factors that require significant judgment", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para101", "text": "due to the impact of the covid-19 pandemic on our business and the extension of our temporary suspension of the expiration of hilton honors points through december 31, 2022, we reassessed the expected redemption rate of our hilton honors points. as a result, we adjusted our estimates of breakage to include, among other factors, the anticipated point expirations that will occur on december 31, 2022.", "highlight": "we reassessed the expected redemption rate of our hilton honors points", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para102", "text": "changes in our estimates and assumptions that are used to determine our estimated cost per point could result in material changes in the balances of our liability for guest loyalty program and deferred revenues in our consolidated balance sheets, and changes in estimates and assumptions that are used to determine the allocation of the fees from strategic partnerships between the ip license fee and the hilton honors points and revenue recognized on point redemptions could result in material changes to our licensing fees and other revenues from managed and franchised properties recognized during the period in our consolidated statements of operations.", "highlight": "changes in our estimates and assumptions that are used to determine our estimated cost per point could result in material changes", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para103", "text": "Income taxes we recognize deferred tax assets and liabilities based on the differences between the financial statement carrying values and the tax basis of assets and liabilities using currently enacted tax rates. we regularly review our deferred tax assets to assess their potential realization and establish a valuation allowance for portions of such assets that we believe will not be ultimately realized. in performing this review, we make estimates and assumptions regarding projected future taxable income, the expected timing of reversals of existing temporary differences and the implementation of tax planning strategies. a change in these assumptions may increase or decrease our valuation allowance resulting in an increase or decrease in our effective tax rate, which could materially affect our consolidated financial statements. refer to note 13: \"income taxes\" for information on the balances of our deferred tax assets and respective valuation allowances as of december 31, 2021.", "highlight": "Income taxes we recognize deferred tax assets and liabilities based on the differences between the financial statement carrying values and the tax basis of assets and liabilities using currently enacted tax rates |||  change in these assumptions may increase or decrease our valuation allowance resulting in an increase or decrease in our effective tax rate, which could materially affect our consolidated financial statements", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para104", "text": "we use a prescribed more-likely-than-not recognition threshold for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return if there is uncertainty in income taxes recognized in the consolidated financial statements. when determining the amount of tax benefit to be recognized, we assume, among other items, the position will be examined, the examiner will have all relevant information and the evaluation of the position will be based on its technical merits. further, estimates based on a tax position's technical merits and amounts we would ultimately accept in a negotiated settlement with the tax authorities are used to measure the largest amount of benefit that is greater than 50 percent likely of being realized upon settlement. changes to these assumptions and estimates can lead to an additional income tax benefit (expense), which could materially affect our consolidated financial statements.", "highlight": "we use a prescribed more-likely-than-not recognition threshold for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return ||| estimates based on a tax position's technical merits and amounts we would ultimately accept in a negotiated settlement with the tax authorities are used to measure the largest amount of benefit that is greater than 50 percent", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220216_10-K_1585689_part2_item7_para105", "text": "Legal contingencies we are subject to various legal proceedings and claims, the outcomes of which are subject to significant uncertainty. an estimated loss from a loss contingency will be accrued as a charge to income if it is probable and the amount of the loss can be reasonably estimated. significant judgment is required when we evaluate, among other factors, the degree of probability of an unfavorable outcome and the ability to make a reasonable estimate of the amount of loss in determining whether an accrual of an estimated loss is appropriate. changes in these factors could materially affect our consolidated financial statements.", "highlight": "an estimated loss from a loss contingency will be accrued as a charge to income if it is probable and the amount of the loss can be reasonably estimated ||| significant judgment is required when we evaluate, among other factors, the degree of probability of an unfavorable outcome and the ability to make a reasonable estimate of the amount of loss in determining whether an accrual of an estimated loss is appropriate", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para1", "text": "Organization and business segments Description of the company and business segments johnson & johnson and its subsidiaries (the company) have approximately 141,700 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. the company conducts business in virtually all countries of the world with the primary focus on products related to human health and well-being.", "highlight": "johnson & johnson and its subsidiaries (the company) have approximately 141,700 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para2", "text": "the company is organized into three business segments: consumer health, pharmaceutical and medical devices. the consumer health segment includes a broad range of products used in the baby care, oral care, skin health/beauty, over-the-counter pharmaceutical, women's health and wound care markets. these products are marketed to the general public and sold online (ecommerce) and to retail outlets and distributors throughout the world. the pharmaceutical segment is focused on six therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals and healthcare professionals for prescription use. the medical devices segment includes a broad range of products used in the orthopaedic, surgery, interventional solutions (cardiovascular and neurovascular) and vision fields. these products are distributed to wholesalers, hospitals and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics.", "highlight": "the company is organized into three business segments: consumer health, pharmaceutical and medical devices", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para3", "text": "the executive committee of johnson & johnson is the principal management group responsible for the strategic operations and allocation of the resources of the company. this committee oversees and coordinates the activities of the consumer health, pharmaceutical and medical devices business segments.", "highlight": "the executive committee of johnson & johnson is the principal management group responsible for the strategic operations and allocation of the resources of the company", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para4", "text": "in all of its product lines, the company competes with other companies both locally and globally, throughout the world. competition exists in all product lines without regard to the number and size of the competing companies involved. competition in research, involving the development and the improvement of new and existing products and processes, is particularly significant. the development of new and innovative products, as well as protecting the underlying intellectual property of the company's product portfolio, is important to the company's success in all areas of its business. the competitive environment requires substantial investments in continuing research. in addition, the development and maintenance of customer demand for the company's consumer products involves significant expenditures for advertising and promotion.", "highlight": "the company competes with other companies both locally and globally, throughout the world ||| in addition, the development and maintenance of customer demand for the company's consumer products involves significant expenditures for advertising and promotion", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para5", "text": "Management's objectives with \"our credo\" as the foundation, the company's purpose is to blend heart, science and ingenuity to profoundly change the trajectory of health for humanity. the company is committed to bringing its full breadth and depth to ensure health for people today and for future generations. united around this common ambition, the company is poised to fulfill its purpose and successfully meet the demands of the rapidly evolving markets in which it competes.", "highlight": "the company's purpose is to blend heart, science and ingenuity to profoundly change the trajectory of health for humanity", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para6", "text": "the company is broadly based in human healthcare, and is committed to creating value by developing accessible, high quality, innovative products and services. new products introduced within the past five years accounted for approximately 25% of 2021 sales. in 2021, $14.7 billion was invested in research and development reflecting management's commitment to create life-enhancing innovations and to create value through partnerships that will profoundly change the trajectory of health for humanity.", "highlight": "in 2021, $14.7 billion was invested in research and development reflecting management's commitment to create life-enhancing innovations and to create value", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para7", "text": "a critical driver of the company's success is the diversity of its 141,700 employees worldwide. employees are empowered and inspired to lead with the company's our credo and purpose as guides. this allows every employee to use the company's reach and size to advance the company's purpose, and to also lead with agility and urgency. leveraging the extensive resources across the enterprise enables the company to innovate and execute with excellence. this ensures the company can remain focused on addressing the unmet needs of society every day and invest for an enduring impact, ultimately delivering value to its patients, consumers and healthcare professionals, employees, communities and shareholders.", "highlight": "employees are empowered and inspired to lead with the company's our credo and purpose as guides", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para8", "text": "Results of operations Analysis of consolidated sales for discussion on results of operations and financial condition pertaining to the fiscal years 2020 and 2019 see the company's annual report on form 10-k for the fiscal year ended january 3, 2021, item 7. management's discussion and analysis of results of operations and financial condition.", "highlight": "annual report on form 10-k", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para9", "text": "In 2021, worldwide sales increased 13.6% to $93.8 billion as compared to an increase of 0.6% in 2020. these sales changes consisted of the following: Sales increase/(decrease) due to: 2021 2020 Volume 12.9 % 3.5 % Price -0.7 -2.3 Currency 1.4 -0.6 Total 13.6 % 0.6 % the net impact of acquisitions and divestitures on the worldwide sales growth was a negative impact of 0.6% in 2021 and a negative impact of 0.3% in 2020.", "highlight": "worldwide sales increased 13.6% to $93.8 billion as compared to an increase of 0.6% in 2020. these sales changes consisted of the following: Sales increase/(decrease) due to: 2021 2020 Volume 12.9 % 3.5 % Price -0.7 -2.3 Currency 1.4 -0.6 Total 13.6 % 0.6 % the net impact of acquisitions and divestitures on the worldwide sales growth was a negative impact of 0.6% in 2021 and a negative impact of 0.3% in 2020.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para10", "text": "sales by u.s. companies were $47.2 billion in 2021 and $43.1 billion in 2020. this represents increases of 9.3% in 2021 and 2.5% in 2020. sales by international companies were $46.6 billion in 2021 and $39.5 billion in 2020. this represents an increase of 18.2% in 2021 and a decrease of 1.3% in 2020.", "highlight": "companies were $47.2 billion in 2021 and $43.1 billion in 2020. this represents increases of 9.3% in 2021 and 2.5% in 2020. sales by international companies were $46.6 billion in 2021 and $39.5 billion in 2020. this represents an increase of 18.2% in 2021 and a decrease of 1.3% in 2020.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para11", "text": "the five-year compound annual growth rates for worldwide, u.s. and international sales were 5.5%, 4.5% and 6.5%, respectively. the ten-year compound annual growth rates for worldwide, u.s. and international sales were 3.7%, 5.0% and 2.6%, respectively.", "highlight": "five-year compound annual growth rates for worldwide, u.s. and international sales were 5.5%, 4.5% and 6.5%, respectively. the ten-year compound annual growth rates for worldwide, u.s. and international sales were 3.7%, 5.0% and 2.6%,", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para12", "text": "in 2021, sales by companies in europe achieved growth of 24.3% as compared to the prior year, which included operational growth of 20.7% and a positive currency impact of 3.6%. sales by companies in the western hemisphere (excluding the u.s.) achieved growth of 7.8% as compared to the prior year, which included operational growth of 7.3% and a positive currency impact of 0.5%. sales by companies in the asia-pacific, africa region achieved growth of 14.1% as compared to the prior year, including operational growth of 11.4% and a positive currency impact of 2.7%.", "highlight": "sales by companies in europe achieved growth of 24.3% as compared to the prior year ||| sales by companies in the asia-pacific, africa region achieved growth of 14.1% as compared to the prior year, including operational growth of 11.4% and a positive currency impact of 2.7%.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para13", "text": "the company estimated that the inclusion of a 53rd week in the fiscal year 2020 results negatively impacted the 2021 comparative sales growth by approximately 1.0%. (see note 1 to the consolidated financial statements for annual closing date details). while the additional week added a few days to sales, it also added a full week's worth of operating costs; therefore, the net earnings impact was negligible.", "highlight": "while the additional week added a few days to sales, it also added a full week's worth of operating costs; therefore, the net earnings impact was negligible.", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para14", "text": "in 2021, the company utilized three wholesalers distributing products for all three segments that represented approximately 14.0%, 11.0% and 11.0% of the total consolidated revenues. in 2020, the company had three wholesalers distributing products for all three segments that represented approximately 16.0%, 12.0% and 12.0% of the total consolidated revenues.", "highlight": "the company utilized three wholesalers distributing products for all three segments that represented approximately 14.0%, 11.0% and 11.0% ||| had three wholesalers distributing products for all three segments that represented approximately 16.0%, 12.0% and 12.0", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para15", "text": "Note: values may have been rounded Analysis of sales by business segments Consumer health segment consumer health segment sales in 2021 were $14.6 billion, an increase of 4.1% from 2020, which included 2.8% operational growth and a positive currency impact of 1.3%. u.s. consumer health segment sales were $6.5 billion, an increase of 2.4%. international sales were $8.1 billion, an increase of 5.6%, which included 3.1% operational growth and a positive currency impact of 2.5%. in 2021, acquisitions and divestitures had a net negative impact of 1.0% on the operational sales growth of the worldwide consumer health segment.", "highlight": "Consumer health segment consumer health segment sales in 2021 were $14.6 billion, an increase of 4.1% from 2020 ||| international sales were $8.1 billion, an increase of 5.6% ||| cquisitions and divestitures had a net negative impact of 1.0% on the operational sales growth of the worldwide consumer health segment.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para16", "text": "Major consumer health franchise sales: % change (dollars in millions) 2021 2020 '21 vs. '20 Otc $ 5,227 4,824 8.4 % Skin health/beauty 4,541 4,450 2.0 Oral care 1,645 1,641 0.2 Baby care 1,566 1,517 3.2 Women's health 917 901 1.8 Wound care/other 739 720 2.6 Total consumer health sales $ 14,635 14,053 4.1 % the otc franchise sales of $5.2 billion increased 8.4% as compared to the prior year. growth was primarily attributable to analgesics, tylenol and motrin , digestive health and the hydration benefit offering (orsl).", "highlight": "primarily attributable to analgesics, tylenol and motrin , digestive health and the hydration benefit offering (orsl).", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para17", "text": "the skin health/beauty franchise sales of $4.5 billion increased 2.0% as compared to the prior year. growth was primarily due to covid-19 recovery, strong performance of neutrogena and aveeno , and ecommerce acceleration partially offset by the divestiture of dr. ci:labo - sedona business in asia pacific and external supply constraints.", "highlight": "due to covid-19 recovery, strong performance of neutrogena and aveeno , and ecommerce acceleration partially offset by the divestiture of dr. ci:labo - sedona business", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para18", "text": "the oral care franchise sales of $1.6 billion increased 0.2% as compared to the prior year. market growth in the u.s. along with strong performance in the asia pacific region due to successful brand building and promotional campaigns and the positive impact of currency offset the negative impact of the floss divestiture and u.s. external supply constraints.", "highlight": "due to successful brand building and promotional campaigns and the positive impact of currency offset the negative impact of the floss divestiture and u.s. external supply constraints.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para19", "text": "the baby care franchise sales of $1.6 billion increased 3.2% compared to the prior year. growth was driven by aveeno asia pacific ecommerce strength, innovation and covid-19 recovery.", "highlight": "driven by aveeno asia pacific ecommerce strength, innovation and covid-19 recovery.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para20", "text": "the women's health franchise sales of $0.9 billion increased 1.8% as compared to the prior year primarily driven by covid-19 market recovery, favorable price and strong brand building in asia pacific partially offset by disruptions in europe due to flooding.", "highlight": "primarily driven by covid-19 market recovery, favorable price and strong brand building in asia pacific partially offset by disruptions in europe due to flooding", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para21", "text": "the wound care/other franchise sales of $0.7 billion increased 2.6% as compared to the prior year. growth was due to strong performance of band-aid brand adhesive bandages in the u.s. partially offset by product discontinuations and competitive pressures in asia pacific.", "highlight": "strong performance of band-aid brand adhesive bandages in the u.s. partially offset by product discontinuations and competitive pressures in asia pacific.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para22", "text": "in november 2021, the company announced its intention to separate the company's consumer health business, with the intention to create a new, publicly traded company. the company is targeting completion of the planned separation in 18 to 24 months after initial announcement.", "highlight": "the company announced its intention to separate the company's consumer health business", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para23", "text": "Pharmaceutical segment pharmaceutical segment sales in 2021 were $52.1 billion, an increase of 14.3% from 2020, which included operational growth of 13.1% and a positive currency impact of 1.2%. u.s. sales were $28.0 billion, an increase of 8.6%. international sales were $24.1 billion, an increase of 21.6%, which included 18.8% operational growth and a positive currency impact of 2.8%. in 2021, acquisitions and divestitures had a net negative impact of 0.5% on the operational sales growth of the worldwide pharmaceutical segment. adjustments to previous sales reserve estimates were approximately $0.7 billion and $0.6 billion in fiscal years 2021 and 2020, respectively.", "highlight": "segment pharmaceutical segment sales in 2021 were $52.1 billion, an increase of 14.3% from 2020 ||| international sales were $24.1 billion, an increase of 21.6%, ||| acquisitions and divestitures had a net negative impact of 0.5% on the operational sales growth of the worldwide pharmaceutical segment ||| adjustments to previous sales reserve estimates were approximately $0.7 billion and $0.6 billion", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para24", "text": "Major pharmaceutical therapeutic area sales*: % change (dollars in millions) 2021 2020 '21 vs. '20 Total immunology $ 16,750 15,055 11.3 % Remicade 3,190 3,747 -14.9 Simponi /simponi aria 2,276 2,243 1.4 Stelara 9,134 7,707 18.5 Tremfya 2,127 1,347 57.9 Other immunology 11 ** Total infectious diseases 5,861 3,574 64.0 Covid-19 vaccine 2,385 ** Edurant /rilpivirine 994 964 3.1 Prezista / prezcobix /rezolsta /symtuza 2,083 2,184 -4.6 Other infectious diseases 399 427 -6.5 Total neuroscience 7,011 6,548 7.1 Concerta /methylphenidate 667 622 7.3 Invega sustenna /xeplion /invega trinza /trevicta 4,022 3,653 10.1 Risperdal consta 592 642 -7.7 Other neuroscience 1,729 1,632 6.0 Total oncology 14,548 12,367 17.6 Darzalex 6,023 4,190 43.8 Erleada 1,291 760 70.0 Imbruvica 4,369 4,128 5.8 Zytiga /abiraterone acetate 2,297 2,470 -7.0 Other oncology (1) 568 821 -30.8 Total pulmonary hypertension 3,450 3,148 9.6 Opsumit 1,819 1,639 11.0 Uptravi 1,237 1,093 13.1 Other pulmonary hypertension 395 416 -5.0 Total cardiovascular / metabolism / other 4,460 4,878 -8.6 Xarelto 2,438 2,345 4.0 Invokana / invokamet 563 795 -29.3 Procrit /eprex 479 552 -13.3 Other 981 1,186 -17.3 Total pharmaceutical sales $ 52,080 45,572 14.3 % *certain prior year amounts have been reclassified to conform to current year presentation ** percentage greater than 100% or not meaningful -1) inclusive of velcade which was previously disclosed separately 24 immunology products achieved sales of $16.8 billion in 2021, representing an increase of 11.3% as compared to the prior year driven by strong uptake of stelara (ustekinumab) in crohn's disease and ulcerative colitis and strength in tremfya (guselkumab) in psoriasis and uptake in psoriatic arthritis. this was partially offset by lower sales of remicade (infliximab) due to biosimilar competition.", "highlight": "sales*: % change (dollars in millions) 2021 2020 '21 vs. '20 Total immunology $ 16,750 15,055 11.3 % Remicade 3,190 3,747 -14.9 Simponi /simponi aria 2,276 2,243 1.4 Stelara 9,134 7,707 18.5 Tremfya 2,127 1,347 57.9 Other immunology 11 ** Total infectious diseases 5,861 3,574 64.0 Covid-19 vaccine 2,385 ** Edurant /rilpivirine 994 964 3.1 Prezista / prezcobix /rezolsta /symtuza 2,083 2,184 -4.6 Other infectious diseases 399 427 -6.5 Total neuroscience 7,011 6,548 7.1 Concerta /methylphenidate 667 622 7.3 Invega sustenna /xeplion /invega trinza /trevicta 4,022 3,653 10.1 Risperdal consta 592 642 -7.7 Other neuroscience 1,729 1,632 6.0 Total oncology 14,548 12,367 17.6 Darzalex 6,023 4,190 43.8 Erleada 1,291 760 70.0 Imbruvica 4,369 4,128 5.8 Zytiga /abiraterone acetate 2,297 2,470 -7.0 Other oncology (1) 568 821 -30.8 Total pulmonary hypertension 3,450 3,148 9.6 Opsumit 1,819 1,639 11.0 Uptravi 1,237 1,093 13.1 Other pulmonary hypertension 395 416 -5.0 Total cardiovascular / metabolism / other 4,460 4,878 -8.6 Xarelto 2,438 2,345 4.0 Invokana / invokamet 563 795 -29.3 Procrit /eprex 479 552 -13.3 Other 981 1,186 -17.3 Total pharmaceutical sales $ 52,080 45,572 14.3 % *certain prior year amounts have been reclassified to conform to current year presentation ** percentage greater than 100% or not meaningful -1)", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para25", "text": "biosimilar versions of remicade have been introduced in the united states and certain markets outside the united states and additional competitors continue to enter the market. continued infliximab biosimilar competition will result in a further reduction in sales of remicade .", "highlight": "continued infliximab biosimilar competition will result in a further reduction in sales of remicade .", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para26", "text": "the latest expiring united states patent for stelara (ustekinumab) will expire in september 2023. stelara (ustekinumab) u.s. sales in fiscal 2021 were approximately $5.9 billion. the expiration of a product patent or loss of market exclusivity is likely to result in a reduction in sales.", "highlight": "the latest expiring united states patent for stelara (ustekinumab) will expire in september 2023", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para27", "text": "infectious disease products achieved sales of $5.9 billion in 2021, representing an increase of 64.0% as compared to the prior year. growth was primarily driven by the contribution of the covid-19 vaccine. this was partially offset by lower sales of prezista and prezcobix /rezolsta (darunavir/cobicistat) due to increased competition and loss of exclusivity of prezista in certain countries outside the u.s.", "highlight": "driven by the contribution of the covid-19 vaccine. this was partially offset by lower sales of prezista and prezcobix /rezolsta", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 1, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para28", "text": "neuroscience products achieved sales of $7.0 billion, representing an increase of 7.1% as compared to the prior year. paliperidone long-acting injectables growth was driven by sales of invega sustenna /xeplion (paliperidone palmitate) and invega trinza /trevicta from new patient starts and persistence as well as the launch of invega hafyera .", "highlight": "driven by sales of invega sustenna /xeplion (paliperidone palmitate) and invega trinza /trevicta from new patient starts and persistence as well as the launch of invega hafyera .", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para29", "text": "oncology products achieved sales of $14.5 billion in 2021, representing an increase of 17.6% as compared to the prior year. contributors to the growth were strong sales of darzalex (daratumumab) driven by continued strong market growth, share gains in all regions and solid uptake of the subcutaneous formulation launched in 2020; the continued global launch uptake of erleada (apalutamide) and imbruvica (ibrutinib) growth primarily driven by market and continued share leadership. the growth of imbruvica (ibrutinib) was partially offset by competitive pressures from novel oral agents and covid-19 related market dynamics including delays in new patient starts.", "highlight": "contributors to the growth were strong sales of darzalex (daratumumab) driven by continued strong market growth ||| primarily driven by market and continued share leadership. the growth of imbruvica (ibrutinib) was partially offset by competitive pressures from novel oral agents and covid-19 related market dynamics including delays in new patient starts.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para30", "text": "pulmonary hypertension products achieved sales of $3.5 billion, representing an increase of 9.6% as compared to the prior year. sales growth of opsumit (macitentan) and uptravi (selexipag) were due to continued share gains and market growth.", "highlight": "due to continued share gains and market growth.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para31", "text": "cardiovascular/metabolism/other products sales were $4.5 billion, a decline of 8.6% as compared to the prior year. the decline was primarily attributable to lower sales of invokana /invokamet (canagliflozin) due to share erosion and procrit / eprex (epoetin alfa) due to biosimilar competition.", "highlight": "was primarily attributable to lower sales of invokana /invokamet (canagliflozin) due to share erosion and procrit / eprex (epoetin alfa) due to biosimilar competition.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para32", "text": "During 2021, the company advanced its pipeline with several regulatory submissions and approvals for new drugs and additional indications for existing drugs as follows: Product name (chemical name) Indication Us approval Eu approval Us filing Eu filing Byannli Maintenance treatment of schizophrenia in adults Cabenuva (rilpivirine and cabotegravir) Hiv treatment for use every two months Covid-19 vaccine Covid-19 emergency use Covid-19 vaccine booster shot Covid-19 emergency use Darzalex (daratumumab) Subcutaneous (sc) formulation treatment for newly diagnosed systemic light chain amyloidosis and gains an additional approval in pre-treated multiple myeloma Darzalex faspro (daratumumab and hyaluronidase-fihj) Combination with carfilzomib and dexamethasone for patients with multiple myeloma after first or subsequent relapse Invega hafyera (paliperidone palmitate) First and only twice-yearly treatment for adults with schizophrenia Ponvory (ponesimod) Treatment of adults with relapsing forms of multiple sclerosis with active disease defined by clinical or imaging features Ponvory (ponesimod) Oral treatment for adults with relapsing multiple sclerosis Rybrevant (amivantamab-vmjw) Treatment for patients with non-small cell lung cancer with egfr exon 20 insertion mutations Spravato (esketamine) Rapid reduction of depressive symptoms in a psychiatric emergency for patients with major depressive disorder Stelara (ustekinumab) Treatment of pediatric patients with juvenille psoriatic arthritis Teclistamab Treatment of patients with relapsed or refractory multiple myeloma Uptravi (selexipag) Intravenous use in adult patients with pulmonary arterial hypertension (pah) Xarelto (rivaroxaban) Help prevent and treat blood clots in pediatric patients Xarelto (rivaroxaban) Expanded peripheral artery disease (pad) indication to include patients after lower-extremity revascularization (ler) Medical devices segment the medical devices segment sales in 2021 were $27.1 billion, an increase of 17.9% from 2020, which included operational growth of 16.2% and a positive currency impact of 1.7%. u.s. sales were $12.7 billion, an increase of 14.9% as compared to the prior year. international sales were $14.4 billion, an increase of 20.6% as compared to the prior year, which included operational growth of 17.3% and a positive currency impact of 3.3%. in 2021, the net impact of acquisitions and divestitures on the medical devices segment worldwide operational sales growth was a negative 0.6% primarily due to the divestiture of advanced sterilization products (asp). the company has seen a market recovery in global procedural volumes in the medical devices segment as compared to the prior year which had significant negative impacts from covid-19. this procedural volume recovery is the primary driver of sales and earnings growth as compared to the prior year.", "highlight": "During 2021, the company advanced its pipeline with several regulatory submissions and approvals for new drugs and additional indications for existing drugs ||| the company has seen a market recovery in global procedural volumes in the medical devices segment as compared to the prior year which had significant negative impacts from covid-19", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para33", "text": "Major medical devices franchise sales: % change (dollars in millions) 2021 2020 '21 vs. '20 Surgery $ 9,812 8,232 19.2 % Advanced 4,622 3,839 20.4 General 5,190 4,392 18.1 Orthopaedics 8,588 7,763 10.6 Hips 1,485 1,280 16.0 Knees 1,325 1,170 13.3 Trauma 2,885 2,614 10.4 Spine, sports & other 2,893 2,699 7.2 Vision 4,688 3,919 19.6 Contact lenses/other 3,440 2,994 14.9 Surgical 1,248 925 34.9 Interventional solutions 3,971 3,046 30.4 Total medical devices sales $ 27,060 22,959 17.9 % the surgery franchise achieved sales of $9.8 billion in 2021 representing an increase of 19.2% from 2020. the growth in advanced surgery was primarily driven by endocutter, biosurgery and energy products attributable to market recovery, market expansion and the success of new products offsetting competitive pressures in the u.s. the growth in general surgery was primarily driven by market recovery and the continued strength of the suture portfolio partially offset by the impact of the asp divestiture in the prior year.", "highlight": "driven by endocutter, biosurgery and energy products attributable to market recovery, market expansion and the success of new products offsetting competitive pressures in the u.s. the growth in general surgery was primarily driven by market recovery and the continued strength of the suture portfolio partially offset by the impact of the asp divestiture in the prior year.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para34", "text": "the orthopaedics franchise achieved sales of $8.6 billion in 2021, representing an increase of 10.6% from 2020. the growth in hips reflects the market recovery combined with continued strength of the portfolio including the actis stem and enabling technologies kincise and velys hip navigation. the growth in knees was primarily driven by procedure recovery and new product introductions. the growth in trauma was driven by global market recovery and uptake of new products. the growth in spine, sports & other was primarily driven by procedure recovery and new product introductions.", "highlight": "the orthopaedics franchise achieved sales of $8.6 billion in 2021, representing an increase of 10.6% from 2020.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para35", "text": "the vision franchise achieved sales of $4.7 billion in 2021, representing an increase of 19.6% from 2020. the contact lenses/other operational growth was due to market recovery and market share gains from new products. surgical vision operational growth was primarily due to market recovery and uptake of recently launched products.", "highlight": "was primarily due to market recovery and uptake of recently launched products.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para36", "text": "the interventional solutions franchise achieved sales of $4.0 billion in 2021, an increase of 30.4% from 2020. growth in the electrophysiology and stroke businesses were driven by market recovery and success of new products and commercial strategies.", "highlight": "driven by market recovery and success of new products and commercial strategies.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para37", "text": "beginning in the fiscal first quarter of 2022, the medical devices segment will be referred to as the medtech segment.", "highlight": "the medical devices segment will be referred to as the medtech segment.", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para38", "text": "Analysis of consolidated earnings before provision for taxes on income consolidated earnings before provision for taxes on income was $22.8 billion and $16.5 billion for the years 2021 and 2020, respectively. as a percent to sales, consolidated earnings before provision for taxes on income was 24.3% and 20.0%, in 2021 and 2020, respectively.", "highlight": "Analysis of consolidated earnings before provision for taxes on income consolidated earnings ||| was $22.8 billion and $16.5 billion for the years 2021 and 2020 ||| before provision for taxes on income was 24.3% and 20.0%, in 2021 and 2020, respectively.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para39", "text": "(dollars in billions. percentages in chart are as a percent to total sales) Cost of products sold and selling, marketing and administrative expenses: (dollars in billions. percentages in chart are as a percent to total sales) Cost of products sold decreased as a percent to sales driven by: Non-recurring prior year covid-19 production related slow-downs and related inventory impacts Fixed cost deleveraging in the medical devices business in the fiscal 2020 Favorable mix within the pharmaceutical business as well as at the enterprise level with a higher percentage of sales coming from the pharmaceutical business Supply chain efficiencies in the consumer health segment the intangible asset amortization expense included in cost of products sold was $4.7 billion for both fiscal years 2021 and 2020.", "highlight": "the intangible asset amortization expense included in cost of products sold was $4.7 billion for both fiscal years 2021 and 2020.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para40", "text": "Selling, marketing and administrative expenses decreased as a percent to sales driven by: Leveraging in the medical devices business resulting from the recovery of sales from the prior years impact of covid-19 Partially offset by: Increased brand marketing expenses in the consumer health business Research and development expense: Research and development expense by segment of business was as follows: 2021 2020 (dollars in millions) Amount % of sales* Amount % of sales* Consumer health $ 455 3.1 % $ 422 3.0 % Pharmaceutical 11,882 22.8 9,563 21.0 Medical devices 2,377 8.8 2,174 9.5 Total research and development expense $ 14,714 15.7 % $ 12,159 14.7 % Percent increase/(decrease) over the prior year 21.0 % 7.1 % *as a percent to segment sales research and development activities represent a significant part of the company's business. these expenditures relate to the processes of discovering, testing and developing new products, upfront payments and developmental milestones, improving existing products, as well as ensuring product efficacy and regulatory compliance prior to launch. the company remains committed to investing in research and development with the aim of delivering high quality and innovative products.", "highlight": "Consumer health $ 455 3.1 % $ 422 3.0 % Pharmaceutical 11,882 22.8 9,563 21.0 Medical devices 2,377 8.8 2,174 9.5 Total research and development expense $ 14,714 15.7 % $ 12,159 14.7 % Percent increase/(decrease) over the prior year 21.0 % 7.1 % *as a percent to segment sales research and development activities represent a significant part of the company's business", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para41", "text": "Research and development increased as a percent to sales primarily driven by: General portfolio progression in the pharmaceutical business Covid-19 vaccine expenses, net of governmental reimbursements in-process research and development (ipr&d): in fiscal year 2021, the company recorded a partial ipr&d charge of $0.9 billion primarily related to expected development delays in the general surgery digital robotics platform (ottava) acquired with the auris health acquisition in 2019. the impairment charge was calculated based on revisions to the discounted cash flow valuation model reflecting a delay of first in human procedures of approximately two years from the initial acquisition model assumption of the second half of 2022. the company will continue to monitor the remaining $1.5 billion ottava platform intangible asset as development program activities are ongoing. in fiscal year 2020, the company recorded an ipr&d charge of $0.2 billion primarily related to a partial impairment due to timing and progression of one of the digital surgery platforms acquired with the auris health acquisition.", "highlight": "primarily driven by: General portfolio progression in the pharmaceutical business Covid-19 vaccine expenses, net of governmental reimbursements in-process research and development ||| primarily related to a partial impairment due to timing and progression of one of the digital surgery platforms acquired with the auris health acquisition.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para42", "text": "on january 28, 2022, subsequent to the fiscal year 2021, additional information regarding efficacy became available which led the company to the decision to terminate the development of bermekimab for atopic dermatitis (ad). the company recorded an intangible asset impairment charge of approximately $0.6 billion related to an in-process research and development asset, bermekimab (jnj-77474462), an investigational drug for the treatment of ad and hidradenitis suppurativa (hs). the impairment charge is related to the ad indication and is a nonrecognized subsequent event and will be reflected in the first quarter 2022 financial statements. the company acquired all rights to bermekimab from xbiotech, inc. in fiscal year 2020.", "highlight": "recorded an intangible asset impairment charge of approximately $0.6 billion related to an in-process research and development asset ||| he company acquired all rights to bermekimab from xbiotech, inc. in fiscal year 2020.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 2, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para43", "text": "other (income) expense, net: other (income) expense, net is the account where the company records gains and losses related to the sale and write-down of certain investments in equity securities held by johnson & johnson innovation - jjdc, inc. (jjdc), unrealized gains and losses on investments, income and losses associated with certain employee benefit programs, gains and losses on divestitures, certain transactional currency gains and losses, acquisition-related costs, litigation accruals and settlements, as well as royalty income.", "highlight": "divestitures, certain transactional currency gains and losses, acquisition-related costs, litigation accruals and settlements, as well as royalty income.\r\n ||| company records gains and losses related to the sale and write-down of certain investments in equity securities held by johnson & johnson innovation", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para44", "text": "Other (income) expense, net for the fiscal year 2021 was favorable by $2.4 billion as compared to the prior year primarily due to the following: (dollars in billions)(income)/expense 2021 2020 Change Litigation expense (1) $ 2.3 5.1 -2.8 Acquisition, integration and divestiture related (2) -0.5 -1.1 0.6 (gains)/losses on securities -0.5 -0.5 0.0 Restructuring related 0.1 0.1 0.0 Employee benefit plan related -0.6 -0.4 -0.2 Other (3) -0.3 -0.3 Total other (income) expense, net $ 0.5 2.9 -2.4 ( 1) 2021 is primarily related to talc and risperdal. 2020 is primarily related to talc and the opioid litigation settlement.", "highlight": "2021 2020 Change Litigation expense (1) $ 2.3 5.1 -2.8 Acquisition, integration and divestiture related (2) -0.5 -1.1 0.6 (gains)/losses on securities -0.5 -0.5 0.0 Restructuring related 0.1 0.1 0.0 Employee benefit plan related -0.6 -0.4 -0.2 Other (3) -0.3 -0.3 Total other (income) expense, net $ 0.5 2.9 -2.4 ( 1) 2021 is primarily related to talc and risperdal", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para45", "text": "-2) 2021 is p rimarily related to divestiture gains of two pharmaceutical brands outside the u.s.", "highlight": "2021 is p rimarily related to divestiture gains of two pharmaceutical brands", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para46", "text": "2020 is primarily driven by a contingent consideration reversal of approximately $1.1 billion related to the timing of certain developmental milestones associated with the auris health acquisition.", "highlight": "primarily driven by a contingent consideration reversal of approximately $1.1 billion related to the timing of certain developmental milestones", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para47", "text": "-3 ) 2021 includes consumer health separation costs of $0.1 billion. costs in future years are expected to be significantly higher.", "highlight": "2021 includes consumer health separation costs of $0.1 billion", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para48", "text": "interest (income) expense: the fiscal year 2021 included net interest expense of $130 million as compared to $90 million net interest expense in the fiscal year 2020. this was primarily due to lower rates of interest earned on cash balances and a higher average debt balance, partially offset by the benefit from net investment hedging. cash, cash equivalents and marketable securities totaled $31.6 billion at the end of 2021, and averaged $28.4 billion as compared to the cash, cash equivalents and marketable securities total of $25.2 billion and $22.2 billion average cash balance in 2020. the total debt balance at the end of 2021 was $33.8 billion with an average debt balance of $34.5 billion as compared to $35.3 billion at the end of 2020 and an average debt balance of $31.5 billion.", "highlight": "the fiscal year 2021 included net interest expense of $130 million as compared to $90 million net interest expense in the fiscal year 2020 ||| cash equivalents and marketable securities totaled $31.6 billion at the end of 2021, and averaged $28.4 billion ||| 25.2 billion and $22.2 billion average cash balance in 2020. the total debt balance at the end of 2021 was $33.8 billion with an average debt balance of $34.5 billion as compared to $35.3 billion at the end of 2020 and an average debt balance of $31.5 billion", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para49", "text": "Income before tax by segment Income (loss) before tax by segment of business were as follows: Income before tax Segment sales Percent of segment sales (dollars in millions) 2021 2020 2021 2020 2021 2020 Consumer health $ 1,294 -1,064 14,635 14,053 8.8 % -7.6 Pharmaceutical 18,181 15,462 52,080 45,572 34.9 33.9 Medical devices 4,373 3,044 27,060 22,959 16.2 13.3 Total (1) 23,848 17,442 93,775 82,584 25.4 21.1 Less: net expense not allocated to segments (2) 1,072 945 Earnings before provision for taxes on income $ 22,776 16,497 93,775 82,584 24.3 % 20.0 -1) see note 17 to the consolidated financial statements for more details.", "highlight": "2021 2020 2021 2020 2021 2020 Consumer health $ 1,294 -1,064 14,635 14,053 8.8 % -7.6 Pharmaceutical 18,181 15,462 52,080 45,572 34.9 33.9 Medical devices 4,373 3,044 27,060 22,959 16.2 13.3 Total (1) 23,848 17,442 93,775 82,584 25.4 21.1 Less: net expense not allocated to segments (2) 1,072 945 Earnings before provision for taxes on income $ 22,776 16,497 93,775 82,584 24.3 % 20.0 -1)", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para50", "text": "-2) amounts not allocated to segments include interest (income) expense and general corporate (income) expense.", "highlight": "interest (income) expense and general corporate (income) expense.", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para51", "text": "Consumer health segment: In 2021, the consumer health segment income before tax as a percent of sales was 8.8% versus a loss before tax of 7.6% in 2020. the increase in the income before tax as a percent of sales was primarily driven by the following: 2021 litigation expense includes $1.6 billion of talc expenses; 2020 includes $3.9 billion of talc expenses Supply chain efficiencies Partially offset by: Increased brand marketing expenses and commodity inflation Pharmaceutical segment: In 2021, the pharmaceutical segment income before tax as a percent to sales was 34.9% versus 33.9% in 2020. the increase in the income before tax as a percent of sales was primarily driven by the following: Divestiture gains of $0.6 billion related to two pharmaceutical brands outside the u.s. in fiscal 2021 2021 litigation expense includes $0.6 billion primarily related to risperdal; 2020 includes $0.8 billion primarily related to the opioid litigation settlement Partially offset by: Research & development investment in the covid-19 vaccine net of governmental reimbursements and general portfolio progression Medical devices segment: in 2021, the medical devices segment income before tax as a percent to sales was 16.2% versus 13.3% in 2020. the increase in the income before tax as a percent to sales was primarily driven by the following: Recovery of prior year covid-19 production related slow downs and related inventory impacts Overall expense leveraging resulting from the medical devices sales recovery Litigation expense of $0.1 billion in 2021 vs. $0.3 billion in 2020 Partially offset by: A contingent consideration reversal of approximately $1.1 billion in the fiscal 2020 related to the timing of certain developmental milestones associated with the auris health acquisition A higher ipr&d charge of $0.7 billion ($0.9 billion in 2021 related to the general surgery offering in digital robotics (ottava) acquired with the auris health acquisition in 2019) restructuring: in the fiscal second quarter of 2018, the company announced plans to implement actions across its global supply chain that are intended to enable the company to focus resources and increase investments in critical capabilities, technologies and solutions necessary to manufacture and supply its product portfolio of the future, enhance agility and drive growth. the company expects these supply chain actions will include expanding its use of strategic collaborations, and bolstering its initiatives to reduce complexity, improving cost-competitiveness, enhancing capabilities and optimizing its network. discussions regarding specific future actions are ongoing and are subject to all relevant consultation requirements before they are finalized. in total, the company expects these actions to generate approximately $0.6 to $0.8 billion in annual pre-tax cost savings that will be substantially delivered by the end of 2022. the company expects to record pre-tax restructuring charges of approximately $2.1 to $2.3 billion. the company estimates that approximately 70% of the cumulative pre-tax costs will result in cash outlays. in 2021, the company recorded a pre-tax charge of $0.5 billion, which is included on the following lines of the consolidated statement of earnings, $0.3 billion in restructuring, $0.1 billion in other (income) expense and $0.1 billion in cost of products sold. total project costs of approximately $1.8 billion have been recorded since the restructuring was announced. the program is set to be completed at the end of 2022.", "highlight": "the consumer health segment income before tax as a percent of sales was 8.8% versus a loss before tax of 7.6% in 2020 ||| 2021 litigation expense includes $1.6 billion of talc expenses; 2020 includes $3.9 billion of talc expenses Supply chain efficiencies  ||| In 2021, the pharmaceutical segment income before tax as a percent to sales was 34.9% versus 33.9% in 2020. ||| Divestiture gains of $0.6 billion related to two pharmaceutical brands outside the u.s. in ||| 2021 litigation expense includes $0.6 billion primarily related to risperdal; 2020 includes $0.8 billion primarily related to the opioid litigation settlement |||  ||| Overall expense leveraging resulting from the medical devices sales recovery Litigation expense of $0.1 billion in 2021 vs. $0.3 billion in 2020 |||  A higher ipr&d charge of $0.7 billion ||| in total, the company expects these actions to generate approximately $0.6 to $0.8 billion in annual pre-tax cost savings that will be substantially delivered by the end of 2022 ||| the company expects to record pre-tax restructuring charges of approximately $2.1 to $2.3 billion. the company estimates that approximately 70% of the cumulative pre-tax costs will result in cash outlays |||  in 2021, the company recorded a pre-tax charge of $0.5 billion", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para52", "text": "see note 20 to the consolidated financial statements for additional details related to the restructuring programs.", "highlight": "note 20 to the consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para53", "text": "provision for taxes on income: the worldwide effective income tax rate was 8.3% in 2021 and 10.8% in 2020.", "highlight": "worldwide effective income tax rate was 8.3% in 2021 and 10.8% in 2020.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para54", "text": "for discussion related to the fiscal 2021 provision for taxes refer to note 8 to the consolidated financial statements.", "highlight": "note 8 to the consolidated financial statements.", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para55", "text": "Liquidity and capital resources Liquidity & cash flows cash and cash equivalents were $14.5 billion at the end of 2021 as compared to $14.0 billion at the end of 2020.", "highlight": "cash and cash equivalents were $14.5 billion at the end of 2021 as compared to $14.0 billion at the end of 2020.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para56", "text": "The primary sources and uses of cash that contributed to the $0.5 billion increase were: (dollars in billions) $ 14.0 Q4 2020 cash and cash equivalents balance 23.4 Cash generated from operating activities -8.7 Net cash used by investing activities -14.0 Net cash used by financing activities -0.2 Effect of exchange rate and rounding $ 14.5 Q4 2021 cash and cash equivalents balance in addition, the company had $17.1 billion in marketable securities at the end of fiscal year 2021 and $11.2 billion at the end of fiscal year 2020. see note 1 to the consolidated financial statements for additional details on cash, cash equivalents and marketable securities.", "highlight": "$ 14.0 Q4 2020 cash and cash equivalents balance 23.4 Cash generated from operating activities -8.7 Net cash used by investing activities -14.0 Net cash used by financing activities -0.2 Effect of exchange rate and rounding $ 14.5 Q4 2021 cash and cash equivalents balance in addition, the company had $17.1 billion in marketable securities at the end of fiscal year 2021 and $11.2 billion at the end of fiscal year 2020.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para57", "text": "Cash flow from operations of $23.4 billion was the result of: (dollars in billions) $ 20.9 Net earnings 6.8 Non-cash expenses and other adjustments primarily for depreciation and amortization, stock-based compensation and asset write-downs partially offset by the deferred tax provision, net gain on sale of assets/businesses and credit losses and accounts receivable allowances -1.1 A decrease in current and non-current liabilities 2.4 An increase in accounts payable and accrued liabilities -5.6 An increase in accounts receivable, inventories and other current and non-current assets $ 23.4 Cash flow from operations Investing activities use of $8.7 billion of cash was primarily used for: (dollars in billions) $ (3.7) Additions to property, plant and equipment -5.4 Net purchases of investments 0.7 Proceeds from the disposal of assets/businesses, net 0.2 Credit support agreements activity, net -0.1 Acquisitions -0.4 Other (primarily licenses and milestones) and rounding $ (8.7) Net cash used for investing activities Financing activities use of $14.0 billion of cash was primarily used for: (dollars in billions) $ (11.0) Dividends to shareholders -3.5 Repurchase of common stock for employee share programs -1.0 Net repayment from short and long term debt 1.0 Proceeds from stock options exercised/employee withholding tax on stock awards, net 0.3 Credit support agreements activity, net 0.2 Other and rounding $ (14.0) Net cash used for financing activities As of january 2, 2022, the company's notes payable and long-term debt was in excess of cash, cash equivalents and marketable securities. as of january 2, 2022, the net debt position was $2.1 billion as compared to the prior year of $10.1 billion. there was a decrease in the net debt position due to repayment of debt and an increase in cash, cash equivalents, and marketable securities generating from operations. the debt balance at the end of 2021 was $33.8 billion as compared to $35.3 billion in 2020. considering recent market conditions and the on-going covid-19 crisis, the company has evaluated its operating cash flows and liquidity profile and does not foresee any significant incremental risk. the company anticipates that operating cash flows, the ability to raise funds from external sources, borrowing capacity from existing committed credit facilities and access to the commercial paper markets will continue to provide sufficient resources to fund operating needs, including the company's approximate $1.1 billion in contractual supply commitments associated with its development of the covid-19 vaccine, the opioid litigation settlement for $5.0 billion and the establishment of the $2.0 billion trust for talc related liabilities (see note 19 to the consolidated financial statements for additional details). in addition, the company monitors the global capital markets on an ongoing basis and from time to time may raise capital when market conditions are favorable. effective beginning in fiscal 2022, the u.s. tax cuts and job act of 2017 currently requires the company to deduct u.s. and international research and development expenditures for tax purposes over 5 to 15 years, instead of in the current fiscal year. as a result, the company is expecting an increase in annual cash tax payments to the u.s treasury of an incremental $1.0 to 1.5 billion beginning in fiscal 2022. the company will concurrently record a deferred tax benefit for the future amortization of the research and development (r&d) for tax purposes and therefore, the company is not expecting a significant impact to its effective tax rate related to this change. the requirement to expense r&d as incurred is unchanged for u.s. gaap purposes and the impact to pre-tax r&d expense is not affected by this provision. additionally, as a result of the tax cuts and jobs act (tcja), the company has access to its cash outside the u.s. at a significantly reduced cost. during the fiscal third quarter of 2021, in accordance with the terms of the agreement associated with the acquisition of actelion, the company's undrawn credit facility with idorsia was terminated.", "highlight": "$ 20.9 Net earnings 6.8 Non-cash expenses and other adjustments  ||| , net gain on sale of assets/businesses and credit losses and accounts receivable allowances -1.1 A decrease in current and non-current liabilities 2.4 An increase in accounts payable and accrued liabilities -5.6 An increase in accounts receivable, inventories and other current and non-current assets $ 23.4 Cash flow from operations Investing activities use of $8.7 billion of cash was primarily used for: (dollars in billions) $ (3.7) Additions to property, plant and equipment -5.4 Net purchases of investments 0.7 Proceeds from the disposal of assets/businesses, net 0.2 Credit support agreements activity, net -0.1 Acquisitions -0.4 Other (primarily licenses and milestones) and rounding $ (8.7) Net cash used for investing activities Financing activities use of $14.0 billion of cash was primarily used for: (dollars in billions) $ (11.0) Dividends to shareholders -3.5 Repurchase of common stock for employee share programs -1.0 Net repayment from short and long term debt 1.0 Proceeds from stock options exercised/employee withholding tax on stock awards, net 0.3 Credit support agreements activity, net 0.2  |||  the net debt position was $2.1 billion as compared to the prior year of $10.1 billion. ||| debt balance at the end of 2021 was $33.8 billion as compared to $35.3 billion in 2020. ||| to provide sufficient resources to fund operating needs, including the company's approximate $1.1 billion in contractual supply commitments associated with its development of the covid-19 vaccine, the opioid litigation settlement for $5.0 billion and the establishment of the $2.0 billion trust for talc related liabilities |||  as a result, the company is expecting an increase in annual cash tax payments to the u.s treasury of an incremental $1.0 to 1.5 billion beginning in fiscal 2022. |||  during the fiscal third quarter of 2021, in accordance with the terms of the agreement associated with the acquisition of actelion, the company's undrawn credit facility with idorsia was terminated.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para58", "text": "the following table summarizes the company's material contractual obligations and their aggregate maturities as of january 2, 2022: to satisfy these obligations, the company intends to use cash from operations.", "highlight": "the following table summarizes the company's material contractual obligations and their aggregate maturities as of january 2, 2022", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para59", "text": "(dollars in millions) Tax legislation (tcja) Debt obligations Interest on Debt obligations Total 2022 $ 812 2,131 909 3,852 2023 1,522 1,551 893 3,966 2024 2,029 1,518 843 4,390 2025 2,536 1,732 789 5,057 2026 1,995 744 2,739 After 2026 23,189 8,786 31,975 Total $ 6,899 32,116 12,964 51,979 for tax matters, see note 8 to the consolidated financial statements. the table does not include activity related to business combinations or the company's approximate $1.1 billion in contractual supply commitments associated with its development of a covid-19 vaccine.", "highlight": "Debt obligations Interest on Debt obligations Total 2022 $ 812 2,131 909 3,852 2023 1,522 1,551 893 3,966 2024 2,029 1,518 843 4,390 2025 2,536 1,732 789 5,057 2026 1,995 744 2,739 After 2026 23,189 8,786 31,975 Total $ 6,899 32,116 12,964 51,979 for tax matters, see note 8 to the consolidated financial statements", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para60", "text": "Financing and market risk the company uses financial instruments to manage the impact of foreign exchange rate changes on cash flows. accordingly, the company enters into forward foreign exchange contracts to protect the value of certain foreign currency assets and liabilities and to hedge future foreign currency transactions primarily related to product costs. gains or losses on these contracts are offset by the gains or losses on the underlying transactions. a 10% appreciation of the u.s. dollar from the january 2, 2022 market rates would increase the unrealized value of the company's forward contracts by $0.1 billion. conversely, a 10% depreciation of the u.s. dollar from the january 2, 2022 market rates would decrease the unrealized value of the company's forward contracts by $0.1 billion. in either scenario, the gain or loss on the forward contract would be offset by the gain or loss on the underlying transaction, and therefore, would have no impact on future anticipated earnings and cash flows.", "highlight": "the company enters into forward foreign exchange contracts to protect the value of certain foreign currency assets and liabilities and to hedge future foreign currency transactions primarily related to product costs ||| the gain or loss on the forward contract would be offset by the gain or loss on the underlying transaction, and therefore, would have no impact on future anticipated earnings and cash flows.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para61", "text": "the company hedges the exposure to fluctuations in currency exchange rates, and the effect on certain assets and liabilities in foreign currency, by entering into currency swap contracts. a 1% change in the spread between u.s. and foreign interest rates on the company's interest rate sensitive financial instruments would either increase or decrease the unrealized value of the company's swap contracts by approximately $2.2 billion. in either scenario, at maturity, the gain or loss on the swap contract would be offset by the gain or loss on the underlying transaction, and therefore, would have no impact on future anticipated cash flows.", "highlight": "a 1% change in the spread between u.s. and foreign interest rates on the company's interest rate sensitive financial instruments would either increase or decrease the unrealized value of the company's swap contracts by approximately $2.2 billion", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para62", "text": "the company does not enter into financial instruments for trading or speculative purposes. further, the company has a policy of only entering into contracts with parties that have at least an investment grade credit rating. the counterparties to these contracts are major financial institutions and there is no significant concentration of exposure with any one counterparty. management believes the risk of loss is remote. the company entered into credit support agreements (csa) with certain derivative counterparties establishing collateral thresholds based on respective credit ratings and netting agreements. see note 6 to the consolidated financial statements for additional details on credit support agreements.", "highlight": "the company does not enter into financial instruments for trading or speculative purposes ||| the company has a policy of only entering into contracts with parties that have at least an investment grade credit rating ||| believes the risk of loss is remote", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para63", "text": "the company invests in both fixed rate and floating rate interest earning securities which carry a degree of interest rate risk. the fair market value of fixed rate securities may be adversely impacted due to a rise in interest rates, while floating rate securities may produce less income than predicted if interest rates fall. a 1% (100 basis points) change in spread on the company's interest rate sensitive investments would either increase or decrease the unrealized value of cash equivalents and current marketable securities by approximately $0.1 billion.", "highlight": "the company invests in both fixed rate and floating rate interest earning securities which carry a degree of interest rate risk ||| a 1% (100 basis points) change in spread on the company's interest rate sensitive investments would either increase or decrease the unrealized value of cash equivalents and current marketable securities by approximately $0.1 billion.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para64", "text": "the company has access to substantial sources of funds at numerous banks worldwide. in september 2021, the company secured a new 364-day credit facility. total credit available to the company approximates $10 billion, which expires on september 8, 2022. interest charged on borrowings under the credit line agreement is based on either secured overnight financing rate (sofr) reference rate or other applicable market rate as allowed plus applicable margins. commitment fees under the agreement are not material.", "highlight": "the company has access to substantial sources of funds at numerous banks worldwide ||| interest charged on borrowings under the credit line agreement is based on either secured overnight financing rate (sofr) reference rate or other applicable market rate as allowed plus applicable margins", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para65", "text": "total borrowings at the end of 2021 and 2020 were $33.8 billion and $35.3 billion, respectively. the decrease in borrowings was due to the repayment of debt. in 2021, net debt (cash and current marketable securities, net of debt) was $2.1 billion compared to net debt of $10.1 billion in 2020. total debt represented 31.3% of total capital (shareholders' equity and total debt) in 2021 and 35.8% of total capital in 2020. shareholders' equity per share at the end of 2021 was $28.16 compared to $24.04 at year-end 2020.", "highlight": "total borrowings at the end of 2021 and 2020 were $33.8 billion and $35.3 billion, respectively ||| in 2021, net debt ||| was $2.1 billion compared to net debt of $10.1 billion in 2020. total debt represented 31.3% of total capital ||| in 2021 and 35.8% of total capital in 2020. shareholders' equity per share at the end of 2021 was $28.16 compared to $24.04 at year-end 2020.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para66", "text": "a summary of borrowings can be found in note 7 to the consolidated financial statements.", "highlight": "note 7 to the consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para67", "text": "Dividends the company increased its dividend in 2021 for the 59th consecutive year. cash dividends paid were $4.19 per share in 2021 and $3.98 per share in 2020.", "highlight": "cash dividends paid were $4.19 per share in 2021 and $3.98 per share in 2020.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para68", "text": "on january 4, 2022, the board of directors declared a regular cash dividend of $1.06 per share, payable on march 8, 2022 to shareholders of record as of february 22, 2022.", "highlight": "cash dividend of $1.06 per share, payable on march 8, 2022", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para69", "text": "Other information Critical accounting policies and estimates management's discussion and analysis of results of operations and financial condition are based on the company's consolidated financial statements that have been prepared in accordance with accounting principles generally accepted in the u.s. (gaap). the preparation of these financial statements requires that management make estimates and assumptions that affect the amounts reported for revenues, expenses, assets, liabilities and other related disclosures. actual results may or may not differ from these estimates. the company believes that the understanding of certain key accounting policies and estimates are essential in achieving more insight into the company's operating results and financial condition. these key accounting policies include revenue recognition, income taxes, legal and self-insurance contingencies, valuation of long-lived assets, assumptions used to determine the amounts recorded for pensions and other employee benefit plans and accounting for stock based awards.", "highlight": "the company believes that the understanding of certain key accounting policies and estimates are essential in achieving more insight into the company's operating results and financial condition.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para70", "text": "the extent to which covid-19 impacts the company's business and financial results will depend on numerous evolving factors including, but not limited to, the magnitude and duration of covid-19, the extent to which it will impact worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. the company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the company and the unknown future impacts of covid-19 as of january 2, 2022 and through the date of this report. the accounting matters assessed included, but were not limited to, the company's allowance for doubtful accounts and credit losses, inventory and related reserves, accrued rebates and associated reserves, and the carrying value of the goodwill and other long-lived assets. while there was not a material impact to the company's consolidated financial statements as of and for the year ended january 2, 2022, the company's future assessment of the magnitude and duration of covid-19, as well as other factors, could result in material impacts to the company's consolidated financial statements in future reporting periods.", "highlight": "the accounting matters assessed included, but were not limited to, the company's allowance for doubtful accounts and credit losses, inventory and related reserves, accrued rebates and associated reserves, and the carrying value of the goodwill and other long-lived assets ||| could result in material impacts to the company's consolidated financial statements in future reporting periods.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para71", "text": "revenue recognition: the company recognizes revenue from product sales when obligations under the terms of a contract with the customer are satisfied; generally, this occurs with the transfer of control of the goods to customers. the company's global payment terms are typically between 30 to 90 days. provisions for certain rebates, sales incentives, trade promotions, coupons, product returns, discounts to customers and governmental clawback provisions are accounted for as variable consideration and recorded as a reduction in sales.", "highlight": "the company's global payment terms are typically between 30 to 90 days", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para72", "text": "product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including consideration of competitor pricing. rebates are estimated based on contractual terms, historical experience, patient outcomes, trend analysis and projected market conditions in the various markets served. the company evaluates market conditions for products or groups of products primarily through the analysis of wholesaler and other third-party sell-through and market research data, as well as internally generated information.", "highlight": "product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including consideration of competitor pricing ||| the company evaluates market conditions for products or groups of products primarily through the analysis of wholesaler and other third-party sell-through and market research data, as well as internally generated information.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para73", "text": "sales returns are estimated and recorded based on historical sales and returns information. products that exhibit unusual sales or return patterns due to dating, competition or other marketing matters are specifically investigated and analyzed as part of the accounting for sales return accruals.", "highlight": "sales returns are estimated and recorded based on historical sales and returns information", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para74", "text": "sales returns allowances represent a reserve for products that may be returned due to expiration, destruction in the field, or in specific areas, product recall. the sales returns reserve is based on historical return trends by product and by market as a percent to gross sales. in accordance with the company's accounting policies, the company generally issues credit to customers for returned goods. the company's sales returns reserves are accounted for in accordance with the u.s. gaap guidance for revenue recognition when right of return exists. sales returns reserves are recorded at full sales value. sales returns in the consumer health and pharmaceutical segments are almost exclusively not resalable. sales returns for certain franchises in the medical devices segment are typically resalable but are not material. the company infrequently exchanges products from inventory for returned products. the sales returns reserve for the total company has been approximately 1.0% of annual net trade sales during the fiscal years 2021 and 2020.", "highlight": "the company generally issues credit to customers for returned goods. the company's sales returns reserves are accounted for in accordance with the u.s. gaap guidance for revenue recognition when right of return exists. ||| the sales returns reserve for the total company has been approximately 1.0% of annual net trade sales during the fiscal years 2021 and 2020.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para75", "text": "Promotional programs, such as product listing allowances and cooperative advertising arrangements, are recorded in the same period as related sales. continuing promotional programs include coupons and volume-based sales incentive programs. the redemption cost of consumer coupons is based on historical redemption experience by product and value. volume-based incentive programs are based on the estimated sales volumes for the incentive period and are recorded as products are sold. these arrangements are evaluated to determine the appropriate amounts to be deferred or recorded as a reduction of revenue. the company also earns profit-share payments through collaborative arrangements of certain products, which are included in sales to customers. for all years presented, profit-share payments were less than 3.0% of the total revenues and are included in sales to customers.", "highlight": "Promotional programs ||| are recorded in the same period as related sales. ||| volume-based incentive programs are based on the estimated sales volumes for the incentive period and are recorded as products are sold. ||| for all years presented, profit-share payments were less than 3.0% of the total revenues and are included in sales to customers.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 2, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para76", "text": "in addition, the company enters into collaboration arrangements that contain multiple revenue generating activities. amounts due from collaborative partners for these arrangements are recognized as each activity is performed or delivered, based on the relative selling price. upfront fees received as part of these arrangements are deferred and recognized over the performance period. see note 1 to the consolidated financial statements for additional disclosures on collaborations.", "highlight": "the company enters into collaboration arrangements that contain multiple revenue generating activities", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para77", "text": "reasonably likely changes to assumptions used to calculate the accruals for rebates, returns and promotions are not anticipated to have a material effect on the financial statements. the company currently discloses the impact of changes to assumptions in the quarterly or annual filing in which there is a material financial statement impact.", "highlight": "the company currently discloses the impact of changes to assumptions in the quarterly or annual filing in which there is a material financial statement impact.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para78", "text": "below are tables that show the progression of accrued rebates, returns, promotions, reserve for doubtful accounts and reserve for cash discounts by segment of business for the fiscal years ended january 2, 2022 and january 3, 2021.", "highlight": "", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para79", "text": "Consumer health segment (dollars in millions) Balance at Beginning of period Accruals Payments/credits Balance at End of period 2021 Accrued rebates (1) $ 289 893 -895 287 Accrued returns 76 136 -136 76 Accrued promotions 428 1,958 -1,999 387 Subtotal $ 793 2,987 -3,030 750 Reserve for doubtful accounts 39 0 -7 32 Reserve for cash discounts 12 213 -210 15 Total $ 844 3,200 -3,247 797 2020 Accrued rebates (1) $ 284 793 -788 289 Accrued returns 63 138 -125 76 Accrued promotions 487 1,988 -2,047 428 Subtotal $ 834 2,919 -2,960 793 Reserve for doubtful accounts 7 -3 39 Reserve for cash discounts 17 201 -206 12 Total $ 886 3,127 -3,169 844 -1) includes reserve for customer rebates of $80 million at january 2, 2022 and $66 million at january 3, 2021, recorded as a contra asset.", "highlight": "Accrued rebates (1) $ 289 893 -895 287 Accrued returns 76 136 -136 76 Accrued promotions 428 1,958 -1,999 387 Subtotal $ 793 2,987 -3,030 750 Reserve for doubtful accounts 39 0 -7 32 Reserve for cash discounts 12 213 -210 15 Total $ 844 3,200 -3,247 797 2020 Accrued rebates (1) $ 284 793 -788 289 Accrued returns 63 138 -125 76 Accrued promotions 487 1,988 -2,047 428 Subtotal $ 834 2,919 -2,960 793 Reserve for doubtful accounts 7 -3 39 Reserve for cash discounts 17 201 -206 12 Total $ 886 3,127 -3,169 844 -1)", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para80", "text": "35 Pharmaceutical segment (dollars in millions) Balance at Beginning of period Accruals Payments/credits (2) Balance at End of period 2021 Accrued rebates (1) $ 9,837 37,922 -37,428 10,331 Accrued returns 460 345 -285 520 Accrued promotions 6 13 -16 3 Subtotal 10,303 38,280 -37,729 10,854 Reserve for doubtful accounts 52 18 -20 50 Reserve for cash discounts 70 1,163 -1,139 94 Total 10,425 39,461 -38,888 10,998 2020 Accrued rebates (1) $ 9,013 32,415 -31,591 9,837 Accrued returns 500 233 -273 460 Accrued promotions 5 10 -9 6 Subtotal $ 9,518 32,658 -31,873 10,303 Reserve for doubtful accounts 24 -8 52 Reserve for cash discounts 65 1,034 -1,029 70 Total $ 9,619 33,716 -32,910 10,425 -1) includes reserve for customer rebates of $218 million at january 2, 2022 and $174 million at january 3, 2021, recorded as a contra asset.", "highlight": "Accruals Payments/credits (2) Balance at End of period 2021 Accrued rebates (1) $ 9,837 37,922 -37,428 10,331 Accrued returns 460 345 -285 520 Accrued promotions 6 13 -16 3 Subtotal 10,303 38,280 -37,729 10,854 Reserve for doubtful accounts 52 18 -20 50 Reserve for cash discounts 70 1,163 -1,139 94 Total 10,425 39,461 -38,888 10,998 2020 Accrued rebates (1) $ 9,013 32,415 -31,591 9,837 Accrued returns 500 233 -273 460 Accrued promotions 5 10 -9 6 Subtotal $ 9,518 32,658 -31,873 10,303 Reserve for doubtful accounts 24 -8 52 Reserve for cash discounts 65 1,034 -1,029 70 Total $ 9,619 33,716 -32,910 10,425 -1)", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para81", "text": "-2) includes prior period adjustments Medical devices segment (dollars in millions) Balance at Beginning of period Accruals Payments/credits Balance at End of period 2021 Accrued rebates ( 1) $ 1,174 5,942 -5,670 1,446 Accrued returns 138 559 -563 134 Accrued promotions 52 140 -138 54 Subtotal 1,364 6,641 -6,371 1,634 Reserve for doubtful accounts 202 12 -66 148 Reserve for cash discounts 9 96 -95 10 Total 1,575 6,749 -6,532 1,792 2020 Accrued rebates (1) $ 1,013 5,144 -4,983 1,174 Accrued returns 118 578 -558 138 Accrued promotions 46 118 -112 52 Subtotal $ 1,177 5,840 -5,653 1,364 Reserve for doubtful accounts 155 95 -48 202 Reserve for cash discounts 10 88 -89 9 Total $ 1,342 6,023 -5,790 1,575 -1) includes reserve for customer rebates of $845 million at january 2, 2022 and $707 million at january 3, 2021, recorded as a contra asset.", "highlight": "Accrued rebates ( 1) $ 1,174 5,942 -5,670 1,446 Accrued returns 138 559 -563 134 Accrued promotions 52 140 -138 54 Subtotal 1,364 6,641 -6,371 1,634 Reserve for doubtful accounts 202 12 -66 148 Reserve for cash discounts 9 96 -95 10 Total 1,575 6,749 -6,532 1,792 2020 Accrued rebates (1) $ 1,013 5,144 -4,983 1,174 Accrued returns 118 578 -558 138 Accrued promotions 46 118 -112 52 Subtotal $ 1,177 5,840 -5,653 1,364 Reserve for doubtful accounts 155 95 -48 202 Reserve for cash discounts 10 88 -89 9 Total $ 1,342 6,023 -5,790 1,575 -1) includes reserve for customer rebates of $845 million at january 2, 2022 and $707 million at january 3, 202", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para82", "text": "36 income taxes: income taxes are recorded based on amounts refundable or payable for the current year and include the results of any difference between u.s. gaap accounting and tax reporting, recorded as deferred tax assets or liabilities. the company estimates deferred tax assets and liabilities based on enacted tax regulations and rates. future changes in tax laws and rates may affect recorded deferred tax assets and liabilities.", "highlight": "income taxes are recorded based on amounts refundable or payable for the current year and include the results of any difference between u.s. gaap accounting and tax reporting ||| future changes in tax laws and rates may affect recorded deferred tax assets and liabilities.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para83", "text": "the company has unrecognized tax benefits for uncertain tax positions. the company follows u.s. gaap, which prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. management believes that changes in these estimates would not have a material effect on the company's results of operations, cash flows or financial position.", "highlight": "the company has unrecognized tax benefits for uncertain tax positions. the company follows u.s. gaap ||| management believes that changes in these estimates would not have a material effect on the company's results of operations, cash flows or financial position.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para84", "text": "the company has recorded deferred tax liabilities on all undistributed earnings prior to december 31, 2017 from its international subsidiaries. the company has not provided deferred taxes on the undistributed earnings subsequent to january 1, 2018 from certain international subsidiaries where the earnings are considered to be indefinitely reinvested. the company intends to continue to reinvest these earnings in those international operations. if the company decides at a later date to repatriate these earnings to the u.s., the company would be required to provide for the net tax effects on these amounts. the company estimates that the tax effect of this repatriation would be approximately $0.7 billion under currently enacted tax laws and regulations and at current currency exchange rates. this amount does not include the possible benefit of u.s. foreign tax credits, which may substantially offset this cost.", "highlight": "the company has recorded deferred tax liabilities on all undistributed earnings ||| the company has not provided deferred taxes on the undistributed earnings ||| the company intends to continue to reinvest these earnings in those international operations ||| company decides at a later date to repatriate these earnings to the u.s., the company would be required to provide for the net tax effects on these amounts ||| company estimates that the tax effect of this repatriation would be approximately $0.7 billion", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 3, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para85", "text": "see note 1 and note 8 to the consolidated financial statements for further information regarding income taxes.", "highlight": "note 1 and note 8 to the consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para86", "text": "legal and self insurance contingencies: the company records accruals for various contingencies, including legal proceedings and product liability claims as these arise in the normal course of business. the accruals are based on management's judgment as to the probability of losses and, where applicable, actuarially determined estimates. the company has self insurance through a wholly-owned captive insurance company. in addition to accruals in the self insurance program, claims that exceed the insurance coverage are accrued when losses are probable and amounts can be reasonably estimated.", "highlight": "the company records accruals for various contingencies, including legal proceedings and product liability claims as these arise in the normal course of business ||| the company has self insurance through a wholly-owned captive insurance company. in addition to accruals in the self insurance program, claims that exceed the insurance coverage are accrued when losses are probable and amounts can be reasonably estimated.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para87", "text": "the company follows the provisions of u.s. gaap when recording litigation related contingencies. a liability is recorded when a loss is probable and can be reasonably estimated.", "highlight": "a liability is recorded when a loss is probable and can be reasonably estimated.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para88", "text": "see notes 1 and 19 to the consolidated financial statements for further information regarding product liability and legal proceedings.", "highlight": "notes 1 and 19 to the consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para89", "text": "long-lived and intangible assets: the company assesses changes, both qualitatively and quantitatively, in economic conditions and makes assumptions regarding estimated future cash flows in evaluating the value of the company's property, plant and equipment, goodwill and intangible assets. as these assumptions and estimates may change over time, it may or may not be necessary for the company to record impairment charges.", "highlight": "these assumptions and estimates may change over time, it may or may not be necessary for the company to record impairment charges.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para90", "text": "employee benefit plans: the company sponsors various retirement and pension plans, including defined benefit, defined contribution and termination indemnity plans, which cover most employees worldwide. these plans are based on assumptions for the discount rate, expected return on plan assets, mortality rates, expected salary increases, healthcare cost trend rates and attrition rates. see note 10 to the consolidated financial statements for further details on these rates.", "highlight": "the company sponsors various retirement and pension plans, including defined benefit, defined contribution and termination indemnity plans, which cover most employees worldwide", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para91", "text": "stock based compensation: the company recognizes compensation expense associated with the issuance of equity instruments to employees for their services. based on the type of equity instrument, the fair value is estimated on the date of grant using either the black-scholes option valuation model or a combination of both the black-scholes option valuation model and monte carlo valuation model, and is expensed in the financial statements over the service period. the input assumptions used in determining fair value are the expected life, expected volatility, risk-free rate and expected dividend yield. prior to fiscal 2020, for performance share units, the fair market value was calculated for each of the three component goals at the date of grant: operational sales, adjusted operational earnings per share and relative total shareholder return. beginning in fiscal 2020, for performance share units, the fair market value is calculated for the two component goals at the date of grant: adjusted operational earnings per share and relative total shareholder return. the fair values for the earnings per share goal of each performance share unit was estimated on the date of grant using the fair market value of the shares at the time of the award, discounted for dividends, which are not paid on the performance share units during the vesting period. the fair value for the relative total shareholder return goal of each performance share unit was estimated on the date of grant using the monte carlo valuation model. see note 16 to the consolidated financial statements for additional information.", "highlight": "the company recognizes compensation expense associated with the issuance of equity instruments to employees for their services ||| the fair value is estimated on the date of grant using either the black-scholes option valuation model or a combination of both the black-scholes option valuation model and monte carlo valuation model ||| for performance share units, the fair market value is calculated for the two component goals at the date of grant: adjusted operational earnings per share and relative total shareholder return", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para92", "text": "New accounting pronouncements refer to note 1 to the consolidated financial statements for recently adopted accounting pronouncements and recently issued accounting pronouncements not yet adopted as of january 2, 2022.", "highlight": "note 1 to the consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para93", "text": "Economic and market factors Covid-19 considerations and business continuity The company has considered various internal and external factors in assessing the potential impact of covid-19 on its business and financial results based upon information available at this time, as follows: operating model: the company has a diversified business model across the healthcare industry with flexibility designed into its manufacturing, research and development clinical operations and commercial capabilities.", "highlight": "The company has considered various internal and external factors in assessing the potential impact of covid-19 on its business and financial results based upon information available at this time", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para94", "text": "supply chain: the company continues to leverage its global manufacturing footprint and dual-source capabilities while closely monitoring and maintaining critical inventory at major distribution centers away from high-risk areas to help ensure adequate and effective distribution.", "highlight": "the company continues to leverage its global manufacturing footprint and dual-source capabilities while closely monitoring and maintaining critical inventory at major distribution centers", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para95", "text": "business continuity: the robust, active business continuity plans across the company's network have been instrumental in preparing the company for events like covid-19 and the ability to meet the majority of patient and consumer needs remains uninterrupted.", "highlight": "the robust, active business continuity plans across the company's network have been instrumental in preparing the company for events like covid-19 and the ability to meet the majority of patient and consumer needs remains uninterrupted.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para96", "text": "workforce: the company has put procedures in place to protect its essential workforce in manufacturing, distribution, commercial and research operations while ensuring appropriate remote working protocols have been established for other employees.", "highlight": "the company has put procedures in place to protect its essential workforce in manufacturing, distribution, commercial and research operations while ensuring appropriate remote working protocols have been established for other employees.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para97", "text": "liquidity: the company's high-quality credit rating allows the company superior access to the financial capital markets for the foreseeable future.", "highlight": "the company's high-quality credit rating allows the company superior access to the financial capital markets for the foreseeable future.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para98", "text": "domestic and foreign legislation: the company will continue to assess and evaluate the on-going global legislative efforts to combat the covid-19 impact on economies and the sectors in which it participates. currently, the recent legislative acts put in place are not expected to have a material impact on the company's operations.", "highlight": "the company will continue to assess and evaluate the on-going global legislative efforts to combat the covid-19 impact on economies and the sectors in which it participates.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para99", "text": "in fiscal 2020 and 2021, the company entered into a series of contract manufacturing arrangements for vaccine production with third party contract manufacturing organizations. these arrangements provide the company with future supplemental commercial capacity for vaccine production and potentially transferable rights to such production if capacity is not required. amounts paid for services to be delivered and contractually obligated to be paid to these contract manufacturing organizations of approximately $1.1 billion are reflected in the prepaid expenses and other, other assets, accrued liabilities and other liabilities accounts in the company's consolidated balance sheet upon execution of each agreement. additionally, the company has entered into certain vaccine development cost sharing arrangements with government related organizations.", "highlight": "the company entered into a series of contract manufacturing arrangements for vaccine production with third party contract manufacturing organizations |||  the company has entered into certain vaccine development cost sharing arrangements with government related organizations.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para100", "text": "the company continues to evaluate and monitor both its internal and external supply arrangements, including its contract with emergent biosolutions and related production activities at its bayview, maryland facility. the company has established a global vaccine supply network, where, in addition to its internal manufacturing site in leiden, the netherlands, ten other manufacturing sites will be involved in the production of vaccine across different countries and continents. the company does not believe that a disruption at a vaccine manufacturing site, or the resulting delay would have a material financial impact on the company's consolidated financial statements or results.", "highlight": "the company does not believe that a disruption at a vaccine manufacturing site, or the resulting delay would have a material financial impact on the company's consolidated financial statements or results.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para101", "text": "the company is aware that its products are used in an environment where, for more than a decade, policymakers, consumers and businesses have expressed concerns about the rising cost of healthcare. in response to these concerns, the company has a long-standing policy of pricing products responsibly. for the period 2011 - 2021, in the u.s., the weighted average compound annual growth rate of the company's net price increases for healthcare products (prescription and over-the-counter drugs, hospital and professional products) was below the u.s. consumer price index (cpi).", "highlight": "the company is aware that its products are used in an environment where, for more than a decade, policymakers, consumers and businesses have expressed concerns about the rising cost of healthcare", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para102", "text": "the company operates in certain countries where the economic conditions continue to present significant challenges. the company continues to monitor these situations and take appropriate actions. inflation rates continue to have an effect on worldwide economies and, consequently, on the way companies operate. the company has accounted for operations in argentina and venezuela as highly inflationary, as the prior three-year cumulative inflation rate surpassed 100%. this did not have a material impact to the company's results in the period. in the face of increasing costs, the company strives to maintain its profit margins through cost reduction programs, productivity improvements and periodic price increases.", "highlight": "the company continues to monitor these situations and take appropriate actions ||| company strives to maintain its profit margins through cost reduction programs, productivity improvements and periodic price increases.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para103", "text": "the company is exposed to fluctuations in currency exchange rates. a 1% change in the value of the u.s. dollar as compared to all foreign currencies in which the company had sales, income or expense in 2021 would have increased or decreased the translation of foreign sales by approximately $0.5 billion and net income by approximately $0.2 billion.", "highlight": "a 1% change in the value of the u.s. dollar as compared to all foreign currencies in which the company had sales, income or expense in 2021 would have increased or decreased the translation of foreign sales by approximately $0.5 billion and net income by approximately $0.2 billion.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para104", "text": "governments around the world consider various proposals to make changes to tax laws, which may include increasing or decreasing existing statutory tax rates. in connection with various government initiatives, companies are required to disclose more information to tax authorities on operations around the world, which may lead to greater audit scrutiny of profits earned in other countries. a change in statutory tax rate in any country would result in the revaluation of the company's deferred tax assets and liabilities related to that particular jurisdiction in the period in which the new tax law is enacted. this change would result in an expense or benefit recorded to the company's consolidated statement of earnings. the company closely monitors these proposals as they arise in the countries where it operates. changes to the statutory tax rate may occur at any time, and any related expense or benefit recorded may be material to the fiscal quarter and year in which the law change is enacted.", "highlight": "governments around the world consider various proposals to make changes to tax laws, which may include increasing or decreasing existing statutory tax rates ||| the company closely monitors these proposals as they arise in the countries where it operates. changes to the statutory tax rate may occur at any time, and any related expense or benefit recorded may be material to the fiscal quarter and year in which the law change is enacted", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para105", "text": "the company faces various worldwide healthcare changes that may continue to result in pricing pressures that include healthcare cost containment and government legislation relating to sales, promotions and reimbursement of healthcare products.", "highlight": "faces various worldwide healthcare changes that may continue to result in pricing pressures that include healthcare cost containment and government legislation relating to sales, promotions and reimbursement of healthcare products.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para106", "text": "changes in the behavior and spending patterns of purchasers of healthcare products and services, including delaying medical procedures, rationing prescription medications, reducing the frequency of physician visits and foregoing healthcare insurance coverage, as a result of the current global economic downturn, may continue to impact the company's businesses.", "highlight": "changes in the behavior and spending patterns of purchasers of healthcare products and services ||| as a result of the current global economic downturn, may continue to impact the company's businesses.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para107", "text": "the company also operates in an environment increasingly hostile to intellectual property rights. firms have filed abbreviated new drug applications or biosimilar biological product applications with the u.s. fda or otherwise challenged the coverage and/or validity of the company's patents, seeking to market generic or biosimilar forms of many of the company's key pharmaceutical products prior to expiration of the applicable patents covering those products. in the event the company is not successful in defending the patent claims challenged in the resulting lawsuits, generic or biosimilar versions of the products at issue will be introduced to the market, resulting in the potential for substantial market share and revenue losses for those products, and which may result in a non-cash impairment charge in any associated intangible asset. there is also a risk that one or more competitors could launch a generic or biosimilar version of the product at issue following regulatory approval even though one or more valid patents are in place.", "highlight": "company also operates in an environment increasingly hostile to intellectual property rights ||| there is also a risk that one or more competitors could launch a generic or biosimilar version of the product at issue following regulatory approval even though one or more valid patents are in place.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para108", "text": "Legal proceedings johnson & johnson and certain of its subsidiaries are involved in various lawsuits and claims regarding product liability, intellectual property, commercial, employment, indemnification and other matters; governmental investigations; and other legal proceedings that arise from time to time in the ordinary course of business.", "highlight": "Legal proceedings johnson & johnson and certain of its subsidiaries are involved in various lawsuits ||| other legal proceedings that arise from time to time in the ordinary course of business", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 1, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para109", "text": "the company records accruals for loss contingencies associated with these legal matters when it is probable that a liability will be incurred and the amount of the loss can be reasonably estimated. as of january 2, 2022, the company has determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated. the company has accrued for these matters and will continue to monitor each related legal issue and adjust accruals as might be warranted based on new information and further developments in accordance with asc 450-20-25. for these and other litigation and regulatory matters discussed below for which a loss is probable or reasonably possible, the company is unable to estimate the possible loss or range of loss beyond the amounts accrued. amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely heavily on estimates and assumptions including timing of related payments. the ability to make such estimates and judgments can be affected by various factors including, among other things, whether damages sought in the proceedings are unsubstantiated or indeterminate; scientific and legal discovery has not commenced or is not complete; proceedings are in early stages; matters present legal uncertainties; there are significant facts in dispute; procedural or jurisdictional issues; the uncertainty and unpredictability of the number of potential claims; ability to achieve comprehensive multi-party settlements; complexity of related cross-claims and counterclaims; and/or there are numerous parties involved. to the extent adverse awards, judgments or verdicts have been rendered against the company, the company does not record an accrual until a loss is determined to be probable and can be reasonably estimated.", "highlight": "the company records accruals for loss contingencies associated with these legal matters when it is probable that a liability will be incurred and the amount of the loss can be reasonably estimated ||| the company has determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated ||| company has accrued for these matters and will continue to monitor each related legal issue and adjust accruals as might be warranted based on new information and further developments in accordance with asc 450-20-25.  ||| the company is unable to estimate the possible loss or range of loss beyond the amounts accrued ||| the company does not record an accrual until a loss is determined to be probable and can be reasonably estimated.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para110", "text": "in the company's opinion, based on its examination of these matters, its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the company's balance sheet, is not expected to have a material adverse effect on the company's financial position. however, the resolution of, or increase in accruals for, one or more of these matters in any reporting period may have a material adverse effect on the company's results of operations and cash flows for that period.", "highlight": "its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the company's balance sheet, is not expected to have a material adverse effect on the company's financial position", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para111", "text": "see note 19 to the consolidated financial statements included in item 8 of this report for further information regarding legal proceedings.", "highlight": "note 19 to the consolidated financial statements included in item 8", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220217_10-K_200406_part2_item7_para112", "text": "Common stock the company's common stock is listed on the new york stock exchange under the symbol jnj. as of february 10, 2022, there were 127,899 record holders of common stock of the company.", "highlight": "there were 127,899 record holders of common stock of the company.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para1", "text": "the following discussion and analysis of our financial condition and results of operations should be read in conjunction with \"item 1a. risk factors\", our consolidated financial statements and related notes thereto, as well as other cautionary statements and risks described elsewhere in this annual report on form 10-k, before deciding to purchase, hold or sell shares of our common stock.", "highlight": "item 1a. risk factors", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para2", "text": "Overview Our company and our businesses nvidia pioneered accelerated computing to help solve the most challenging computational problems. since our original focus on pc graphics, we have expanded to several other large and important computationally intensive fields. fueled by the sustained demand for exceptional 3d graphics and the scale of the gaming market, nvidia has leveraged its gpu architecture to create platforms for scientific computing, ai, data science, av, robotics, ar and vr.", "highlight": "nvidia has leveraged its gpu architecture to create platforms for scientific computing, ai, data science, av, robotics, ar and vr.", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para3", "text": "our two operating segments are \"graphics\" and \"compute & networking.\" refer to note 17 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k for additional information.", "highlight": "part iv, item 15 ||| note 17 of the notes", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para4", "text": "headquartered in santa clara, california, nvidia was incorporated in california in april 1993 and reincorporated in delaware in april 1998.", "highlight": "", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para5", "text": "Recent developments, future objectives and challenges Termination of the arm share purchase agreement on february 8, 2022, nvidia and softbank announced the termination of the share purchase agreement whereby nvidia would have acquired arm from softbank. the parties agreed to terminate because of significant regulatory challenges preventing the completion of the transaction. we intend to record in operating expenses a $1.36 billion charge in the first quarter of fiscal year 2023 reflecting the write-off of the prepayment provided at signing in september 2020.", "highlight": "nvidia and softbank announced the termination of the share purchase agreement ||| intend to record in operating expenses a $1.36 billion charge", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 2, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para6", "text": "Demand demand for our products is based on many factors, including our product introductions, time to market, transitions, competitor product releases and announcements, and competing technologies, all of which can impact the timing and volume of our revenue. gpus have use cases in addition to their designed and marketed use case, such as for digital currency mining, including blockchain-based platforms such as ethereum. it is difficult for us to estimate with any reasonable degree of precision the past or current impact of cryptocurrency mining, or forecast the future impact of cryptocurrency mining, on demand for our products. volatility in the cryptocurrency market, including new compute technologies, price changes in cryptocurrencies, government cryptocurrency policies and regulations, and new cryptocurrency standards can impact and have impacted in the past cryptocurrency demand, and further impact demand for our products and our ability to estimate demand for our products. changes to cryptocurrency standards and processes including, but not limited to, the pending ethereum 2.0 standard may decrease the usage of gpus for ethereum mining and may also create increased aftermarket resale of our gpus, impact retail prices for our gpus, increase returns of our products in the distribution channel, and may reduce demand for our new gpus. we have introduced lhr geforce gpus with limited ethereum mining capability and increased the supply of cmp in an effort to address demand from gamers and direct miners to cmp. beginning in the second quarter of fiscal year 2022, nearly all our desktop nvidia ampere architecture geforce gpu shipments were lhr in our effort to direct geforce to gamers. if attempts in the aftermarket to improve the hash rate capabilities of our lhr cards are successful, our gaming cards may become more attractive to miners, and therefore limit our ability to supply our cards to non-mining customers. we cannot predict whether our strategy of using lhr cards and cmp will achieve our desired outcome. additionally, consumer and enterprise behavior during the covid-19 pandemic has made it more difficult for us to estimate future demand and may have changed pre-pandemic behaviors, and these challenges may be more pronounced or volatile in the future on both a global and regional basis. in estimating demand and evaluating trends, we make multiple assumptions, any of which may prove to be incorrect.", "highlight": "new compute technologies, price changes in cryptocurrencies, government cryptocurrency policies and regulations, and new cryptocurrency standards can impact and have impacted in the past cryptocurrency demand ||| ethereum 2.0 standard may decrease the usage of gpus for ethereum mining and may also create increased aftermarket resale of our gpus, impact retail prices for our gpus, increase returns of our products in the distribution channel, and may reduce demand for our new gpus ||| have introduced lhr geforce gpus with limited ethereum mining capability and increased the supply of cmp in an effort to address demand from gamers and direct miners to cmp", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 1, "4": 0, "5": 0, "6": 1, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para7", "text": "Supply Our manufacturing lead times are very long and in some cases, extend to be twelve months or longer, which requires us to make estimates of customers' future demand. these conditions could lead to a significant mismatch between supply and demand, giving rise to product shortages or excess inventory, and make our demand forecast more uncertain. to 30 have shorter shipment lead times and quicker delivery schedules for our customers, we may build finished products and maintain inventory for anticipated periods of growth which do not occur, anticipating demand that does not materialize, or for what we believe is pent-up demand. during fiscal year 2022, we made substantial strides in broadening our supply base to scale our company and better serve customer demand. we expect to remain supply-constrained into the first half of fiscal year 2023, primarily in gaming and networking. we have placed non-cancellable inventory orders for certain supply in advance of our historical lead times, paid premiums and provided deposits to secure future supply and capacity and may need to continue to do so in the future. ordering product in advance of our historical lead times to secure supply in a constrained environment may trigger excess inventory or other charges if there is a partial or complete reduction in long-term demand for our products or if such demand is served by our competitors. given our long lead times on inventory purchasing, demand may be perishable or may disappear. given our current long lead times, we may order components before our product design is finalized and changes to the product design or end demand could trigger excess inventory. our supply deliveries and production may be non-linear within a quarter or year which could cause changes to expected revenue or cash flows.", "highlight": "made substantial strides in broadening our supply base to scale our company and better serve customer demand ||| placed non-cancellable inventory orders for certain supply  ||| paid premiums and provided deposits ||| order components before our product design is finalized and changes to the product design or end demand could trigger excess inventory", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 0, "4": 0, "5": 0, "6": 1, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para8", "text": "Covid-19 the covid-19 pandemic continued during fiscal year 2022. most of our employees continue to work remotely and we have paused most business travel. during fiscal year 2022, our gaming, data center and professional visualization market platforms have benefited from stronger demand as people continue to work, learn, and play from home. our professional visualization market platform also benefited from demand for workstations as enterprises support hybrid work environments. as our offices begin to reopen, we expect to incur incremental expenses as we resume onsite services and related in-office costs.", "highlight": "gaming, data center and professional visualization market platforms have benefited from stronger demand ||| benefited from demand for workstations", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para9", "text": "as the covid-19 pandemic continues, the timing and overall demand from customers, the availability of supply chain, logistical services and component supply, and the impact of rising inflation may have a material net negative impact on our business and financial results.", "highlight": "may have a material net negative impact on our business and financial results", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para10", "text": "we believe our existing balances of cash, cash equivalents and marketable securities, along with commercial paper arrangements, will be sufficient to satisfy our working capital needs, capital asset purchases, dividends, debt repayments and other liquidity requirements associated with our existing operations.", "highlight": "will be sufficient to satisfy our working capital needs, capital asset purchases, dividends, debt repayments and other liquidity requirements", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para11", "text": "Fiscal year 2022 summary Year ended January 30, 2022 January 31, 2021 Change ($ in millions, except per share data) Revenue $ 26,914 $ 16,675 Up 61% Gross margin 64.9 % 62.3 % Up 260 bps Operating expenses $ 7,434 $ 5,864 Up 27% Income from operations $ 10,041 $ 4,532 Up 122% Net income $ 9,752 $ 4,332 Up 125% Net income per diluted share $ 3.85 $ 1.73 Up 123% we specialize in markets where our computing platforms can provide tremendous acceleration for applications. these platforms incorporate processors, interconnects, software, algorithms, systems, and services to deliver unique value. our platforms address four large markets where our expertise is critical: gaming, data center, professional visualization, and automotive.", "highlight": "specialize in markets where our computing platforms can provide tremendous acceleration for applications", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para12", "text": "revenue for fiscal year 2022 was $26.91 billion, up 61% from a year ago.", "highlight": "revenue for fiscal year 2022 was $26.91 billion", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para13", "text": "gaming revenue was up 61% from a year ago reflecting higher sales of geforce gpus. we continue to benefit from strong demand for nvidia ampere architecture products, and believe the increase in gaming revenue during fiscal year 2022 resulted from a combination of factors, including: the ramp of new rtx 30 series gpus; the release of new games supporting ray tracing; the rising popularity of gaming, esports, content creation and streaming; the demand for new and upgraded systems to support the increase in remote work; and the ability of end users to engage in cryptocurrency mining.", "highlight": "reflecting higher sales of geforce gpus ||| continue to benefit from strong demand for nvidia ampere architecture products, and believe the increase in gaming revenue", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para14", "text": "31 although nearly all desktop nvidia ampere architecture geforce gpu shipments are lhr to help direct geforce gpus to gamers, our gpus are capable of cryptocurrency mining. gamers and others are therefore able to mine cryptocurrency using our gpus, although we have limited visibility into how much this impacts our overall gpu demand. volatility in the cryptocurrency market, including changes in the prices of cryptocurrencies or method of verifying transactions, such as proof of work or proof of stake, can impact demand for our products and degrade our ability to accurately estimate it. we are unable to estimate with any degree of precision the impact this volatility is likely to have in the future.", "highlight": "volatility in the cryptocurrency market ||| can impact demand for our products and degrade our ability to accurately estimate", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 1, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para15", "text": "data center revenue was up 58% from a year ago primarily driven by sales of nvidia ampere architecture gpus across both training and inference for cloud computing and ai workloads such as natural language processing and deep recommender models.", "highlight": "driven by sales of nvidia ampere architecture gpus", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para16", "text": "professional visualization revenue was up 100% from a year ago driven by the ramp of nvidia ampere architecture products and strong demand for workstations as enterprises support hybrid work environments, as well as growth in workloads such as 3d design, ai and rendering.", "highlight": "driven by the ramp of nvidia ampere architecture products and strong demand for workstations", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para17", "text": "automotive revenue was up 6% from a year ago due to self-driving and ai cockpit solutions offset by a decline in legacy cockpit revenue.", "highlight": "due to self-driving and ai cockpit solutions", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para18", "text": "oem and other revenue was up 84% from a year ago primarily driven by cmp sales. cmp revenue was $550 million for the fiscal year and was nominal in the prior year.", "highlight": "driven by cmp sales", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para19", "text": "revenue for our cmp products declined significantly in the fourth quarter of fiscal year 2022. we are unable to estimate with any degree of precision the impact that volatility in the cryptocurrency market, as discussed above, is likely to have on future cmp sales.", "highlight": "revenue for our cmp products declined significantly in the fourth quarter", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para20", "text": "gross margin for fiscal year 2022 was up 260 basis points from a year ago driven by lower mellanox acquisition-related charges, including a non-recurring inventory step-up charge of $161 million in fiscal year 2021. margins also benefited from a higher-end mix within gaming, partially offset by a mix shift within data center.", "highlight": "driven by lower mellanox acquisition-related charges, including a non-recurring inventory step-up charge of $161 million", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 2, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para21", "text": "operating expenses for fiscal year 2022 were up 27% from a year ago primarily driven by stock-based compensation, compensation-related costs associated with employee growth and higher infrastructure costs.", "highlight": "driven by stock-based compensation, compensation-related costs", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para22", "text": "income from operations was $10.04 billion, up 122% from a year ago. net income and net income per diluted share were $9.75 billion and $3.85, up 125% and 123%, respectively, from a year ago.", "highlight": "income from operations was $10.04 billion ||| net income and net income per diluted share were $9.75 billion and $3.85", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para23", "text": "cash, cash equivalents and marketable securities were $21.21 billion, up from $11.56 billion a year earlier. the increase reflects operating cash flow generation and $5.00 billion of debt issuance proceeds.", "highlight": "cash, cash equivalents and marketable securities were $21.21 billion", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para24", "text": "we paid $399 million in quarterly cash dividends in fiscal year 2022.", "highlight": "we paid $399 million in quarterly cash dividends", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 2, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para25", "text": "Market platform highlights at our november 2021 gpu technology conference, we announced general availability of nvidia omniverse enterprise; 65 new and updated software development kits, including nvidia riva, modulus, reopt, morpheus, cunumeric, and clara holoscan; nvidia quantum-2 400gbps switch and end-to-end networking platform; and nvidia jetson agx orin for edge ai and autonomous machines.", "highlight": "announced general availability of nvidia omniverse enterprise", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para26", "text": "in our gaming platform during fiscal year 2022, we further expanded our desktop and laptop geforce rtx 30 series gpu line-ups; expanded the rtx ecosystem of games and applications to over 240; announced plans to integrate nvidia dlss into the unity game engine; and introduced a new high-performance membership tier to geforce now.", "highlight": "expanded our desktop and laptop geforce rtx 30 series gpu line-ups; expanded the rtx ecosystem of games and applications  ||| announced plans to integrate nvidia dlss into the unity game engine", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 1, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para27", "text": "in our data center platform, we launched new nvidia a30 and a10 gpus for mainstream ai, data analytics and graphics; debuted a new class of nvidia-certified systems with leading server oems; unveiled nvidia grace, our first arm-based data center cpu; launched the nvidia ai enterprise software suite; unveiled the nvidia base command and fleet command ai software offerings; and announced plans to build earth-2, an ai supercomputer dedicated to addressing the global climate change crisis.", "highlight": "launched new nvidia a30 and a10 gpus ||| debuted a new class of nvidia-certified systems ||| unveiled nvidia grace, our first arm-based data center cpu ||| launched the nvidia ai enterprise software suite ||| unveiled the nvidia base command and fleet command ai software offerings ||| announced plans to build earth-2,", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 1, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para28", "text": "in our professional visualization platform, we unveiled nvidia rtx gpus for next-generation notebook and desktop workstations; and launched nvidia omniverse enterprise for collaborative 3d design, digital twins and virtual worlds and nvidia omniverse for creators.", "highlight": "led nvidia rtx gpus ||| nvidia omniverse enterprise", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para29", "text": "32 in our automotive platform, we unveiled the nvidia drive atlan next-generation soc; announced design wins with mercedes-benz for the ai cockpit in its new eqs sedan; with volvo cars for the autonomous driving computer in its next-generation cars, beginning with the xc90 in 2022; with energy vehicles from r-auto, im motors, nio, faraday future, vinfast and xpeng; with robotaxis including cruise, amazon zoox, pony.ai and autox; with autonomous trucking companies embark, kodiak robotics and plus; formed a multi-year partnership with jaguar land rover to jointly develop and deliver next-generation automated driving systems, plus ai-enabled services and experiences; and announced that desay, flex, quanta, valeo and zf are using the nvidia drive hyperion platform to manufacture safe and secure av systems for vehicle makers.", "highlight": "unveiled the nvidia drive atlan next-generation soc ||| announced design", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para30", "text": "Critical accounting policies and estimates management's discussion and analysis of financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the united states, or u.s. gaap. the preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, cost of revenue, expenses and related disclosure of contingencies. on an on-going basis, we evaluate our estimates, including those related to inventories, revenue recognition, income taxes, and goodwill. we base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities.", "highlight": "we base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para31", "text": "we believe the following critical accounting policies affect our significant judgments and estimates used in the preparation of our consolidated financial statements. our management has discussed the development and selection of these critical accounting policies and estimates with the audit committee of our board of directors. the audit committee has reviewed our disclosures relating to our critical accounting policies and estimates in this annual report on form 10-k.", "highlight": "the audit committee has reviewed our disclosures relating to our critical accounting policies", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para32", "text": "Inventories inventory cost is computed on an adjusted standard basis, which approximates actual cost on an average or first-in, first-out basis. we charge cost of sales for inventory provisions to write-down our inventory to the lower of cost or net realizable value or for obsolete or excess inventory. most of our inventory provisions relate to excess quantities of products or components, based on our inventory levels and future product purchase commitments compared to assumptions about future demand and market conditions.", "highlight": "inventory cost is computed on an adjusted standard basis ||| inventory provisions relate to excess quantities of products or components ||| purchase commitments compared to assumptions about future demand and market conditions.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para33", "text": "situations that may result in excess or obsolete inventory include changes in business and economic conditions, changes in market conditions, sudden and significant decreases in demand for our products, inventory obsolescence because of changing technology and customer requirements, new product introductions resulting in less demand for existing products or inconsistent spikes in demand due to unexpected end use cases, failure to estimate customer demand properly, ordering in advance of historical lead-times and the impact of changes in future demand, or increase in demand for competitive products, including competitive actions. cancellation or deferral of customer purchase orders could result in our holding excess inventory.", "highlight": "situations that may result in excess or obsolete inventory include changes in business and economic conditions ||| cancellation or deferral of customer purchase orders could result in our holding excess inventory", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para34", "text": "the overall net effect on our gross margin from inventory provisions and sales of items previously written down was an unfavorable impact of 0.9% in fiscal year 2022 and insignificant in fiscal year 2021. as a fabless semiconductor company, we must make commitments to purchase inventory based on forecasts of future customer demand. in doing so, we must account for our third-party manufacturers' lead times and constraints. our manufacturing lead times are very long and in some cases, extend on to be twelve months or longer, which requires us to make estimates of customers' future demand. we place non-cancellable inventory orders for certain products in advance of our historical lead times, pay premiums and provide deposits to secure future supply and capacity. we also adjust to other market factors, such as product offerings and pricing actions by our competitors, new product transitions, and macroeconomic conditions - all of which may impact demand for our products.", "highlight": "the overall net effect on our gross margin from inventory provisions and sales of items previously written down was an unfavorable impact of 0.9%", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para35", "text": "refer to the gross profit and gross margin discussion below in this management's discussion and analysis for further discussion.", "highlight": "gross profit and gross margin discussion", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para36", "text": "Revenue recognition We derive our revenue from product sales, including hardware and systems, license and development arrangements, software licensing, and cloud services. we determine revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract (where revenue is 33 allocated on a relative standalone selling price basis by maximizing the use of observable inputs to determine the standalone selling price for each performance obligation); and (5) recognition of revenue when, or as, we satisfy a performance obligation.", "highlight": "we determine revenue recognition through the following steps", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para37", "text": "Product sales revenue revenue from product sales is recognized upon transfer of control of products to customers in an amount that reflects the consideration we expect to receive in exchange for those products. certain products are sold with support or an extended warranty for the incorporated system, hardware, and/or software. support and extended warranty revenue are recognized ratably over the service period, or as services are performed. revenue is recognized net of allowances for returns, customer programs and any taxes collected from customers.", "highlight": "revenue is recognized net of allowances for returns, customer programs and any taxes collected from customers.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para38", "text": "for products sold with a right of return, we record a reduction to revenue by establishing a sales return allowance for estimated product returns at the time revenue is recognized, based primarily on historical return rates. however, if product returns for a fiscal period are anticipated to exceed historical return rates, we may determine that additional sales return allowances are required to properly reflect our estimated exposure for product returns.", "highlight": "record a reduction to revenue by establishing a sales return allowance for estimated product returns at the time revenue is recognized", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para39", "text": "our customer programs involve rebates, which are designed to serve as sales incentives to resellers of our products in various target markets, and marketing development funds, or mdfs, which represent monies paid to our partners that are earmarked for market segment development and are designed to support our partners' activities while also promoting nvidia products. we account for customer programs as a reduction to revenue and accrue for potential rebates and mdfs based on the amount we expect to be claimed by customers.", "highlight": "customer programs involve rebates ||| and marketing development funds, or mdfs ||| account for customer programs as a reduction to revenue", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para40", "text": "License and development arrangements our license and development arrangements with customers typically require significant customization of our ip components. as a result, we recognize the revenue from the license and the revenue from the development services as a single performance obligation over the period in which the development services are performed. we measure progress to completion based on actual cost incurred to date as a percentage of the estimated total cost required to complete each project. if a loss on an arrangement becomes probable during a period, we record a provision for such loss in that period.", "highlight": "recognize the revenue from the license and the revenue from the development services as a single performance obligation ||| measure progress to completion based on actual cost incurred to date as a percentage of the estimated total cost required to complete each project", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para41", "text": "refer to note 1 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k for additional information.", "highlight": "part iv, item 15 ||| note 1 of the notes", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para42", "text": "Income taxes we recognize federal, state and foreign current tax liabilities or assets based on our estimate of taxes payable or refundable in the current fiscal year by tax jurisdiction. we recognize federal, state and foreign deferred tax assets or liabilities, as appropriate, for our estimate of future tax effects attributable to temporary differences and carryforwards; and we record a valuation allowance to reduce any deferred tax assets by the amount of any tax benefits that, based on available evidence and judgment, are not expected to be realized.", "highlight": "recognize federal, state and foreign deferred tax assets or liabilities, as appropriate, for our estimate of future tax effects ||| record a valuation allowance to reduce any deferred tax assets", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para43", "text": "our calculation of deferred tax assets and liabilities is based on certain estimates and judgments and involves dealing with uncertainties in the application of complex tax laws. our estimates of deferred tax assets and liabilities may change based, in part, on added certainty or finality to an anticipated outcome, changes in accounting standards or tax laws in the united states, or foreign jurisdictions where we operate, or changes in other facts or circumstances. in addition, we recognize liabilities for potential united states and foreign income tax contingencies based on our estimate of whether, and the extent to which, additional taxes may be due. if we determine that payment of these amounts is unnecessary or if the recorded tax liability is less than our current assessment, we may be required to recognize an income tax benefit or additional income tax expense in our financial statements accordingly.", "highlight": "estimates of deferred tax assets and liabilities may change ||| recognize liabilities for potential united states and foreign income tax contingencies", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para44", "text": "as of january 30, 2022, we had a valuation allowance of $907 million related to state and certain other deferred tax assets that management determined are not likely to be realized due to jurisdictional projections of future taxable income, tax attributes usage limitation by certain jurisdictions, and potential utilization limitations of tax attributes acquired as a result of stock ownership changes. to the extent realization of the deferred tax assets becomes more-likely-than-not, we would recognize such deferred tax assets as an income tax benefit during the period.", "highlight": "valuation allowance of $907 million related to state and certain other deferred tax assets ||| would recognize such deferred tax assets as an income tax benefit during the period.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 2, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para45", "text": "we recognize the benefit from a tax position only if it is more-likely-than-not that the position would be sustained upon audit based solely on the technical merits of the tax position. our policy is to include interest and penalties related to unrecognized tax benefits as a component of income tax expense.", "highlight": "recognize the benefit from a tax position ||| include interest and penalties related to unrecognized tax benefits", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para46", "text": "34 refer to note 14 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k for additional information.", "highlight": "part iv, item 15", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para47", "text": "Goodwill goodwill is subject to our annual impairment test during the fourth quarter of our fiscal year, or earlier, if indicators of potential impairment exist, using either a qualitative or a quantitative assessment. our impairment review process compares the fair value of the reporting unit in which the goodwill resides to its carrying value. as of january 30, 2022, the total carrying amount of goodwill was $4.35 billion and the amount of goodwill allocated to our graphics and compute & networking reporting units was $361 million and $3.99 billion, respectively. determining the fair value of a reporting unit requires us to make judgments and involves the use of significant estimates and assumptions. we also make judgments and assumptions in allocating assets and liabilities to each of our reporting units. we base our fair value estimates on assumptions we believe to be reasonable but that are unpredictable and inherently uncertain.", "highlight": "the total carrying amount of goodwill was $4.35 billion ||| goodwill allocated to our graphics and compute & networking reporting units was $361 million and $3.99 billion", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 2, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para48", "text": "we performed our annual goodwill assessment during the fourth quarter of fiscal year 2022 using a qualitative assessment and concluded there was no goodwill impairment.", "highlight": "there was no goodwill impairment.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para49", "text": "refer to note 6 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k for additional information.", "highlight": "part iv, item 15", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para50", "text": "Results of operations a discussion regarding our financial condition and results of operations for fiscal year 2022 compared to fiscal year 2021 is presented below. a discussion regarding our financial condition and results of operations for fiscal year 2021 compared to fiscal year 2020 can be found under item 7 in our annual report on form 10-k for the fiscal year ended january 31, 2021, filed with the sec on february 26, 2021, which is available free of charge on the sec's website at http://www.sec.gov and at our investor relations website, http://investor.nvidia.com.", "highlight": "under item 7 in our annual report on form 10-k for the fiscal year ended january 31, 2021, filed with the sec on february 26, 2021 ||| http://www.sec.gov ||| http://investor.nvidia.com.", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para51", "text": "the following table sets forth, for the periods indicated, certain items in our consolidated statements of income expressed as a percentage of revenue.", "highlight": "", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para52", "text": "Year ended January 30, 2022 January 31, 2021 Revenue 100.0 % 100.0 % Cost of revenue 35.1 37.7 Gross profit 64.9 62.3 Operating expenses: Research and development 19.6 23.5 Sales, general and administrative 8.0 11.6 Total operating expenses 27.6 35.1 Income from operations 37.3 27.2 Interest income 0.1 0.3 Interest expense -0.9 -1.1 Other, net 0.4 0.1 Other income (expense), net -0.4 -0.7 Income before income tax expense 36.9 26.5 Income tax expense 0.7 0.5 Net income 36.2 % 26.0 % 35 Revenue Revenue by reportable segments Year ended January 30, 2022 January 31, 2021 $Change % Change ($ in millions) Graphics $ 15,868 $ 9,834 $ 6,034 61 % Compute & networking 11,046 6,841 4,205 61 % Total $ 26,914 $ 16,675 $ 10,239 61 % graphics - graphics segment revenue increased by 61% in fiscal year 2022 compared to fiscal year 2021. we continue to benefit from strong demand for nvidia ampere architecture products, and believe the increase in gaming revenue during fiscal year 2022 resulted from a combination of factors, including: the ramp of new rtx 30 series gpus; the release of new games supporting ray tracing; the rising popularity of gaming, esports, content creation and streaming; the demand for new and upgraded systems to support the increase in remote work; and the ability of end users to engage in cryptocurrency mining.", "highlight": "continue to benefit from strong demand for nvidia ampere architecture products ||| believe the increase in gaming revenue during fiscal year 2022 resulted from a combination of factors", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para53", "text": "compute & networking - compute & networking segment revenue increased by 61% in fiscal year 2022 compared to fiscal year 2021, driven primarily by sales of nvidia ampere architecture products to hyperscale customers for cloud computing and workloads such as natural language processing and deep recommender models, as well as to vertical industries. the increase compared to fiscal year 2021 also reflects the strong sales of networking products and that fiscal year 2022 includes a full year of networking revenue as mellanox was acquired in april 2020. cmp contributed $550 million in fiscal year 2022 compared to an insignificant amount in the prior year.", "highlight": "driven primarily by sales of nvidia ampere architecture products to hyperscale customers for cloud computing and workloads such as natural language processing and deep recommender models, as well as to vertical industries", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para54", "text": "Concentration of revenue revenue from sales to customers outside of the united states accounted for 84% and 81% of total revenue for fiscal years 2022 and 2021, respectively. revenue by geographic region is allocated to individual countries based on the location to which the products are initially billed even if the revenue is attributable to end customers in a different location.", "highlight": "revenue from sales to customers outside of the united states accounted for 84% and 81% of total revenue for fiscal years 2022 and 2021,", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para55", "text": "no customer represented 10% or more of total revenue for fiscal years 2022 and 2021.", "highlight": "no customer represented 10% or more of total revenue", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para56", "text": "Gross profit and gross margin gross profit consists of total revenue, net of allowances, less cost of revenue. cost of revenue consists primarily of the cost of semiconductors, including wafer fabrication, assembly, testing and packaging, board and device costs, manufacturing support costs, including labor and overhead associated with such purchases, final test yield fallout, inventory and warranty provisions, memory and component costs, tariffs, and shipping costs. cost of revenue also includes acquisition-related costs, development costs for license and service arrangements, ip-related costs, and stock-based compensation related to personnel associated with manufacturing.", "highlight": "gross profit consists of total revenue, net of allowances, less cost of revenue", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para57", "text": "our overall gross margin was 64.9% and 62.3% for fiscal years 2022 and 2021, respectively. the increase in fiscal year 2022 was primarily due to lower mellanox acquisition-related charges, including a non-recurring inventory step-up charge of $161 million in fiscal year 2021. the increase also benefited from a higher-end mix within graphics, partially offset by a mix shift within compute & networking.", "highlight": "primarily due to lower mellanox acquisition-related charges, including a non-recurring inventory step-up charge of $161 million in fiscal year 2021 ||| benefited from a higher-end mix within graphics, partially offset by a mix shift within compute & networking", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para58", "text": "inventory provisions totaled $354 million and $116 million for fiscal years 2022 and 2021, respectively. sales of inventory that was previously written-off or written-down totaled $111 million and $145 million for fiscal years 2022 and 2021, respectively. as a result, the overall net effect on our gross margin was an unfavorable impact of 0.9% in fiscal year 2022 and insignificant in fiscal year 2021.", "highlight": "inventory provisions totaled $354 million and $116 million ||| sales of inventory that was previously written-off or written-down totaled $111 million and $145 million ||| overall net effect on our gross margin was an unfavorable impact of 0.9%", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para59", "text": "the gross margin of our graphics segment increased during fiscal year 2022 when compared to fiscal year 2021, primarily due to higher-end mix within geforce gpus.", "highlight": "primarily due to higher-end mix within geforce gpus.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para60", "text": "the gross margin of our compute & networking segment decreased during fiscal year 2022 when compared to fiscal year 2021, primarily due to a shift in product mix and partially offset by a reduced contribution from automotive solutions.", "highlight": "primarily due to a shift in product mix and partially offset by a reduced contribution from automotive solutions", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para61", "text": "36 Operating expenses Year ended January 30, 2022 January 31, 2021 $Change % Change ($ in millions) Research and development expenses $ 5,268 $ 3,924 $ 1,344 34 % % of net revenue 19.6 % 23.5 % Sales, general and administrative expenses 2,166 1,940 226 12 % % of net revenue 8.0 % 11.6 % Total operating expenses $ 7,434 $ 5,864 $ 1,570 27 % Research and development research and development expenses increased by 34% in fiscal year 2022 compared to fiscal year 2021, primarily driven by stock-based compensation, compensation-related costs associated with employee growth and higher infrastructure costs.", "highlight": "primarily driven by stock-based compensation, compensation-related costs associated with employee growth and higher infrastructure costs.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para62", "text": "Sales, general and administrative sales, general and administrative expenses increased by 12% in fiscal year 2022 compared to fiscal year 2021, primarily driven by stock-based compensation, compensation-related costs associated with employee growth, partially offset by lower amortization of intangibles.", "highlight": "primarily driven by stock-based compensation, compensation-related costs associated with employee growth, partially offset by lower amortization of intangibles.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para63", "text": "Other income (expense), net interest income consists of interest earned on cash, cash equivalents and marketable securities. interest income was $29 million and $57 million in fiscal years 2022 and 2021, respectively. the decrease in interest income was primarily due to lower interest rates earned on our investments.", "highlight": "was primarily due to lower interest rates earned on our investments", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para64", "text": "interest expense is primarily comprised of coupon interest and debt discount amortization related to our notes. interest expense was $236 million and $184 million in fiscal years 2022 and 2021, respectively. the increase in expense reflects interest on the $5.00 billion note issued in june 2021.", "highlight": "interest expense was $236 million and $184 million  ||| increase in expense reflects interest on the $5.00 billion", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para65", "text": "other, net, consists primarily of realized or unrealized gains and losses from investments in non-affiliated entities and the impact of changes in foreign currency rates. other, net, was an income of $107 million during fiscal year 2022 and not significant during fiscal year 2021. the increase was primarily due to unrealized gains from our investments in non-affiliated entities. refer to note 9 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k for additional information regarding our investments in non-affiliated entities.", "highlight": "unrealized gains and losses from investments in non-affiliated entities and the impact of changes in foreign currency rates. other, net, was an income of $107 million during fiscal year 2022", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para66", "text": "Income taxes we recognized income tax expense of $189 million and $77 million for fiscal years 2022 and 2021, respectively. our annual effective tax rate was 1.9% and 1.7% for fiscal years 2022 and 2021, respectively.", "highlight": "income tax expense of $189 million and $77 million for fiscal years 2022 and 2021, respectively. our annual effective tax rate was 1.9% and 1.7%", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para67", "text": "the increase in our effective tax rate in fiscal year 2022 as compared to fiscal year 2021 was primarily due to an increase in the amount of earnings subject to u.s. tax, and a decreased impact of tax benefits from the u.s. federal research tax credit, partially offset by the benefit of the foreign-derived intangible income deduction, and the discrete benefit of the domestication of a foreign subsidiary, or the domestication.", "highlight": "primarily due to an increase in the amount of earnings subject to u.s. tax, and a decreased impact of tax benefits from the u.s. federal research tax credit, partially offset by the benefit of the foreign-derived intangible income deduction", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para68", "text": "our effective tax rate for fiscal year 2022 was lower than the u.s. federal statutory rate of 21% due to tax benefits from the foreign-derived intangible income deduction, income earned in jurisdictions, including the british virgin islands and israel, that are subject to taxes lower than the u.s. federal statutory tax rate, excess tax benefits related to stock-based compensation, recognition of u.s. federal research tax credit and the one-time benefits of the domestication.", "highlight": "due to tax benefits from the foreign-derived intangible income deduction, income earned in jurisdictions,", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para69", "text": "our effective tax rate for fiscal year 2021 was lower than the u.s. federal statutory rate of 21% due primarily to income earned in jurisdictions, including the british virgin islands, israel, and hong kong, where the tax rate was lower than the u.s. federal statutory tax rate, recognition of u.s. federal research tax credits, and excess tax benefits related to stock-based compensation.", "highlight": "due primarily to income earned in jurisdictions, including the british virgin islands, israel, and hong kong, where the tax rate was lower than the u.s. federal statutory tax rate", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para70", "text": "37 refer to note 14 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k for additional information, including the domestication.", "highlight": "part iv, item 15", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para71", "text": "Liquidity and capital resources January 30, 2022 January 31, 2021 (in millions) Cash and cash equivalents $ 1,990 $ 847 Marketable securities 19,218 10,714 Cash, cash equivalents, and marketable securities $ 21,208 $ 11,561 Year ended January 30, 2022 January 31, 2021 (in millions) Net cash provided by operating activities $ 9,108 $ 5,822 Net cash provided by (used in) investing activities $ (9,830) $ (19,675) Net cash provided by financing activities $ 1,865 $ 3,804 as of january 30, 2022, we had $21.21 billion in cash, cash equivalents and marketable securities, an increase of $9.65 billion from the end of fiscal year 2021. our investment policy requires the purchase of highly rated fixed income securities, the diversification of investment types and credit exposures, and certain maturity limits on our portfolio.", "highlight": "we had $21.21 billion in cash, cash equivalents and marketable securities, an increase of $9.65 billion from the end of fiscal year 2021", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para72", "text": "cash provided by operating activities increased in fiscal year 2022 compared to fiscal year 2021, due to higher net income, partially offset by changes in working capital. changes in working capital were primarily driven by prepayments of $1.87 billion for long-term supply agreements and increases in trade receivables due to higher revenue.", "highlight": "due to higher net income, partially offset by changes in working capital. ||| increases in trade receivables due to higher revenue.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para73", "text": "cash used in investing activities decreased in fiscal year 2022 compared to cash provided in fiscal year 2021, reflecting lower payments in acquiring businesses as compared to the acquisition of mellanox in fiscal year 2021, and higher marketable securities sales and maturities, partially offset by higher purchases of marketable securities.", "highlight": "reflecting lower payments in acquiring businesses as compared to the acquisition of mellanox in fiscal year 2021, and higher marketable securities sales and maturities, partially offset by higher purchases of marketable securities.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para74", "text": "cash provided by financing activities decreased in fiscal year 2022 compared to cash provided in fiscal year 2021, which primarily reflects a debt repayment in the fiscal year 2022 and higher tax payments on restricted stock units.", "highlight": "primarily reflects a debt repayment in the fiscal year 2022 and higher tax payments on restricted stock units.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para75", "text": "Liquidity our primary sources of liquidity are our cash and cash equivalents, our marketable securities, and the cash generated by our operations. as of january 30, 2022, we had $21.21 billion in cash, cash equivalents and marketable securities. we believe that we have sufficient liquidity to meet our operating requirements for at least the next twelve months, and for the foreseeable future, including our future supply obligations and additional supply. we continuously evaluate our liquidity and capital resources, including our access to external capital, to ensure we can finance our future capital requirements.", "highlight": "believe that we have sufficient liquidity to meet our operating requirements for at least the next twelve months, and for the foreseeable future, including our future supply obligations and additional supply ||| evaluate our liquidity and capital resources, including our access to external capital, to ensure we can finance our future capital requirements.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 1, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para76", "text": "our marketable securities consist of certificates of deposits and debt securities issued by the u.s. government and its agencies, highly rated corporations and financial institutions, and foreign government entities. these marketable securities are primarily denominated in u.s. dollars. refer to note 8 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k for additional information.", "highlight": "refer to note 8 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k for additional information.", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para77", "text": "during fiscal year 2023, we expect to use our existing cash and cash equivalents, our marketable securities, and the cash generated by our operations to fund our capital investments of approximately $1.4 billion related to property and equipment.", "highlight": "we expect to use our existing cash and cash equivalents, our marketable securities, and the cash generated by our operations to fund our capital investments of approximately $1.4 billion related to property and equipment", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 1, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para78", "text": "We have approximately $1.4 billion of cash, cash equivalents, and marketable securities held outside the u.s. for which we have not accrued any related foreign or state taxes if we repatriate these amounts to the u.s. other than that, substantially all of our cash, cash equivalents and marketable securities held outside of the u.s. as of january 30, 2022 are available for use in the u.s. without incurring additional u.s. federal income taxes. following the domestication, we 38 have utilized almost all of our accumulated u.s. federal research tax credits during fiscal year 2022, resulting in higher cash tax payments starting in fiscal year 2023. in addition, beginning in fiscal year 2023, the tcja requires taxpayers to capitalize research and development expenditures and to amortize domestic expenditures over five years and foreign expenditures over fifteen years. this will impact cash flows from operations and result in significantly higher cash tax payments starting in fiscal year 2023. refer to note 14 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k for additional information.", "highlight": "this will impact cash flows from operations and result in significantly higher cash tax payments starting in fiscal year 2023", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 2, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para79", "text": "Capital return to shareholders in fiscal year 2022, we paid $399 million in quarterly cash dividends. our cash dividend program and the payment of future cash dividends under that program are subject to our board's continuing determination that the dividend program and the declaration of dividends thereunder are in the best interests of our shareholders.", "highlight": "we paid $399 million in quarterly cash dividends", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 2, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para80", "text": "as of january 30, 2022, we were authorized, subject to certain specifications, to repurchase additional shares of our common stock up to $7.24 billion through december 2022. we did not repurchase any shares during fiscal year 2022.", "highlight": "repurchase additional shares of our common stock up to $7.24 billion through december 2022", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 1, "7": 1, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para81", "text": "Outstanding indebtedness and commercial paper program As of january 30, 2022, we had outstanding: $1.25 billion of notes due 2023; $1.25 billion of notes due 2024; $1.00 billion of notes due 2026; $1.25 billion of notes due 2028; $1.50 billion of notes due 2030; $1.25 billion of notes due 2031; $1.00 billion of notes due 2040; $2.00 billion of notes due 2050; and $500 million of notes due 2060.", "highlight": "As of january 30, 2022, we had outstanding: $1.25 billion of notes due 2023; $1.25 billion of notes due 2024; $1.00 billion of notes due 2026; $1.25 billion of notes due 2028; $1.50 billion of notes due 2030; $1.25 billion of notes due 2031; $1.00 billion of notes due 2040; $2.00 billion of notes due 2050; and $500 million of notes due 2060.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para82", "text": "we have a $575 million commercial paper program to support general corporate purposes. as of january 30, 2022, we had not issued any commercial paper.", "highlight": "commercial paper program to support general corporate purposes.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para83", "text": "refer to note 12 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k for further discussion.", "highlight": "in part iv, item 15 of this annual report on form 10-k", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para84", "text": "Contractual obligations we have unrecognized tax benefits of $729 million, which includes related interest and penalties of $59 million recorded in non-current income tax payable as of january 30, 2022. we are unable to reasonably estimate the timing of any potential tax liability, interest payments, or penalties in individual years due to uncertainties in the underlying income tax positions and the timing of the effective settlement of such tax positions. we are currently under examination by the internal revenue service for our fiscal years 2018 and 2019. refer to note 14 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k for further information.", "highlight": "we have unrecognized tax benefits of $729 million, which includes related interest and penalties of $59 million recorded in non-current income tax payable as of january 30, 2022 ||| we are currently under examination by the internal revenue service for our fiscal years 2018 and 2019", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 3, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para85", "text": "for a description of our long-term debt, purchase obligations, and operating lease obligations, refer to note 12, note 13, and note 3 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k, respectively.", "highlight": "refer to note 12, note 13, and note 3 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para86", "text": "Climate change refer to part i, item 1 of this annual report on form 10-k for a description of environmental, social and corporate governance activities. to date, there has been no material impact to our results of operations associated with global sustainability regulations, compliance, costs from sourcing renewable energy or climate-related business trends. there are no material current climate change regulations impacting us, however, we are monitoring potential regulation changes in california, the united states, the united kingdom, the european union and other jurisdictions. we believe that climate change has not had a material impact to our revenue to date. we have not experienced any significant physical effects of climate change to date on our operations and results, nor any significant impacts on the cost or availability of insurance. in fiscal year 2023, we plan to build earth-2, an ai supercomputer dedicated to predicting the impacts of climate change and increase our purchases of renewable energy credits.", "highlight": "we plan to build earth-2, an ai supercomputer dedicated to predicting the impacts of climate change and increase our purchases of renewable energy credits.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 1, "7": 0, "0": 0}}
{"id": "20220318_10-K_1045810_part2_item7_para87", "text": "39 Adoption of new and recently issued accounting pronouncements refer to note 1 of the notes to the consolidated financial statements in part iv, item 15 of this annual report on form 10-k for a discussion of adoption of new and recently issued accounting pronouncements.", "highlight": "refer to note 1 of the notes to the consolidated financial statements in part iv, item 15", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para1", "text": "Overview we are on a journey to execute our customer first, people led, innovation driven strategy within our better not bigger framework. we are focused on improving revenue quality, reducing our cost to serve, growing operating profit and allocating capital in a disciplined fashion. the customer first component of our strategy focuses on, among other things, enhancing the capabilities that we believe our customers value the most: speed and ease of access to our services. the people led component of our strategy aims to enhance the employee value proposition. our innovation driven strategic approach utilizes technology and automation to deliver sustainable improvements to our network and to enhance the customer experience.", "highlight": "we are on a journey to execute our customer first, people led, innovation driven strategy within our better not bigger framework", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para2", "text": "we have two reportable segments: u.s. domestic package and international package, which are together referred to as our global small package operations. our remaining businesses are reported as supply chain solutions. for the year, we increased average daily volume, revenue per piece and operating margin within global small package operations, with growth led by small- and medium-sized businesses (\"smbs\") as we executed on our strategy. the covid-19 pandemic continued to have, and is expected to continue to have, an impact on our business. we experienced a year-over-year increase in commercial volume as business returned to pre-pandemic levels, while business-to-consumer volume declined, partly due to the surge in e-commerce at the onset of the pandemic. in the second half of the year, covid-19 resulted in a reduction in the number of flights we operated in asia relative to our expectations, which contributed to an overall decline in international volume in the fourth quarter. within supply chain solutions, operating margin increased with demand for our services particularly strong in forwarding and healthcare logistics, including covid-19 relief efforts.", "highlight": "we have two reportable segments: u.s. domestic package and international package, which are together referred to as our global small package operations. our remaining businesses are reported as supply chain solutions", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para3", "text": "the overall economic environment continues to be challenging. global supply chain disruption continues, and resulted in capacity constraints that drove higher transportation costs, particularly in our supply chain solutions businesses. rising inflation and labor market challenges continue to cause wage pressures in certain markets. we continue to monitor the impacts of these external conditions on our business; however, we anticipate that demand for our services will remain strong.", "highlight": "the overall economic environment continues to be challenging. global supply chain disruption continues, and resulted in capacity constraints that drove higher transportation costs, particularly in our supply chain solutions businesses ||| rising inflation and labor market challenges continue to cause wage pressures in certain markets", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 1, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para4", "text": "during the first quarter of 2021, following enactment of the american rescue plan act (\"arpa\"), we remeasured the ups/ibt full time employee pension plan. this resulted in a $3.3 billion pre-tax mark-to-market gain in the first quarter. we completed the divestiture of ups freight on april 30, 2021, and used the cash proceeds of $848 million to reduce outstanding indebtedness. we recognized a pre-tax gain of $46 million for the year in respect of this transaction. the divestiture triggered a remeasurement of certain of our u.s. defined benefit pension and postretirement benefit plans, which had only an immaterial impact on results of operations for the year. for additional information on this divestiture, see note 4 to the audited, consolidated financial statements. following the divestiture, we renamed our supply chain & freight businesses supply chain solutions.", "highlight": "this resulted in a $3.3 billion pre-tax mark-to-market gain in the first quarter ||| used the cash proceeds of $848 million to reduce outstanding indebtedness |||  recognized a pre-tax gain of $46 million for the year in respect of this transaction", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para5", "text": "in october 2021, we completed the acquisition of roadie, a technology platform focused on same-day delivery services, for $586 million. the results of roadie are reported within supply chain solutions. the acquisition did not have a material impact on our results of operations for the year. see note 9 to the audited, consolidated financial statements for additional information on this transaction.", "highlight": "we completed the acquisition of roadie, a technology platform focused on same-day delivery services, for $586 million ||| the acquisition did not have a material impact on our results of operations for the year", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 2, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para6", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Highlights of our results for the years ended december 31, 2021 and 2020, which are discussed in more detail in the sections that follow, include: Year ended december 31, Change 2021 2020 $% Revenue (in millions) $ 97,287 $ 84,628 $ 12,659 15.0 % Operating expenses (in millions) 84,477 76,944 7,533 9.8 % Operating profit (in millions) $ 12,810 $ 7,684 $ 5,126 66.7 % Operating margin 13.2 % 9.1 % Net income (in millions) $ 12,890 $ 1,343 $ 11,547 859.8 % Basic earnings per share $ 14.75 $ 1.55 $ 13.20 851.6 % Diluted earnings per share $ 14.68 $ 1.54 $ 13.14 853.2 % Operating days 254 255 Average daily package volume (in thousands) 25,250 24,676 2.3 % Average revenue per piece $ 12.32 $ 10.94 $ 1.38 12.6 % revenue increased in all segments, with double digit revenue per piece growth in both u.s. domestic package and international package.", "highlight": "Year ended december 31, Change 2021 2020 $% Revenue (in millions) $ 97,287 $ 84,628 $ 12,659 15.0 % Operating expenses (in millions) 84,477 76,944 7,533 9.8 % Operating profit (in millions) $ 12,810 $ 7,684 $ 5,126 66.7 % Operating margin 13.2 % 9.1 % Net income (in millions) $ 12,890 $ 1,343 $ 11,547 859.8 % Basic earnings per share $ 14.75 $ 1.55 $ 13.20 851.6 % Diluted earnings per share $ 14.68 $ 1.54 $ 13.14 853.2 % Operating days 254 255 Average daily package volume (in thousands) 25,250 24,676 2.3 % Average revenue per piece $ 12.32 $ 10.94 $ 1.38 12.6 %", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para7", "text": "average daily package volume increases were driven by growth in smb and business-to-business volume.", "highlight": "were driven by growth in smb and business-to-business volume.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para8", "text": "operating expenses increased, primarily driven by fuel and third-party transportation costs.", "highlight": "driven by fuel and third-party transportation costs.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para9", "text": "operating profit and operating margin increased in global small package and supply chain solutions.", "highlight": "operating profit and operating margin increased", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para10", "text": "We reported net income of $12.9 billion and diluted earnings per share of $14.68. adjusted diluted earnings per share was $12.13 after adjusting for the after-tax impacts of: A gain on the divestiture of ups freight of $35 million or $0.04 per diluted share; Transformation strategy costs of $285 million or $0.32 per diluted share; and a pension mark-to-market gain recognized outside of a 10% corridor of $2.5 billion or $2.83 per share.", "highlight": "net income of $12.9 billion and diluted earnings per share of $14.68. ||| adjusted diluted earnings per share was $12.13 ||| gain on the divestiture of ups freight of $35 million or $0.04 per diluted share ||| Transformation strategy costs of $285 million or $0.32 per diluted share ||| pension mark-to-market gain recognized outside of a 10% corridor of $2.5 billion or $2.83 per share", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para11", "text": "in the u.s. domestic package segment, volume increases were driven by strong growth from smbs. revenue and revenue per piece increased through execution of our revenue quality initiatives, with favorable shifts in customer and product mix and base rate increases, as well as increases in fuel and demand-related surcharges. expenses increased primarily due to higher fuel prices and increases in employee compensation and benefit costs, which were slightly offset by productivity improvements.", "highlight": "domestic package segment, volume increases ||| revenue and revenue per piece increased through execution of our revenue quality initiatives, with favorable shifts in customer and product mix and base rate increases, as well as increases in fuel and demand-related surcharges", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para12", "text": "the international package segment also experienced volume growth for the year, driven by business-to-business volume. revenue and revenue per piece increased due to fuel and demand-related surcharges, base rate increases, shifts in customer and product mix and favorable currency movements. expense increases were primarily due to higher network costs, driven by higher fuel prices, and volume growth, which resulted in additional third-party pickup and delivery expense.", "highlight": "driven by business-to-business volume ||| fuel and demand-related surcharges, base rate increases, shifts in customer and product mix and favorable currency movements ||| driven by higher fuel prices, and volume growth, which resulted in additional third-party pickup and delivery expense", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para13", "text": "in supply chain solutions, the impact of divesting ups freight was more than offset by revenue growth from the remaining businesses, primarily forwarding and logistics. forwarding growth was driven by higher volumes in our air and ocean freight businesses and market rate and base pricing increases. within logistics, we experienced strong growth in our healthcare operations. expense increases in supply chain solutions were primarily due to higher third-party transportation costs.", "highlight": "the impact of divesting ups freight was more than offset by revenue growth from the remaining businesses ||| within logistics, we experienced strong growth in our healthcare operations. expense increases", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para14", "text": "2020 compared to 2019 see item 7. management's discussion and analysis of financial condition and results of operations of the company's annual report on form 10-k for the year ended december 31, 2020 filed with the securities and exchange commission on february 22, 2021.", "highlight": "form 10-k for the year ended december 31, 2020  ||| 2020 compared to 2019 see item 7", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para15", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Supplemental information - items affecting comparability we supplement the reporting of our financial information determined under generally accepted accounting principles in the united states (\"gaap\") with certain non-gaap financial measures. these include: \"adjusted\" compensation and benefits; operating expenses; operating profit; operating margin; other income and (expense); income before income taxes; income tax expense; effective tax rate; net income; and earnings per share. adjusted financial measures may exclude the impact of period over period exchange rate changes and hedging activities, amounts related to mark-to-market gains or losses, transformation and other charges, goodwill and asset impairment charges and divestitures, as described below.", "highlight": "Supplemental information - items affecting comparability we supplement the reporting of our financial information determined under generally accepted accounting principles in the united states (\"gaap\") with certain non-gaap financial measures.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para16", "text": "we believe that these non-gaap measures provide additional meaningful information to assist users of our financial statements in more fully understanding our financial results and assessing our ongoing performance, because they exclude items that may not be indicative of, or are unrelated to, our underlying operations, and may provide a useful baseline for analyzing trends in our underlying businesses. these non-gaap measures are used internally by management for business unit operating performance analysis, business unit resource allocation and in connection with incentive compensation award determinations.", "highlight": "we believe that these non-gaap measures provide additional meaningful information to assist users of our financial statements in more fully understanding our financial results and assessing our ongoing performance, because they exclude items that may not be indicative of, or are unrelated to, our underlying operations, and may provide a useful baseline for analyzing trends in our underlying businesses", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para17", "text": "adjusted financial measures should be considered in addition to, and not as an alternative for, our reported results prepared in accordance with gaap. our adjusted financial measures do not represent a comprehensive basis of accounting. therefore, our adjusted financial measures may not be comparable to similarly titled measures reported by other companies.", "highlight": "adjusted financial measures should be considered ||| our adjusted financial measures do not represent a comprehensive basis of accounting ||| adjusted financial measures may not be comparable to similarly titled measures reported by other companies.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 1, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para18", "text": "Adjusted amounts reflect the following (in millions): Year ended december 31, Non-gaap adjustments 2021 2020 Operating expenses: Transformation strategy costs $ 380 $ 348 Goodwill and asset impairment charges, and divestitures -46 686 Total adjustments to operating expenses $ 334 $ 1,034 Other income and (expense): Defined benefit plans mark-to-market (gain) loss $ (3,272) $ 6,484 Total adjustments to other income and (expense) $ (3,272) $ 6,484 Total adjustments to income before income taxes $ (2,938) $ 7,518 Income tax (benefit) expense from defined benefit plans mark-to-market $ 784 $ (1,555) Income tax benefit from transformation strategy costs -95 -83 Income tax (benefit) expense from goodwill and asset impairment charges, and divestitures 11 -57 Total adjustments to income tax expense $ 700 $ (1,695) Total adjustments to net income $ (2,238) $ 5,823 these items have been excluded from comparisons of \"adjusted\" compensation and benefits, operating expenses, operating profit, operating margin, other income and (expense), income tax expense and effective tax rate in the discussion that follows. the income tax impacts from transformation and other charges; mark-to-market gains and losses; goodwill and asset impairment charges, and divestitures are calculated by multiplying the statutory tax rates applicable in each tax jurisdiction, including the u.s. federal jurisdiction and various u.s. state and non-u.s. jurisdictions, by the tax-deductible adjustments. the blended average effective tax rates in 2021 and 2020 were 23.8% and 22.5%, respectively.", "highlight": "Year ended december 31, Non-gaap adjustments 2021 2020 Operating expenses: Transformation strategy costs $ 380 $ 348 Goodwill and asset impairment charges, and divestitures -46 686 Total adjustments to operating expenses $ 334 $ 1,034 Other income and (expense): Defined benefit plans mark-to-market (gain) loss $ (3,272) $ 6,484 Total adjustments to other income and (expense) $ (3,272) $ 6,484 Total adjustments to income before income taxes $ (2,938) $ 7,518 Income tax (benefit) expense from defined benefit plans mark-to-market $ 784 $ (1,555) Income tax benefit from transformation strategy costs -95 -83 Income tax (benefit) expense from goodwill and asset impairment charges, and divestitures 11 -57 Total adjustments to income tax expense $ 700 $ (1,695) Total adjustments to net income $ (2,238) $ 5,823 these items have been excluded from comparisons of \"adjusted\" compensation and benefits ||| the blended average effective tax rates in 2021 and 2020 were 23.8% and 22.5%, respectively.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para19", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Transformation and other charges, goodwill and asset impairment charges, and divestitures we supplement the presentation of our operating profit, operating margin, income before income taxes, net income and earnings per share with non-gaap measures that exclude the impact of charges related to transformation activities, goodwill and asset impairment charges and divestitures. for more information regarding transformation activities, see note 19 to the audited, consolidated financial statements. for more information regarding goodwill and asset impairment charges and divestitures, see note 4 to the audited, consolidated financial statements.", "highlight": "Transformation and other charges, goodwill and asset impairment charges, and divestitures we supplement the presentation of our operating profit, operating margin, income before income taxes, net income and earnings per share with non-gaap measures that exclude the impact of charges related to transformation activities ||| goodwill and asset impairment charges and divestitures", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para20", "text": "Changes in foreign currency exchange rates and hedging activities we also supplement the reporting of revenue, revenue per piece and operating profit with adjusted measures that exclude the period over period impact of foreign currency exchange rate changes and hedging activities. we believe currency-neutral revenue, revenue per piece and operating profit information allows users of our financial statements to understand growth trends in our products and results. we evaluate the performance of international package and supply chain solutions on this currency-neutral basis.", "highlight": "Changes in foreign currency exchange rates and hedging activities we also supplement the reporting of revenue ||| we believe currency-neutral revenue, revenue per piece and operating profit information allows users of our financial statements to understand growth trends in our products and results ||| we evaluate the performance of international package and supply chain solutions on this currency-neutral basis.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 1, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para21", "text": "currency-neutral revenue, revenue per piece and operating profit are calculated by dividing current period reported u.s. dollar revenue, revenue per piece and operating profit by the current period average exchange rates to derive current period local currency revenue, revenue per piece and operating profit. the derived amounts are then multiplied by the average foreign currency exchange rates used to translate the comparable results for each month in the prior year period (including the period over period impact of foreign currency hedging activities). the difference between the current period reported u.s. dollar revenue, revenue per piece and operating profit and the derived current period u.s. dollar revenue, revenue per piece and operating profit is the period over period impact of currency fluctuations.", "highlight": "the difference between the current period reported u.s. dollar revenue, revenue per piece and operating profit and the derived current period u.s. dollar revenue, revenue per piece and operating profit is the period over period impact of currency fluctuations.", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para22", "text": "Defined benefit plans mark-to-market impacts we recognize changes in the fair value of plan assets and net actuarial gains and losses in excess of a 10% corridor for our pension and postretirement defined benefit plans immediately as part of investment income (expense) and other within other income and (expense) . we supplement the presentation of our income before income taxes, net income and earnings per share with non-gaap measures that exclude the impact of these gains and losses and the related income tax effects. we believe excluding these mark-to-market impacts provides important supplemental information by removing the volatility associated with short-term changes in market interest rates, equity values and similar factors.", "highlight": "we supplement the presentation of our income before income taxes, net income and earnings per share with non-gaap measures that exclude the impact of these gains and losses and the related income tax effects ||| we believe excluding these mark-to-market impacts provides important supplemental information by removing the volatility associated with short-term changes in market interest rates, equity values and similar factors.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para23", "text": "investment income (expense) and other reflects the actual return on plan assets (9.11% in 2021 and 12.54% in 2020) and the discount rate used to measure the projected benefit obligation at the december 31st measurement date (3.11% in 2021 and 2.87% in 2020). adjusted investment income (expense) and other utilizes the expected return on plan assets (6.40% in 2021 and 7.70% in 2020) and the discount rate used to determine net periodic benefit cost (2.87% in 2021 and 3.55% in 2020).", "highlight": "investment income (expense) and other reflects the actual return on plan assets  ||| the discount rate used to measure the projected benefit obligation at the december 31st measurement date ||| adjusted investment income (expense) and other utilizes the expected return on plan assets ||| the discount rate used to determine net periodic benefit cost", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para24", "text": "the remeasurement of our pension and postretirement defined benefit plans' assets and liabilities resulted in a $3.3 billion mark-to-market gain in 2021 and $6.5 billion loss in 2020.", "highlight": "the remeasurement of our pension and postretirement defined benefit plans' assets and liabilities resulted in a $3.3 billion mark-to-market gain in 2021", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para25", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations The table below shows the amounts associated with each component of the pre-tax mark-to-market gain (loss), as well as the weighted-average actuarial assumptions used to determine our net periodic benefit cost, for each year: Year ended december 31, Components of mark-to-market gain (loss) (in millions): 2021 2020 Discount rates $ 1,871 $ (6,540) Return on assets -269 2,390 Demographic and other assumption changes -97 -381 Coordinating benefits attributable to the central states pension fund 1,767 -1,953 Total mark-to-market gain (loss) $ 3,272 $ (6,484) Year ended december 31, Weighted-average actuarial assumptions: 2021 2020 Expected rate of return on plan assets 6.40 % 7.70 % Actual rate of return on plan assets 9.11 % 12.54 % Discount rate used for net periodic benefit cost 2.87 % 3.55 % Discount rate at measurement date 3.11 % 2.87 % The pre-tax mark-to-market gains and losses for the years ended december 31, 2021 and 2020 consisted of the following: 2021 - $3.3 billion pre-tax mark-to-market gain: discount rates ($1.9 billion pre-tax gain): this gain was driven by the interim remeasurement of the ups/ibt plan in the first quarter of 2021. the weighted-average discount rate for our ups/ibt plan increased from 2.98% as of december 31, 2020 to 3.70% as of march 31, 2021, primarily due to an increase in u.s. treasury yields.", "highlight": ": this gain was driven by the interim remeasurement of the ups/ibt plan in the first quarter of 2021 ||| primarily due to an increase in u.s. treasury yields.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para26", "text": "return on assets ($0.3 billion pre-tax loss): this loss was primarily driven by the interim remeasurement of the ups/ibt plan in the first quarter of 2021. as of march 2021, the actual rate of return on the plan assets was approximately 220 basis points lower than our expected rate of return, primarily due to weak global equity and u.s. bond market performance.", "highlight": "primarily due to weak global equity and u.s. bond market performance.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para27", "text": "demographic and other assumption changes ($0.1 billion pre-tax loss): this represents the difference between actual and estimated participant data and demographic factors, including items such as healthcare cost trends, compensation rate increases and rates of termination, retirement and mortality.", "highlight": "this represents the difference between actual and estimated participant data and demographic factors,", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para28", "text": "coordinating benefits attributable to the central states pension fund ($1.8 billion pre-tax gain): this represents the reduction of the liability for potential coordinating benefits that may be required to be paid related to the central states pension fund.", "highlight": "this represents the reduction of the liability for potential coordinating benefits that may be required to be paid related to the central states pension fund.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para29", "text": "2020 - $6.5 billion pre-tax mark-to-market loss: discount rates ($6.5 billion pre-tax loss): the weighted-average discount rate for our pension and postretirement medical plans decreased from 3.55% as of december 31, 2019 to 2.87% as of december 31, 2020, primarily due to a decline in u.s. treasury yields that was slightly offset by an increase in credit spreads on aa-rated corporate bonds.", "highlight": "primarily due to a decline in u.s. treasury yields that was slightly offset by an increase in credit spreads on aa-rated corporate bonds.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para30", "text": "return on assets ($2.4 billion pre-tax gain): in 2020, the actual rate of return on plan assets was higher than our expected rate of return, primarily due to strong global equity and u.s. bond market performance.", "highlight": "the actual rate of return on plan assets was higher than our expected rate of return,", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para31", "text": "demographic and other assumption changes ($0.4 billion pre-tax loss): this represents the difference between actual and estimated participant data and demographic factors, including items such as healthcare cost trends, compensation rate increases and rates of termination, retirement and mortality.", "highlight": "this represents the difference between actual and estimated participant data and demographic factors", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para32", "text": "coordinating benefits attributable to the central states pension fund ($2.0 billion pre-tax loss): this represents our current best estimate of additional potential coordinating benefits that may be required to be paid related to the central states pension fund.", "highlight": "this represents our current best estimate of additional potential coordinating benefits that may be required to be paid", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para33", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Expense allocations certain operating expenses are allocated between our operating segments using activity-based costing methods. these activity-based costing methods require us to make estimates that impact the amount of each expense category that is attributed to each segment. changes in these estimates would directly impact the amount of expense allocated to each segment, and therefore the operating profit of each reporting segment. our allocation methodologies are refined periodically, as necessary, to reflect changes in our businesses.", "highlight": "changes in these estimates would directly impact the amount of expense allocated to each segment, and therefore the operating profit of each reporting segment", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para34", "text": "in the first quarter of 2021, we updated our cost allocation methodology for aircraft engine maintenance expense to better align with aircraft utilization by segment. this change resulted in a reallocation of expense from our u.s. domestic package segment to our international package segment of approximately $73 million for the year.", "highlight": "we updated our cost allocation methodology for aircraft engine maintenance expense to better align with aircraft utilization by segment", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para35", "text": "upon the divestiture of ups freight, revenue and costs associated with the ground with freight pricing (\"gfp\") product began to be reported in u.s. domestic package.", "highlight": "revenue and costs associated with the ground with freight pricing (\"gfp\") product began to be reported in u.s. domestic package", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 2, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para36", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations U.s. domestic package Year ended december 31, Change 2021 2020 $% Average daily package volume (in thousands): Next day air 2,093 1,987 5.3 % Deferred 1,723 1,783 -3.4 % Ground 17,646 17,371 1.6 % Total average daily package volume 21,462 21,141 1.5 % Average revenue per piece: Next day air $ 18.83 $ 16.82 $ 2.01 12.0 % Deferred 13.36 12.46 0.90 7.2 % Ground 9.92 8.87 1.05 11.8 % Total average revenue per piece $ 11.06 $ 9.92 $ 1.14 11.5 % Operating days in period 254 255 Revenue (in millions): Next day air $ 10,009 $ 8,522 $ 1,487 17.4 % Deferred 5,846 5,665 181 3.2 % Ground 44,462 39,312 5,150 13.1 % Total revenue $ 60,317 $ 53,499 $ 6,818 12.7 % Operating expenses (in millions): Operating expenses $ 53,881 $ 49,608 $ 4,273 8.6 % Transformation and other charges -281 -237 -44 18.6 % Adjusted operating expenses $ 53,600 $ 49,371 $ 4,229 8.6 % Operating profit (in millions) and operating margin: Operating profit $ 6,436 $ 3,891 $ 2,545 65.4 % Adjusted operating profit $ 6,717 $ 4,128 $ 2,589 62.7 % Operating margin 10.7 % 7.3 % Adjusted operating margin 11.1 % 7.7 % Revenue The change in revenue was due to the following factors: Revenue change drivers: Volume Rates / Product mix Fuel Surcharge Total revenue Change 2021 vs. 2020 1.1 % 9.2 % 2.4 % 12.7 % Volume average daily volume increased slightly, driven by smb customer volume growth of 18% as a result of the continued execution of the customer first component of our strategy, which was partially offset by a decline in ground residential volume from our large customers. we anticipate this decline will moderate in 2022 and be offset by growth in ground residential volume from our smb customers. we expect overall volume growth levels in 2022 will remain consistent with 2021.", "highlight": "driven by smb customer volume growth of 18% as a result of the continued execution of the customer first component of our strategy, which was partially offset by a decline in ground residential volume from our large customers", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para37", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations business-to-consumer shipments represented approximately 60.7% of average daily volume compared to 63.6% in 2020. the decrease in 2021 was attributable to elevated e-commerce spending and a reduction in business-to-business activity in 2020 as a result of the covid-19 pandemic. business-to-business shipments increased 9.4%, primarily in our ground commercial product, as business activity largely recovered from the impacts of the covid-19 pandemic.", "highlight": "the decrease in 2021 was attributable to elevated e-commerce spending and a reduction in business-to-business activity in 2020 as a result of the covid-19 pandemic ||| as business activity largely recovered from the impacts of the covid-19 pandemic.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para38", "text": "average daily volume in our next day air product increased as a result of the increase in business-to-business activity from smbs and large customers. higher residential demand also contributed to the growth in next day air. deferred volume decreased but remained slightly above pre-pandemic levels, with shifts in customer mix impacting product demand.", "highlight": "higher residential demand also contributed to the growth in next day air. deferred volume decreased but remained slightly above pre-pandemic levels, with shifts in customer mix impacting product demand.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para39", "text": "surepost average daily volume decreased 10.7%, driven by declines in volume from large customers. ground commercial volume increased 7.0%, with growth in all customer segments.", "highlight": "surepost average daily volume decreased 10.7% ||| commercial volume increased 7.0%", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para40", "text": "Rates and product mix overall revenue per piece increased in all customer segments, driven by increases in base rates and the increase in commercial volume discussed above. revenue per piece was favorably impacted by the growth in smb volume resulting from continued execution of our strategy, and from demand-related and fuel surcharges. rates for ground and air services increased an average of 4.9% in december 2020, and our surepost rates also increased at that time. we anticipate demand-related surcharges will remain largely unchanged in 2022.", "highlight": "we anticipate demand-related surcharges will remain largely unchanged in 2022.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para41", "text": "revenue per piece for our next day air and deferred products increased as a result of the factors described above. the increase was slightly offset by the impact of a reduction in average billable weight per piece. revenue per piece for our ground product increased due to an increase in average billable weight per piece in addition to the factors described above.", "highlight": "revenue per piece for our next day air and deferred products increased ||| the increase was slightly offset by the impact of a reduction in average billable weight per piece ||| revenue per piece for our ground product increased", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para42", "text": "we are focused on continuing to grow revenue per piece through execution of our strategy.", "highlight": "we are focused on continuing to grow revenue", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para43", "text": "Fuel surcharges We apply a fuel surcharge on our domestic air and ground services that is adjusted weekly. the air fuel surcharge is based on the u.s. department of energy's (\"doe\") gulf coast spot price for a gallon of kerosene-type jet fuel, while the ground fuel surcharge is based on the doe's on-highway diesel fuel price. based on published rates, the average fuel surcharge rates for domestic air and ground products were as follows: Year ended december 31, % point change 2021 2020 2021 vs. 2020 Next day air / deferred 8.1 % 3.9 % 4.2 % Ground 8.6 % 6.6 % 2.0 % while fluctuations in fuel surcharges can be significant from period to period, fuel surcharges are only one of the many individual components of our market pricing strategy that impact our overall revenue and yield. additional components include the mix of services sold, the base price and additional charges for these services and the pricing discounts offered.", "highlight": "We apply a fuel surcharge on our domestic air and ground services that is adjusted weekly ||| Year ended december 31, % point change 2021 2020 2021 vs. 2020 Next day air / deferred 8.1 % 3.9 % 4.2 % Ground 8.6 % 6.6 % 2.0 % while fluctuations in fuel surcharges can be significant from period to period", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para44", "text": "total domestic fuel surcharge revenue increased by $1.3 billion, driven by a significant increase in fuel surcharge indices. we expect the impact of these increases will continue in 2022.", "highlight": "total domestic fuel surcharge revenue increased by $1.3 billion, ||| expect the impact of these increases will continue in 2022.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para45", "text": "Operating expenses Operating expenses, and operating expenses excluding the year-over-year impact of transformation and other charges, increased, driven by a $1.7 billion increase in the cost of operating our integrated air and ground network and a $1.7 billion increase in pickup and delivery costs. in addition, the cost of package sorting increased $514 million and other indirect operating costs increased by $245 million. the increase in expense was driven by: higher fuel costs, primarily attributable to increases in the price of jet fuel, diesel and gasoline, which we expect to persist.", "highlight": "Operating expenses Operating expenses, and operating expenses excluding the year-over-year impact of transformation and other charges, increased |||  cost of package sorting increased $514 million ||| other indirect operating costs increased by $245 million", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para46", "text": "higher employee benefit expense for our union workforce due to contractual contribution rate increases to multiemployer plans and additional headcount becoming eligible for health, welfare and retirement benefits.", "highlight": "due to contractual contribution rate increases to multiemployer plans and additional headcount becoming eligible for health, welfare and retirement benefits", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para47", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations additional compensation expense due to contractual rate increases for our union workforce. cost of living and wage-rate adjustments driven by inflation and other market factors also drove higher compensation costs. volume growth also contributed to the increase. these increases were partially offset by productivity improvements. management payroll increased, primarily due to incentive compensation and commission payments.", "highlight": "due to contractual rate increases for our union workforce ||| driven by inflation and other market factors also drove higher compensation costs ||| partially offset by productivity improvements. management payroll increased, primarily due to incentive compensation and commission payments", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para48", "text": "higher third-party transportation costs as a result of our investments to improve time-in-transit within our ground network partially offset by lower third-party carrier costs for surepost and rail due to lower volumes.", "highlight": "as a result of our investments to improve time-in-transit within our ground network partially offset by lower third-party carrier costs for surepost and rail due to lower volumes", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para49", "text": "the reallocation of expense for the gfp product following the divestiture of ups freight resulted in an increase of $281 million in segment operating expenses.", "highlight": "in an increase of $281 million in segment operating expenses", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para50", "text": "total cost per piece, and adjusted cost per piece excluding the year-over-year impact of transformation and other charges, increased 7.4%. we anticipate that overall costs and cost per piece may continue to increase during 2022 as a result of contractual cost increases and market factors, including inflation and the availability and cost of labor. we expect this expense growth to moderate in 2022 due to additional operational improvements.", "highlight": "total cost per piece, and adjusted cost per piece excluding the year-over-year impact of transformation and other charges, increased 7.4%. |||  expect this expense growth to moderate in 2022", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para51", "text": "Operating profit and margin as a result of the factors described above, operating profit increased $2.5 billion, with operating margin increasing 340 basis points to 10.7%. excluding the year-over-year impact of transformation and other charges, adjusted operating profit increased $2.6 billion, with adjusting operating margin increasing 340 basis points to 11.1%.", "highlight": "operating profit increased $2.5 billion, with operating margin increasing 340 basis points to 10.7%.  ||| adjusted operating profit increased $2.6 billion, with adjusting operating margin increasing 340 basis points to 11.1%.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para52", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations International package Year ended december 31, Change 2021 2020 $% Average daily package volume (in thousands): Domestic 1,988 1,863 6.7 % Export 1,800 1,672 7.7 % Total average daily package volume 3,788 3,535 7.2 % Average revenue per piece: Domestic $ 7.31 $ 6.65 $ 0.66 9.9 % Export 32.83 28.52 4.31 15.1 % Total average revenue per piece $ 19.44 $ 16.99 $ 2.45 14.4 % Operating days in period 254 255 Revenue (in millions): Domestic $ 3,690 $ 3,160 $ 530 16.8 % Export 15,012 12,159 2,853 23.5 % Cargo & other 839 626 213 34.0 % Total revenue $ 19,541 $ 15,945 $ 3,596 22.6 % Operating expenses (in millions): Operating expenses $ 14,895 $ 12,509 $ 2,386 19.1 % Transformation and other charges -74 -96 22 -22.9 % Adjusted operating expenses $ 14,821 $ 12,413 $ 2,408 19.4 % Operating profit (in millions) and operating margin: Operating profit $ 4,646 $ 3,436 $ 1,210 35.2 % Adjusted operating profit $ 4,720 $ 3,532 $ 1,188 33.6 % Operating margin 23.8 % 21.5 % Adjusted operating margin 24.2 % 22.2 % Currency translation benefit / (cost) (in millions)*: Revenue $ 402 Operating expenses -300 Operating profit $ 102 * net of currency hedging; amount represents the change compared to the prior year.", "highlight": "Change 2021 2020 $% Average daily package volume (in thousands): Domestic 1,988 1,863 6.7 % Export 1,800 1,672 7.7 % Total average daily package volume 3,788 3,535 7.2 % Average revenue per piece: Domestic $ 7.31 $ 6.65 $ 0.66 9.9 % Export 32.83 28.52 4.31 15.1 % Total average revenue per piece $ 19.44 $ 16.99 $ 2.45 14.4 % Operating days in period 254 255 Revenue (in millions): Domestic $ 3,690 $ 3,160 $ 530 16.8 % Export 15,012 12,159 2,853 23.5 % Cargo & other 839 626 213 34.0 % Total revenue $ 19,541 $ 15,945 $ 3,596 22.6 % Operating expenses (in millions): Operating expenses $ 14,895 $ 12,509 $ 2,386 19.1 % Transformation and other charges -74 -96 22 -22.9 % Adjusted operating expenses $ 14,821 $ 12,413 $ 2,408 19.4 % Operating profit (in millions) and operating margin: Operating profit $ 4,646 $ 3,436 $ 1,210 35.2 % Adjusted operating profit $ 4,720 $ 3,532 $ 1,188 33.6 % Operating margin 23.8 % 21.5 % Adjusted operating margin 24.2 % 22.2 % Currency translation benefit / (cost) (in millions)*: Revenue $ 402 Operating expenses -300 Operating profit $ 102 * net of currency hedging", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para53", "text": "Revenue The change in revenue was due to the following: Revenue change drivers: Volume Rates / Product mix Fuel Surcharges Currency Total revenue Change 2021 vs. 2020 6.7 % 8.1 % 5.2 % 2.6 % 22.6 % United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Volume average daily volume increased for both domestic and export products, with growth primarily in the first half of the year. volume declined in the fourth quarter, largely due to the year-over-year impacts of covid-19 on consumer behavior. for the year, we experienced growth from both smbs and large customers, primarily in the retail, manufacturing and technology sectors. business-to-business volume increased 10.8% as commercial activity largely returned to pre-pandemic levels. business-to-consumer volume increased 5.1%, with growth primarily in the first quarter when covid-19 driven volume was not present in the comparative period. we expect overall volume growth to accelerate in 2022.", "highlight": "Revenue change drivers: Volume Rates / Product mix Fuel Surcharges Currency Total revenue Change 2021 vs. 2020 6.7 % 8.1 % 5.2 % 2.6 % 22.6 % ||| Volume average daily volume increased for both domestic and export products ||| volume declined in the fourth quarter, ||| experienced growth from both smbs and large customers ||| business-to-consumer volume increased 5.1%, ||| business-to-business volume increased 10.8%", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para54", "text": "export volume increased for the year, led by europe and the americas, while asia volume was largely unchanged. volume growth was strongest on intra-europe trade lanes, as well as from europe and the americas to the united states. trade between europe and the united kingdom declined throughout the year as a result of brexit, which became effective on january 1, 2021. asia export volume grew significantly in the first quarter, but was then impacted in the second quarter by a reduction in shipments of personal protective equipment relative to 2020. additionally, covid-19 impacts within the region reduced the number of flights operated in the second half of the year.", "highlight": "export volume increased for the year, led by europe and the americas, while asia volume was largely unchanged ||| volume growth was strongest on intra-europe trade lanes ||| asia export volume grew significantly in the first quarter, but was then impacted in the second quarter by a reduction in shipments of personal protective equipment relative to 2020", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para55", "text": "premium products saw volume growth of 14.9%, driven by worldwide express and transborder express products. volume for non-premium products increased 6.9%, driven by growth in our transborder standard product. worldwide standard volume increased primarily as a result of brexit, with shipments between the united kingdom and the european union that are now subject to duties and taxes shifting from transborder to worldwide products.", "highlight": "premium products saw volume growth of 14.9%, ||| volume for non-premium products increased 6.9%, ||| worldwide standard volume increased", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para56", "text": "domestic volume increased for the year in many markets, with the strongest growth in the united kingdom and western europe, largely due to the impact of covid-19 on business-to-consumer demand. during the fourth quarter, domestic volume declined, driven by a reduction in e-commerce resulting in fewer residential deliveries, that was slightly offset by growth in commercial volume.", "highlight": "domestic volume increased for the year in many markets, with the strongest growth in the united kingdom and western europe ||| during the fourth quarter, domestic volume declined", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para57", "text": "Rates and product mix in december 2020, we implemented an average 4.9% net increase in base and accessorial rates for international shipments originating in the united states. rate changes for shipments originating outside the u.s. are made throughout the year and vary by geographic market. in response to capacity constraints resulting from the covid-19 pandemic, we began to apply demand-related surcharges on certain lanes in the second quarter of 2020. these surcharges are expected to remain elevated in 2022.", "highlight": "we implemented an average 4.9% net increase in base and accessorial rates for international shipments originating in the united states ||| we began to apply demand-related surcharges on certain lanes in the second quarter of 2020. these surcharges are expected to remain elevated in 2022.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para58", "text": "total revenue per piece increased 14.4%, driven by changes in base pricing, fuel and demand-related surcharges and favorable shifts in customer and product mix. currency movements contributed to the increase in revenue per piece for the year, but had a negative impact in the fourth quarter. excluding the impact of currency, revenue per piece increased 12.0% for the year.", "highlight": "total revenue per piece increased 14.4%, ||| currency movements contributed to the increase in revenue per piece for the year, but had a negative impact in the fourth quarter ||| revenue per piece increased 12.0% for the year.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para59", "text": "export revenue per piece increased 15.1% as a result of the factors described above. excluding the impact of currency movements, export revenue per piece increased 13.2%.", "highlight": "export revenue per piece increased 15.1% ||| export revenue per piece increased 13.2%.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para60", "text": "domestic revenue per piece increased 9.9% due to changes in base pricing, fuel surcharges and customer and product mix. although currency movements negatively impacted revenue per piece in the fourth quarter, they contributed to the increase in revenue per piece for the year. excluding the impact of currency movements, revenue per piece increased 5.6%.", "highlight": "domestic revenue per piece increased 9.9%  ||| contributed to the increase in revenue per piece for the year. excluding the impact of currency movements, revenue per piece increased 5.6%.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para61", "text": "we expect revenue per piece growth to moderate in 2022.", "highlight": "we expect revenue per piece growth to moderate in 2022.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para62", "text": "Fuel surcharges the fuel surcharge for international air services originating inside or outside the u.s. is largely indexed to the doe's gulf coast spot price for a gallon of kerosene-type jet fuel. the fuel surcharges for ground services originating outside the u.s. are indexed to fuel prices in the region or country where the shipment originates.", "highlight": "the fuel surcharges for ground services originating outside the u.s. are indexed to fuel prices in the region ||| the fuel surcharge for international air services originating inside or outside the u.s. is largely indexed to the doe's gulf coast spot price for a gallon of kerosene-type jet fuel", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para63", "text": "while fluctuations can be significant from period to period, fuel surcharges represent one of the many individual components of our market pricing strategy that impact our overall revenue and yield. additional components include the mix of services sold, the base price and extra service charges and any pricing discounts offered. total international fuel surcharge revenue increased by $866 million, primarily due to increases in fuel surcharge indices, as well as overall volume growth and changes in customer and product mix.", "highlight": "total international fuel surcharge revenue increased by $866 million", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para64", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Operating expenses operating expenses, and operating expenses excluding the year-over-year impact of transformation and other charges, increased. the costs of operating our integrated international air and ground network increased $1.2 billion driven by the impact of higher fuel prices and volume growth. we expect these trends to continue in 2022.", "highlight": "the costs of operating our integrated international air and ground network increased $1.2 billion", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para65", "text": "in addition to variability in usage and market prices, the manner in which we purchase fuel also influences the net impact of costs on our results. the majority of our contracts for fuel purchases utilize index-based pricing formulas plus or minus a fixed locational/supplier differential. while many of the indices are aligned, each index may fluctuate at a different pace, driving variability in the prices paid for fuel. because of this, our operating results may be affected should the market price of fuel suddenly change by a significant amount or change by amounts that do not result in an adjustment in our fuel surcharges, which can significantly affect our earnings either positively or negatively in the short-term.", "highlight": "the manner in which we purchase fuel also influences the net impact of costs on our results ||| each index may fluctuate at a different pace, driving variability in the prices paid for fuel.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para66", "text": "pickup and delivery costs increased $718 million, primarily due to volume growth that drove additional third-party transportation expense. package sorting costs increased $198 million, also as a result of overall volume growth. we anticipate that these operating expenses may continue to increase due to volume growth and external market factors, such as fuel prices and inflation.", "highlight": "primarily due to volume growth that drove additional third-party transportation expense ||| also as a result of overall volume growth ||| due to volume growth and external market factors, such as fuel prices and inflation.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para67", "text": "the remaining increase in operating expenses was due to increases in other indirect operating costs.", "highlight": "was due to increases in other indirect operating costs.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para68", "text": "Operating profit and margin as a result of the factors described above, operating profit increased $1.2 billion, with operating margin increasing 230 basis points to 23.8%. excluding the year-over-year impact of transformation and other charges, adjusted operating profit also increased $1.2 billion, with operating margin increasing 200 basis points to 24.2%.", "highlight": "operating profit increased $1.2 billion, with operating margin increasing 230 basis points to 23.8% ||| adjusted operating profit also increased $1.2 billion ||| operating margin increasing 200 basis points to 24.2%.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para69", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Supply chain solutions Year ended december 31, Change 2021 2020 $% Freight less-than-truckload statistics: Revenue (in millions) $ 881 $ 2,566 $ (1,685) -65.7 % Revenue per hundredweight $ 29.93 $ 27.46 $ 2.47 9.0 % Shipments (in thousands) 2,829 8,847 -68.0 % Shipments per day (in thousands) 33.3 34.8 -4.3 % Gross weight hauled (in millions of lbs) 2,944 9,343 -68.5 % Weight per shipment (in lbs) 1,041 1,056 -1.4 % Operating days in period 85 254 Revenue (in millions): Forwarding $ 9,872 $ 6,975 $ 2,897 41.5 % Logistics 4,767 4,073 694 17.0 % Freight 1,064 3,149 -2,085 -66.2 % Other 1,726 987 739 74.9 % Total revenue $ 17,429 $ 15,184 $ 2,245 14.8 % Operating expenses (in millions): Operating expenses $ 15,701 $ 14,827 $ 874 5.9 % Transformation strategy costs -25 -15 -10 66.7 % Goodwill, asset impairment charges and divestitures 46 -686 732 N/m Adjusted operating expenses $ 15,722 $ 14,126 $ 1,596 11.3 % Operating profit (in millions) and operating margins: Operating profit $ 1,728 $ 357 $ 1,371 384.0 % Adjusted operating profit $ 1,707 $ 1,058 $ 649 61.3 % Operating margin 9.9 % 2.4 % Adjusted operating margin 9.8 % 7.0 % Currency translation benefit / (cost) (in millions)*: Revenue $ 96 Operating expenses -132 Operating profit $ (36) * amount represents the change compared to the prior year.", "highlight": "Change 2021 2020 $% Freight less-than-truckload statistics: Revenue (in millions) $ 881 $ 2,566 $ (1,685) -65.7 % Revenue per hundredweight $ 29.93 $ 27.46 $ 2.47 9.0 % Shipments (in thousands) 2,829 8,847 -68.0 % Shipments per day (in thousands) 33.3 34.8 -4.3 % Gross weight hauled (in millions of lbs) 2,944 9,343 -68.5 % Weight per shipment (in lbs) 1,041 1,056 -1.4 % Operating days in period 85 254 Revenue (in millions): Forwarding $ 9,872 $ 6,975 $ 2,897 41.5 % Logistics 4,767 4,073 694 17.0 % Freight 1,064 3,149 -2,085 -66.2 % Other 1,726 987 739 74.9 % Total revenue $ 17,429 $ 15,184 $ 2,245 14.8 % Operating expenses (in millions): Operating expenses $ 15,701 $ 14,827 $ 874 5.9 % Transformation strategy costs -25 -15 -10 66.7 % Goodwill, asset impairment charges and divestitures 46 -686 732 N/m Adjusted operating expenses $ 15,722 $ 14,126 $ 1,596 11.3 % Operating profit (in millions) and operating margins: Operating profit $ 1,728 $ 357 $ 1,371 384.0 % Adjusted operating profit $ 1,707 $ 1,058 $ 649 61.3 % Operating margin 9.9 % 2.4 % Adjusted operating margin 9.8 % 7.0 % Currency translation benefit / (cost) (in millions)*: Revenue $ 96 Operating expenses -132 Operating profit $ (36) * amount", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para70", "text": "Year ended december 31, Change 2021 2020 $% Transformation strategy costs (in millions): Forwarding $ 8 $ 8 $% Logistics 5 6 -1 -16.7 % Freight 1 1 % Other 11 11 N/a Total transformation strategy costs $ 25 $ 15 $ 10 66.7 % on april 30, 2021, we completed the divestiture of ups freight. for the year ended december 31, 2021, we recognized a pre-tax gain of $46 million related to this divestiture. see note 4 to the audited, consolidated financial statements for additional information.", "highlight": "Change 2021 2020 $% Transformation strategy costs (in millions): Forwarding $ 8 $ 8 $% Logistics 5 6 -1 -16.7 % Freight 1 1 % Other 11 11 N/a Total transformation strategy costs $ 25 $ 15 $ 10 66.7 % on april 30, 2021 ||| we recognized a pre-tax gain of $46 million related to this divestiture", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para71", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Revenue total revenue for supply chain solutions increased $2.2 billion.", "highlight": "Results of operations Revenue total revenue for supply chain solutions increased $2.2 billion.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para72", "text": "forwarding revenue increased for the year. in our international air freight business, revenue growth was driven by higher volume as a result of strong outbound demand globally. demand-related surcharges and rate increases also contributed to revenue growth as demand continued to exceed capacity in the market. we expect the elevated level of demand to persist. ocean freight forwarding revenue increased, driven by asia-export volume and higher market rates throughout the year. we expect surcharges for ocean freight forwarding to be lower in 2022 relative to 2021 as supply and demand within the market begins to normalize. revenue in our truckload brokerage business increased due to market rate increases and the continued execution of our strategy, slightly offset by a reduction in volume.", "highlight": "revenue growth was driven by higher volume as a result of strong outbound demand globally ||| contributed to revenue growth as demand continued to exceed capacity in the market ||| driven by asia-export volume and higher market rates throughout the year ||| due to market rate increases and the continued execution of our strategy, slightly offset by a reduction in volume.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para73", "text": "within logistics, our healthcare operations experienced strong revenue growth across a broad range of customers, including covid-19 relief efforts. revenue in our mail services business increased as a result of rate increases and a favorable shift in product characteristics, partially offset by lower volumes. our other distribution operations experienced year-over-year revenue increases, driven by new business growth.", "highlight": "healthcare operations experienced strong revenue growth ||| revenue in our mail services business increased ||| . our other distribution operations experienced year-over-year revenue increases", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para74", "text": "as a result of the divestiture, ups freight revenue decreased $2.1 billion for the year.", "highlight": "ups freight revenue decreased $2.1 billion for the year.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para75", "text": "revenue from the other businesses within supply chain solutions increased, driven by services provided to the acquirer of ups freight under certain transition services agreements and by growth in our logistics consulting services, ups capital and additional volume from service contracts with the u.s. postal service.", "highlight": "driven by services provided to the acquirer of ups freight under certain transition services agreements and by growth in our logistics consulting services, ups capital and additional volume from service contracts with the u.s. postal service.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para76", "text": "Operating expenses total operating expenses for supply chain solutions, and operating expenses excluding the year-over-year impact of transformation and other charges, increased in 2021.", "highlight": "Operating expenses total operating expenses for supply chain solutions ||| increased in 2021.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para77", "text": "forwarding operating expenses increased $2.6 billion, driven by an increase in purchased transportation of $2.5 billion. this increase was primarily due to higher market rates across all of our forwarding businesses that were driven by supply constraints and demand-related surcharges, as well as volume growth in our international air freight and ocean freight forwarding businesses. capacity constraints are expected to persist, resulting in purchased transportation cost remaining elevated.", "highlight": "driven by an increase in purchased transportation of $2.5 billion. ||| due to higher market rates across all of our forwarding businesses that were driven by supply constraints and demand-related surcharges, as well as volume growth in our international air freight and ocean freight forwarding businesses", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para78", "text": "logistics operating expenses increased $538 million, due to higher purchased transportation expense and operational expense growth in our healthcare operations as a result of covid-19 relief efforts and strong demand for our healthcare logistics services. carrier rate increases drove higher expense within mail services and business growth in our other distribution operations also resulted in additional purchased transportation expense.", "highlight": "due to higher purchased transportation expense and operational expense growth in our healthcare operations as a result of covid-19 relief efforts and strong demand for our healthcare logistics services", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para79", "text": "ups freight operating expenses decreased $2.8 billion as a result of the divestiture.", "highlight": "freight operating expenses decreased $2.8 billion", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para80", "text": "expense for the other businesses within supply chain solutions increased, primarily due to higher third-party transportation expense in logistics consulting and transportation and other costs incurred under transition services agreements with the acquirer of ups freight.", "highlight": "primarily due to higher third-party transportation expense in logistics consulting and transportation and other costs incurred under transition services agreements with the acquirer of ups freight.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para81", "text": "Operating profit and margin as a result of the factors described above, total operating profit increased $1.4 billion, with operating margin increasing 750 basis points to 9.9%. excluding the year-over-year impact of transformation and other charges and other gains, adjusted operating profit increased $649 million, with adjusted operating margin increasing 280 basis points to 9.8%.", "highlight": "total operating profit increased $1.4 billion, with operating margin increasing 750 basis points to 9.9% ||| adjusted operating profit increased $649 million, with adjusted operating margin increasing 280 basis points to 9.8%.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para82", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Consolidated operating expenses Year ended december 31, Change 2021 2020 $% Operating expenses (in millions): Compensation and benefits $ 46,707 $ 44,529 $ 2,178 4.9 % Transformation and other charges -206 -211 5 -2.4 % Adjusted compensation and benefits 46,501 44,318 2,183 4.9 % Repairs and maintenance 2,443 2,365 78 3.3 % Depreciation and amortization 2,953 2,698 255 9.5 % Purchased transportation 19,058 15,631 3,427 21.9 % Fuel 3,847 2,582 1,265 49.0 % Other occupancy 1,698 1,539 159 10.3 % Other expenses 7,771 7,600 171 2.3 % Total other expenses 37,770 32,415 5,355 16.5 % Transformation and other charges -174 -137 -37 27.0 % Goodwill, asset impairment charges and divestitures 46 -686 732 N/m Adjusted total other expenses $ 37,642 $ 31,592 $ 6,050 19.2 % Total operating expenses $ 84,477 $ 76,944 $ 7,533 9.8 % Adjusted total operating expenses $ 84,143 $ 75,910 $ 8,233 10.8 % Currency (benefit) / cost - (in millions)* $ 432 *amount represents the change in currency translation compared to the prior year.", "highlight": "Change 2021 2020 $% Operating expenses (in millions): Compensation and benefits $ 46,707 $ 44,529 $ 2,178 4.9 % Transformation and other charges -206 -211 5 -2.4 % Adjusted compensation and benefits 46,501 44,318 2,183 4.9 % Repairs and maintenance 2,443 2,365 78 3.3 % Depreciation and amortization 2,953 2,698 255 9.5 % Purchased transportation 19,058 15,631 3,427 21.9 % Fuel 3,847 2,582 1,265 49.0 % Other occupancy 1,698 1,539 159 10.3 % Other expenses 7,771 7,600 171 2.3 % Total other expenses 37,770 32,415 5,355 16.5 % Transformation and other charges -174 -137 -37 27.0 % Goodwill, asset impairment charges and divestitures 46 -686 732 N/m Adjusted total other expenses $ 37,642 $ 31,592 $ 6,050 19.2 % Total operating expenses $ 84,477 $ 76,944 $ 7,533 9.8 % Adjusted total operating expenses $ 84,143 $ 75,910 $ 8,233 10.8 % Currency (benefit) / cost - (in millions)* $ 432 *amount", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para83", "text": "Year ended december 31, Change 2021 2020 $% Adjustments to operating expenses (in millions): Transformation strategy costs: Compensation $ 30 $ 34 $ (4) -11.8 % Benefits 176 177 -1 -0.6 % Other occupancy 3 8 -5 -62.5 % Other expenses 171 129 42 32.6 % Total transformation strategy costs $ 380 $ 348 $ 32 9.2 % Goodwill and asset impairment charges, and divestitures: Other expenses $ (46) $ 686 $ (732) N/m Total adjustments to operating expenses $ 334 $ 1,034 $ (700) -67.7 % United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Compensation and benefits total compensation and benefits, and total compensation and benefits excluding the year-over-year impact of transformation and other charges, increased in 2021.", "highlight": "Change 2021 2020 $% Adjustments to operating expenses (in millions): Transformation strategy costs: Compensation $ 30 $ 34 $ (4) -11.8 % Benefits 176 177 -1 -0.6 % Other occupancy 3 8 -5 -62.5 % Other expenses 171 129 42 32.6 % Total transformation strategy costs $ 380 $ 348 $ 32 9.2 % Goodwill and asset impairment charges, and divestitures: Other expenses $ (46) $ 686 $ (732) N/m Total adjustments to operating expenses $ 334 $ 1,034 $ (700) -67.7 %", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para84", "text": "Total compensation costs, and total compensation costs excluding the year-over-year impact of transformation and other charges, increased $1.0 billion or 3.8%, primarily as a result of: u.s. domestic compensation increased $704 million as a result of higher direct labor costs due to contractual rate increases for our union workforce, as well as wage-rate and cost of living adjustments driven by inflation and other market factors. volume growth drove additional headcount and an increase in average daily union hours, which was partially offset by productivity improvements.", "highlight": "primarily as a result of: u.s. domestic compensation increased $704 million as a result of higher direct labor costs due to contractual rate increases for our union workforce, as well as wage-rate and cost of living adjustments driven by inflation and other market factors ||| partially offset by productivity improvements", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para85", "text": "international cost increased $380 million, primarily due to volume growth, as well as the impacts of operational disruption last year that resulted from covid-19 restrictions.", "highlight": "primarily due to volume growth, as well as the impacts of operational disruption last year that resulted from covid-19 restrictions", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para86", "text": "management compensation increased $416 million due to salary increases, higher incentive compensation and sales commissions and workforce growth that was primarily from additional part-time positions.", "highlight": "due to salary increases, higher incentive compensation and sales commissions and workforce growth that was primarily from additional part-time positions", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para87", "text": "these increases were partially offset by the impact of divesting ups freight, which decreased cost by $583 million.", "highlight": "were partially offset by the impact of divesting ups freight", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para88", "text": "Benefits costs increased $1.3 billion. excluding the year-over-year impact of transformation and other charges, adjusted benefits increased $1.2 billion as a result of: health and welfare costs increased $530 million, driven by increased contributions to multiemployer plans resulting from growth in the eligible workforce and contractual rate increases.", "highlight": "driven by increased contributions to multiemployer plans resulting from growth in the eligible workforce and contractual rate increases.\r\n ||| as a result of: health and welfare costs", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para89", "text": "pension and postretirement benefits increased $374 million due to an increase in the overall size of the workforce, increased contributions to multiemployer plans as a result of contractually-mandated rate increases and higher service costs for company-sponsored plans.", "highlight": "due to an increase in the overall size of the workforce,", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para90", "text": "vacation, excused absence, payroll taxes and other expenses increased $212 million, primarily driven by salary increases, increases in the overall size of the workforce and additional discretionary payments to certain employees.", "highlight": "primarily driven by salary increases, increases in the overall size of the workforce and additional discretionary payments to certain employees", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para91", "text": "workers' compensation expense increased $51 million due to an increase in total hours worked and higher claim counts, partially offset by improved claims trends relative to the previous year and lower activity resulting from the divestiture of ups freight.", "highlight": "due to an increase in total hours worked and higher claim counts, partially offset by improved claims trends relative to the previous year and lower activity resulting from the divestiture of ups freight.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para92", "text": "Repairs and maintenance the increase in repairs and maintenance expense was driven by additional aircraft engine maintenance cost, primarily due to the increase in operating activity. routine repairs and maintenance for buildings and facilities, and maintenance costs for our other transportation equipment, increased slightly.", "highlight": "was driven by additional aircraft engine maintenance cost, primarily due to the increase in operating activity", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para93", "text": "Depreciation and amortization depreciation and amortization expense increased as a result of additional operating facilities coming into service and investments in internally developed software, as well as growth in the size of our vehicle and aircraft fleets.", "highlight": "as a result of additional operating facilities coming into service and investments in internally developed software", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para94", "text": "Purchased transportation The increase in purchased transportation expense charged to us by third-party air, ocean and truck carriers was primarily driven by: supply chain solutions expense increased $2.2 billion, primarily due to market rate and volume increases in our international air freight and ocean freight businesses and rate increases in our truckload brokerage business. these increases were partially offset by the impact of the divestiture of ups freight, which reduced third-party transportation costs by $596 million.", "highlight": "primarily due to market rate and volume increases in our international air freight and ocean freight businesses and rate increases in our truckload brokerage business ||| partially offset by the impact of the divestiture of ups freight,", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para95", "text": "international package expense increased $617 million, primarily due to additional volume being handled by third-party pickup and delivery services in asia and europe. currency movements also negatively impacted expense, primarily in europe.", "highlight": "primarily due to additional volume being handled by third-party pickup and delivery services in asia and europe ||| currency movements also negatively impacted", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para96", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations u.s. domestic package expense increased $310 million due to ongoing investments to improve time-in-transit in our u.s. ground network and overall increases in per-shipment costs. these impacts were partially offset by decreases in rail and surepost volumes for the year.", "highlight": "due to ongoing investments to improve time-in-transit in our u.s. ground network and overall increases in per-shipment costs ||| offset by decreases in rail and surepost volumes for the year.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para97", "text": "Fuel higher fuel prices increased expense $1.2 billion. increases in usage from additional aircraft block hours and miles driven were partly offset by the impact of the divestiture of ups freight.", "highlight": "Fuel higher fuel prices increased expense $1.2 billion", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para98", "text": "Other occupancy the increase in other occupancy expense, and other occupancy expense excluding the year-over-year impact of transformation and other charges, was due to higher utilities costs, rent and property tax increases and ongoing facility maintenance.", "highlight": "was due to higher utilities costs, rent and property tax increases and ongoing facility maintenance.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para99", "text": "Other expenses Other expenses, and other expenses excluding the year-over-year impact of transformation strategy costs and goodwill, asset impairment charges and divestitures, increased as a result of: other operational expenses, including vehicle and equipment rentals, increased $214 million, primarily driven by business growth.", "highlight": "Other expenses, and other expenses excluding the year-over-year impact of transformation strategy costs and goodwill, asset impairment charges and divestitures, increased as a result of: other operational expenses, including vehicle and equipment rentals, increased $214 million", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para100", "text": "the cost of business services that support our operating segments increased $129 million, driven by business growth and the expansion of services provided.", "highlight": "driven by business growth and the expansion of services provided.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para101", "text": "customer claims increased $108 million, driven by changes to our claims policy, which resulted in higher claims for lost packages.", "highlight": "driven by changes to our claims policy, which resulted in higher claims for lost packages.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para102", "text": "other increases included the cost of goods provided under transitional service agreements to the acquirer of ups freight, information technology expenses, payment processing fees and the write down of certain construction in progress activities.", "highlight": "other increases included the cost of goods provided under transitional service agreements to the acquirer", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para103", "text": "these increases were partially offset by reductions in self-insured automobile liability claims due to improvements in claims experience, a reduction in our allowance for credit losses and a reduction in purchases of covid-related safety and cleaning supplies.", "highlight": "partially offset by reductions in self-insured automobile liability claims due to improvements in claims experience", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para104", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Other income and (expense) The following table sets forth investment income (expense) and other and interest expense for the years ended december 31, 2021 and 2020 (in millions): Year ended december 31, Change 2021 2020 $% Investment income (expense) and other $ 4,479 $ (5,139) $ 9,618 N/m Defined benefit plans mark-to-market (gain) loss -3,272 6,484 -9,756 N/m Adjusted investment income (expense) and other $ 1,207 $ 1,345 $ (138) -10.3 % Interest expense -694 -701 7 -1.0 % Total other income and (expense) $ 3,785 $ (5,840) $ 9,625 N/m Adjusted other income and (expense) $ 513 $ 644 $ (131) -20.3 % Investment income (expense) and other investment and other income increased $9.6 billion, primarily due to a net $3.3 billion mark-to-market gain from remeasurements of our defined benefit plans in 2021 compared to a $6.5 billion loss in 2020. excluding the impact of these mark-to-market gains and losses, adjusted investment and other income decreased $138 million, driven by a decrease in other pension income which includes expected returns on pension assets, net of interest cost on projected benefit obligations and prior service costs.", "highlight": "Year ended december 31, Change 2021 2020 $% Investment income (expense) and other $ 4,479 $ (5,139) $ 9,618 N/m Defined benefit plans mark-to-market (gain) loss -3,272 6,484 -9,756 N/m Adjusted investment income (expense) and other $ 1,207 $ 1,345 $ (138) -10.3 % Interest expense -694 -701 7 -1.0 % Total other income and (expense) $ 3,785 $ (5,840) $ 9,625 N/m Adjusted other income and (expense) $ 513 $ 644 $ (131) -20.3 ||| Investment income (expense) and other investment and other income increased $9.6 billion ||| adjusted investment and other income decreased $138 million", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para105", "text": "expected returns on pension assets decreased due to a reduction in our expected rate of return assumption. this was partially offset by a higher asset base due to discretionary contributions and positive asset returns in 2020.", "highlight": "due to a reduction in our expected rate of return assumption ||| partially offset by a higher asset base", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para106", "text": "pension interest cost decreased, driven by a reduction in projected benefit obligations following interim plan remeasurements. the interim plan remeasurements were triggered by the signing into law of the arpa in march 2021 and by the divestiture of ups freight in april 2021. we also experienced a reduction in prior service cost.", "highlight": "driven by a reduction in projected benefit obligations following interim plan remeasurements ||| were triggered by the signing into law of the arpa in march 2021 and by the divestiture of ups freight in april 2021", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para107", "text": "the remaining items in other income decreased due to foreign currency losses, partially offset by net gains from certain non-current investments.", "highlight": "due to foreign currency losses, partially offset by net gains from certain non-current investments.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para108", "text": "Interest expense interest expense for the year decreased due to lower average outstanding debt balances and lower effective interest rates on floating rate debt and commercial paper, partially offset by a reduction in capitalization of interest.", "highlight": "due to lower average outstanding debt balances and lower effective interest rates on floating rate debt and commercial paper ||| offset by a reduction in capitalization of interest.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para109", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Income tax expense The following table sets forth income tax expense and our effective tax rate for the years ended december 31, 2021 and 2020 (in millions): Year ended december 31, Change 2021 2020 $% Income tax expense: $ 3,705 $ 501 $ 3,204 639.5 % Income tax impact of: Defined benefit plans mark-to-market -784 1,555 -2,339 N/m Transformation strategy costs 95 83 12 14.5 % Goodwill, asset impairment charges and divestitures -11 57 -68 N/m Adjusted income tax expense $ 3,005 $ 2,196 $ 809 36.8 % Effective tax rate 22.3 % 27.2 % Adjusted effective tax rate 22.0 % 23.5 % for additional information on income tax expense and our effective tax rate, see note 16 to the audited, consolidated financial statements.", "highlight": "Year ended december 31, Change 2021 2020 $% Income tax expense: $ 3,705 $ 501 $ 3,204 639.5 % Income tax impact of: Defined benefit plans mark-to-market -784 1,555 -2,339 N/m Transformation strategy costs 95 83 12 14.5 % Goodwill, asset impairment charges and divestitures -11 57 -68 N/m Adjusted income tax expense $ 3,005 $ 2,196 $ 809 36.8 % Effective tax rate 22.3 % 27.2 % Adjusted effective tax rate 22.0 % 23.5 %", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para110", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Liquidity and capital resources as of december 31, 2021, we had $10.6 billion in cash, cash equivalents and marketable securities. we believe that these positions, expected cash from operations, access to commercial paper programs and capital markets and other available liquidity options will be adequate to fund our material short- and long-term cash requirements, including our business operations, planned capital expenditures and pension contributions, transformation strategy costs, debt obligations and planned shareowner returns. we regularly evaluate opportunities to optimize our capital structure, including through issuances of debt to refinance existing debt and to fund operations. we deploy a disciplined and balanced approach to capital allocation, including returns to shareowners through dividends and share repurchases.", "highlight": "we had $10.6 billion in cash, cash equivalents and marketable securities", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para111", "text": "Cash flows from operating activities The following is a summary of the significant sources (uses) of cash from operating activities (in millions): 2021 2020 Net income $ 12,890 $ 1,343 Non-cash operating activities (a) 3,335 11,181 Pension and postretirement benefit plan contributions (company-sponsored plans) -576 -3,125 Hedge margin receivables and payables 272 -507 Income tax receivables and payables 170 205 Changes in working capital and other non-current assets and liabilities -1,106 1,383 Other operating activities 22 -21 Net cash from operating activities $ 15,007 $ 10,459 (a) represents depreciation and amortization, gains and losses on derivative transactions and foreign currency exchange, deferred income taxes, allowances for expected credit losses, amortization of operating lease assets, pension and postretirement benefit plan (income) expense, stock compensation expense, changes in casualty self-insurance reserves, goodwill and other asset impairment charges and other non-cash items.", "highlight": "2021 2020 Net income $ 12,890 $ 1,343 Non-cash operating activities (a) 3,335 11,181 Pension and postretirement benefit plan contributions (company-sponsored plans) -576 -3,125 Hedge margin receivables and payables 272 -507 Income tax receivables and payables 170 205 Changes in working capital and other non-current assets and liabilities -1,106 1,383 Other operating activities 22 -21 Net cash from operating activities $ 15,007 $ 10,459", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para112", "text": "Net cash from operating activities increased $4.5 billion year to date, primarily due to improved performance. additional impacts included: contributions to our company-sponsored pension and u.s. postretirement medical benefit plans totaled $576 million and $3.1 billion in 2021 and 2020, respectively. this included discretionary contributions of $200 million and $2.8 billion, respectively.", "highlight": "primarily due to improved performance. additional impacts included: contributions to our company-sponsored pension and u.s. postretirement medical benefit plans totaled $576 million and $3.1 billion in 2021 and 2020", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para113", "text": "our net hedge margin collateral position increased by $779 million due to changes in the fair value of derivative contracts used in our currency and interest rate hedging programs.", "highlight": "due to changes in the fair value of derivative contracts used in our currency and interest rate hedging programs.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para114", "text": "cash payments for income taxes were $1.9 billion and $1.1 billion for 2021 and 2020, respectively, with changes primarily driven by an increase in income.", "highlight": "cash payments for income taxes were $1.9 billion and $1.1 billion for 2021 and 2020", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para115", "text": "during 2020, our working capital benefited from a one-time deferral of employer payroll taxes of approximately $1.1 billion under the cares act. during the fourth quarter of 2021, we paid $577 million of these deferred employer payroll taxes. other changes in working capital were driven by business growth and the timing of duty and tax settlements.", "highlight": "our working capital benefited from a one-time deferral of employer payroll taxes of approximately $1.1 billion  ||| we paid $577 million of these deferred employer payroll taxes", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 2, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para116", "text": "as part of our ongoing efforts to improve our working capital efficiency, certain financial institutions offer a supply chain finance (\"scf\") program to certain of our suppliers. we agree to commercial terms with our suppliers, including prices, quantities and payment terms, regardless of whether the supplier elects to participate in the scf program. suppliers issue invoices to us based on the agreed-upon contractual terms. if they participate in the scf program, our suppliers, at their sole discretion, determine which invoices, if any, to sell to the financial institutions. our suppliers' voluntary inclusion of invoices in the scf program has no bearing on our payment terms. no guarantees are provided by us under the scf program. we have no economic interest in a supplier's decision to participate, and we have no direct financial relationship with the financial institutions, as it relates to the scf program.", "highlight": "we agree to commercial terms with our suppliers, including prices, quantities and payment terms, regardless of whether the supplier elects to participate in the scf program. ||| we have no economic interest in a supplier's decision to participate, and we have no direct financial relationship with the financial institutions, as it relates to the scf program", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para117", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations amounts due to our suppliers that participate in the scf program are included in accounts payable in our consolidated balance sheets. we have been informed by the participating financial institutions that as of december 31, 2021 and 2020, suppliers sold them $545 and $639 million, respectively, of our outstanding payment obligations. amounts due to suppliers that participate in the scf program may be reflected in cash flows from operating activities or cash flows from investing activities in our consolidated statements of cash flows. the amounts settled through the scf program were approximately $1.7 and $1.8 billion for the years ended december 31, 2021 and 2020, respectively.", "highlight": "we have been informed by the participating financial institutions that as of december 31, 2021 and 2020, suppliers sold them $545 and $639 million, respectively ||| the amounts settled through the scf program were approximately $1.7 and $1.8 billion for the years ended december 31, 2021 and 2020, respectively", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para118", "text": "as of december 31, 2021, approximately $3.1 billion of our total worldwide holdings of cash, cash equivalents and marketable securities were held by foreign subsidiaries. the amount of cash, cash equivalents and marketable securities held by our u.s. and foreign subsidiaries fluctuates throughout the year due to a variety of factors, including the timing of cash receipts and disbursements in the normal course of business. cash provided by operating activities in the u.s. continues to be our primary source of funds to finance domestic operating needs, capital expenditures, share repurchases, pension contributions and dividend payments to shareowners. all cash, cash equivalents and marketable securities held by foreign subsidiaries are generally available for distribution to the u.s. without any u.s. federal income taxes. any such distributions may be subject to foreign withholding and u.s. state taxes. when amounts earned by foreign subsidiaries are expected to be indefinitely reinvested, no accrual for taxes is provided.", "highlight": "approximately $3.1 billion of our total worldwide holdings of cash, cash equivalents and marketable securities were held by foreign subsidiaries ||| cash provided by operating activities in the u.s. continues to be our primary source of funds to finance domestic operating needs, capital expenditures, share repurchases, pension contributions and dividend payments to shareowners", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para119", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Cash flows from investing activities Our primary sources (uses) of cash from investing activities for the years ended december 31, 2021 and 2020 were as follows (in millions): 2021 2020 Net cash used in investing activities $ (3,818) $ (5,283) Capital expenditures: Buildings, facilities and plant equipment $ (1,635) $ (2,460) Aircraft and parts -1,185 -1,145 Vehicles -807 -1,002 Information technology -567 -805 Total capital expenditures (1) : $ (4,194) $ (5,412) Capital expenditures as a % of revenue 4.3 % 6.4 % Other investing activities: Proceeds from disposals of businesses, property, plant and equipment $ 872 $ 40 Net change in finance receivables $ 34 $ 44 Net (purchases), sales and maturities of marketable securities $ 54 $ 106 Cash paid for business acquisitions, net of cash and cash equivalents acquired $ (602) $ (20) Other investing activities $ 18 $ (41) -1) in addition to capital expenditures of $4.2 and $5.4 billion in 2021 and 2020, respectively, there were capital expenditures relating to principal repayments of finance lease obligations of $208 and $192 million, respectively. these are included in cash flows from financing activities.", "highlight": "2021 2020 Net cash used in investing activities $ (3,818) $ (5,283) Capital expenditures: Buildings, facilities and plant equipment $ (1,635) $ (2,460) Aircraft and parts -1,185 -1,145 Vehicles -807 -1,002 Information technology -567 -805 Total capital expenditures (1) : $ (4,194) $ (5,412) Capital expenditures as a % of revenue 4.3 % 6.4 % Other investing activities: Proceeds from disposals of businesses, property, plant and equipment $ 872 $ 40 Net change in finance receivables $ 34 $ 44 Net (purchases), sales and maturities of marketable securities $ 54 $ 106 Cash paid for business acquisitions, net of cash and cash equivalents acquired $ (602) $ (20) Other investing activities $ 18 $ (41) -1) in addition to capital expenditures of $4.2 and $5.4 billion in 2021 and 2020", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para120", "text": "we have commitments for the purchase of aircraft, vehicles, equipment and real estate to provide for the replacement of existing capacity and anticipated future growth. future capital spending for anticipated growth and replacement assets will depend on a variety of factors, including economic and industry conditions. our current investment program anticipates investments in technology initiatives and enhanced network capabilities, including over $1 billion of projects to support our environmental sustainability goals. it also provides for maintenance of buildings, facilities and plant equipment and replacement of certain aircraft within our fleet. we currently expect that our capital expenditures will be approximately $5.5 billion in 2022, of which approximately 60 percent will be allocated to expansion projects.", "highlight": "we have commitments for the purchase of aircraft, vehicles, equipment and real estate to provide for the replacement of existing capacity and anticipated future growth ||| we currently expect that our capital expenditures will be approximately $5.5 billion in 2022, of which approximately 60 percent will be allocated to expansion projects.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 1, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para121", "text": "in 2021, capital expenditures on buildings, facilities and operating equipment decreased in our global small package business, as we reduced spending on facility expansion projects. capital spending on aircraft increased slightly as final payments associated with the delivery of aircraft were largely offset by reductions in contract deposits on open aircraft orders. capital expenditures on information technology decreased due to the timing of projects.", "highlight": "capital expenditures on buildings, facilities and operating equipment decreased ||| capital spending on aircraft increased slightly ||| capital expenditures on information technology decreased", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para122", "text": "proceeds from the disposal of businesses, property, plant and equipment increased as we completed the divestiture of ups freight for cash proceeds of $848 million in the second quarter. the proceeds were used to reduce outstanding indebtedness.", "highlight": "proceeds from the disposal of businesses, property, plant and equipment increased as we completed the divestiture of ups freight for cash proceeds of $848 million in the second quarter", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para123", "text": "the net change in finance receivables was primarily due to reductions in outstanding balances within our finance portfolios. purchases and sales of marketable securities are largely determined by liquidity needs and the periodic rebalancing of investment types, and will fluctuate from period to period.", "highlight": "due to reductions in outstanding balances within our finance portfolios ||| determined by liquidity needs and the periodic rebalancing of investment types, and will fluctuate from period to period.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para124", "text": "cash paid for business acquisitions in 2021 was primarily attributable to the acquisition of roadie and the purchase of development areas for the ups store. cash paid for business acquisitions in 2020 related to the purchase of development areas for the ups store. other investing activities were impacted by changes in our non-current investments, purchase contract deposits and various other items.", "highlight": "primarily attributable to the acquisition of roadie and the purchase of development areas for the ups store ||| related to the purchase of development areas for the ups store ||| impacted by changes in our non-current investments, purchase contract deposits and various other items.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para125", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Cash flows from financing activities Our primary sources (uses) of cash for financing activities were as follows (amounts in millions, except per share data): 2021 2020 Net cash used in financing activities $ (6,823) $ (4,517) Share repurchases: Cash paid to repurchase shares $ (500) $ (224) Number of shares repurchased -2.6 -2.1 Shares outstanding at period end 870 865 Percent increase (decrease) in shares outstanding 0.6 % 0.9 % Dividends: Dividends declared per share $ 4.08 $ 4.04 Cash paid for dividends $ (3,437) $ (3,374) Borrowings: Net borrowings (repayments) of debt principal $ (2,773) $ (851) Other financing activities: Cash received for common stock issuances $ 251 $ 285 Other financing activities $ (364) $ (353) Capitalization: Total debt outstanding at year end $ 21,915 $ 24,654 Total shareowners' equity at year end 14,269 669 Total capitalization $ 36,184 $ 25,323 we repurchased 2.6 million shares of class b common stock for $500 million under our stock repurchase program in 2021. we repurchased 2.1 million shares of class a and class b common stock for $217 million in 2020 ($224 million in repurchases is reported on the statement of cash flows for 2020 due to the timing of settlements). for additional information on our share repurchase activities, see note 13 to the audited, consolidated financial statements.", "highlight": "2021 2020 Net cash used in financing activities $ (6,823) $ (4,517) Share repurchases: Cash paid to repurchase shares $ (500) $ (224) Number of shares repurchased -2.6 -2.1 Shares outstanding at period end 870 865 Percent increase (decrease) in shares outstanding 0.6 % 0.9 % Dividends: Dividends declared per share $ 4.08 $ 4.04 Cash paid for dividends $ (3,437) $ (3,374) Borrowings: Net borrowings (repayments) of debt principal $ (2,773) $ (851) Other financing activities: Cash received for common stock issuances $ 251 $ 285 Other financing activities $ (364) $ (353) Capitalization: Total debt outstanding at year end $ 21,915 $ 24,654 Total shareowners' equity at year end 14,269 669 Total capitalization $ 36,184 $ 25,323 we repurchased 2.6 million shares of class b common stock for $500 million under our stock repurchase program in 2021. we repurchased 2.1 million shares of class a and class b common stock for $217 million in 2020 ($224 million in repurchases is reported on the statement of cash flows for 2020 due to the timing of settlements)", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para126", "text": "for the years ended december 31, 2021 and 2020, dividends reported within shareowners' equity include $167 and $178 million, respectively, of non-cash dividends that were settled in shares of class a common stock.", "highlight": "dividends reported within shareowners' equity include $167 and $178 million, respectively", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para127", "text": "the declaration of dividends is subject to the discretion of the board and depends on various factors, including our net income, financial condition, cash requirements, future prospects and other relevant factors. in the first quarter of 2022, we increased our quarterly dividend from $1.02 to $1.52 per share.", "highlight": "in the first quarter of 2022, we increased our quarterly dividend from $1.02 to $1.52 per share.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para128", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Issuances of debt in 2021 consisted of short-term borrowings under our commercial paper program, of which none remained outstanding as of december 31, 2021. issuances of debt in 2020 consisted of borrowings under our commercial paper program and issuances of fixed-rate senior notes as follows (in millions): Principal amount in usd 2020 Fixed-rate senior notes: 3.900% senior notes $ 1,000 4.450% senior notes 750 5.200% senior notes 500 5.300% senior notes 1,250 Total $ 3,500 repayments of debt in 2021 included our $1.5 billion 3.125% senior notes, our $700 million 2.050% senior notes and our $350 million floating rate senior notes. we also reduced our commercial paper balances and made scheduled principal payments on our finance lease obligations. repayments of debt in 2020 included our $424 million 8.375% debentures and our 500 million floating rate senior notes. we also paid down commercial paper balances and made scheduled principal payments on our finance lease obligations.", "highlight": "issuances of debt in 2020 consisted of borrowings under our commercial paper program and issuances of fixed-rate senior notes as follows (in millions): Principal amount in usd 2020 Fixed-rate senior notes: 3.900% senior notes $ 1,000 4.450% senior notes 750 5.200% senior notes 500 5.300% senior notes 1,250 Total $ 3,500 repayments of debt in 2021 included our $1.5 billion 3.125% senior notes, our $700 million 2.050% senior notes and our $350 million floating rate senior notes. we also reduced our commercial paper balances and made scheduled principal payments on our finance lease obligations. repayments of debt in 2020 included our $424 million 8.375%", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para129", "text": "we have $2.0 billion of fixed and floating rate notes that mature in 2022. we may repay these amounts when due with cash generated from operations or other borrowings, depending on various factors. we consider the overall fixed and floating interest rate mix of our portfolio and the related overall cost of borrowing when planning for future issuances and non-scheduled repayments of debt.", "highlight": "we have $2.0 billion of fixed and floating rate notes that mature in 2022 ||| consider the overall fixed and floating interest rate mix of our portfolio", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para130", "text": "The amount of commercial paper outstanding fluctuates throughout the year based on daily liquidity needs. the following is a summary of our commercial paper program (in millions): Functional currency outstanding balance at year end Outstanding balance at year end ($) Average balance outstanding Average balance outstanding ($) Average interest rate 2021 Usd $$$ 151 $ 151 0.05 % Total $Functional currency outstanding balance at year end Outstanding balance at year end ($) Average balance outstanding Average balance outstanding ($) Average interest rate 2020 Usd $ 15 $ 15 $ 1,426 $ 1,426 0.78 % Eur $432 $ 493 -0.39 % Total $ 15 as of december 31, 2021, we had no outstanding balances under our u.s. and european commercial paper program.", "highlight": "Average interest rate 2021 Usd $$$ 151 $ 151 0.05 % Total $Functional currency outstanding balance at year end Outstanding balance at year end ($) Average balance outstanding Average balance outstanding ($) Average interest rate 2020 Usd $ 15 $ 15 $ 1,426 $ 1,426 0.78 % Eur $432 $ 493 -0.39 % Total $ 15", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para131", "text": "except as disclosed in note 10 to the audited, consolidated financial statements, we do not have guarantees or other off-balance sheet financing arrangements, including variable interest entities, which we believe could have a material impact on our financial condition or liquidity.", "highlight": "we do not have guarantees or other off-balance sheet financing arrangements", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para132", "text": "the variation in cash received from common stock issuances was driven by the number of stock options exercised by employees and movements in other employee-related plans in 2021 and 2020.", "highlight": "driven by the number of stock options exercised by employees and movements in other employee-related plans", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para133", "text": "other financing activities includes cash used to repurchase shares to satisfy tax withholding obligations on vested stock awards of $358 and $340 million in 2021 and 2020, respectively. the increase in cash used was driven by changes in payment levels for certain of our awards.", "highlight": "driven by changes in payment levels for certain of our awards.", "type": {"0": 0, "1": 0, "2": 0, "3": 1, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para134", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Sources of credit see note 10 to the audited, consolidated financial statements for a discussion of our available credit and debt covenants.", "highlight": "note 10 to the audited, consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para135", "text": "Contractual commitments we have material cash requirements for known contractual obligations and commitments in the form of finance leases, operating leases, debt obligations, purchase commitments and certain other liabilities that are disclosed in the notes to the audited, consolidated financial statements and discussed below. we expect to fund these obligations and other discretionary payments, including expected returns to shareowners, primarily through cash from operations.", "highlight": "we expect to fund these obligations and other discretionary payments, including expected returns to shareowners, primarily through cash from operations.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para136", "text": "we anticipate making discretionary contributions to our company-sponsored u.s. pension and postretirement benefit plans of approximately $1.9 billion in 2022, which are included within expected employer contributions to plan trusts shown in note 6 to the audited, consolidated financial statements. there are currently no anticipated required minimum cash contributions to our qualified u.s. pension plans. the amount of any minimum funding requirement, as applicable, for these plans could change significantly in future periods depending on many factors, including plan asset returns, discount rates, other actuarial assumptions, changes to pension plan funding regulations and the discretionary contributions that we make. actual contributions made in future years could materially differ and consequently required minimum contributions beyond 2022 cannot be reasonably estimated.", "highlight": "we anticipate making discretionary contributions to our company-sponsored u.s. pension and postretirement benefit plans of approximately $1.9 billion in 2022", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 1, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para137", "text": "as discussed in note 7 to the audited, consolidated financial statements, we are not currently subject to any minimum contributions or surcharges with respect to the multiemployer pension and health and welfare plans in which we participate. contribution rates to these multiemployer pension and health and welfare plans are established through the collective bargaining process.", "highlight": "we are not currently subject to any minimum contributions or surcharges with respect to the multiemployer pension and health and welfare plans in which we participate", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para138", "text": "we have outstanding letters of credit and surety bonds that are discussed in note 10 to the audited, consolidated financial statements. additionally, we have $2.0 billion of fixed- and floating-rate senior notes that mature in 2022. we may repay these amounts when due with cash generated from operations or other borrowings, depending on various factors. annual principal payments on our long-term debt, estimated debt interest obligations and purchase commitments are also set out in note 10.", "highlight": "we have $2.0 billion of fixed- and floating-rate senior notes that mature in 2022", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para139", "text": "included within purchase commitments as disclosed in note 10, we have firm commitments to purchase two new boeing 747-8f aircraft to be delivered in 2022 and 19 new boeing 767-300 aircraft to be delivered between 2023 and 2025. we have an option to purchase an additional 8 new boeing 767-300 aircraft for delivery in 2025 and 2026 which are not reflected in our purchase commitments.", "highlight": "we have firm commitments to purchase two new boeing 747-8f aircraft to be delivered in 2022 and 19 new boeing 767-300 aircraft to be delivered between 2023 and 2025. we have an option to purchase an additional 8 new boeing 767-300 aircraft for delivery in 2025 and 2026 which are not reflected in our purchase commitments.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para140", "text": "our finance lease obligations, including purchase options that are reasonably certain to be exercised, relate primarily to leases on aircraft and real estate. these obligations, together with our obligations under operating leases are set out in note 12 to the audited, consolidated financial statements.", "highlight": "note 12 to the audited, consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para141", "text": "under provisions of the tax cuts and jobs act (the \"tax act\"), we elected to pay a one-time transition tax on certain unrepatriated earnings of foreign subsidiaries over eight years through 2025. additionally, we have uncertain tax positions that are further discussed in note 16 to the audited, consolidated financial statements.", "highlight": "we elected to pay a one-time transition tax on certain unrepatriated earnings of foreign subsidiaries over eight years through 2025", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para142", "text": "in 2022, we will pay $558 million of employer payroll taxes that we deferred under the cares act.", "highlight": "we will pay $558 million of employer payroll taxes", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para143", "text": "Contingencies see note 6 to the audited, consolidated financial statements for a discussion of pension related matters and note 11 to the audited, consolidated financial statements for a discussion of judicial proceedings and other matters arising from the conduct of our business activities.", "highlight": "note 6 to the audited, consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para144", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Collective bargaining agreements Status of collective bargaining agreements see note 7 to the audited, consolidated financial statements for a discussion of the status of collective bargaining agreements.", "highlight": "note 7 to the audited, consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para145", "text": "Multiemployer benefit plans we contribute to a number of multiemployer pension and health and welfare plans under the terms of collective bargaining agreements that cover our union represented employees. these agreements set forth the annual contribution rate increases for the plans that we participate in.", "highlight": "these agreements set forth the annual contribution rate increases for the plans that we participate in.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para146", "text": "New accounting pronouncements Recently adopted accounting standards see note 1 to the audited, consolidated financial statements for a discussion of recently adopted accounting standards.", "highlight": "see note 1 to the audited, consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para147", "text": "Accounting standards issued but not yet effective see note 1 to the audited, consolidated financial statements for a discussion of accounting standards issued, but not yet effective.", "highlight": "note 1 to the audited, consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para148", "text": "Rate adjustments from time to time we adjust published rates applicable to our services. these rates, when published, are made available on our website at www.ups.com . we provide the address to our internet site solely for information. we do not intend for this address to be an active link or to otherwise incorporate the contents of any website into this or any other report we file with the securities and exchange commission.", "highlight": "we provide the address to our internet site solely for information. we do not intend for this address to be an active link or to otherwise incorporate the contents of any website into this or any other report we file with the securities and exchange commission", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para149", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Critical accounting estimates the amounts of assets, liabilities, revenue and expenses reported in our financial statements are affected by estimates and judgments that are necessary to comply with gaap. we base our estimates on prior experience, current trends, various other assumptions and third-party input that we consider reasonable to our circumstances. actual results could differ materially from our estimates, which would affect the related amounts reported in our consolidated financial statements. while estimates and judgments are applied in arriving at many reported amounts, we believe that the following critical accounting estimates involve a higher degree of judgment and complexity.", "highlight": "we base our estimates on prior experience, current trends, various other assumptions and third-party input that we consider reasonable to our circumstances ||| we believe that the following critical accounting estimates involve a higher degree of judgment and complexity.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para150", "text": "Contingencies from time to time, we are involved in various legal proceedings and have exposure to various other contingent obligations. the events that may impact our contingent liabilities are often unique and generally are not predictable. at the time a contingency is identified, we consider all relevant facts as part of our evaluation. we apply judgment when establishing a range of reasonably possible losses for our contingencies. our judgment is influenced by our understanding of information currently available for legal actions and potential outcomes of these actions, including the advice from our internal counsel, external counsel and senior management .", "highlight": "we consider all relevant facts as part of our evaluation. we apply judgment when establishing a range of reasonably possible losses for our contingencies", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 1, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para151", "text": "we record a liability for a loss when the loss is probable of occurring and reasonably estimable. for such accruals, we record the amount we consider to be the best estimate within a range of potential losses; however, when there appears to be a range of equally possible losses, our accrual is based on the low-end of this range. the likelihood of a loss with respect to a particular contingency is often difficult to predict and determining a reasonable estimate of the loss or a range of loss may not be practicable based on the information available. additionally, events may arise that were not anticipated and, as a result, the outcome of a contingency may result in a loss that differs materially from our previously estimated liability. except as disclosed in note 11 to the audited, consolidated financial statements, contingent losses that were probable and estimable were not material to our financial position or results of operations as of, or for the year ended, december 31, 2021. in addition, we have certain contingent liabilities that have not been recognized as of, or for the year ended, december 31, 2021, because a loss was not reasonably estimable. obligations relating to income taxes and self-insurance are discussed below.", "highlight": "we record the amount we consider to be the best estimate within a range of potential losses", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para152", "text": "Goodwill and intangible asset impairments we assess goodwill for impairment at the reporting unit level. the determination of reporting units requires judgment, and if we changed the definition of our reporting units, it is possible that we would have reached different conclusions when performing our impairment tests.", "highlight": "we assess goodwill for impairment at the reporting unit level", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para153", "text": "We initially evaluate qualitative factors to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. if the qualitative assessment is not conclusive, we quantitatively assess the fair value of a reporting unit to test goodwill for impairment. this assessment uses a combination of income and market approaches: the income approach uses a discounted cash flow (\"dcf\") model, which requires us to make a number of significant assumptions to produce an estimate of future cash flows. these assumptions include projections of future revenue, costs, capital expenditures, working capital and the cost of capital. we are also required to make assumptions relating to our overall business and operating strategy, and the regulatory and market environment. changes in any of these assumptions could significantly impact the fair value of any one of our reporting units. the projections that we use in our dcf model are updated annually and will change over time based on the historical performance and changing business conditions for each of our reporting units.", "highlight": "We initially evaluate qualitative factors to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount ||| the income approach uses a discounted cash flow (\"dcf\") model, which requires us to make a number of significant assumptions to produce an estimate of future cash flows ||| we are also required to make assumptions relating to our overall business and operating strategy", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para154", "text": "the market approach uses observable market data of comparable public companies to estimate fair value utilizing financial metrics (such as enterprise value to net sales). we apply judgment to select appropriate comparison companies based on the business operations, size and operating results of our reporting units. changes to our selection of comparable companies may result in changes to the estimates of fair value of our reporting units.", "highlight": "we apply judgment to select appropriate comparison companies based on the business operations, size and operating results of our reporting units", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para155", "text": "for reporting units tested using a quantitative model during 2021, we concluded the fair value of each reporting unit exceeded its carrying value by more than 10 percent. our truckload brokerage reporting unit was most sensitive to changes in valuation assumptions. the ratio of excess fair value of this reporting unit to its carrying value would decrease by approximately one percentage point if the cost of capital increased by ten basis points.", "highlight": "we concluded the fair value of each reporting unit exceeded its carrying value by more than 10 percent", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para156", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations goodwill impairment charges could have a material impact on our results of operations. none of our reporting units incurred any goodwill impairment charges in 2021. during 2020, we recognized a goodwill impairment charge of $494 million in our ups freight reporting unit in conjunction with our evaluation of assets held for sale, which is discussed in note 4 to the audited, consolidated financial statements.", "highlight": "none of our reporting units incurred any goodwill impairment charges in 2021", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para157", "text": "we evaluate the indefinite-lived trade name associated with our truckload brokerage business for impairment using the relief from royalty method. this valuation approach requires that we make a number of assumptions to estimate fair value, including projections of future revenues, market royalty rates, tax rates, discount rates and other relevant variables. the projections we use in the model are updated annually and will change over time based on the historical performance and changing business conditions. if the carrying value of the trade name exceeds its estimated fair value, an impairment charge would be recognized for the excess amount.", "highlight": "we evaluate the indefinite-lived trade name associated with our truckload brokerage business for impairment using the relief from royalty method ||| the projections we use in the model are updated annually and will change over time based on the historical performance and changing business conditions", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para158", "text": "our annual impairment test for the current year indicated that the fair value of the indefinite-lived trade name remained greater than its carrying value, although this excess was less than 10 percent. our valuation estimate was most sensitive to changes in royalty rates and the cost of capital. the ratio of excess fair value to carrying value would decrease by approximately one percentage point if the royalty rate decreased by five basis points or the cost of capital increased by ten basis points. our truckload brokerage business has been negatively impacted by increases in the market rates at which it purchases transportation, which has in turn negatively impacted its operating margins. business performance below current forecasts or unfavorable changes in valuation assumptions, such as a lower royalty rate or higher cost of capital, could result in an impairment of the trade name in the future.", "highlight": "our valuation estimate was most sensitive to changes in royalty rates and the cost of capital ||| our truckload brokerage business has been negatively impacted by increases in the market rates at which it purchases transportation, which has in turn negatively impacted its operating margins.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para159", "text": "our finite-lived intangible assets are amortized over their estimated useful lives. impairment tests for these assets are only performed when a triggering event occurs that indicates that the carrying value of the intangible may not be recoverable based on its undiscounted future cash flows. if the carrying amount of the intangible is determined not to be recoverable, a write-down to fair value is recorded. fair values are estimated using a dcf model. if impairment indicators are present, the resulting impairment charges could have a material impact on our results of operations. see note 8 to the audited, consolidated financial statements for details of finite-lived intangible asset impairments.", "highlight": "our finite-lived intangible assets are amortized over their estimated useful lives", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para160", "text": "Self-insurance accruals we base self-insurance reserves on actuarial estimates, which are determined, with the assistance of third-party actuaries, through a complex process that includes the application of various actuarial methods and assumptions. the process incorporates actual loss experience and judgments about expected future development based on historical experience, recent and projected trends in claim frequency and severity, and changes in claims handling practices, among other factors.", "highlight": "we base self-insurance reserves on actuarial estimates, which are determined, with the assistance of third-party actuaries, through a complex process that includes the application of various actuarial methods and assumptions", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para161", "text": "workers' compensation, automobile liability and general liability insurance claims may take several years to resolve. consequently, actuarial estimates are required to project the ultimate cost that will be incurred to resolve a claim. several factors can affect the actual cost, or severity, of a claim, including the length of time the claim remains open, trends in healthcare costs, the results of any related litigation and changes in legislation. furthermore, claims may emerge in a future year for events that occurred in a prior policy period at a rate that differs from actuarial projections. all these factors can result in revisions to actuarial projections and produce a material difference between estimated and actual operating results. we increased our total reserves related to prior year claims by $34 million and $169 million in 2021 and 2020, respectively.", "highlight": "we increased our total reserves related to prior year claims by $34 million and $169 million in 2021 and 2020, respectively.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para162", "text": "due to the complexity and inherent uncertainty associated with the estimation of our workers' compensation, automobile and general liability claims, the third-party actuary develops a range of expected losses. we believe our estimated reserves for such claims are adequate; however, actual experience in claim frequency and/or severity of a claim could materially differ from our estimates and affect our results of operations.", "highlight": "we believe our estimated reserves for such claims are adequate; however, actual experience in claim frequency and/or severity of a claim could materially differ from our estimates and affect our results of operations.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para163", "text": "we also sponsor several health and welfare insurance plans for our employees. liabilities and expenses related to these plans are based on estimates of the number of employees and eligible dependents covered under the plans, global health events, anticipated utilization by participants and overall trends in medical costs and inflation. we believe our estimates are reasonable and appropriate. actual experience may differ materially from these estimates and, therefore, produce a material difference between estimated and actual operating results.", "highlight": "we also sponsor several health and welfare insurance plans for our employees ||| we believe our estimates are reasonable and appropriate. actual experience may differ materially from these estimates and, therefore, produce a material difference between estimated and actual operating results.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para164", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Self-insurance reserves as of december 31, 2021 and 2020 were as follows (in millions): 2021 2020 Current self-insurance reserves $ 1,048 $ 1,085 Non-current self-insurance reserves (1) 1,855 1,619 Total self-insurance reserves $ 2,903 $ 2,704 -1) included within other non-current liabilities in the consolidated balance sheets.", "highlight": "2021 2020 Current self-insurance reserves $ 1,048 $ 1,085 Non-current self-insurance reserves (1) 1,855 1,619 Total self-insurance reserves $ 2,903 $ 2,704 -1)", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para165", "text": "a five percent reduction or improvement in the assumed claim severity and claim frequency rates used to estimate our self-insurance reserves would result in an increase or decrease of approximately $290 million, respectively, in our reserves and expenses as of, and for the year ended, december 31, 2021.", "highlight": "a five percent reduction or improvement in the assumed claim severity and claim frequency rates used to estimate our self-insurance reserves would result in an increase or decrease of approximately $290 million", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para166", "text": "Pension and other postretirement medical benefits our pension and other postretirement medical benefit costs are calculated using various actuarial assumptions and methodologies. these assumptions include discount rates, healthcare cost trend rates, inflation, compensation increases, expected returns on plan assets, mortality rates, regulatory requirements and other factors. the assumptions utilized in recording the obligations under our plans represent our best estimates, and we believe that they are reasonable, based on information as to historical experience and performance as well as other factors that might cause future expectations to differ from past trends.", "highlight": "our pension and other postretirement medical benefit costs are calculated using various actuarial assumptions and methodologies ||| we believe that they are reasonable, based on information as to historical experience and performance as well as other factors that might cause future expectations to differ from past trends.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para167", "text": "Differences in actual experience or changes in assumptions may affect our pension and other postretirement obligations and future expenses. the primary factors contributing to actuarial gains and losses each year are: Changes in the discount rate used to value pension and postretirement benefit obligations as of the measurement date; Differences between expected and the actual return on plan assets; Changes in demographic assumptions including mortality; Differences in participant experience from demographic assumptions; and changes in coordinating benefits with plans not sponsored by ups.", "highlight": "Differences in actual experience or changes in assumptions may affect our pension and other postretirement obligations and future expenses", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para168", "text": "we recognize changes in the fair value of plan assets and net actuarial gains or losses in excess of a corridor (defined as 10% of the greater of the fair value of plan assets or the plans' projected benefit obligations) in pension expense upon remeasurement of a plan. the remaining components of pension expense (referred to as \"ongoing net periodic benefit cost\"), primarily service and interest costs and the expected return on plan assets, are reported on a quarterly basis.", "highlight": "we recognize changes in the fair value of plan assets and net actuarial gains or losses in excess of a corridor |||  pension expense upon remeasurement of a plan", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para169", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations The following sensitivity analysis shows the impact of a 25 basis point change in the assumed discount rate and return on assets for our pension and postretirement benefit plans, and the resulting increase (decrease) in our obligations and expense as of, and for the year ended, december 31, 2021 (in millions): Pension plans 25 basis point Increase 25 basis point Decrease Discount rate: Effect on ongoing net periodic benefit cost $ (41) $ 41 Effect on net periodic benefit cost for amounts recognized outside the 10% corridor -210 447 Effect on projected benefit obligation -2,498 2,662 Return on assets: Effect on ongoing net periodic benefit cost (1) -134 134 Effect on net periodic benefit cost for amounts recognized outside the 10% corridor (2) $$Postretirement medical plans Discount rate: Effect on ongoing net periodic benefit cost $ 4 $ (4) Effect on net periodic benefit cost for amounts recognized outside the 10% corridor -32 58 Effect on accumulated postretirement benefit obligation -54 64 Healthcare cost trend rate: Effect on ongoing net periodic benefit cost Effect on net periodic benefit cost for amounts recognized outside the 10% corridor 11 -12 Effect on accumulated postretirement benefit obligation $ 12 $ (14) -1) amount calculated based on 25 basis point increase / decrease in the expected return on assets.", "highlight": "Pension plans 25 basis point Increase 25 basis point Decrease Discount rate: Effect on ongoing net periodic benefit cost $ (41) $ 41 Effect on net periodic benefit cost for amounts recognized outside the 10% corridor -210 447 Effect on projected benefit obligation -2,498 2,662 Return on assets: Effect on ongoing net periodic benefit cost (1) -134 134 Effect on net periodic benefit cost for amounts recognized outside the 10% corridor (2) $$Postretirement medical plans Discount rate: Effect on ongoing net periodic benefit cost $ 4 $ (4) Effect on net periodic benefit cost for amounts recognized outside the 10% corridor -32 58 Effect on accumulated postretirement benefit obligation -54 64 Healthcare cost trend rate: Effect on ongoing net periodic benefit cost Effect on net periodic benefit cost for amounts recognized outside the 10% corridor 11 -12 Effect on accumulated postretirement benefit obligation $ 12 $ (14) -1)", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para170", "text": "-2) amount calculated based on 25 basis point increase / decrease in the actual return on assets.", "highlight": "amount calculated based on 25 basis point increase / decrease", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para171", "text": "refer to note 6 to the audited, consolidated financial statements for information on our potential liability for coordinating benefits related to the central states pension fund.", "highlight": "refer to note 6 to the audited, consolidated financial statements", "type": {"0": 0, "1": 0, "2": 0, "3": 0, "4": 1}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para172", "text": "Depreciation, residual value and impairment of fixed assets as of december 31, 2021, we had $33.5 billion of net fixed assets, the most significant category of which was aircraft. in accounting for fixed assets, we make estimates of the expected useful lives and residual values. we evaluate the useful lives of our property, plant and equipment based on our usage, maintenance and replacement policies, and taking into account physical and economic factors that may affect the useful lives of the assets. our accounting policy for long-lived assets is set out in note 1 to the audited, consolidated financial statements.", "highlight": "we had $33.5 billion of net fixed assets, the most significant category of which was aircraft.", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para173", "text": "in estimating the useful lives and expected residual values of aircraft, we consider actual experience with the same or similar aircraft types and future volume projections for our air products. adverse changes in volume forecasts, or a shortfall in our actual volume compared with our projections, could result in our current aircraft capacity exceeding current or projected demand. this situation could lead to an excess of a particular aircraft, resulting in an impairment charge or a reduction of the expected useful life of an aircraft that may result in increased depreciation expense. revisions to estimates of useful lives and residual values could also be caused by changes to our maintenance programs, governmental regulations on aging aircraft and changing market prices of new and used aircraft of the same or similar types. we periodically evaluate these estimates and assumptions, and adjust them as necessary. adjustments are accounted for on a prospective basis through depreciation expense.", "highlight": "we consider actual experience with the same or similar aircraft types and future volume projections for our air products ||| this situation could lead to an excess of a particular aircraft, resulting in an impairment charge or a reduction of the expected useful life of an aircraft that may result in increased depreciation expense.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para174", "text": "we monitor our long-lived assets for indicators of impairment which may include, but are not limited to, a significant change in the extent to which an asset is utilized and operating or cash flow losses associated with the use of the asset. if circumstances are present that indicate the carrying value of our long-lived assets may not be recoverable, we then perform impairment testing at the asset group level.", "highlight": "we monitor our long-lived assets for indicators of impairment which may include, but are not limited to, a significant change in the extent to which an asset is utilized and operating or cash flow losses associated with the use of the asset.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para175", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations asset groups represent the lowest level at which independent cash flows can be identified. determining the asset group requires judgment and changes in the way asset groups are defined could have material impact to the results of impairment testing. we perform recoverability testing by comparing the undiscounted cash flows of the asset group to the carrying value of the asset group. if the carrying amount of the asset is determined not to be recoverable, a write-down to fair value is recorded. fair values are determined based on quoted market values, discounted cash flows or external appraisals, as appropriate. details of long-lived asset impairments are included in note 5 to the audited, consolidated financial statements.", "highlight": "we perform recoverability testing by comparing the undiscounted cash flows of the asset group to the carrying value of the asset group", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para176", "text": "Fair value measurements in the normal course of business, we hold and issue financial instruments that contain elements of market risk, including derivatives, marketable securities, finance receivables, pension assets, other investments and debt. certain of these financial instruments are required to be recorded at fair value, principally derivatives, marketable securities, pension assets and certain other investments. these financial instruments are measured and reported at fair value on a recurring basis based upon a fair value hierarchy (levels 1, 2 and 3). fair values are based on listed market prices (level 1), when such prices are available. to the extent that listed market prices are not available, fair value is determined based on other relevant factors, including dealer price quotations (level 2). if listed market prices or other relevant factors are not available, inputs are developed from unobservable data reflecting our own assumptions and include situations where there is little or no market activity for the asset or liability (level 3). certain financial instruments, including over-the-counter derivative instruments, are valued using pricing models that consider, among other factors, contractual and market prices, correlations, time value, credit spreads and yield curve volatility factors. changes in the fixed income, foreign currency exchange and commodity markets will impact our estimates of fair value in the future, potentially affecting our results of operations. further information on our accounting polices relating to fair value measurements can be found in note 1 to the audited, consolidated financial statements.", "highlight": "we hold and issue financial instruments that contain elements of market risk ||| changes in the fixed income, foreign currency exchange and commodity markets will impact our estimates of fair value in the future", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 1, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para177", "text": "as of december 31, 2021, the majority of our financial instruments were categorized as either level 1 or level 2. refer to notes 3, 10 and 18 to the audited, consolidated financial statements for further information on these instruments. a quantitative sensitivity analysis of our exposure to changes in commodity prices, foreign currency exchange rates and interest rates is presented in the quantitative and qualitative disclosures about market risk section of this report.", "highlight": "the majority of our financial instruments were categorized as either level 1 or level 2.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para178", "text": "within our pension assets, we hold investments in hedge, risk parity, private debt, private equity and real estate funds which are primarily measured using net asset value (\"nav\") as a practical expedient for fair value, as appropriate. these investments were valued at $9.6 billion as of december 31, 2021. in order to estimate nav, we evaluate audited and unaudited financial reports from fund managers and make adjustments for investment activity between the date of the financial reports and december 31st. these investments are not actively traded, and their values can only be estimated using these assumptions. if our estimates of activity changed, this could have a material impact on the reported value of these investments and on the return on assets that we report. refer to note 6 to the audited, consolidated financial statements for further information on our pension assets.", "highlight": "these investments were valued at $9.6 billion as of december 31, 2021 ||| these investments are not actively traded, and their values can only be estimated using these assumptions", "type": {"0": 0, "1": 0, "2": 1, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 1, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para179", "text": "certain non-financial assets and liabilities are measured at fair value on a nonrecurring basis, including property, plant, and equipment, goodwill and intangible assets. these assets are subject to fair value adjustments in certain circumstances, such as when there is evidence of an impairment or when an asset or disposal group is classified as held for sale.", "highlight": "certain non-financial assets and liabilities are measured at fair value on a nonrecurring basis, including property, plant, and equipment, goodwill and intangible assets", "type": {"0": 1, "1": 0, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para180", "text": "in accounting for business acquisitions, we allocate the fair value of purchase consideration to the assets acquired and liabilities assumed based on their estimated fair values. estimating the fair value of assets acquired and liabilities assumed requires judgment, especially with respect to identified intangible assets as there may be limited or no observable transactions within the market, requiring us to develop internal models to estimate fair value. for example, estimating the fair value of identified intangible assets may require us to develop valuation assumptions, including but not limited to, future expected cash flows from identified intangible assets, synergies and the cost of capital. certain inputs require us to determine assumptions that are reflective of a market participant view of fair value. changes in any of these assumptions may materially impact the amount we recognize for identifiable assets and liabilities, in addition to the residual amount allocated to goodwill.", "highlight": "we allocate the fair value of purchase consideration to the assets acquired and liabilities assumed based on their estimated fair values ||| changes in any of these assumptions may materially impact the amount we recognize for identifiable assets and liabilities, in addition to the residual amount allocated to goodwill.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para181", "text": "United parcel service, inc. and subsidiaries Management's discussion and analysis of financial condition and Results of operations Income taxes we make certain estimates and judgments in determining income tax expense for financial statement purposes. these estimates and judgments occur in the calculation of income by legal entity and jurisdiction, tax credits, benefits and deductions, and in the calculation of deferred tax assets and liabilities, which arise from differences in the timing of recognition of revenue and expense for tax and financial statement purposes, as well as tax, interest and penalties related to uncertain tax positions. significant changes to these estimates may result in an increase or decrease to our tax provision in a subsequent period.", "highlight": "Income taxes we make certain estimates and judgments in determining income tax expense for financial statement purposes ||| significant changes to these estimates may result in an increase or decrease to our tax provision in a subsequent period.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 1, "4": 0, "5": 0, "6": 0, "7": 0, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para182", "text": "we assess the likelihood that we will be able to recover our deferred tax assets. if recovery is not likely, we must increase our provision for taxes by recording a valuation allowance against the deferred tax assets that we estimate will not ultimately be recoverable. we believe that we will ultimately recover a substantial majority of the deferred tax assets recorded on our consolidated balance sheets. however, should there be a change in our ability to recover our deferred tax assets, our tax provision would increase in the period in which we determined that the recovery was not likely.", "highlight": "we assess the likelihood that we will be able to recover our deferred tax assets", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 1, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
{"id": "20220222_10-K_1090727_part2_item7_para183", "text": "the calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax regulations. we recognize liabilities for uncertain tax positions based on a two-step process. the first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. once it is determined that the position meets the recognition threshold, the second step requires us to estimate and measure the largest amount of tax benefit that is more likely than not to be realized upon ultimate settlement. the difference between the amount of recognizable tax benefit and the total amount of tax benefit from positions filed or to be filed with the tax authorities is recorded as a liability for uncertain tax benefits. it is inherently difficult and subjective to estimate such amounts, as we have to determine the probability of various possible outcomes. we reevaluate uncertain tax positions on a quarterly basis. this evaluation is based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit and new audit activity. such a change in recognition or measurement could result in the recognition of a tax benefit or an additional charge to the tax provision.", "highlight": "we recognize liabilities for uncertain tax positions based on a two-step process ||| we reevaluate uncertain tax positions on a quarterly basis. this evaluation is based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit and new audit activity. such a change in recognition or measurement could result in the recognition of a tax benefit or an additional charge to the tax provision.", "type": {"0": 0, "1": 1, "2": 0, "3": 0, "4": 0}, "topic": {"1": 0, "2": 0, "3": 0, "4": 0, "5": 0, "6": 0, "7": 3, "0": 0}}
